産科合併症　改訂2版

出版社： メディカ出版
著者：
発行日： 2013-04-05
分野： 臨床医学：外科  >  産婦人科学
ISBN： 9784840436663
電子書籍版： 2013-07-01 （電子書籍版）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

26,400 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

26,400 円(税込)

購入する

商品紹介

妊娠期、分娩期、胎児に関してそれぞれの異常や疾患について、定義、原因、症状、診断、治療など、必要な項目を網羅している。国内外の文献を検討した世界標準的な内容で、臨床におけるdecision makingで実際に役立つ。

目次

  • 産科合併症　改訂2版

    ―目次―

    【第 1 章 妊娠悪阻】
    【第 2 章 胎盤・臍帯の異常】
    【第 3 章 流産・不育症】
    【第 4 章 早産・PROM】
    【第 5 章 多胎妊娠】
    【第 6 章 高血圧】
    【第 7 章 血液型不適合妊娠】
    【第 8 章 羊水過多・羊水過少】
    【第 9 章 子宮内胎児死亡】
    【第 10 章 妊娠第3三半期における性器出血】
    【第 11 章 過期妊娠】
    【第 12 章 胎児well-being の評価】
    【第 13 章 分娩時胎児評価】
    【第 14 章 分娩進行異常】
    【第 15 章 胎児位置異常】
    【第 16 章 分娩時における特殊手技】
    【第 17 章 帝王切開術】
    【第 18 章 分娩・産褥期出血】
    【第 19 章 産科麻酔】
    【第 20 章 母体救急疾患と集中管理】
    【第 21 章 出生前胎児診断法】
    【第 22 章 胎児発育異常】
    【第 23 章 胎児形態異常】
    【第 24 章 胎児水腫】
    【第 25 章 胎内治療】
    【第 26 章 感染症】
    【第 27 章 妊産婦の栄養】
    【第 28 章 母乳育児】
    【第 29 章 加齢と妊娠】

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 妊娠悪阻

P.9 掲載の参考文献
1) Jewell, D., Young, G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2010, (9), CD000145.
PubMed
2) Bailit, JL. Hyperemesis gravidarium : Epidemiologic findings from a large cohort. Am J Obstet Gynecol. 2005, 193(3 Pt 1), 811-4.
 
3) Fell, DB., Dodds. L., Joseph, KS., Allen, VM., Butler, B. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol. 107(2 Pt 1), 2006, 277-84.
 
4) Lacasse, A., Berard, A. Validation of the nausea and vomiting of pregnancy specific health related quality of life questionnaire. Health Qual Life Outcomes. 6, 2008, 32.
PubMed
5) Goodwin, TM., Montoro, M., Mestman, JH. Transient hyperthyroidism and hyperemesis gravidarum : clinical aspects. Am J Obstet Gynecol. 167(3), 1992, 648-52.
PubMed
6) Gadsby, R., Barnie-Adshead, AM., Jagger, C. Pregnancy nausea related to women's obstetric and personal histories. Gynecol Obstet Invest. 43(2), 1997, 108-11.
PubMed
7) Lacasse, A., Rey, E., Ferreira, E., Morin, C., Berard, A. Epidemiology of nausea and vomiting of pregnancy : prevalence, severity, determinants, and the importance of race/ethnicity. BMC Pregnancy Childbirth. 9, 2009, 26.
PubMed
8) Buckwalter, JG., Simpson, SW. Psychological factors in the etiology and treatment of severe nausea and vomiting in pregnancy. Am J Obstet Gynecol. 186(5 Suppl Understanding), 2002, S210-4.
 
9) Kimura, M. et al. Gestational thyrotoxicosis and hyperemesis gravidarum : Possible role of hCG with higher stimulating activity. Clin Endocrinol. 38, 1993, 345-50.
PubMed
10) Goodwin, TM. et al. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab. 75, 1992, 1333-7.
PubMed
11) Wilson, R. et al. Thyroid function tests are rarely abnormal in patients with severe hyperemesis gravidarum. Clin Endocrinol. 37, 1992, 331-4.
PubMed
12) Depue, RH., Bernstein, L., Ross, RK., Judd, HL., Henderson, BE. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors : a seroepidemiologic study. Am J Obstet Gynecol. 156(5), 1987, 1137-41.
PubMed
13) Bernstein, L., Pike, MC., Lobo, RA., Depue, RH., Ross, RK., Henderson, BE. Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels. Br J Obstet Gynaecol. 96(1), 1989, 92-6.
PubMed
14) Frigo, P. et al. Hyperemesis gravidarum associated with Helicobacter pylori serosensitivity. Obstet Gynecol. 91, 1998, 615-7.
 
15) Hayakawa, S. et al. Frequent presence of Helicobacter pylori genome in the saliva of patients with hyperemesis gravidarum. Am J Perinatol. 17, 2000, 243-7.
PubMed
16) Sandven, I., Abdelnoor, M., Nesheim, BI., Melby, KK. Helicobacter pylori infection and hyperemesis gravidarum : a systematic review and meta-analysis of case-control studies. Acta Obstet Gynecol Scand. 88(11), 2009, 1190-200.
PubMed
17) El Younis, CM. et al. Rapid marked response of severe hyperemesis gravidarum to oral erythromycin. Am J Perinatol. 15, 1998, 533-4.
PubMed
18) Jacoby, EB. et al. Helicobacter pylori infection and persistent hyperemesis gravidarum. Am J Perinatol. 16, 1999, 85-8.
PubMed
19) Spruill, SC., Kuller, JA. Hyperemesis gravidarum complicated by Wernicke's encephalopathy. Obstet Gynecol. 99(5 Pt 2), 2002, 875-7.
 
20) Chiossi, G., Neri, I, Cavazzuti, M., Basso, G., Facchinetti, F. Hyperemesis gravidarum complicated by Wernicke encephalopathy : background, case report, and review of the literature. Obstet Gynecol Surv. 61(4), 2006, 255-68. Review.
PubMed
21) Fejzo, MS., Poursharif, B., Korst, LM., Munch, S., MacGibbon, KW., Romero, R., Goodwin, TM. Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum. J Womens Health (Larchmt). 18(12), 2009, 1981-7.
PubMed
22) Gross, S. et al. Maternal weight loss associated with hyperemesis gravidarum : A predictor of fetal outcome. Am J Obstet Gynecol. 160, 1989, 906-9.
PubMed
23) Paauw, JD., Bierling, S., Cook, CR., Davis, AT. Hyperemesis gravidarum and fetal outcome. JPEN J Parenter Enteral Nutr. 29(2), 2005, 93-6.
PubMed
24) Dodds, L., Fell, DB., Joseph, KS., Allen, VM., Butler, B. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol. 107(2 Pt 1), 2006, 285-92.
 
25) Hallak, M., Tsalamandris, K., Dombrowski, MP., Isada, NB., Pryde, PG., Evans, MI. Hyperemesis gravidarum. Effects on fetal outcome. J Reprod Med. 41(11), 1996, 871-4.
PubMed
26) Tan, PC., Jacob, R., Quek, KF., Omar, SZ. Pregnancy outcome in hyperemesis gravidarum and the effect of laboratory clinical indicators of hyperemesis severity. J Obstet Gynaecol Res. 33(4), 2007, 457-64.
PubMed
27) Zhang, J., Cai, WW. Severe vomiting during pregnancy : antenatal correlates and fetal outcomes. 2(6), 1991, 454-7.
 
28) Weigel, MM., Weigel, RM. Nausea and vomiting of early pregnancy and pregnancy outcome. An epidemiological study. Br J Obstet Gynaecol. 96(11), 1989, 1304-11.
PubMed
29) Lao, TT. et al. The outcome of hyperemetic pregnancies complicated by transient hyperthyroidism. Aust NZ J Obstet Gynecol. 27, 1987, 99-101.
 
30) Morari, GA. et al. Abnormal liver enzymes and ketouria in hyperemesis gravidarum : A retrospective review of 80 patients. J Clin Gastroenterol. 12, 1990, 303-9.
 
31) Ekblad, U. et al. Carcinoma of the stomach associated with pregnancy : Two case reports. Eur J Obstet Gynecol Reprod Biol. 37, 1990, 191-4.
PubMed
32) Neutel, CI., Johansen, HL. Measuring drug effectiveness by default : the case of Bendectin. Can J Public Health. 86(1), 1995, 66-70.
PubMed
33) Czeizel, AE., Dudas, I., Fritz, G., Tecsoi, A., Hanck, A., Kunovits, G. The effect of periconceptional multivitaminmineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Arch Gynecol Obstet. 251(4), 1992, 181-5.
PubMed
34) Emelianova, S., Mazzotta, P., Einarson, A., Koren, G. Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clin Invest Med. 22(3), 1999, 106-10.
PubMed
35) Borrelli, F., Capasso, R., Aviello, G., Pittler, MH., Izzo, AA. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol. 105(4), 2005, 849-56.
PubMed
36) Matthews, A., Dowswell, T., Haas, DM., Doyle, M., O'Mathuna, DP. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 8(9), 2010, CD007575. Review.
 
37) ACOG practice bulletin. No.52, 2004, 868-80.
 
38) Vutyavanich, T., Wongtra-ngan, S., Ruangsri, R. Pyridoxine for nausea and vomiting of pregnancy : a randomized, doubleblind, placebo-controlled trial. Am J Obstet Gynecol. 173(3 Pt 1), 1995, 881-4.
 
39) Safari, HR., Fassett, MJ., Souter, IC., Alsulyman, OM., Goodwin, TM. The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum : a randomized, double-blind, controlled study. Am J Obstet Gynecol. 179(4), 1998, 921-4.
PubMed
40) Yost, NP., McIntire, DD., Wians, FH Jr., Ramin, SM., Balko, JA., Leveno, KJ. A randomized, placebo-controlled trial of corticosteroids for hyperemesis due to pregnancy. Obstet Gynecol. 102(6), 2003, 1250-4.
PubMed
41) Bondok, RS., El Sharnouby, NM., Eid, HE., Abd Elmaksoud, AM. Pulsed steroid therapy is an effective treatment for intractable hyperemesis gravidarum. Crit Care Med. 34(11), 2006, 2781-3.
PubMed
42) Nelson-Piercy, C., Fayers, P., de Swiet, M. Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. BJOG. 108(1), 2001, 9-15.
PubMed
43) Moran, P., Taylor, R. Management of hyperemesis gravidarum : the importance of weight loss as a criterion for steroid therapy. QJM. 95(3), 2002, 153-8.
PubMed
44) Levine, MG. et al. Total parenteral nutrition for the treatment of severe hyperemesis gravidarum : Maternal nutritional effects and fetal outcome. Obstet Gynecol. 72, 1988, 102-7.
PubMed
45) Greenspoon, JS. et al. Use of the peripherally inserted central catheter for parenteral nutrition during pregnancy. Obstet Gynecol. 81, 1993, 831-4.
PubMed
46) Hsu, JJ. et al. Nasogastric enteral feeding in the management of hyperemesis gravidarum. Obstet Gynecol. 88, 1996, 343-6.
PubMed
47) Godsey, RK., Newman, RB. Hyperemesis gravidarum. A comparison of single and multiple admissions. J Reprod Med. 36(4), 1991, 287-90.
PubMed

第2章 胎盤・臍帯の異常

P.23 掲載の参考文献
1) Benirschke, K. et al. Pathology of the human placenta. 4 ed. New York, Springer-Verlag, 2000, 947p.
 
2) Takechi, K. et al. Ultrastructural and immunohistochemical studies of Wharton's jelly umbilical cord cells. Placenta. 14(2), 1993, 235-45.
PubMed
3) Weissman, A. et al. Sonographic measurements of the umbilical cord and vessels during normal pregnancies. J Ultrasound Med. 13(1), 1994, 11-4.
PubMed
4) Ross, JA. et al. Umbilical cord cysts in early pregnancy. Obstet Gynecol. 89(3), 1997, 442-5.
PubMed
5) Machin, GA. et al. Abnormal umbilical cord coiling is associated with adverse perinatal outcomes. Pediatr Dev Pathol. 3(5), 2000, 462-71.
PubMed
6) Strong, TH Jr. et al. Non-coiled umbilical blood vessels : a new marker for the fetus at risk. Obstet Gynecol. 81(3), 1993, 409-11.
PubMed
7) Hoddick, WK. et al. Placental thickness. J Ultrasound Med. 4(9), 1985, 479-82.
PubMed
8) Suzuki, S. Clinical significance of pregnancies with circumvallate placenta. J Obstet Gynaecol Res. 34, 2008, 51-4
 
9) Pearlstone, M. et al. Subchorionic hematoma : a review. Obstet Gynecol Surv. 48(2), 1993, 65-8.
PubMed
10) Richards, DS. et al. Prenatal ultrasound diagnosis of massive subchorionic thrombohematoma. Ultrasound Obstet Gynecol. 11(5), 1998, 364-6.
PubMed
11) Jauniaux, E. et al. Ultrasonographic assessment of placental abnormalities. Am J Obstet Gynecol. 163(5 Pt 1), 1990, 1650-8.
 
12) Fox, H. Pathology of the placenta. London, WB Saunders, 1978, 491p.
 
13) Hadi, HA. et al. Placental chorioangioma : prenatal diagnosis and clinical significance. Am J Perinatol. 10(2), 1993, 146-9.
PubMed
14) Wallenburg, HC. Chorioangioma of the placenta : Thirteen new cases and a review of the literature from 1939 to 1970 with special reference to the clinical complications. Obstet Gynecol Surv. 26(6), 1971, 411-25.
 
15) Reinhart, RD. et al. Focal aneurysmal dilatation of subchorionic vessels simulating chorioangioma. Ultrasound Obstet Gynecol. 13(2), 1999, 147-9.
PubMed
16) Bromley, B. et al. Solid masses on the fetal surface of the placenta : differential diagnosis and clinical outcome. J Ultrasound Med. 13(11), 1994, 883-6.
PubMed
17) Sepulveda, W. et al. Endoscopic laser coagulation of feeding vessels in large placental chorioangiomas : Report of three cases and review of invasive treatment options. Prenat Diagn. 29, 2009, 201-6
 
18) Grannum, PA. et al. The ultrasonic changes in the maturing placenta and their relation to fetal pulmonic maturity. Am J Obstet Gynecol. 133(8), 1979, 915-22.
PubMed
19) Ananth, CV. et al. Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol. 144(9), 1996, 881-9.
PubMed
20) Miller, DA. et al. Clinical risk factors for placenta previaplacenta accreta. Am J Obstet Gynecol. 177(1), 1997, 210-4.
PubMed
21) Chattopadhyay, SK. et al. Placenta praevia and accreta after previous caesarean section. Eur J Obstet Gynecol Reprod Biol. 52(3), 1993, 151-6.
PubMed
22) Cox, SM. et al. Placenta percreta : ultrasound diagnosis and conservative surgical management. Obstet Gynecol. 71(3 Pt 2), 1988, 454-6.
 
23) Levine, D. et al. Placenta accreta : evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology. 205(3), 1997, 773-6.
 
24) Hoffman-Tretin, JC. et al. Placenta accreta : Additional sonographic observations. J Ultrasound Med. 11(1), 1992, 29-34.
PubMed
25) Jauniaux, E. et al. Sonographic diagnosis of a non-previa placenta accreta. Ultrasound Obstet Gynecol. 7(1), 1996, 58-60.
PubMed
26) Guy, GP. et al. Ultrasonographic evaluation of uteroplacental blood flow patterns of abnormally located and adherent placentas. Am J Obstet Gynecol. 163(3), 1990, 723-7.
PubMed
27) Chou, MM. et al. Prenatal diagnosis of placenta previa accreta with power amplitude ultrasonic angiography. Am J Obstet Gynecol. 177(6), 1997, 1523-5.
PubMed
28) Comstock, CH. et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 190(4), 2004, 1135-40.
PubMed
29) 土井宏太郎ほか. 前置胎盤症例における癒着胎盤の画像評価. 日本産婦人科・新生児血液学会誌. 16(2), 2007, 40-4.
Medical*Online
30) Bakri, YN. et al. Placenta previa-percreta : magnetic resonance imaging findings and methotrexate therapy after hysterectomy. Am J Obstet Gynecol. 169(1), 1993, 213-4.
PubMed
31) Silver, LE. et al. Placenta previa percreta with bladder involvement : new considerations and review of the literature. Ultrasound Obstet Gynecol. 9(2), 1997, 131-8.
PubMed
32) Schorge, JO. et al. Recent advances in gestational trophoblastic disease. J Reprod Med. 45(9), 2000, 692-700.
PubMed
33) Semer, DA. et al. Gestational trophoblastic disease : epidemiology. Semin Oncol. 22(2), 1995, 109-12.
PubMed
34) Saji, F. et al. A new approach using DNA fingerprinting for the determination of androgenesis as a cause of hydatidiform mole. Placenta. 10(4), 1989, 399-405.
PubMed
35) Rustin, GJ. et al. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. Br Med J (Clin Res Ed). 288(6411), 1984, 103-6.
PubMed
36) Bower, M. et al. EMA/CO for high-risk gestational trophoblastic tumors : results from a cohort of 272 patients. J Clin Oncol. 15(7), 1997, 2636-43.
PubMed
37) Lurain, JR. et al. Prognostic factors in gestational trophoblastic tumors : a proposed new scoring system based on multivariate analysis. Am J Obstet Gynecol. 164(2), 1991, 611-6.
PubMed
38) Berkowitz, RS. et al. Subsequent pregnancy outcome in patients with molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 32(9), 1987, 680-4.
PubMed
39) Buyse, M. Birth Defects Encyclopedia. Cambridge, England, Blackwell Scientific, 1990.
 
40) Torpin, R. Amniochorionic mesoblastic fibrosis strings and amniotic bands. Am J Obstet Gynecol. 91, 1965, 65.
 
41) Quintero, RA. et al. In utero lysis of amniotic bands. Ultrasound Obstet Gynecol. 10(5), 1997, 316-20.
PubMed
42) Jassani, MN. et al. Prenatal diagnosis of single umbilical artery by ultrasound. J Clin Ultrasound. 8(5), 1980, 447-8.
 
43) Persutte, WH. et al. Single umbilical artery : a clinical enigma in modern prenatal diagnosis. Ultrasound Obstet Gynecol. 6(3), 1995, 216-29.
PubMed
44) Leung, AK. et al. Single umbilical artery : A report of 159 cases. Am J Dis Child. 143(1), 1989, 108-11.
PubMed
45) Cohen, HL. et al. The multivessel umbilical cord : an antenatal indicator of possible conjoined twinning. J Clin Ultrasound. 20(4), 1992, 278-82.
PubMed
46) Giacoia, GP. Body stalk anomaly : congenital absence of the umbilical cord. Obstet Gynecol. 80(3 Pt 2), 1992, 527-9.
 
47) Mann, L. et al. Prenatal assessment of anterior abdominal wall defects and their prognosis. Prenat Diagn. 4(6), 1984, 427-35.
PubMed
48) Seashore, JH. Congenital abdominal wall defects. Clin Perinatol. 5(1), 1978, 61-77.
PubMed
49) Finberg, H. "Umbilical cord and amniotic membranes". Diagnostic ultrasound : A logical approach. McGahan, J. et al. eds. Philadelphia, Lippincott-Raven, 1998.
 
50) Rayburn, WF. et al. Umbilical cord length and intrapartum complications. Obstet Gynecol. 57(4), 1981, 450-2.
PubMed
51) Collins, JC. et al. Prenatal observation of umbilical cord abnormalities : a triple knot and torsion of the umbilical cord. Am J Obstet Gynecol. 169(1), 1993, 102-4.
PubMed
52) Jeanty, P. Fetal and funicular vascular anomalies : identification with prenatal US. Radiology. 173(2), 1989, 367-70.
PubMed
53) Entezami, M. et al. Notch in the umbilical artery Doppler profile in umbilical cord compression in a twin. Ultraschall Med. 18(6), 1997, 277-9.
 
54) Miser, WF. Outcome of infants born with nuchal cords. J Fam Pract. 34(4), 1992, 441-5.
 
55) Clapp, JF 3rd. et al. Nuchal cord and neurodevelopmental performance at 1 year. J Soc Gynecol Investig. 6(5), 1999, 268-72.
PubMed
56) Clapp, JF 3rd. et al. The natural history of antenatal nuchal cords. Am J Obstet Gynecol. 189(2), 2003, 488-93.
PubMed
57) Hashimoto, K. et al. The effect of nuchal cord on amniotic fluid and cord blood erythropoietin at delivery. J Soc Gynecol Investig. 10(7), 2003, 406-11.
PubMed
58) Heinonen, S. et al. Perinatal diagnostic evaluation of velamentous umbilical cord insertion. Obstet Gynecol. 87(1), 1996, 112-7.
PubMed
59) Hasegawa, J., Matsuoka, R., Ichizuka, K., Kotani, M., Nakamura, M., Mikoshiba T, Sekizawa, A., Okai, T. Atypical variable deceleration in the first stage of labor is a characteristic fetal heart-rate pattern for velamentous cord insertion and hypercoiled cord. J Obstet Gynaecol Res. 35, 2009, 35-9.
 
60) Di Salvo, DN. et al. Sonographic evaluation of the placental cord insertion site. Am J Roentgenol. 170(5), 1998, 1295-8.
 
61) 宇津正二. 臍帯過捻転と周産期管理. 産科と婦人科. 62, 1995, 703-14.
Medical*Online
62) Ramirez, P. et al. Significance of prenatal diagnosis of umbilical cord cyst in a fetus with trisomy 18. Am J Obstet Gynecol. 173(3 Pt 1), 1995, 955-7.
 
63) Jauniaux, E. et al. Umbilical cord pseudocyst in trisomy 18. Prenat Diagn. 8(8), 1988, 557-63.
PubMed
64) Sepulveda, W. et al. Discordant umbilical artery flow velocity waveforms in spontaneous umbilical cord hematoma. J Clin Ultrasound. 23(5), 1995, 330-2.
PubMed
65) Petrikovsky, BM. et al. Prenatal diagnosis of non-iatrogenic hematoma of the umbilical cord. J Clin Ultrasound. 24(1), 1996, 37-9.
PubMed
66) Benirschke, K. Obstetrically important lesions of the umbilical cord. J Reprod Med. 39(4), 1994, 262-72.
PubMed
67) Ballas, S. et al. Fetal heart rate variation with umbilical haematoma. Postgrad Med J. 61(718), 1985, 753-5.
PubMed
68) Shimizu, S., Kawagishi, R., Arimoto-Ishida, E., Wada, K., Shimoya, K., Murata, Y. Fetal hemorrhage associated with congenital intestinal atresia. J Obstet Gynaecol Res. 29, 2003, 312-6.
PubMed
69) Ohyama, M., Itani, Y., Ishikawa, H., Tanaka, Y. Is umbilical cord ulcer associated with congenital upper intestinal atresia so rare? : Japanese case series and review of the literature. Fetal Diagn Ther. 28, 2010, 236-7.
PubMed

第3章 流産・不育症

P.44 掲載の参考文献
1) Wilcox, AJ. et al. Incidence of early loss of pregnancy. N Engl J Med. 82, 1988, 854-9.
 
2) Regan, L. et al. Influence of past reproductive performance on risk of spontaneous abortion. BMJ. 340, 1989, 1796-9.
 
3) Kajii, T. et al. Anatomic and chromosomal anomalies in 639 spontaneous abortuses. Hum Genet. 55, 1980, 87-98.
PubMed
4) Bianco, K et al. History of miscarriage and increased incidence of fetal aneuploidy in subsequent pregnancy. Obstet Gynecol. 107, 2006, 1098-102.
PubMed
5) Daya, S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage : A meta-analysis of controlled trials. Br J Obstet Gynaecol. 96(3), 1989, 275-80.
PubMed
6) Mills, JL. et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 319, 1988, 1617-23.
PubMed
7) Tulppala, M. et al. Polycystic ovaries and levels of gonadotropins and androgens in recurrent miscarriage : prospective study in 50 women. Br J Obstet Gynaecol. 2, 1993, 385-90.
 
8) Kuttech, WH. et al. Recurrent pregnancy loss. Adv Obstet Gynecol. 2, 1995, 147.
 
9) Harlap, S. et al. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet. 2, 1980, 173-8.
PubMed
10) Kline, J. et al. Smoking : a risk factor of spontaneous abortion. N Engl J Med. 297, 1977, 793-6.
PubMed
11) Floyd, RL. et al. Alcohol use prior to pregnancy recognition. Am J Prev Med. 17, 1999, 101-7.
PubMed
12) Kline, J. et al. Drinking during pregnancy and spontaneous abortion. Lancet. 8187, 1980, 176-80.
PubMed
13) Cavallo, F. et al. Moderate alcohol consumption and spontaneous abortion. Alcohol Alcohol. 30, 1995, 195-201.
PubMed
14) Armstrong, BG. et al. Cigarette, alcohol, and coffee consumption and spontaneous abortion. Am J Public Health. 82, 1992, 85-7.
PubMed
15) Cnattingius, S. et al. Caffeine intake and the risk of firsttrimester spontaneous abortion. N Engl J Med. 343, 2000, 1839-45.
PubMed
16) Gaillard, DA. et al. Spontaneous abortions during the second trimester of gestation. Arch Pathol Lab Med. 117, 1993, 1022-6.
PubMed
17) Romero, R. et al. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence : prevalence and clinical significance. Am J Obstet Gynecol. 167, 1992, 1086-91.
PubMed
18) McGregor, JA. et al. Premature rupture of membranes and bacterial vaginosis. Am J Obstet Gynecol. 169, 1993, 463-6.
PubMed
19) Lee, SE. et al. The frequency and significance of intraamniotic inflammation in patients with cervical insufficiency. Am J Obstet Gynecol. 198(6), 2008, 633, e1-8. Epub 2008 Mar 14.
 
20) Bennett, MJ. et al. Preterm labour and congenital malformations of the uterus. Ultrasound Med Biol. 5, 1979, 83-5.
PubMed
21) Leible, S. et al. Uterine artery blood flow velocity waveforms in pregnant women with mullerian duct anomaly : a biologic model for uteroplacental insufficiency. Am J Obstet Gynecol. 178, 1998, 1048-53.
PubMed
22) Strassman, EO. Fertility and unification of double uterus. Fertil Steril. 17, 1966, 165-76.
 
23) Heinonen, PK. Reproductive performance of women with uterine anomalies : An evaluation of 182 cases. Acta Obstet Gynecol Scand. 61, 1982, 157-62.
PubMed
24) Blum, M. Prevention of spontaneous abortion by cervical suture of the malformed uterus. Int Surg. 62, 1977, 213-5.
PubMed
25) DeCherney, AH. et al. Resectoscopic management of mullerian fusion defects. Fertil Steril. 45, 1986, 726-8.
PubMed
26) Valle, RF. Hysteroscopic treatment of partial and complete uterine septum. Int J Fertil Menopausal Stud. 41, 1996, 310-5.
PubMed
27) Buttram, VC. et al. Uterine leiomyomata : etiology, symptomatology, and management. Fertil Steril. 36, 1981, 433-45.
PubMed
28) Schenker, JG. et al. Intrauterine adhesions : an updated appraisal. Fertil Steril. 37, 1982, 593-610.
PubMed
29) Feng, ZC. et al. Diagnostic and therapeutic hysteroscopy for traumatic intrauterine adhesions after induced abortions : clinical analysis of 365 cases. Gyneaecol Endosc. 8, 1999, 95-8.
 
30) Tongsong, T. et al. Transvaginal ultrasound in threatened abortions with empty gestational sacs. Int J Gtneacol Obstet. 46, 1994, 297-301.
 
31) Tong, S. et al. Miscarriage risk for asymptomatic women after a normal first-trimester prenatal visit. Obstet Gynecol. 111(3), 2008, 710-4.
PubMed
32) Varelas, FK. et al. Yolk sac size and embryonic heart rate as prognostic factors of first trimester pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 138(1), 2008, 10-3. Epub 2007 Aug 10.
 
33) Mukri, F. et al. Evidence of early first-trimester growth restriction in pregnancies that subsequently end in miscarriage. BJOG. 115(10), 2008, 1273-8.
PubMed
34) Qureshi, NS. et al. First trimester threatened miscarriage treatment with human chorionic gonadotrophins : a randomised controlled trial. BJOG. 112(11), 2005, 1536-41.
PubMed
35) Dorman, JS. et al. Temporal trends in spontaneous abortions associated with Type 1 diabetes. Diabetes Res Clin Pract. 43, 1999, 41-7.
PubMed
36) Sanson, BJ. et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost. 75, 1996, 387-8.
PubMed
37) Hashimoto, K. et al. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion. Hum Reprod. 14, 1999, 1872-4.
PubMed
38) Blumenfeld, Z. et al. Thrombophilia : associated pregnancy wastages. Fertil Steril. 72, 1999, 765-74.
PubMed
39) Jurkovic, D. et al. Three-dimentional ultrasound for the assessment of uterine anatomy and detection of congenital anomalies : a comparison with hystersalpingography and twodimentional sonography. Ultrasound Obstet Gynecol. 5,　1995, 233-7.
 
40) Jurkovic, D. et al. Ultrasound screening for congenital uterine anomalies. Br J Obstet Gynaecol. 104, 1997, 1320-1.
PubMed
41) Maneschi, F. et al. Hysteroscopically detected asymptomatic mullerian anomalies. Prevalance and reproductive implications. J Reprod Med. 40, 1995, 684-8.
PubMed
42) Sorensen, SS., Trauelsen, AG. Obstetric implications of minor mullerian anomalies in oligomenorrheic women. Am J Obstet Gynecol. 156, 1987, 1112-8.
PubMed
43) Mowbray, JF. et al. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet. 1985, 941-3.
PubMed
44) ACOG Practice Bulletin. Management of recurrent pregnancy loss. Number 24. February 2001. Int J Gynaecol Obstet. 78(2), 2002, 179-90.
PubMed
45) Balasch, J. et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod. 8, 1993, 2234-9.
PubMed
46) Kuttech, WH. Antiphospholipid antibody : associated recurrent pregnancy loss ; treatment with heparin and lowdose aspirin in superior to low-dose aspirin alone. Am J Obstet Gynecol. 174, 1996, 1584-9.
 
47) Laskin, CA. et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med. 337(3), 1997, 148-53.
 
48) Kuttech, WH. et al. Effects of antiphospholipid antibodies in women undergoing in-vitro fertilization : role of heparin and aspirin. Hum Reprod. 12, 1997, 1171-5.
 
49) Geva, E. et al. Prevention of early pregnancy loss in autoantibody seropositive women. Lancet. 351, 1998, 34-5.
PubMed
50) Boomsma, CM., Keay, SD., Macklon, NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev. 2012 Jun 13 ; 6 : CD005996.
 
51) Clifford, K. et al. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod. 12, 1997, 387-9.
PubMed
52) Goosens, V. et al. ESHRE PGD Consorium data collection IX : cycles from January to December 2006 with pregnancy follow-up to October 2007. Hum Reprod. 24, 2009, 1786-810.
 
53) Harper, J. et al. What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee. Hum Reprod. 25(4), 2010, 821-3.
 
54) Sugiura-Ogasawara, M. et al. Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocations. Fertil Steril. 81(2), 2004, 367-73.
PubMed
55) Sugiura-Ogasawara, M. et al. Subsequent pregnancy outcomes in recurrent miscarriage patients with a paternal or maternal carrier of a structural chromosome rearrangement. J Hum Genet. 53(7), 2008, 622-8.
 
56) Franssen, MT. et al. Reproductive outcome after chromosome analysis in couples with two or more miscarriages : index [corrected]-control study. BMJ. 332(7544), 2006, 759-63.
 
57) Jauniaux, E. et al. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 21, 2006, 2216-22.
PubMed

第4章 早産・PROM

P.77 掲載の参考文献
1) Guyer, B. et al. Annual summary of vital statistics-1996. Pediatrics. 100, 1997, 905-18.
PubMed
2) Tucker, JM. et al. Etiologies of preterm birth in an indigent population : Is prevention a logical expectation? Obstet Gynecol. 77, 1991, 343-7.
 
3) Goldenberg, RL., Rouse, DJ. Prevention of premature birth. N Engl J Med. 339, 1998, 313-20.
PubMed
4) Goldenberg, RL. et al. What we have learned about the predictors of preterm birth. Semin Perinatol. 27, 2003, 185-93.
PubMed
5) 母子保健の主なる統計 (2009). 財団法人母子衛生研究会. 2010, 49.
 
6) Fanaroff, A. et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 196, 2007, 147. e1-8.
 
7) Hugh MacDonald, and Committee on Fetus and Newborn. American Academy of Pediatrics : Perinatal Care at the Threshold of Viability. Pediatrics. 110(5), 2002, 1024-7.
 
8) Bastek, JA. Adverse neonatal outcomes : examining the risks between preterm, late preterm, and term infants. Am J Obstet Gynecol. 199(4), 2008, 367. e1-8.
 
9) Petrini, JR. et al. Increased risk of adverse neurological development for late preterm infants. J Pediatr. 154(2), 2009, 159-60.
 
10) ACOG Committee Opinion No.404. Late-Preterm Infants. 2008.
PubMed
11) Moos, MK. Understanding prematurity : Sorting fact from fiction. AWHONN Lifelines. 8, 2004, 32-7.
PubMed
12) Pschirrer, ER., Monga, M. Risk factors for preterm labor. Clin Obstet Gynecol. 43, 2000, 727-34.
PubMed
13) Mercer, BM. et al. The preterm prediction study : effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 181, 1999, 1216-21.
PubMed
14) Goldenberg, RL. et al. The preterm prediction study : risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 175, 1996, 1047-53.
PubMed
15) Zahl, PA., Bjerknes, C. Induction of decidua-placental hemorrhage in mice by the endotoxins of certain gramnegative bacteria. Proc Soc Exp Biol Med. 54, 1943, 329.
 
16) Yost, NP., Cox, SM. Infection and preterm labor. Clin Obstet Gynecol. 43, 2000, 759-67.
PubMed
17) Romero, R. et al. The role of inflammation and infection in preterm birth. Semin Reprod Med. 25(1), 2007, 21-39.
 
18) Lockwood, CJ. Predicting premature delivery : no easy task. N Engl J Med. 346, 2002, 282-4.
PubMed
19) Klein, LL., Gibbs, RS. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol. 190, 2004, 1493-502.
PubMed
20) Jeffcoat, MK. et al. Periodontal infection and preterm birth : results of a prospective study. J Am Dent Assoc. 132, 2001, 875-80.
PubMed
21) Jeffcoat, MK. et al. Current evidence regarding periodontal disease as a risk factor in preterm birth. Ann Periodontol. 6, 2001, 183-8.
PubMed
22) Gomez, R., Romero, R., Ghezzi, F. et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 179, 1998, 194-202.
PubMed
23) Jackson, GM. et al. The accuracy of digital examination and ultrasound in the evaluation of cervical length. Obstet Gynecol. 79, 1992, 214-8.
PubMed
24) American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 5th ed. 2002, 163-72.
 
25) American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 6th ed. 2007, 175-85.
 
26) Williams, M., Iams, JD. Cervical length measurement and cervical cerclage to prevent preterm birth. Clin Obstet Gynecol. 47, 2004, 775-83, discussion 881-2.
 
27) Owen, J., Iams, JD. What we have learned about cervical ultrasound. Semin Perinatol. 27, 2003, 194-203.
PubMed
28) Zilianti, M. et al. Monitoring the effacement of the uterine cervix by transperineal sonography : a new perspective. J Ultrasound Med. 14, 1995, 719-24.
PubMed
29) Iams, JD. et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. N Engl J Med. 334, 1996, 567-72.
 
30) Andrews, WW. et al. Second-trimester cervical ultrasound : associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol. 95, 2000, 222-6.
PubMed
31) Owen, J. et al. Maternal-Fetal Medicine Units Network. Can shortened midtrimester cervical length predict very early spontaneous preterm birth? Am J Obstet Gynecol. 191, 2004, 298-303.
PubMed
32) Rust, OA. et al. Does the presence of a funnel increase the risk of adverse perinatal outcome in a patient with a short cervix? Am J Obstet Gynecol. 192, 2005, 1060-6.
 
33) ACOG Practice Bulletin. No.101. Ultrasonography in pregnancy. Obstet Gynecol. 113, 2009, 451-61.
PubMed
34) ACOG Committee Opinion. No.522. Incidentally detected short cervical length. Obstet Gynecol. 119(4), 2012, 879.
PubMed
35) Lockwood, CJ. et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med. 325, 1991, 669-74.
PubMed
36) Andersen, HF. Use of fetal fibronectin in women at risk for preterm delivery. Clin Obstet Gynecol. 43, 2000, 746-58.
PubMed
37) Bernhardt, J., Dorman, K. Pre-term birth risk assessment tools : Exploring fetal fibronectin and cervical length for validating risk. AWHONN Lifelines. 8, 2004, 38-44.
PubMed
38) Peaceman, AM. et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms : a multicenter trial. Am J Obstet Gynecol. 177, 1997, 13-8.
PubMed
39) Iams, JD. et al. The Preterm Prediction Study : recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 178, 1998, 1035-40.
PubMed
40) ACOG Practice Bulletin No.43. Management of preterm labor. 2003.
 
41) Gyetvai, K. et al. Tocolytics for preterm labor : a systematic review. Obstet Gynecol. 94, 1999, 869-77.
PubMed
42) Crowther, CA. et al. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 4, 2002.
PubMed
43) Rouse, DJ. et al. A randomized controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 359, 2008, 895.
PubMed
44) Doyle, LW. et al. Magnesium sulfate for women at risk of preterm birth for neuroprotection of the fetus. Chocrane Database Syst Rev. 1, 2009, CD004661.
 
45) Rodts-Palenik, S., Morrison, JC. Tocolysis : an update for the practitioner. Obstet Gynecol Surv. 57, 2002, S9-34.
PubMed
46) マグセント(R)注100mL (東亜新薬株式会社) 添付文書.
 
47) King, JF. et al. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev. 1, 2003.
PubMed
48) Cole, S. et al. Tocolysis : current controversies, future directions. Curr Opin Investig Drugs. 5, 2004, 424-9.
PubMed
49) The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG. 108, 2001, 133-42.
 
50) Johnston, TA., Cameron, AD. Atosiban for the primary prevention of preterm labour. BJOG. 108, 2001, 886-7.
PubMed
51) Doret, M. et al. In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor : Comparison and combination with other tocolytic agents. BJOG. 109, 2002, 983-8.
PubMed
52) Guerguerian, AM. et al. Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs. Am J Obstet Gynecol. 179, 1998, 1618-26.
PubMed
53) McWhorter, J. et al. Rofecoxib versus magnesium sulfate to arrest preterm labor : a randomized trial. Obstet Gynecol. 103, 2004, 923-30.
PubMed
54) Oei, SG. et al. Myocardial infarction during nifedipine therapy for preterm labor. N Engl J Med. 340, 1999, 154.
PubMed
55) Ferguson, JE 2nd. et al. Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. Am J Obstet Gynecol. 148, 1984, 166-71.
PubMed
56) Katz, M. et al. Cardiovascular complications associated with terbutaline treatment for preterm labor. Am J Obstet Gynecol. 139, 1981, 605-8.
PubMed
57) Macones, GA. et al. Efficacy of oral beta-agonist maintenance therapy in preterm labor : a meta-analysis. Obstet Gynecol. 85, 1995, 313-7.
PubMed
58) Rust, OA. et al. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol. 175, 1996, 838-42.
PubMed
59) Sanchez-Ramos, L. et al. Efficacy of maintenance therapy after acute tocolysis : a meta-analysis. Am J Obstet Gynecol. 181, 1999, 484-90.
PubMed
60) Borna, S., Sahabi, N. Progesterone for maintenance tocolytic therapy after threatened preterm labour : a randomised controlled trial. Aust N Z J Obstet Gynaecol. 48(1), 2008, 58-63.
PubMed
61) Crowley, P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2, 2000.
PubMed
62) ACOG Committee Opinion. Number 273. Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 99, 2002, 871-3.
 
63) ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43. Management of preterm labor. May 2003. Obstet Gynecol. 101, 2003, 1039-47.
 
64) Baud, O. et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J M. 341, 1999, 1190-6.
 
65) Elimian, A. et al. Antenatal betamethasone compared with dexamethasone (betacode trial) : a randomized controlled trial. Obstet Gynecol. 110(1), 2007, 26-30.
 
66) Ring, AM. et al. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates : a cohort study. Am J Obstet Gynecol. 196(5), 2007, 457.e1-6.
 
67) Kairalla, AB. Hypothalamic-pituitary-adrenal axis function in premature neonates after extensive prenatal treatment with betamethasone : a case history. Am J Perinatol. 9, 1992, 428-30.
PubMed
68) French, NP. et al. Repeated antenatal corticosteroids : size at birth and subsequent development. Am J Obstet Gynecol. 180, 1999, 114-21.
PubMed
69) Guinn, DA. et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery : A randomized controlled trial. JAMA. 286, 2001, 1581-7.
PubMed
70) Antenatal Corticosteroids Revisited : Repeat Courses. NIH Consensus Statement Online. 17, 2000.
 
71) Crowther, CA., Harding, J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev. 3, 2003.
PubMed
72) ACOG Committee Opinion. Number402. March 2008.
 
73) ACOG Practice Bulletin. Number 56. Multiple gestation : complicated twin, triplet, and high-order multifetal pregnancy. Obstet Gynecol. 104, 2004, 869-83.
 
74) King, J., Flenady, V. Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev. 2, 2000.
PubMed
75) Kenyon, SL. et al. Broad-spectrum antibiotics for spontaneous preterm labour : the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet. 357, 2001, 989-94.
 
76) Kenyon, SL. et al. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes : the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet. 357, 2001, 979-88.
 
77) King, J., Flenady, V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 4, 2002.
PubMed
78) Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010.
 
79) ACOG Committee Opinion. Number 485. April 2011. Prevention of early-onset group B streptococcal disease in newborns.
 
80) Goldenberg, RL. et al. Bed rest in pregnancy. Obstet Gynecol. 84, 1994, 131-6.
PubMed
81) Saurel-Cubizolles, MJ. et al. Pregnancy and its outcome among hospital personnel according to occupation and working conditions. J Epidemiol Community Health. 39, 1985, 129-34.
PubMed
82) Teitelman, AM. et al. Effect of maternal work activity on preterm birth and low birth weight. Am J Epidemiol. 131, 1990, 104-13.
PubMed
83) Sosa, C. et al. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev. 1, 2004.
PubMed
84) Hobel, CJ. et al. The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women. Am J Obstet Gynecol. 170, 1994, 54-62.
PubMed
85) Crowther, CA. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev. 1, 2001.
PubMed
86) Tita, AT. et al. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 37, 2010, 339-54.
PubMed
87) Romero, R. et al. Antibiotic treatment of preterm labor with intact membranes : a multicenter, randomized, doubleblinded, placebo-controlled trial. Am J Obstet Gynecol. 169, 1993, 764-74.
PubMed
88) Romero, R. et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 169, 1993, 805-16.
PubMed
89) Yoon, BH. et al. Amniotic fluid interleukin-6 : A sensitive test for antenatal diagnosis of acute inflammatory lesion of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 172, 1995, 960-70.
PubMed
90) Tsatsaris, V. et al. Place of amniocentesis in the assessment of preterm labour. Eur J Obstet Gynecol Reprod Biol. 93, 2000, 19-25.
 
91) Silver, HM. Listeriosis during pregnancy. Obstet Gynecol Surv. 53(12), 1998, 737-40.
PubMed
92) Hopkins, L. et al. Antibiotic regimens for management of intraamniotic infection. Cochrane Database Syst Rev. 3, 2002, CD003254.
PubMed
93) Kanayama, N. et al. Urinary trypsin inhibitor : a new drug to treat preterm labor ; a comparative study with ritodrine. Eur J Obstet Gynecol Reprod Biol. 67, 1996, 133-8.
PubMed
94) Matsuda, Y. et al. Effects of urinary trypsin inhibitor in patients at risk for premature labor with a bulging fetal membrane. Fetal Diagn Ther. 17, 2002, 69-74.
PubMed
95) Amsel, R. et al. Nonspecific vaginitis : Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 74, 1983, 14-22.
PubMed
96) Nugent, RP. et al. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 29, 1991, 297-301.
PubMed
97) Hillier, SL. et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 333, 1995, 1737-42.
 
98) Kurki, T. et al. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol. 80, 1992, 173-7.
PubMed
99) Leitich, H. et al. Bacterial vaginosis as a risk factor for preterm delivery : a meta-analysis. Am J Obstet Gynecol. 189, 2003, 139-47.
PubMed
100) Morales, WJ. et al. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis : a placebo-controlled, double-blind study. Am J Obstet Gynecol. 171, 1994, 345-7, discussion 348-9.
 
101) Hauth, JC. et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med. 333, 1995, 1732-6.
PubMed
102) Carey, JC. et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 342, 2000, 534-40.
PubMed
103) Leitich, H. et al. Antibiotic treatment of bacterial vaginosis in pregnancy : a meta-analysis. Am J Obstet Gynecol. 188, 2003, 752-8.
PubMed
104) McDonald, H. et al. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 1, 2005.
PubMed
105) ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. Number 31. October 2001 (Replaces Technical Bulletin. number 206, June 1995 ; Committee Opinion. number 172, May 1996 ; Committee Opinion. number 187, September 1997 ; Committee Opinion. number 198, February 1998 ; and Committee Opinion. number 251, January 2001). Obstet Gynecol. 98, 2001, 709-16.
PubMed
106) Wally, P. Bacreriuria of pregnancy. Am J Obstet Gynecol. 97, 1967, 723-38.
 
107) Moller, M. et al. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet. 2, 1984, 69-70.
 
108) White, CP. et al. Premature delivery and group B streptococcal bacteriuria. Lancet. 2, 1984, 586.
 
109) Thomsen, AC. et al. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour. Lancet. 1, 1987, 591-3.
 
110) Locksmith, G., Duff, P. Infection, antibiotics, and preterm delivery. Semin Perinatol. 25, 2001, 295-309.
PubMed
111) Romero, R. et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol. 73, 1989, 576-82.
PubMed
112) Smaill, F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2, 2001.
PubMed
113) American Academy of Pediatrics and the American College of Obstetricians and Gynecologists Guidelines for Perinatal Care. 6th ed. 2007, 83-137.
 
114) Gilstrap, LC 3rd., Ramin, SM. Urinary tract infections during pregnancy. Obstet Gynecol Clin North Am. 28, 2001, 581-91.
PubMed
115) Goldenberg, RL. et al. Sexually transmitted diseases and adverse outcomes of pregnancy. Clin Perinatol. 24, 1997, 23-41.
PubMed
116) Cotch, MF. et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 24, 1997, 353-60.
 
117) Klebanoff, MA. et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med. 345, 2001, 487-93.
PubMed
118) Kigozi, GG. et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy : a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol. 189, 2003, 1398-400.
PubMed
119) Goldenberg, RL. et al. Intrauterine infection and preterm delivery. N Engl J Med. 342, 2000, 1500-07.
PubMed
120) Andrews, WW. et al. Infection and preterm birth. Am J Perinatol. 17, 2000, 357-65.
PubMed
121) Goldenberg, RL. et al. The preterm prediction study : fetal fibronectin, bacterial vaginosis, and peripartum infection. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol. 87, 1996, 656-60.
PubMed
122) Andrews, WW. et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol. 101, 2003, 847-55.
PubMed
123) Andrews, WW., Goldenberg, RL. What we have learned from an antibiotic trial in fetal fibronectin positive women. Semin Perinatol. 27, 2003, 231-8.
PubMed
124) Meis, PJ. et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 348, 2003, 2379-85.
PubMed
125) da Fonseca, EB. et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk : a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 188, 2003, 419-24.
 
126) Fonseca, EB. et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 3357(5), 2007, 462-9.
 
127) Rouse, DJ. et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 357(5), 2007, 454-61.
PubMed
128) Romero, R. et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity : a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 206(2), 2012, 124. e1-19.
 
129) 日本産科婦人科学会・日本産婦人科医会編集・監修. 産婦人科診療ガイドライン : 産科編2011.
 
130) Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. MRC/RCOG Working Party on Cervical Cerclage. Br J Obstet Gynaecol. 100, 1993, 516-23.
 
131) ACOG Practice Bulletin. Cervical insufficiency. Obstet Gynecol. 102, 2003, 1091-9.
PubMed
132) To, MS. et al. Cervical cerclage for prevention of preterm delivery in women with short cervix : randomised controlled trial. Lancet. 363, 2004, 1849-53.
PubMed
133) Owen, J. et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol. 201(4), 2009, 375. e1-8.
 
134) Berghella, V. et al. Cerclage for short cervix on ultrasonography. Obstet Gynecol. 106, 2005, 181-9.
PubMed
135) Alfirevic, Z. et al. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review). The Cochrane Library 2012, Issue 4.
 
136) Gunn, GC. et al. Premature rupture of the fetal membranes : A review. Am J Obstet Gynecol. 106, 1970, 469-83.
PubMed
137) Kaltreider, DF., Kohl, S. Epidemiology of preterm delivery. Clin Obstet Gynecol. 23, 198, 17-31.
 
138) Harger, JH. et al. Risk factors for preterm premature rupture of fetal membranes : a multicenter case-control study. Am J Obstet Gynecol. 163, 1990, 130-7.
PubMed
139) Odibo, AO. et al. Does transvaginal ultrasound of the cervix predict preterm premature rupture of membranes in a highrisk population? Ultrasound Obstet Gynecol. 18, 2001, 223-7.
 
140) Hallak, M., Bottoms, SF. Accelerated pulmonary maturation from preterm premature rupture of membranes : a myth. Am J Obstet Gynecol. 169, 1993, 1045-9.
PubMed
141) Nelson, DM. et al. Association of prolonged, preterm premature rupture of the membranes and abruptio placentae. J Reprod Med. 31, 1986, 249-53.
PubMed
142) Vintzileos, AM. et al. Preterm premature rupture of the membranes : a risk factor for the development of abruptio placentae. Am J Obstet Gynecol. 156, 1987, 1235-8.
PubMed
143) Rotschild, A. et al. Neonatal outcome after prolonged preterm rupture of the membranes. Am J Obstet Gynecol. 162, 1990, 46-52.
PubMed
144) Skinner, SJ. et al. Collagen content of human amniotic membranes : effect of gestation length and premature rupture. Obstet Gynecol. 57, 1981, 487-9.
PubMed
145) Parry, S., Strauss, JF 3rd. Premature rupture of the fetal membranes. N Engl J Med. 338, 1998, 663-70.
PubMed
146) Romero, R., Mazor, M. Infection and preterm labor. Clin Obstet Gynecol. 31, 1988, 553-84.
PubMed
147) Smith, RP. A technic for the detection of rupture of the membranes : A review and preliminary report. Obstet Gynecol. 48, 1976, 172-6.
PubMed
148) Reece, EA. et al. Amniotic fluid arborization : effect of blood, meconium, and pH alterations. Obstet Gynecol. 64, 1984, 248-50.
PubMed
149) Harstad, TW. et al. Antepartum prediction of pulmonary hypoplasia : an elusive goal? Am J Perinatol. 10, 1993, 8-11.
PubMed
150) Greig, PC. The diagnosis of intrauterine infection in women with preterm premature rupture of the membranes (PPROM). Clin Obstet Gynecol. 41, 1998, 849-63.
PubMed
151) Broekhuizen, FF. et al. Amniocentesis for gram stain and culture in preterm premature rupture of the membranes. Obstet Gynecol. 66, 1985, 316-21.
PubMed
152) Romero, R. et al. The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol. 159, 1988, 114-9.
PubMed
153) ACOG Practice Bulletin Number 80. April 2007 Premature rupture of membranes.
 
154) Locksmith, GJ. Antibiotic therapy in preterm premature rupture of membranes. Clin Obstet Gynecol. 41, 1998, 864-9.
PubMed
155) Mercer, BM. et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes : A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA. 278, 1997, 989-95.
PubMed
156) Crowley, P. et al. The effects of corticosteroid administration before preterm delivery : an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 97, 1990, 11-25.
PubMed
157) Ohlsson, A. Treatments of preterm premature rupture of the membranes : a meta-analysis. Am J Obstet Gynecol. 160, 1989, 890-906.
PubMed
158) Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA. 273, 1995, 413-8.
PubMed
159) Gardner, MO. et al. Antenatal corticosteroids in pregnancies complicated by preterm premature rupture of membranes. Obstet Gynecol. 90, 1997, 851-3.
PubMed
160) Harding, JE. et al. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? Am J Obstet Gynecol. 184, 2001, 131-9.
PubMed
161) Allen, SR. Tocolytic therapy in preterm PROM. Clin Obstet Gynecol. 41, 1998, 842-8.
PubMed
162) Weiner, CP. et al. The therapeutic efficacy and costeffectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol. 159, 1988, 216-22.
PubMed
163) Combs, CA. et al. Aggressive tocolysis does not prolong pregnancy or reduce neonatal morbidity after preterm premature rupture of the membranes. Am J Obstet Gynecol. 190, 2004, 1723-8, discussion 1728-31.
 
164) Mercer, BM. Preterm premature rupture of the membranes. Obstet Gynecol. 101, 2003, 178-93.
PubMed
165) Reddy, UM. et al. In vitro sealing of punctured fetal membranes : potential treatment for midtrimester premature rupture of membranes. Am J Obstet Gynecol. 185, 2001, 1090-3.
PubMed
166) Lewi, L. et al. Successful patching of iatrogenic rupture of the fetal membranes. Placenta. 25, 2004, 352-6.
PubMed
167) Asrat, T. et al. Rate of recurrence of preterm premature rupture of membranes in consecutive pregnancies. Am J Obstet Gynecol. 165, 1991, 1111-5.
PubMed
168) Duff, P. et al. Management of premature rupture of membranes and unfavorable cervix in term pregnancy. Obstet Gynecol. 63, 1984, 697-702.
PubMed
169) Hannah, ME. et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. Term PROM Study Group. N Engl J Med. 334, 1996, 1005-10.
 
170) Mozurkewich, EL., Wolf, FM. Premature rupture of membranes at term : a meta-analysis of three management schemes. Obstet Gynecol. 89, 1997, 1035-43.
PubMed
171) Hannah, ME. et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term : the role of induction of labor. Term PROM Study Group. Am J Obstet Gynecol. 177, 1997, 780-5.
 
172) Tan, BP., Hannah, ME. Oxytocin for prelabour rupture of membranes at or near term. Cochrane Database Syst Rev. 2, 2000.
 
173) Tan, BP., Hannah, ME. Prostaglandins for prelabour rupture of membranes at or near term. Cochrane Database Syst Rev. 2, 2000.
 
174) Mozurkewich, E. Management of premature rupture of membranes at term : an evidence-based approach. Clin Obstet Gynecol. 42, 1999, 749-56.
PubMed

第5章 多胎妊娠

P.99 掲載の参考文献
1) 今泉洋子. 多胎分娩の増加と家族のすがた. 産科と婦人科. 72, 2005, 1259-64.
Medical*Online
2) 日本人口動態統計. 総理府官房庁統計局, 2004-2008.
 
3) 日本産科婦人科学会会告 (会長・水口弘司). 多胎妊娠に関する見解. 日本産科婦人科学会雑誌. 48(11), 1996, 巻頭.
 
4) 苛原稔. 日本における多胎妊娠の現状と対策. 産科と婦人科. 72, 2005, 1265-71.
Medical*Online
5) 生殖補助医療における多胎妊娠防止に関する見解. 日本産科婦人科学会会告, 2008年.
 
6) Yokoyama, Y. et al. Prevalence of cerebral palsy in twins, triplets and quadruplets. Int J Epidemiol. 24, 1995, 943-8.
PubMed
7) Petterson, B. et al. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ. 307, 1993, 1239-43.
PubMed
8) Grether, JK. et al. Twinning and cerebral palsy : experience in four northern California counties, births 1983 through 1985. Pediatrics. 92, 1993, 854-8.
PubMed
9) McDonald, S. et al. Perinatal outcomes of in vitro fertilization twins : a systematic review and meta-analysis. Am J Obstet Gynecol. 193, 2005, 141-52.
PubMed
10) Ombelet, W. et al. Obstetric and perinatal outcome of 1655 ICSI and 3974 IVF singleton and 1102 ICSI and 2901 IVF twin births : a comparative analysis. Reprod Biomed Online. 11, 2005, 76-85.
PubMed
11) Rao, A. et al. Obstetric complications of twin pregnancies. Best Pract Res Clin Obstet Gynaecol. 18, 2004, 557-76.
PubMed
12) トマス・W・サドラー. ラングマン人体発生学. 安田峯生, 沢野十蔵訳. メディカル・サイエンス・インターナショナル, 1996, 92-110.
 
13) Menon, DK. A retrospective study of the accuracy of sonographic chorionicity determination in twin pregnancies. Twin Res Hum Genet. 8, 2005, 259-61.
PubMed
14) Hill, LM. et al. Sonographic determination of first trimester twin chorionicity and amnionicity. J Clin Ultrasound. 24, 1996, 305-8.
PubMed
15) Cunningham, FG. et al. eds. "Multifetal pregnancy". Williams Obstetrics. 21st. ed. New York, McGraw-Hill, 2001, 765-810.
 
16) Luke, B. The changing pattern of multiple births in the United States : maternal and infant characteristics, 1973 and 1990. Obstet Gynecol. 84(1), 1994, 101-6.
PubMed
17) Meath, AJ. et al. Comparative longitudinal study of cervical length and induced shortening changes among singleton, twin, and triplet pregnancies. Am J Obstet Gynecol. 192, 2005, 1410-5.
PubMed
18) Goldenberg, RL. et al. The preterm prediction study : risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 175, 1996, 1047-53.
PubMed
19) Ramin, KD. et al. Ultrasonographic assessment of cervical length in triplet pregnancies. Am J Obstet Gynecol. 180, 1999, 1442-5.
PubMed
20) Goldenberg, RL. et al. The Preterm Prediction Study : sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 182, 2000, 636-43.
PubMed
21) Singer, E., Pilpel, S., Bsat, F., Plevyak, M., Healy, A., Markenson, G. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor. Obstet Gynecol. 109(5), 2007, 1083-7.
PubMed
22) Fox, NS., Saltzman, DH., Klauser, CK., Peress, D., Gutierrez, CV., Rebarber, A. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length. Am J Obstet Gynecol. 201(3), 2009, 313, e1-5.
 
23) Crowther, CA. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev 2001, CD000110.
PubMed
24) Andrews, WW. et al. Elective hospitalization in the management of twin pregnancies. Obstet Gynecol. 77, 1991, 826-31.
PubMed
25) Adams, DM. et al. Perinatal outcome associated with outpatient management of triplet pregnancy. Am J Obstet Gynecol. 178, 1998, 843-7.
PubMed
26) Dor, J. et al. Elective cervical suture of twin pregnancies diagnosed ultrasonically in the first trimester following induced ovulation. Gynecol Obstet Invest. 13, 1982, 55-60.
PubMed
27) Interim report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomized trial of cervical cerclage. MRC/RCOG Working Party on Cervical Cerclage. Br J Obstet Gynaecol. 95, 1988, 437-45.
 
28) Elimian, A. et al. Perinatal outcome of triplet gestation : does prophylactic cerclage make a difference? J Matern Fetal Med. 8, 1999, 119-22.
PubMed
29) Hartikainen-Sorri, AL. et al. Inefficacy of 17 alphahydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol. 56, 1980, 692-5.
PubMed
30) Ashworth, MF. et al. Failure to prevent preterm labour and delivery in twin pregnancy using prophylactic oral salbutamol. Br J Obstet Gynaecol. 97, 1990, 878-82.
PubMed
31) Garite, TJ. et al. Uterine activity characteristics in multiple gestations. Obstet Gynecol. 76, 1990, 56S-59S.
PubMed
32) Gabriel, R. et al. Prolonged intravenous ritodrine therapy : a comparison between multiple and singleton pregnancies. Eur J Obstet Gynecol Reprod Biol. 57, 1994, 65-71.
PubMed
33) Norman, JE., Mackenzie, F. et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT) : a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet. 373(9680), 2009, 2034-40.
PubMed
34) Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Statement 12, 1994, 1-24.
PubMed
35) Perry, KG Jr. et al. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol. 173, 1995, 1273-7.
PubMed
36) Foglia, LM., Deering, SH., Lim, E., Landy, H. Maternal glucose levels after dexamethasone for fetal lung development in twin vs singleton pregnancies. Am J Obstet Gynecol. 199(4), 2008, 380, e1-4.
 
37) Schinzel, AA. et al. Monozygotic twinning and structural defects. J Pediatr. 95, 1979, 921-30.
PubMed
38) Rauh-Hain, JA. et al. Risk for developing gestational diabetes in women with twin pregnancy. J Matern Fetal Neonatal Med. 22(4), 2009, 293-9.
PubMed
39) Sivan, E. et al. Impact of fetal reduction on the incidence of gestational diabetes. Obstet Gynecol. 99, 2002, 91-4.
PubMed
40) Corrado, F. et al. Gestational glucose intolerance in multiple pregnancy. Diabetes Care. 26, 2003, 1646.
PubMed
41) Sibai, BM. et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 182, 2000, 938-42.
PubMed
42) Mastrobattista, JM. et al. The rate of severe preeclampsia is increased in triplet as compared to twin gestations. Am J Perinatol. 14, 1997, 263-5.
PubMed
43) Lynch, A. et al. Preeclampsia in multiple gestation : the role of assisted reproductive technologies. Obstet Gynecol. 99, 2002, 445-51.
PubMed
44) Luke, B., Keith, LG. The contribution of singletons, twins and triplets to low birth weight, infant mortality and handicap in the United States. J Reprod Med. 37, 1992, 661-6.
PubMed
45) Feldman, DM. et al. Clinical implications of velamentous cord insertion in triplet gestations. Am J Obstet Gynecol. 186, 2002, 809-11.
PubMed
46) Bagchi, S., Salihu, HM. Birth weight discordance in multiple gestations : occurrence and outcomes. J Obstet Gynaecol. 26(4), 2006, 291-6.
PubMed
47) Talbot, GT. et al. Is size discordancy an indication for delivery of preterm twins? Am J Obstet Gynecol. 177, 1997, 1050-4.
PubMed
48) Hsieh, TT. et al. Growth discordancy, birth weight, and neonatal adverse events in third trimester twin gestations. Gynecol Obstet Invest. 38, 1994, 36-40.
PubMed
49) Klam, SL., Rinfret, D., Leduc, L. Prediction of growth discordance in twins with the use of abdominal circumference ratios. Am J Obstet Gynecol. 192(1), 2005, 247-51.
PubMed
50) Nassar, AH. et al. Neonatal outcome of growth discordant twin gestations. J Perinat Med. 31, 2003, 330-6.
PubMed
51) Redman, ME. et al. The ninety-fifth percentile for growth discordance predicts complications of twin pregnancy. Am J Obstet Gynecol. 187, 2002, 667-71.
PubMed
52) Cohen, SB. et al. Outcome of twin pregnancies with extreme weight discordancy. Am J Perinatol. 18, 2001, 427-32.
PubMed
53) Appleton, C., Pinto, L. et al. Near term twin pregnancy : clinical relevance of weight discordance at birth. J Perinat Med. 35(1), 2007, 62-6.
 
54) Sairam, S. et al. Prospective risk of stillbirth in multiplegestation pregnancies : a population-based analysis. Obstet Gynecol. 100, 2002, 638-41.
PubMed
55) Saacks, CB. et al. Cohort study of twinning in an academic health center : changes in management and outcome over forty years. Am J Obstet Gynecol. 173, 1995, 432-7, discussion 437-9.
 
56) Devoe, LD., Ware, DJ. Antenatal assessment of twin gestation. Semin Perinatol. 19, 1995, 413-23.
 
57) Porter, TF. et al. Normal values for amniotic fluid index during uncomplicated twin pregnancy. Obstet Gynecol. 87, 1996, 699-702.
PubMed
58) Giles, W. et al. The Doppler assessment in multiple pregnancy randomised controlled trial of ultrasound biometry versus umbilical artery Doppler ultrasound and biometry in twin pregnancy. BJOG. 110, 2003, 593-7.
PubMed
59) Lewi, L., Lewi, P., Diemert, A. et al. The role of ultrasound examination in the first trimester and at 16 weeks' gestation to predict fetal complications in monochorionic diamniotic twin pregnancies.Am J Obstet Gynecol. 199(5), 2008, 493, e1-7. Epub 2008 Jun 9.
 
60) Rausen, AR. et al. Twin transfusion syndrome : A review of 19 cases studied at one institution. J Pediatr. 66, 1965, 613-28.
 
61) Quintero, RA. et al. Staging of twin-twin transfusion syndrome. J Perinatol. 19(8 Pt 1), 1999, 550-5.
 
62) Urig, MA. et al. Twin-twin transfusion syndrome. Am J Obstet Gynecol. 163, 1990, 1522-6.
PubMed
63) Chescheir, NC., Seeds, JW. Polyhydramnios and oligohydramnios in twin gestations. Obstet Gynecol. 71, 1988, 882-4.
PubMed
64) Talbert, DG., et al. Hydrostatic and osmotic pressure gradients produce manifestations of fetofetal transfusion syndrome in a computerized model of monochorial twin pregnancy. Am J Obstet Gynecol. 174, 1996, 598-608.
 
65) Mari, G. et al. Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome : results of the International Amnioreduction Registry. Am J Obstet Gynecol. 185, 2001, 708-15.
PubMed
66) Saunders, NJ. et al. Therapeutic amniocentesis in twin-twin transfusion syndrome appearing in the second trimester of pregnancy. Am J Obstet Gynecol. 166, 1992, 820-4.
PubMed
67) Fichera, A., Lanna, M., Fratelli, N., Rustico, M., Frusca, T. Twin-to-twin transfusion syndrome presenting at early stages : is there still a possible role for amnioreduction? Prenat Diagn. 30(2), 2010, 144-8.
 
68) Saade, GR. et al. Amniotic septostomy for the treatment of twin oligohydramnios-polyhydramnios sequence. Fetal Diagn Ther. 13, 1998, 86-93.
PubMed
69) Johnson, JR. et al. Amnioreduction versus septostomy in twin-twin transfusion syndrome. Am J Obstet Gynecol. 185, 2001, 1044-7.
PubMed
70) Moise, KJ Jr. et al. A randomized trial of amnioreduction versus septostomy in the treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol. 193, 2005, 701-7.
PubMed
71) Rujiwetpongstorn, J., Tongsong, T. Amniotic band syndrome following septostomy in management of twin-twin transfusion syndrome : a case report. J Perinatol. 28(5), 2008, 377-9.
PubMed
72) Chmait, RH., Aghajanian, P., Kontopoulos, EV., Quintero, RA. Prenatal diagnosis of spontaneous septostomy of the dividing membranes in complicated monochorionic diamniotic multiple gestations. J Ultrasound Med. 28(5), 2009, 663-8.
PubMed
73) Machin, GA. Placental vascular anatomy and twin transfusion syndrome. Am J Obstet Gynecol. 174, 1996, 799-800.
PubMed
74) De Lia, JE. et al. Fetoscopic neodymium : YAG laser occlusion of placental vessels in severe twin-twin transfusion syndrome. Obstet Gynecol. 75, 1990, 1046-53.
PubMed
75) Bajoria, R. et al. Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome. Am J Obstet Gynecol. 172, 1995, 856-63.
 
76) Lopriore, E., Deprest, J., Slaghekke, F., Oepkes, D., Middeldorp, JM., Vandenbussche, FP., Lewi, L. Placental characteristics in monochorionic twins with and without twin anemia-polycythemia sequence. Obstet Gynecol. 112(4), 2008, 753-8.
PubMed
77) Senat, MV. et al. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med. 351(2), 2004, 136-44. Epub 2004 Jul 6.
 
78) Rossi, AC., D'Addario, V. Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome : a metaanalysis and review of literature. Am J Obstet Gynecol. 198(2), 2008, 147-52. Review.
PubMed
79) Graef, C. et al. Long-term neurodevelopmental outcome of 167 children after intrauterine laser treatment for severe twin-twin transfusion syndrome. Am J Obstet Gynecol. 194(2), 2006, 303-8.
PubMed
80) Habli, M. et al. Acute effects of selective fetoscopic laser photocoagulation on recipient cardiac function in twin-twin transfusion syndrome. Am J Obstet Gynecol. 199(4), 2008, 412, e1-6. Epub 2008 Aug 22.
 
81) Lopriore, E. et al. Long-term neurodevelopmental outcome in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery. Am J Obstet Gynecol. 196(3), 2007, 231, e1-4.
 
82) Gratacos, E. et al. A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin. Ultrasound Obstet Gynecol. 30(1), 2007, 28-34.
PubMed
83) Habli, M. et al. The outcome of twin-twin transfusion syndrome complicated with placental insufficiency. Am J Obstet Gynecol. 199(4), 2008, 424, e1-6.
 
84) Ong, SS., Zamora, J., Khan, KS., Kilby, MD. Prognosis for the co-twin following single-twin death : a systematic review. BJOG. 113(9), 2006, 992-8. Epub 2006 Aug 10. Review.
 
85) Fusi, L., Gordon, H. Twin pregnancy complicated by single intrauterine death. Problems and outcome with conservative management. Br J Obstet Gynaecol. 97, 1990, 511-6.
PubMed
86) Landy, HJ., Weingold, AB. Management of a multiple gestation complicated by an antepartum fetal demise. Obstet Gynecol Surv. 44, 1989, 171-6.
PubMed
87) Axt, R. et al. Maternal and neonatal outcome of twin pregnancies complicated by single fetal death. J Perinat Med. 27, 1999, 221-7.
PubMed
88) Kilby, MD. et al. Outcome of twin pregnancies complicated by a single intrauterine death : a comparison with viable twin pregnancies. Obstet Gynecol. 84, 1994, 107-9.
PubMed
89) Santema, JG. et al. Expectant management of twin pregnancy with single fetal death. Br J Obstet Gynaecol. 102, 1995, 26-30.
PubMed
90) Bejar, R. et al. Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol. 162, 1990, 1230-6.
PubMed
91) Pharoah, PO., Adi, Y. Consequences of in-utero death in a twin pregnancy. Lancet. 355, 2000, 1597-602.
 
92) van Heteren, CF. et al. Risk for surviving twin after fetal death of co-twin in twin-twin transfusion syndrome. Obstet Gynecol. 92, 1998, 215-9.
PubMed
93) Moore, CM. et al. Intrauterine disseminated intravascular coagulation : a syndrome of multiple pregnancy with a dead twin fetus. J Pediatr. 74, 1969, 523-8.
PubMed
94) Durkin, MV. et al. Analysis of etiologic factors in cerebral palsy with severe mental retardation. I. Analysis of gestational, parturitional and neonatal data. Eur J Pediatr. 123, 1976, 67-81.
PubMed
95) Benirschke, K. Twin placenta in perinatal mortality. NY State J Med. 61, 1961, 1499-508.
 
96) Fusi, L. et al. Acute twin-twin transfusion : a possible mechanism for brain-damaged survivors after intrauterine death of a monochorionic twin. Obstet Gynecol. 78, 1991, 517-20.
PubMed
97) 日本産科婦人科学会・日本産婦人科医会 編集・監修. 産婦人科診療ガイドライン : 産科編2011. 295-7.
 
98) Jelin, AC., Norton, ME., Bartha, AI., Fick, AL., Glenn, OA. Intracranial magnetic resonance imaging findings in the surviving fetus after spontaneous monochorionic cotwin demise. Am J Obstet Gynecol. 199(4), 2008, 398, e1-5.
 
99) Letsky, EA. Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol. 15, 2001, 623-44.
PubMed
100) Petersen, IR., Nyholm, HC. Multiple pregnancies with single intrauterine demise. Description of twenty-eight pregnancies. Acta Obstet Gynecol Scand. 78, 1999, 202-6.
PubMed
101) Sau, AK. et al. Monoamniotic twins : what should be the optimal antenatal management? Twin Res. 6, 2003, 270-4.
PubMed
102) Hack, KE. et al. Placental characteristics of monoamniotic twin pregnancies in relation to perinatal outcome. Placenta. 30(1), 2009, 62-5. Epub 2008 Nov 17.
 
103) Demaria, F. et al. Monoamniotic twin pregnancies : antenatal management and perinatal results of 19 consecutive cases. BJOG. 111, 2004, 22-6.
 
104) Sutter, J. et al. Monoamniotic twins : antenatal diagnosis and management. Am J Obstet Gynecol. 155, 1986, 836-7.
PubMed
105) Belfort, MA. et al. The use of color flow Doppler ultrasonography to diagnose umbilical cord entanglement in monoamniotic twin gestations. Am J Obstet Gynecol. 168, 1993, 601-4.
PubMed
106) Arabin, B. et al. Early prenatal diagnosis of cord entanglement in monoamniotic multiple pregnancies. Ultrasound Obstet Gynecol. 13, 1999, 181-6.
PubMed
107) Babinszki, A. et al. Diagnosing amnionicity at 6 weeks of pregnancy with transvaginal three-dimensional ultrasonography : case report. Fertil Steril. 71, 1999, 1161-4.
PubMed
108) Heyborne, KD. et al. Improved perinatal survival of monoamniotic twins with intensive inpatient monitoring. Am J Obstet Gynecol. 192, 2005, 96-101.
PubMed
109) Van Allen, MI. et al. Twin reversed arterial perfusion (TRAP) sequence : a study of 14 twin pregnancies with acardius. Semin Perinatol. 7, 1983, 285-93.
PubMed
110) Malinowski, W., Wierzba, W. Twin reversed arterial perfusion syndrome. Acta Genet Med. Gemellol (Roma). 47, 1998, 75-87.
PubMed
111) Sullivan, AE. et al. The management of acardiac twins : a conservative approach. Am J Obstet Gynecol. 189, 2003, 1310-3.
PubMed
112) Allan, LD. Examining the fetal heart. Br J Obstet Gynaecol. 93, 1986, 305-6.
PubMed
113) Shenker, L. et al. Fetal cardiac Doppler flow studies in prenatal diagnosis of heart disease. Am J Obstet Gynecol. 158, 1988, 1267-73.
PubMed
114) Quintero, RA. et al. In utero percutaneous umbilical cord ligation in the management of complicated monochorionic multiple gestations. Ultrasound Obstet Gynecol. 8, 1996, 16-22.
PubMed
115) Porreco, RP. et al. Occlusion of umbilical artery in acardiac, acephalic twin. Lancet. 337, 1991, 326-7.
PubMed
116) Robyr, R. et al. Selective feticide in complicated monochorionic twin pregnancies using ultrasound-guided bipolar cord coagulation. BJOG. 112, 2005, 1344-8.
PubMed
117) Edmonds, LD., Layde, PM. Conjoined twins in the united states, 1970-1977. Teratology. 25, 1982, 301-8.
PubMed
118) Minakami, H., Sato, I. Reestimating date of delivery in multifetal pregnancies. JAMA. 275, 1996, 1432-4.
PubMed
119) Soucie, JE. et al. Neonatal mortality and morbidity rates in term twins with advancing gestational age. Am J Obstet Gynecol. 195(1), 2006, 172-7. Epub 2006 Mar 30.
 
120) Kleinman, JC. et al. Comparison of infant mortality among twins and singletons : United States 1960 and 1983. Am J Epidemiol. 133, 1991, 133-43.
PubMed
121) Williams, KP., Galerneau, F. Intrapartum influences on cesarean delivery in multiple gestation. Acta Obstet Gynecol Scand. 82, 2003, 241-5.
PubMed
122) Kurzel, RB. et al. Cesarean section for the second twin. J Reprod Med. 42, 1997, 767-70.
 
123) Ananth, CV. et al. Placental abruption among singleton and twin birth in the United States : risk factor profiles. Am J Epidemiol. 153, 2001, 771-8.
PubMed
124) Armson, BA. et al. Determinants of perinatal mortality and serious neonatal morbidity in the second twin. Obstet Gynecol. 108(3 Pt 1), 2006, 556-64.
 
125) Rayburn, WF. et al. Multiple gestation : time interval between delivery of the first and second twins. Obstet Gynecol. 63, 1984, 502-6.
PubMed
126) Chervenak, FA. et al. Intrapartum management of twin gestation. Obstet Gynecol. 65, 1985, 119-24.
PubMed
127) Morales, WJ. et al. The effect of mode of delivery on the risk of intraventricular hemorrhage in nondiscordant twins gestations under 1500g. Obstet Gynecol. 73, 1989, 107-10.
 
128) Schmitz, T. et al. Neonatal outcomes of twin pregnancy according to the planned mode of delivery. Obstet Gynecol. 111(3), 2008, 695-703.
 
129) Cetrulo, CL. The controversy of mode of delivery in twins : the intrapartum management of twin gestation (Part I). Semin Perinatol. 10, 1986, 39-43.
PubMed
130) Cetrulo, CL. et al. Management of multiple gestation. Clin Obstet Gynecol. 23, 1980, 533-48.
PubMed
131) Yang, Q. et al. Neonatal death and morbidity in vertexnonvertex second twins according to mode of delivery and birth weight. Am J Obstet Gynecol. 192, 2005, 840-7.
PubMed
132) Blickstein, I. et al. Vaginal delivery of the second twin in breech presentation. Obstet Gynecol. 69, 1987, 774-6.
PubMed
133) Gocke, SE. et al. Management of the nonvertex second twin : primary cesarean section, external version, or primary breech extraction. Am J Obstet Gynecol. 161, 1989, 111-4.
PubMed
134) Hogle, KL. et al. Cesarean delivery for twins : a systematic review and meta-analysis. Am J Obstet Gynecol. 188, 2003, 220-7.
PubMed
135) Davison, L. et al. Breech extraction of low-birth-weight second twins : can cesarean section be justified? Am J Obstet Gynecol. 166, 1992, 497-502.
PubMed
136) Mauldin, JG. et al. Cost-effective delivery management of the vertex and nonvertex twin gestation. Am J Obstet Gynecol. 179, 1998, 864-9.
PubMed
137) Chervenak, FA. et al. Intrapartum external version of the second twin. Obstet Gynecol. 62, 1983, 160-5.
PubMed
138) Kaplan, B. et al. Successful external version of B-twin after the birth of A-twin for vertex--non-vertex twins. Eur J Obstet Gynecol Reprod Biol. 58, 1995, 157-60.
PubMed
139) Rabinovici, J. et al. Internal podalic version with unruptured membranes for the second twin in transverse lie. Obstet Gynecol. 71, 1988, 428-30.
PubMed
140) Osbourne, GK., Patel, NB. An assessment of perinatal mortality in twin pregnancies in Dundee. Acta Genet Med Gemellol (Roma). 34, 1985, 193-9.
PubMed
141) 坪内弘明. 双胎経腟分娩における, 第一子娩出前後の第二子胎児心拍の変化について. 産婦人科の実際. 54, 2005, 1615-9.
 
142) American College of Obstetricians and Gynecologists. Special problems of multiple gestation. Educational Bulletin. No.253, 1998.
PubMed
143) Stein, W., Misselwitz, B., Schmidt, S. Twin-to-twin delivery time interval : influencing factors and effect on short-term outcome of the second twin. Acta Obstet Gynecol Scand. 87(3), 2008, 346-53.
PubMed
144) American College of Obstetricians and Gynecologists. Multiple gestation : Complicated twin, triplet, and high-order multifetal pregnancy. Practice Bulletin. No.56, 2004.
PubMed
145) Sentilhes, L. et al. Attempted vaginal versus planned cesarean delivery in 195 breech first twin pregnancies. Acta Obstet Gynecol Scand. 86(1), 2007, 55-60.
PubMed
146) Herbst, A., Kallen, K. Influence of mode of delivery on neonatal mortality in the second twin, at and before term. BJOG. 115(12), 2008, 1512-7.
PubMed
147) Kingdom, JC. et al. Discordant growth in twins. Prenat Diagn. 25, 2005, 759-65.
PubMed
148) Kontopoulos, EV. et al. The influence of mode of delivery on twin neonatal mortality in the US : varience by birthweight discordance. Am J Obstet Gynecol. 192, 2005, 252-6.
 
149) Takahashi, Y. et al. Uterine contractions might increase heart preload in the recipient fetus in early-onset twin-twin transfusion syndrome : an ultrasound assessment. Prenat Diagn. 24, 2004, 977-80.
PubMed
150) Su, LL. Monoamniotic twins : diagnosis and management. Acta Obstet Gynecol Scand. 81, 2002, 995-1000.
PubMed
151) Ezra, Y. et al. Intensive management and early delivery reduce antenatal mortality in monoamniotic twin pregnansies. Acta Obstet Gynecol Scand. 84, 2005, 432-5.
 
152) Shveiky, D. et al. Monoamniotic twins : an update on antenatal diagnosis and treatment. J Matern Fetal Neonatal Med. 16, 2004, 180-6.
PubMed
153) Clarke, JP., Roman, JD. A review of 19 sets of triplets : the positive results of vaginal delivery. Aust N Z J Obstet Gynaecol. 34, 1994, 50-3.
 
154) Alamia, V Jr. et al. Preliminary experience with a prospective protocol for planned vaginal delivery of triplet gestations. Am J Obstet Gynecol. 179, 1998, 1133-5.
PubMed
155) Vintzileos, AM. et al. Mode of delivery and risk of stillbirth and infant mortality in triplet gestations : United States, 1995 through 1998. Am J Obstet Gynecol. 192, 2005, 464-9.
PubMed
156) Francois, K. et al. Is peripartum hysterectomy more common in multiple gestations? Obstet Gynecol. 105, 2005, 1369-72.
PubMed
157) Suzuki, S., Kikuchi, F., Ouchi, N., Nagayama, C., Nakagawa, M., Inde, Y., Igarashi, M., Miyake, H. Risk factors for postpartum hemorrhage after vaginal delivery of twins. J Nippon Med Sch. 74(6), 2007, 414-7.
PubMed

第6章 高血圧

P.138 掲載の参考文献
1) 平成17年度妊婦血圧測定問題小委員会報告. 日本妊娠高血圧症学会誌. 13, 2005, 168-9.
 
2) Magee, LA. et al. Management hypertension in pregnancy. BMJ. 318, 1999, 1332-6.
PubMed
3) 三宅良明. "高血圧". 妊娠中毒症. 中林正雄編. 中山書店, 2001, 137-52, (新女性医学大系24).
 
4) Zetterstrom, K. Maternal complications in women with chronic hypertension : apopulation-based cohort study. Acta Obstet Gynecol Scand. 84, 2005, 419-24.
 
5) Sibai, BM. et al. Risk factors for preeclampsia, abruptio placenta and adverse neonatal outcomes among women with chronic hypertension. N Eng J Med. 339, 1998, 667-71.
 
6) Sibai, BM. et al. Biomaker for hypertension-preeclampsia : are we close yet? Am J Obstet Gynecol. 197(1), 2007, 1-2.
 
7) Sibai, BM. et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 162, 1990, 960-6.
 
8) Abalos, E. et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 24, 2007, CD002252.
PubMed
9) Von Dadelszen, P. et al. Fall in MAP and fetal growth restriction in pregnancy hypertension : A meta-analysis. Lancet. 355, 2000, 87-92.
PubMed
10) Working group report on high blood pressure in pregnancy. NIH publication no 00-3029, 2000.
 
11) Jones, DC. et al. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Eng J Med. 355, 1996, 226-32.
PubMed
12) Khalli, A. et al. Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders. Plos one. 3(7), 2008, e2766.
 
13) Cartis, S. et al. Low dose aspirin to prevent preeclampsia in women at high risk. New Eng J Med. 338, 1998, 701-5.
 
14) Caton, AR. et al. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension. 54, 2009, 63-70.
PubMed
15) Ochsenbein-Kolble, N. et al. Cross sectional study of automated blood pressure measurements throughout pregnancy. BJOG. 111(4), 2004, 319-25.
PubMed
16) BOSHI Study Group. Seasonal trends of blood pressure during pregnancy in Japan : the babies and their parents? longitudinal observation in Suzuki Memorial Hospital in Intrauterine Period study.
 
17) Brown, MA. et al. The natural history of white coat hypertension during pregnancy. BJOG. 112, 2005, 601-6.
PubMed
18) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 183, 2000, 1-22.
 
19) Brown, MA. et al. The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy : Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 20(1), 2001, IX-XIV.
 
20) Martin, JN Jr. et al. The spectrum of severe preeclampsia : comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 180, 1999, 1373-84.
PubMed
21) Katz, VL. et al. Preeclampsia into eclampsia : toward a new paradigm. Am J Obstet Gynecol. 182, 2000, 1389-96.
 
22) Nishizawa, H. et al. The etiological role of allogeneic fetal rejection in preeclampsia. Am J Reprod Immunol. 58, 2007, 11-20.
PubMed
23) Santner-Nanan, B. et al. Systemic increase in the ratio between Fox3p3+and IL-17-producing CD4+ T cell in healthy pregnancy but not in preeclampsia. J Immunol. 183, 2009, 7023-73.
 
24) Hiby, SE. et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 200, 2004, 957.
PubMed
25) Rote, NS., Vogt, E. et al. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol. 39, 1998, 125-36.
PubMed
26) Chesley, LC. Hypertensive Disorders in Pregnancy. New York, Appleton-Century-Crofts, 1978.
 
27) Ying, Li. et al. Placental HtrA3 is related by oxygen tension and serum levels are altered during early pregnancy in women destined to develop preeclampsia. J Clini Endocrine Metab. 96, 2010, 1-9.
 
28) Zhou, Y. et al. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype-One cause of defective endovascular invasion in this syndrome. J Clin Invest. 99, 1997, 2152-64.
 
29) Zhou, Y. et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A Stragety for successful endovascular invasion. J Clin Invest. 99, 1997, 2139-51.
 
30) Caniggia, I., Mostachfi, H., Winter, J. et al. Hypoxia-inducible factor-1 mediates th ebiological effects of oxygen on human trophoblast differentiation through TGF β3. J Clin Invest. 105, 2000, 577-87.
 
31) Maynard, SE., Min, JY., Merchan, J., Lim, KH., Li, J., Mondal, S., Liberman, TA., Morgan, LP., Sellke, FW., Stollman, IE., Epstein, FH., Sukhatme, VP., Karumanchi, A. Excess placental soluble fms-like tyrosine kinase1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 111(5), 2003, 649-58.
 
32) Levine, RJ., Maynard, SE., Quian, C., Lim, KH., England, LJ., Yu, KF., Schisterman, EF., Thadhani, R., Sachs, BP., Epstein, FH., Sibai, BM., Sukhatme, VP., Karumanchi, SA. Circulating Angiogenic Factors and the Risk of Preeclampsia. New E J Med. 350, 2004, 672-83.
 
33) Li, Z. et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension. 50, 2007, 686-92.
 
34) Vaisbuch, E. et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. AJOG. 204(2), 2011, 152, e1-9.
 
35) Venkatesha, S. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 12, 2006, 642-9.
 
36) Barnea, ER. et al. Catechol-o-methyl transferase activity in the human term placenta. Am J Perinatol. 5, 2005, 121-7.
 
37) Kanasaki, K. et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with preeclampsia. Nature. 453, 2008, 1117-21.
PubMed
38) Braekke, K. et al. Homocysteine, cysteine, and related metabolites in maternal and fetal plasma in preeclampsia. Pediatr Res. 62, 2007, 319-24.
PubMed
39) Wen, SW. et al. Folic acid and supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 198, 2008, 45-7.
 
40) Redman, CW. et al. Preeclampsia : an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 180, 1999, 499-506.
PubMed
41) AbdAlla, S., Lother, H., el Massiery, A., Quitterer, U. Increased AT (1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med. 7, 2001, 1003-9.
PubMed
42) Wallukat, G., Homuth, V., Fischer, T., Lindschau, C., Horstkamp, B., Jupner, A., Bauer, E., Nissen, E., Vetter, K., Neichel, D., Dudenhausen, JW., Haller, H., Luft, FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 103, 1999, 945-52.
 
43) Marin, R., Gorostidi, M., Portal, CG., Sanchez, M., Sanchez, E., Alvarez, J. Long-term prognosis of hypertension in pregnancy. Hypertens pregnancy. 19(2), 2000, 199-209.
 
44) Moutquin, JM., Lindsay, C., Arial, N., Grandpre, PD., Gaudreault, RC., Forest, JC., Masse, J. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study. Am J Obstet Gynecol. 177, 1997, 1483-90.
 
45) Eastering, TR., Benedetti, TJ. Preeclampsia : A hypertdynamic disease model. Am J Obstet Gynecol. 160, 1989, 1447-53.
 
46) Eastering, TR., Benedetti, TJ., Carson, KC., Brateng, DA., Wilson, J., Schumucker, BS. The effect of maternal hemodynamics on fetal growth in hypertensive pregnancies. Am J Obstet Gynecol. 165, 1991, 902-6.
 
47) Visser, N., Wallenberg, HCS. Central hemodynamic observations in untreated preeclamptic patients. Hypertension. 17, 1991, 1072-7.
 
48) Bosio, PM., Mckenna, PJ., Conroy, R., O'Herlihy, C. Maternal central hemodynamics in hypertensive disorders of pregnancies. Obstet Gynecol. 94, 1999, 978-84.
PubMed
49) Furchgott, RF. Role of endothelium in the responses of vascular smooth muscle. Circ Res. 53, 1983, 558.
 
50) Guyton, A. Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens. 2, 1989, 575-85.
PubMed
51) Valensise, H. et al. Early and late preeclampsia two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 52, 2008, 873-80.
PubMed
52) Sibai, BM. et al. Maternal and uteroplacental hemodynamics for the classification and prediction of preeclampsia. Hypertension. 52(2), 2008, 805-6.
 
53) Conde-Agudelo, A. et al. Evaluation of Methods used in the prediction of Hypertensive disorders of pregnancy. Obstet Gynecol Survey. 49, 1994, 210-22.
 
54) 三宅良明. "高血圧". 妊娠中毒症. 中林正雄編. 中山書店, 2001, 137-52, (新女性医学大系24).
 
55) Verlohren, S. et al. An automated method of the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 202, 2010, 161, e1-11.
 
56) Poon, LC. et al. First trimester prediction of hypertensive disorders in pregnancy. Hypertension. 53(5), 2009, 812-8.
PubMed
57) Brown, MA., Reiter, L., Smith, B. et al. Measuring blood pressure in pregnant women : a comparison of direct and indirect methods. Am J Obstet Gynecol. 171, 1994, 661-7.
PubMed
58) Penny, JA., Shennan, AH., Halligan, AW., Taylar, DJ., de Swiet, M., Anthony, J. Blood pressure measurement in severe preeclampsia. Lancet. 349, 1997, 1518.
 
59) Brown, MA., Buddle, ML., Farrell, TJ. Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V. Lancet. 352, 1998, 777-81.
PubMed
60) Johenning, AR., Barron, WM. Indirect blood pressure measurement in pregnancy : Korotkoff phase 4 versus phase 5. Am J Obstet Gynecol. 167, 1992, 577-80.
PubMed
61) Lopez, MC., Belizan, JM., Villar, J., Bergel, E. The measurement of diastolic blood pressure during pregnancy : which Korotkoff phase should be use? Am J Obstet Gynecol. 170, 1994, 574-8.
PubMed
62) Shennan, A., Gupta, M., Halligan, A. et al. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphyngomanometry. Lancet, 347, 1996, 139-42.
PubMed
63) 三宅良明, 佐藤和雄. 偶発合併症妊娠. 豊田長康ほか編. メジカルビュー社, 2000, 32-43, (図説産婦人科View39).
 
64) Myers, MG. Trough-to-peak ratio and 24-hour blood pressure control. Am J Hypertens. 8, 1995, 214-9.
PubMed
65) Seligman, SA. Diurnal blood pressure variation in pregnancy. J Obstet Gynecol Br Commonw. 78, 1971, 417-22.
 
66) Dame, WR., Bachour, G., Bottcher, HD., Beller, FK. Continuous monitoring of direct intra-arterial blood pressure in normal and preeclamptic pregnancies. Geburtshilfe Freunenheilkunde. 37, 1977, 708-14.
PubMed
67) Halligan, A., O'Brien, E., O'Malley, K. et al. Twenty-fourhour ambulatory blood pressure measurement in a primigravid population. J Hypertens. 11, 1993, 869-73.
 
68) Moutquin, JM., Desmarais, L., Bastide, A. et al. Prediction of pre-eclampsia : Ambulatory arterial hypertension. J Gynecol Obstet Biol Reprod (Paris). 21, 1992, 313-5.
PubMed
69) Cugini, P., Di Palma, L., Battisti, P. et al. Describing and interpreting 24hrs blood pressure patterns in physiologic pregnancy. Am J Obstet Gynecol. 166, 1992, 54-60.
 
70) Fischer, RL. et al. Maternal serum uric acid levels in twin gestations. Obstet Gynecol. 85, 1995, 60-4.
PubMed
71) Yoshimura, A. et al. Significance of uric acid clearance in preeclampsia. Am J Obstet Gynecol. 162, 1990, 1639-40.
PubMed
72) Dunlop, W. et al. Maternal hemoglobin concentration, hematcritand renal handling of urate in pregnancies ending in the births of small-for-dates infants. Br J Obstet Gynecol. 85, 1978, 938-40.
 
73) Odendaal, HJ. et al. Are high uric acid levels in patients with early preeclampsia an indication for delivery. S Afr Med J. 87, 1997, 213.
PubMed
74) Anim-Nyame, N. et al. A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by preeclampsia. BJOG. 109, 2002, 708-13.
PubMed
75) Rodriguez, MH. et al. Calcium/Creatinine ratio and microalbuminuria in the prediction of preeclampsia. Am J Obstet Gynecol. 159, 1988, 1452-5.
PubMed
76) 松川高久, 三宅良明, 山本樹生. 妊娠時耐糖能異常ならびに高血圧発症別にみた妊娠経過に伴う血圧, 心拍数, 脈血圧の変化. 糖尿病と妊娠. 2(1), 2002, 59-63.
 
77) Teran, E. et al. Elevated C-reactive protein and proinflammatory cytokines in Andean women with preeclampsia. Int J Obstet Gynecol. 75, 2001, 243-9.
 
78) Schobel, HP. et al. Preeclampsia : A state of sympathetic overactivity. N Engl J Med. 335(20), 1996, 1480-5.
PubMed
79) Yang, CC. Preeclamptic pregnancy is associated with increased sympathetic and decreased parasympathetic control of heart rate. Am J Physiol Heart Circ Physiol. 278(4), 2000, H1269-73.
PubMed
80) Woisetschlager, C. Increased blood pressure response to the cold pressure test in pregnant women developing preeclampsia. J Hypertens. 18(4), 2000, 399-403.
 
81) Wahlestedt, C. et al. Norepinephrine and neuropeptide Y : vasoconstrictor cooperation in vivo and in vitro. Am J Obstet Gynecol. 258, 1990, 736-42.
 
82) Siver, HM. Comparison of vagal baroreflex function in nonpregnant women and in women with normal pregnancy, preeclampsia, or gestational hypertension. Am J Obstet Gynecol. 184(6), 2001, 1189-95.
PubMed
83) Eastering, TR. et al. Maternal hemodynamics in normal and preeclamptic pregnancies. A longitudinal study. Obstet Gynecol. 76, 1990, 1061-9.
 
84) Thadhani, R. et al. Pulse pressure and risk of preeclampsia : A prospective study. Obstet Gynecol. 97, 2001, 515-9.
PubMed
85) Speksnijder, L. et al. Amino-terminal pro-brain natriuretic peptide (NT-proBNP) is a biomarker of cardiac filling pressures in preeclampsia. Euro J Obstet Gynecol Reprod Biol. 153, 2010, 12-5.
 
86) 日本母性保護産婦人科医会. 妊娠中毒症. 研修ノートNo64.
 
87) 日高敦夫. 妊娠中毒症 : その病態論的アプローチ, 母児循環動態に関する基礎的, 臨床的研究. 日本産科婦人科学会雑誌. 40, 1988, 1010-20.
 
88) Sibai, SM., Sherif, A., Fairlie, F. et al. A protocol for managing severe preeclampsia in thescound trimester. Am J Obstet Gynecol. 163, 1990, 733.
 
89) Chua, S., Redman, CWG. Prognosis for preeclampsia complicated by 5g or more of proteinuria in 24hrs. Eur J Obstet Gynecol Reprod Biol. 43, 1992, 9.
 
90) Schiff, E., Friedman, SA., Lu Kao, RN. et al. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol. 175, 1996, 1313.
 
91) Kirsten, GF. The long term neurodevelopmental outcome of infants born to mothers with severe preeclampsia and absent end diastolic umbilical artery flow velocity waveforms. MD dissertation. Stellenbosch University, 1996.
 
92) Smith, GN., Walker, MC. et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol. 200, 2009, 58, e1-8.
 
93) Redman, CWG., Beilin, LJ., Bonnar, J. et al. Plasmaurate measurements in predicting fetal death in hypertensive pregnancy. Lancet. 1, 1976, 1370.
 
94) Odendaal, HJ., Pienaar, ME. Are high uric acid levels in patients with early preeclampsia an indication for delivery. S Afr Med J. 87, 1997, 213.
PubMed
95) Dekker, GA., de Varies, JI. et al. Underlying disorders associated with severe early onset preeclampsia. Am J Obstet Gynecol. 173, 1995, 1042-8.
 
96) Sibai, BM., Mercer, B., Sarinoglu, C. Severe preeclampsia in the secound trimester : Recurrence risk and long-term prognosis. Am J Obstet Gynecol. 165, 1991, 1408.
 
97) Nisell, H., Lintu, H., Lunell, NO., Mollerstrom, G. et al. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynecol. 102, 1995, 876-81.
 
98) Nisell, H., Lntu, H. et al. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynecol. 102, 1995, 876-81.
 
99) Martin, R. et al. Long term prognosis of hypertension in pregnancy. Hypertens pregnancy. 19(2), 2000, 199-209.
 
100) Levine, RJ. et al. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function : nested case control and population based study. BMJ. 339, 2009, b4336.
PubMed
101) Bellamy, L. et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life. BMJ. 335, 2007, 974-7.
PubMed
102) McDonald, SD. et al. Kidney disease after preeclampsia : A systematic review and meta-analysis. Am J Kidney Dis. 55, 2010, 1026-39.
PubMed
103) Caritis, S. et al. Low Dose Aspirin to prevent Preeclampsia in women at High Risk. N Engl J Med. 338, 1998, 701-5.
 
104) Rotchell, YE. et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP) : a randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol. 105, 1998, 286-92.
PubMed
105) Golding, J. et al. A randomised trial of low dose aspirin for primiparae in pregnancy. Br J Obstet Gynaecol. 105, 1998, 293-9.
PubMed
106) CLASP Collaborative Group. Low dose aspirin in pregnancy and early childhood development : follow up of the collaborative low dose aspirin study in pregnancy. Br J Obstet Gynaecol. 102, 1995, 861-8.
 
107) ECPPA. Randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynaecol. 103, 1996, 39-47.
PubMed
108) Levine, RJ. et al. Trial of Calcium for Preeclampsia Prevention (CPEP) : Rationale. Design and Methods. 17, 1996, 442-69.
PubMed
109) Kharb, S. Vitamin E and C in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 93(1), 2000, 37-9.
 
110) Akyol, D. et al. Maternal levels of vitamin E in normal and preeclamptic pregnancy. Arch Gynecol Obstet. 263(4), 2000, 151-5.
PubMed
111) Poston, L. et al. Vitamin C and vitamin E in pregnant women at risk for preeclampsia (VIP trial) : randomised placebocontrolled trial. Lancet. 267, 2006, 1145-54.
 
112) Bujold, E. et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. Obstet Gynecol. 116, 2010, 402-14.
PubMed
113) National institute for health and clinical excellence. Hypertension in pregnancy (clinical guideline 107). 2010. www.nice.org.uk/CG107
 
114) Kumasawa, K. et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. PNAS. 108, 2011, 1451-5.
 
115) Costantine, MM. et al. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol. 116, 2010, 114-20.
 

第7章 血液型不適合妊娠

P.158 掲載の参考文献
1) Levine, P. et al. Isoimmunization in pregnancy : Its possible bearing on etiology of erythroblastosis foetalis. JAMA. 116, 1941, 825.
 
2) 浮田昌彦. 血液型不適合妊娠についての最近の進歩. 臨床婦人科産科. 38, 1984, 653-6.
 
3) Taslimi, MM. et al. Immunoglobulin G subclasses and isoimmunized pregnancy outcome. Am J Obstet Gynecol. 154, 1986, 1327-32.
PubMed
4) American College of Obstetricians and Gynecologists (ACOG). Management of Isoimmunization in Pregnancy. Technical Bulletin. No.90, January, 1986.
 
5) 浮田昌彦. 血液型不適合妊娠と胎児・新生児溶血性疾患 : 第2編 ; 感作妊娠における重症溶血性疾患罹患胎児の子宮内治療. 日本産婦人科・新生児血液学会雑誌. 2, 1992, 1-15.
 
6) 白川光一. 近年の血液型不適合妊娠の管理法 : 特に本邦の実情に鑑みて. 日本産科婦人科学会雑誌. 36, 1984, 1969-74.
 
7) Pirelli, K., Pietz, B., Johnson, S., Pinder, H., Bellissimo, D. Molecular determination of RhD zygosity. Am J Obstet Gynecol. 195, 2006, S172.
 
8) Lo, YM., Hjelm, NM., Fidler, C. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med. 339, 1998, 1734-8.
PubMed
9) Finning, K., Martin, P., Summers, J., Daniels, G. Fetal genotyping for the K (kell) and RhC, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion. 47, 2007, 2126-33.
 
10) 浮田昌彦. わが国の主要産科医療施設におけるRho (D)不適合妊娠の現況について. 産婦人科の実際. 41, 1992, 139-44.
 
11) 生水真紀夫, 赤祖父一知. RhE不適合妊娠による新生児溶血性疾患の臨床像. 日本新生児誌. 28, 1992, 411-20.
 
12) 山口英夫. 大阪府赤十字血液センターにおける赤血球抗体について. 日本輸血学会雑誌. 28, 1982, 448-51.
Medical*Online
13) 田村真ほか. 不規則性抗体の検出頻度からもとめた赤血球抗原の相対的抗原性 (Relative Antigenecity). 日本輸血学会雑誌. 28, 1982, 97.
 
14) 金岡毅. 血液型不適合妊娠. 産婦人科治療. 577, 1988, 42-4.
 
15) Danforth, DN., Scott, JR. Obstetrics and Gynecology. 5th ed. Philadelphia, Lippincott, 1986, 419.
 
16) Cormode, EJ. et al. Analbuminemia in a neonate. J Pediatr. 86, 1975, 862.
 
17) Moise, KJ. et al. Do abnormal starling forces cause fetal hydrops in red blood cell alloimmunization? Am J Obstet Gynecol. 167, 1992, 907.
PubMed
18) Zupanska, B. et al. The ability of cellular assays to predict the necessity for cordocentesis in pregnancies at risk of haemolytic disease of the newborn. Vox Sang. 80, 2001, 234.
PubMed
19) Wenk, RE., Goldstein, P., Felix, JK. Alloimmunization by hr'(c), hemolytic disease of newborns, and perinatal management. Obstet Gynecol. 67, 1986, 623-6.
 
20) Kozlowski, CL., Lee, D., Shwe KH.et al. Quantification of anti-c in haemolytic disease of the newborn. Transfus Med. 5, 1995, 37-42.
 
21) Hackney, DN., Knudson, EJ., Rossi, KQ. et al. Management of pregnancies complicated by anti-c isoimmunization. Obstet Gynecol. 103, 2004, 24-30.
 
22) van Kamp, IL., Klumper, FJ., Bakkum, RS. et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol. 185 2001, 668-73.
PubMed
23) Bowman, JM., Pollock, JM., Manning, FA. et al. Severe anti-C hemolitic disease of the newborn. Am J Obstet Gynecol. 166, 1992, 1239-43.
 
24) Joy, SD., Rossi, KQ., Krugh, D. et al. Management of pregnancies compicated by anti-E alloimmunization. Obstet Gynecol. 105, 2005, 24-8.
 
25) 浮田昌彦. 血液型不適合妊娠と胎児・新生児溶血性疾患 : 第4編 ; 抗D抗体以外の赤血球抗体による胎児・新生児溶血性疾患. 日本産婦人科・新生児血液学会雑誌. 3, 1993, 55-80.
 
26) Bowman, JM., Pollock, JM., Manning, FA. et al. Maternal Kell blood group alloimmunization. Obstet Gynecol. 79, 1992, 239-44.
PubMed
27) Berkowitz, RL., Beyth, Y., Sadovsky, E. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid. Obstet Gynecol. 60, 1982, 746-9.
PubMed
28) Caine, ME., Muller-Heubach, E. Kell sensitization in pregnancy. Am J Obstet Gynecol. 154, 1986, 85-90.
 
29) Weiner, CP., Widness, JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol. 174, 1996, 547-51.
PubMed
30) van Dongen, H., Klumper, FJ., Sikkel, E. et al. Non-invasive tests to predict fetal anemia in Kell-alloimmunized pregnancies. Ultrasound Obstet Gynecol. 25, 2005, 341-5.
PubMed
31) Rimon, E., Peltz, R., Gamzu, R. et al. Management of Kell isoimmunization : Evaluation of a Doppler-guided approach. Ultrasound Obstet Gynecol. 28, 2006, 814-20.
PubMed
32) Vaughan, JI., Warwick, R., Letsky, E. et al. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol. 171, 1994, 247-52.
PubMed
33) McKenna, DS. et al. Management of Pregnancies Complicated by Anti-Kell Isoimmunization. Obstet Gynecol. 93, 1999, 667-73.
PubMed
34) Young-Owens, AD. et al. Anti-M Isoimmunization : Management and outcome at The Ohio State University from 1969 to 1995. Obstet Gynecol. 90, 1997, 962-6.
 
35) Van Den Veyver, IB. et al. Prenatal diagnosis of the RhD fetal blood type on amniotic fluid by polymerase chain reaction. Obstet Gynecol. 87, 1996, 419.
PubMed
36) Yankowitz, J. et al. Polymerase chain reaction determination of RhC, Rhc, and RhE blood types : An evaluation of accuracy and clinical utility. Am J Obstet Gynecol. 176, 1997, 1107.
PubMed
37) Liley, AW. Liquor amnii analysis in management of pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol. 82, 1961, 1359-70.
 
38) Cunningham, FG., Gant, NF., Leveno, KJ. et al. Williams Obstetrics. 21st eds. McGraw-Hill, 2001.
 
39) Queenan, JT. et al. Deviathion in amniotic fluid optical density at a wavelength of 450nm in Rh isoimmunized pregnancies from 14 to 40 weeks gestation : A proposal for clinical management. Am J Obstet Gynecol. 168, 1993, 1370-6.
 
40) Weiner, CP. Human fetal bilirubin levels and fetal hemolytic disease. Am J Obstet Gynecol. 166, 1992, 1449-54.
PubMed
41) Yaffe, AB., Sadovsky, E. Sinusoidal fetal heart rate pattern with severe fetal anemia. Br J Obstet Gynaecol. 87, 1980, 916-9.
 
42) Kirkinen, P., Jouppila, P. Umbilical vein blood flow in rhesusisoimmunization. Br J Obstet Gynaecol. 90, 1983, 640-3.
PubMed
43) Nicolaides, KH. et al. Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization. Am J Obstet Gynecol. 158, 1988, 920-6.
PubMed
44) Copel, JA. et al. Pulsed doppler flow-velocity waveforms in the prediction of fetal hematocrit of the severely isoimmunized pregnancy. Am J Obstet Gynecol. 161, 1989, 341-4.
PubMed
45) Hecher, K. et al. Fetal venous, arterial, and intracardiac blood flows in red blood cell isoimmunization. Obstet Gynecol. 85, 1995, 122-8.
PubMed
46) Mari, G. et al. Noninvasive diagnosis by doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization : Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 342, 2000, 9-14.
 
47) Divakaran, TG., Waugh, J., Clark, TJ. et al. Noninvasive techniques to detect fetal anemia due to red blood cell alloimmunization : A systemic review. Obstet Gynecol. 98, 2001, 509-17.
 
48) Zimmerman, R., Carpenter, RJ Jr., Durig, P. et al. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation : A prospective multicentre trial with intention-to-treat. BJOG. 109, 2002, 746-52.
PubMed
49) Oepkes, D., Seaward, PG., Vandenbussche, FP. et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med. 355, 2006, 156-64.
PubMed
50) Vintzileos, AM. et al. Fetal liver ultrasound measurements in isoimmunized pregnancies. Obstet Gynecol. 68, 1986, 162-8.
PubMed
51) Roberts, AB. et al. Fetal liver length in normal and isoimmunized pregnancies. Am J Obstet Gynecol. 161, 1989, 42-6.
PubMed
52) Oepkes, D. et al. Ultrasonographic fetal spleen measurements in red blood cell-alloimmunized pregnancies. Am J Obstet Gynecol. 169, 1993, 121-8.
PubMed
53) Bahado-Singh, R. et al. Fetal splenic size in anemia due to Rh-alloimmunization. Obstet Gynecol. 92, 1998, 828-32.
PubMed
54) Spinnato, JA. Hemolytic disease of the fetus. Obstet Gynecol. 80, 1992, 873-7.
PubMed
55) Reece, EA. et al. Diagnostic fetal umbilical blood sampling in the management of isoimmunization. Am J Obstet Gynecol. 159, 1988, 1057-62.
PubMed
56) Rose, BD. ed. Up To Date. Wellesley, Mass, 2003.
 
57) Quinlan, RW. et al. Fetal pulmonary maturity in isoimmunized pregnancies. Am J Obstet Gynecol. 148, 1984, 787-9.
PubMed
58) Horenstein, J., Golde, SH., Platt, LD. Lung profiles in the isoimmunized pregnancies. Am J Obstet Gynecol. 153, 1985, 443-7.
PubMed
59) 光田信明ほか. 胎児採血による胎児・新生児溶血性疾患の管理. ペリネイタルケア. 12, 1993, 222-31.
 
60) Liley, AW. Intrauterine transfusion of foetus in haemolytic disease. BMJ. 2, 1963, 1107.
PubMed
61) Rodeck, CH. et al. Direct intravascular fetal blood transfusion by fetoscopy in severe rhesus isoimmunization. Lancet. 1981, 625.
PubMed
62) 谷川原真吾ほか. 超音波ガイド下胎児臍帯内輸血により生児を得たRh不適合妊娠の一例. 日本産科婦人科学会雑誌. 41, 1989, 621-4.
 
63) Bowman, JM. The management of Rh-isoimmunization. Obstet Gynecol. 52, 1978, 1.
PubMed
64) Nicolaides, KH. et al. Rh disease : Intravascular fetal blood transfusion by cordocentesis. Fetal Ther. 1, 1986, 185-92.
PubMed
65) Nicolaides, KH. et al. Fetal haemoglobin measurement in the assessment of red cell isoimmunization. Lancet. 14, 1988, 1073.
 
66) Mandelbrot, L. et al. Assessment of fetal blood volume for computer-assisted management of in utero transfusion. Fetal Ther. 3, 1988, 1.
PubMed
67) Giannina, G. et al. A simple method to estimate the volume for fetal intravascular transfusion. Fetal Diagn Ther. 13, 1998, 94.
PubMed
68) Harman, CR. et al. Intrauterine transfusion-Intraperitoneal versus intravascular approach : A case-control comparison. Am J Obstet Gynecol. 162, 1990, 1053-9.
PubMed
69) EL-Azeem, SA. et al. The effect of the source of transfused red blood cells in pregnancies affected by red cell alloimmunization. Am J Obstet Gynecol. 177, 1997, 753-7.
PubMed
70) Moise, KJ Jr. et al. Comparison of four types of intrauterine transfusion : Effect on fetal hematocrit. Fetal Ther. 4, 1989, 126.
PubMed
71) Berkowitz, RL. et al. Intrauterine intravascular transfusion for severe red blood cell isoimmunization : Ultrasoundguided percutaneous approach. Am J Obstet Gynecol. 155, 1986, 574.
PubMed
72) Daffos, F. et al. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound : a study of 606 consecutive cases. Am J Obstet Gynecol. 153, 1985, 655-60.
PubMed
73) Berkowitz, RL. et al. Intravascular monitoring and management of erythroblastosis fetalis. Am J Obstet Gynecol. 158, 1988, 783-95.
PubMed
74) Barss, VA. et al. Management of isoimmunized pregnancy by use of intravascular techniques. Am J Obstet Gynecol. 159, 1988, 932-7.
PubMed
75) Grannum, PAT. et al. The reversal hydrops fetalis intravascular intrauterine transfusion in severe isoimmune fetal anemia. Am J Obstet Gynecol. 158, 1988, 914-9.
 
76) Schumacher, B., Moise, KJ Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol. 88, 1996, 137.
PubMed
77) van Kamp, IL. et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol. 185, 2001, 668.
PubMed
78) Janssens, HM. et al. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr. 131, 1997, 373.
PubMed
79) Hudon, L. et al. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol. 179, 1998, 858.
PubMed
80) Grab, D. et al. Treatment of fetal erythroblastosis by intravascular transfusions : outcome at 6 years. Obstet Gynecol. 93, 1999, 165.
PubMed
81) Hardy, J., Napier, JAF. Red cell antibodies detected in antenatal tests on rhesus positive women in south and mid wales, 1948-1978. Br J Obstet Gynaecol. 88, 1981, 91-100.
 
82) Bowman, JM. Controversies in Rh prophylaxis : Who needs Rh immune globulin and when should it be given? Am J Obstet Gynecol. 151, 1985, 289-94.
 
83) Creasy, RK., Resnik, R. Maternal-Fetal Medicine. 5th ed. Pennsylvania, Saunders, 2004.
 
84) American College of Obstetricians and Gynecologists. Prevention of Rh D alloimmunization. ACOG Practice Bulletin. No.4. May 1999.
PubMed
85) Synder, EL. Prevention of hemolytic disease of the newborn due to anti-D. Prenatal/perinatal testing and Rh immune globulin administration. Am Assoc Blood Banks Bull. 1998, 98-2.
 
86) Bowman, JM. The prevention of Rh immunization. Transfus Med Rev. 2, 1988, 129.
PubMed
87) 浮田昌彦ほか. Rho (D) 不適合妊娠における未感作妊婦の感作予防 : 妊娠28週と分娩後における抗D免疫グロブリンの投与について. 周産期医学. 22, 1992, 1605-8.
 
88) 浮田昌彦ほか. 抗Dヒト免疫グロブリン常用後のD陰性妊婦の実態. 周産期医学. 19, 1989, 845-51.
 
89) Freda, VJ. et al. Prevention of Rh hemolytic disease : Ten years' clinical experience with Rh immune globulin. N Eng J Med. 292, 1975, 1014-6.
 
90) Chavez, GF. et al. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA. 265, 1991, 3270-4.
PubMed

第8章 羊水過多・羊水過少

P.170 掲載の参考文献
1) Wallenburg, HC. The amniotic fluid I. Water and electrolyte homeostasis. J Perinat Med. 5(5), 1977, 193-205.
PubMed
2) Seeds, AE. Current concepts of amniotic fluid dynamics. Am J Obstet Gynecol. 138, 1980, 575-86.
PubMed
3) Brace, RA. Amniotic fluid volume and its relationship to fetal fluid balance : review of experimental data. Semin Perinatol. 10(2), 1986, 103-12.
PubMed
4) Gilbert, WM. et al. Amniotic fluid volume dynamics. Fetal Medicine Review. 3, 1991, 89-104.
 
5) Rabinowitz, R. et al. Measurement of fetal urine production in normal pregnancy by real-time ultrasonography. Am J Obstet Gynecol. 161(5), 1989, 1264-6.
PubMed
6) Pritchard, JA. Fetal swallowing and amniotic fluid volume. bstet Gynecol. 28(5), 1966, 606-10.
PubMed
7) Brace, RA. et al. Normal amniotic fluid volume changes throughout pregnancy. Am J Obstet Gynecol. 161(2), 1989, 382-8.
PubMed
8) Charles, D. et al. Preliminary data on the use of sodium aminohippurate to determine amniotic fluid volumes. Am J Obstet Gynecol. 95(2), 1966, 266-9.
PubMed
9) Magann, EF. et al. Do multiple measurements employing different ultrasonic techniques improve the accuracy of amniotic fluid volume assessment? Aust N Z J Obstet Gynaecol. 38(2), 1998, 172-5.
PubMed
10) Manning, FA. et al. Qualitative amniotic fluid volume determination by ultrasound : antepartum detection of intrauterine growth retardation. Am J Obstet Gynecol. 139(3), 1981, 254-8.
PubMed
11) Chamberlain, PF. et al. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol. 150(3), 1984, 245-9.
PubMed
12) Crowley, P. et al. The value of ultrasound measurement of amniotic fluid volume in the management of prolonged pregnancies. Br J Obstet Gynaecol. 91(5), 1984, 444-8.
PubMed
13) Magann, EF. et al. Measurement of amniotic fluid volume : accuracy of ultrasonography techniques. Am J Obstet Gynecol. 167(6), 1992, 1533-7.
PubMed
14) Phelan, JP. et al. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation. J Reprod Med. 32(7), 1987, 540-2.
PubMed
15) Moore, TR. et al. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol. 162(5), 1990, 1168-73.
PubMed
16) Magann, EF. et al. The amniotic fluid index, single deepest pocket, and two-diameter pocket in normal human pregnancy. Am J Obstet Gynecol. 182(6), 2000, 1581-8.
PubMed
17) Hinh, ND., Ladinsky, JL. Amniotic fluid index measurements in normal pregnancy after 28 gestational weeks. Int J Gynaecol Obstet. 91(2), 2005, 132-6.
PubMed
18) Machado, MR., Cecatti, JG., Krupa, F, Faundes, A. Curve of amniotic fluid index measurements in low-risk pregnancy. Acta Obstet Gynecol Scand. 86(1), 2007, 37-41.
PubMed
19) Schrimmer, DB. et al. Sonographic evaluation of amniotic fluid volume. Clin Obstet Gynecol. 45(4), 2002, 1026-38.
PubMed
20) Carlson, DE. et al. Quantifiable polyhydramnios : diagnosis and management. Obstet Gynecol. 75(6), 1990, 989-93.
PubMed
21) Bruner, JP. et al. Intraobserver and interobserver variability of the amniotic fluid index. Am J Obstet Gynecol. 168(4), 1993, 1309-13.
PubMed
22) Del Valle, GO. et al. Comparison of three types of ultrasound transducers in evaluating the amniotic fluid index. J Reprod Med. 39(11), 1994, 869-72.
PubMed
23) Rutherford, SE. et al. Four-quadrant assessment of amniotic fluid volume : Interobserver and intraobserver variation. J Reprod Med. 32(8), 1987, 587-9.
PubMed
24) Moore, TR. Superiority of the four-quadrant sum over the single-deepest-pocket technique in ultrasonographic identification of abnormal amniotic fluid volumes. Am J Obstet Gynecol. 163(3), 1990, 762-7.
PubMed
25) Hill, LM. Oligohydramnios : sonographic diagnosis and clinical implications. Clin Obstet Gynecol. 40(2), 1997, 314-27.
PubMed
26) Magann, EF. et al. Ultrasound estimation of amniotic fluid volume using the largest vertical pocket containing umbilical cord : measure to or through the cord? Ultrasound Obstet Gynecol. 20(5), 2002, 464-7.
PubMed
27) Croom, CS. et al. Do semi quantitative amniotic fluid indexes reflect actual volume? Am J Obstet Gynecol. 167(4 Pt 1), 1992, 995-9.
 
28) Magann, EF. et al. How well do the amniotic fluid index and single deepest pocket indices (below the 3rd and 5th and above the 95th and 97th percentiles) predict oligohydramnios and hydramnios? Am J Obstet Gynecol. 190(1), 2004, 164-9.
PubMed
29) Magann, EF. et al. Amniotic fluid volume estimation and the biophysical profile : a confusion of criteria. Obstet Gynecol. 96(4), 2000, 640-2.
PubMed
30) Nageotte, MP. et al. The value of a negative antepartum test : contraction stress test and modified biophysical profile. Obstet Gynecol. 84(2), 1994, 231-4.
PubMed
31) Magann, EF. et al. Amniotic fluid volume of third-trimester diamniotic twin pregnancies. Obstet Gynecol. 85(6), 1995, 957-60.
PubMed
32) Watson, WJ. et al. Sonographic assessment of amniotic fluid in normal twin pregnancy. Am J Perinatol. 12(2), 1995, 122-4.
PubMed
33) Quintero, RA. et al. Staging of twin-twin transfusion syndrome. J Perinatol. 19(8 Pt 1), 1999, 550-5.
 
34) Barnhard, Y. et al. Is polyhydramnios in an ultrasonographically normal fetus an indication for genetic evaluation? Am J Obstet Gynecol. 173(5), 1995, 1523-7.
 
35) Wallenburg, HC. et al. The amniotic fluid. II. Polyhydramnios and oligohydramnios. J Perinat Med. 5(6), 1977, 233-43.
PubMed
36) Stoll, CG. et al. Study of 156 cases of polyhydramnios and congenital malformations in a series of 118, 265 consecutive births. Am J Obstet Gynecol. 165(3), 1991, 586-90.
 
37) Biggio, JR. et al. Hydramnios prediction of adverse perinatal outcome. Obstet Gynecol. 94(5 Pt 1), 1999, 773-7.
 
38) Golan, A. et al. Hydramnios in singleton pregnancy : sonographic prevalence and etiology. Gynecol Obstet Invest. 35(2), 1993, 91-3.
PubMed
39) Hill, LM. et al. Polyhydramnios : ultrasonically detected prevalence and neonatal outcome. Obstet Gynecol. 69(1), 1987, 21-5.
PubMed
40) Damato, N. et al. Frequency of fetal anomalies in sonographically detected polyhydramnios. J Ultrasound Med. 12(1), 1993, 11-5.
PubMed
41) Cousins, L. Pregnancy complications among diabetic women : review 1965-1985. Obstet Gynecol Surv. 42(3), 1987, 140-9.
PubMed
42) Wladimiroff, JW. et al. Sonographically determined anomalies and outcome in 170 chromosomally abnormal fetuses. Prenat Diagn. 15(5), 1995, 431-8.
PubMed
43) Carlson, DE. et al. The ultrasound triad of fetal hydramnios, abnormal hand posturing, and any other anomaly predicts autosomal trisomy. Obstet Gynecol. 79(5 Pt 1), 1992, 731-4.
 
44) Maymon, E. et al. Isolated hydramnios at term gestation and the occurrence of peripartum complications. Eur J Obstet Gynecol Reprod Biol. 77(2), 1998, 157-61.
PubMed
45) Elliott, JP. et al. Large-volume therapeutic amniocentesis in the treatment of hydramnios. Obstet Gynecol. 84(6), 1994, 1025-7.
PubMed
46) Cabrol, D. et al. Treatment of symptomatic polyhydramnios with indomethacin. Eur J Obstet Gynecol Reprod Biol. 66(1), 1996, 11-5.
PubMed
47) Peek, MJ. et al. Medical amnioreduction with sulindac to reduce cord complications in monoamniotic twins. Am J Obstet Gynecol. 176(2), 1997, 334-6.
PubMed
48) Kirshon, B. et al. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Obstet Gynecol. 75(2), 1990, 202-5.
PubMed
49) Mamopoulos, M. et al. Maternal indomethacin therapy in the treatment of polyhydramnios. Am J Obstet Gynecol. 162(5), 1990, 1225-9.
PubMed
50) Moise, KJ Jr. et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med. 319(6), 1988, 327-31.
PubMed
51) Mozar, M. et al. Polyhydramnios as an independent risk factor for perinatal risk factor for perinatal mortality and intrapartum morbidity in preterm delivery. Eur J Obstet Gynecol Reprod Biol. 70, 1996, 41.
 
52) Smith, CV. et al. Relation of mild idiopathic polyhydramnios to perinatal outcome. Obstet Gynecol. 79(3), 1992, 387-9.
PubMed
53) Horsager, R. et al. Correlation of measured amniotic fluid volume and sonographic predictions of oligohydramnios. Obstet Gynecol. 83(6), 1994, 955-8.
PubMed
54) Elliott, JP., Gilpin, B., Strong, TH Jr., Finberg, HJ. Chronic abruption-oligohydramnios sequence. J Reprod Med. 43(5), 1998, 418-22.
PubMed
55) Shenker, L. et al. Significance of oligohydramnios complicating pregnancy. Am J Obstet Gynecol. 164(6 Pt 1), 1991, 1597-9.
 
56) Mercer, LJ. et al. Fetal outcome with oligohydramnios in the second trimester. Obstet Gynecol. 67(6), 1986, 840-2.
PubMed
57) Marks, AD. et al. Longitudinal study of the amniotic fluid index in post-dates pregnancy. Obstet Gynecol. 79(2), 1992, 229-33.
PubMed
58) Vintzileos, AM. et al. Fetal biophysical profile scoring : current status. Clin Perinatol. 16(3), 1989, 661-89.
PubMed
59) O'Brien, JM. et al. Amniotic fluid index in hospitalized hypertensive patients managed expectantly. Obstet Gynecol. 82(2), 1993, 247-50.
PubMed
60) Hickok, DE. et al. The association between decreased amniotic fluid volume and treatment with nonsteroidal antiinflammatory agents for preterm labor. Am J Obstet Gynecol. 160(6), 1989, 1525-30.
PubMed
61) Rutherford, SE. et al. The four-quadrant assessment of amniotic fluid volume : an adjunct to antepartum fetal heart rate testing. Obstet Gynecol. 70(3 Pt 1), 1987, 353-6.
 
62) Dizon-Townson, D. et al. Amniotic fluid index and perinatal morbidity. Am J Perinatol. 13(4), 1996, 231-4.
 
63) Jeng, CJ. et al. Amniotic fluid index measurement with the four-quadrant technique during pregnancy. J Reprod Med. 35(7), 1990, 674-7.
PubMed
64) Magann, EF., Magann, MI., Morrison, JC., Chauhan, SP., Doherty DA. The evidence for abandoning the amniotic fluid index in favor of the single deepest pocket. Am J Perinatol. 24(9), 2007, 549-55.
PubMed
65) Nabhan, AF., Abdelmoula, YA. Amniotic fluid index versus single deepest vertical pocket : a meta-analysis of randomized controlled trials. Int J Gynaecol Obstet. 104(3), 2009, 184-8.
PubMed
66) Lagrew, DC. et al. How frequently should the amniotic fluid index be repeated? Am J Obstet Gynecol. 167(4 Pt 1), 1992, 1129-33.
 
67) Wing, DA. et al. How frequently should the amniotic fluid index be performed during the course of antepartum testing? Am J Obstet Gynecol. 174(1 Pt 1), 1996, 33-6.
 
68) Clement, D. et al. Acute oligohydramnios in postdate pregnancy. Am J Obstet Gynecol. 157(4 Pt 1), 1987, 884-6.
 
69) Gembruch, U. et al. Artificial instillation of amniotic fluid as a new technique for the diagnostic evaluation of cases of oligohydramnios. Prenat Diagn. 8(1), 1988, 33-45.
PubMed
70) Quetel, TA. et al. Amnioinfusion : an aid in the ultrasonographic evaluation of severe oligohydramnios in pregnancy. Am J Obstet Gynecol. 167(2), 1992, 333-6.
PubMed
71) Winn, HN. et al. Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes : a critical analysis. Am J Obstet Gynecol. 182(6), 2000, 1638-44.
PubMed
72) 中田高公ほか. "Second trimesterに発症した長期破水症例においての肺低形成の予測". 周産期学シンポジウム. No.19. 東京, メジカルビュー社, 2001, 27-39.
 
73) McCurdy, CM Jr. et al. Oligohydramnios : problems and treatment. Semin Perinatol. 17(3), 1993, 183-96.
PubMed
74) Johnson, MP. et al. In utero surgical treatment of fetal obstructive uropathy : a new comprehensive approach to identify appropriate candidates for vesicoamniotic shunt therapy. Am J Obstet Gynecol. 170(6), 1994, 1770-6, discussion 1776-9.
 
75) Freedman, AL. et al. Fetal therapy for obstructive uropathy : past, present, future? Pediatr Nephrol. 14(2), 2000, 167-76.
PubMed
76) Magann, EF. et al. Does an amniotic fluid index of </=5cm necessitate delivery in high-risk pregnancies? A case-control study. Am J Obstet Gynecol. 180(6 Pt 1), 1999, 1354-9.
 
77) Rainford, M. et al. Amniotic fluid index in the uncomplicated term pregnancy : Prediction of outcome. J Reprod Med. 46(6), 2001, 589-92.
PubMed
78) Ott, WJ. Reevaluation of the relationship between amniotic fluid volume and perinatal outcome. Am J Obstet Gynecol. 192(6), 2005, 1803-9, discussion 1809.
PubMed
79) Zhang, J. et al. Isolated oligohydramnios is not associated with adverse perinatal outcomes. BJOG. 111(3), 2004, 220-5.
PubMed
80) Moore, TR. Sonographic screening for oligohydramnios : does it decrease or increase morbidity? Obstet Gynecol. 104(1), 2004, 3-4.
 
81) Ek, S., Andersson, A., Johansson, A., Kublicas, M. Oligohydramnios in uncomplicated pregnancies beyond 40 completed weeks : A prospective, randomised, pilot study on maternal and neonatal outcomes. Fetal Diagn Ther. 20(3), 2005, 182-5.
 
82) Miyazaki, FS. et al. Saline amnioinfusion for relief of variable or prolonged decelerations : A preliminary report. Am J Obstet Gynecol. 146(6), 1983, 670-8.
 
83) Hofmeyr, GJ. Amnioinfusion for meconium-stained liquor in labour. Cochrane Database Syst Rev. (2), 2000, CD000014.
PubMed
84) Hofmeyr, GJ. Amnioinfusion for umbilical cord compression in labour. Cochrane Database Syst Rev. (2), 2000, CD000013.
PubMed
85) Pierce, J. et al. Intrapartum amnioinfusion for meconiumstained fluid : meta-analysis of prospective clinical trials. Obstet Gynecol. 95(6 Pt 2), 2000, 1051-6.
 
86) Pitt, C. et al. Prophylactic amnioinfusion for intrapartum oligohydramnios : a meta-analysis of randomized controlled trials. Obstet Gynecol. 96(5 Pt 2), 2000, 861-6.
 
87) ACOG Committee Obstetric Practice. ACOG Committee Opinion Number 346, October 2006 : amnioninfusion does not prevent meconium aspiration syndrome. Obstet Gynecol. 108(4), 2006, 1053.
 
88) Fraser, WD., Hofmeyr, J., Lede, R., Faron, G., Alexander, S., Goffinet, F., Ohlsson, A., Goulet, C., Turcot-Lemay, L., Prendiville, W., Marcoux, S., Laperriere, L., Roy, C., Petrou, S., Xu, HR., Wei, B. Amnioinfusion Trial Group. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med. 353(9), 2005, 909-17.
PubMed

第9章 子宮内胎児死亡

P.185 掲載の参考文献
1) 日本産科婦人科学会編. 産科婦人科用語集・用語解説集. 改訂第2版. 東京, 金原出版, 2008, 191.
 
2) French, FE. et al. Probabilities of fetal mortality. Public Health Rep. 77, 1962, 835-47.
PubMed
3) Taylor, WF. "The probability of fetal death". Congenital Malformations. Clarke-Fraster, F. et al. eds. Amsterdam, Excerpta Medica, 1970, 307-20.
 
4) Shapiro, S. et al. Factors associated with early and late fetal loss. Advances in Planned Parenthood. 6, 1971, 45-63.
 
5) Harlap, S. et al. Spontaneous foetal losses in women using different contraceptives around the time of contraception. Int J Epidemiol. 9, 1980, 49-56.
PubMed
6) Miller, JF. et al. Fetal loss after implantation. Lancet. 2, 1980, 554-6.
PubMed
7) Kline, J. et al. "Estimates of very early fetal loss". Abstracts of the ninth meeting of the international epidemiological association. Edinburgh, Scotland, 1981. 8.
 
8) 厚生労働省雇用均等・児童家庭局母子保健課, 母子衛生研究会. 母子保健の主なる統計. 母子保健事業団, 2009, 82.
 
9) Minakami, H. et al. Stillbirth risk in Japan. Lancet. 341, 1993, 1603-4.
PubMed
10) Yerushalmy, J. et al. Studies ontwins. I. The relation of order of birth and age of parents to frequency of like-sexed and unlike-sexed twin deliveries. Hum Biol. 12, 95-113.
 
11) Hook, EB. Rates of chromosome abnomalities at different maternal ages. Obstet Gynecol. 58, 1981, 282-5.
 
12) Newman, NM. et al. Effects of alcohol in pregnancy. Med J Ausat. 2, 1980, 5-10.
 
13) Kline, J. et al. Smoking : a risk factor for spontaneous abortion. N Engl J Med. 297, 1978, 793-6.
 
14) Meyer, MB. "Effects of maternal smoking and altitude on birthweight and gestation". The epidemiology of prematurity. Reed, DM. et al. eds. Baltimore, Urban and Schwarzenberg, 1977, 81-104.
 
15) Pitkin, RM. Fetal death : Diagnosis and management. Am J Obstet Gynecol. 157, 1987, 583-9.
PubMed
16) Stewart, AM. The study of freegas in the foetus as a sign of intrauterine death. Br J Radiol. 34, 1961, 187-93.
 
17) Bennett, R. Unequivocal radiological evidence of intrauterine foetal death, including demonstration of gas formation within the foetal circulation : report of a case, and review of thirtyseven cases of foetal death. Clin Radiol. 11, 1960, 200-4.
 
18) Noonan, CD. Radiographic diagnosis of fetal death. Radiol Clin North Am. 12, 1974, 29-35.
PubMed
19) Slezak, P. Intrafetal gas. Radiology. 89, 1967, 881-2.
 
20) Gruber, FH. Gas in the umbilical vessels as a sign of fetal death. Radiology. 89, 1967, 878-80.
 
21) Bernard, KG. et al. Sonographic differentiation between blighted ovum and early viable pregnancy. AJR. 144, 1985, 597-602.
PubMed
22) Nyberg, DA. et al. Threatened abortion : sonographic distinction of normal and abnormal gestaion sacs. Radiology. 158, 1986, 397-400.
PubMed
23) Lyons, EA. et al. "Ultrasound in the first trimester of pregnancy". Ultrasonography in Obstetrics and Gynecology. Callen, PW. ed. Philadelphia, WB Saunders, 1983, 6.
 
24) Goldstein, SR. Embryonic death in early pregnancy : A new look at the first trimester. Obstet Gynecol. 84, 1994, 294-7.
 
25) Cunningham, FG. et al. "Disease and Injuries of the Fetus and Newborn". Williams Obstetrics. 23rd ed. New York, MC Grow Hill, 2010, 631.
 
26) 佐藤昌司. 本邦における死産の疫学 : 日本産科婦人科学会周産期登録データベースから. 日本周産期・新生児医学会雑誌. 43, 2007, 937-40.
Medical*Online
27) Angell, RR. et al. Chromosome variation in perinatal mortality : a survey of 500 cases. J Med Genet. 21, 1984, 39-44.
 
28) Warburton, D. et al. "Cytogenetic abnomarities in spontaneous abortions in recognized conception". Perinatal genetics : diagnosis and treatment. Porter, IH. et al. eds. New York, Academic Press, 1986, 133-148.
 
29) Warburton, D. Chromosomal causes of fetal death. Clin Obstet Gynecol. 30, 1987, 268-77.
PubMed
30) Poland, BJ. et al. The use of spontaneous abortuses and stillbirths in genetic counseling. Am J Obstet Gynecol. 118, 1974, 322-36.
PubMed
31) Faye-Petersen, OM. et al. The value of perinatal autopsy. Obstet Gynecol. 94, 1999, 915-20.
PubMed
32) Hall, BD. Nonchromosomal malformations and syndromes associated with stillbirth. Clin Obstet Gynecol. 30, 1987, 278-83.
PubMed
33) Trimble, BK. et al. Congenital anomalies of central nervous system. Incidence in British Columbia, 1952-72. Tetratology. 17, 1978, 43-50.
 
34) Ossipoff, V. et al. Etologic factors in amniotic band syndrome. BD : OAS. 13, 1977, 117-32.
 
35) Curry, CJR. et al. The Potter sequence : a clinical analysis of 80 cases. Am J Med Genet. 19, 1984, 679-702.
 
36) Baird, PA. et al. An epidemiologic study of congenital malformations of the anterior abdominal wall in more than half million consecutive live births. Am J Hum Genet. 33, 1981, 470-8.
PubMed
37) Clementi, M. et al. Further investigations when abdominal wall defects are diagnosed in utero. Lancet. II, 1983, 1083-4.
 
38) Shannon, MW. et al. X-linked hydrocephalus. J Med Genet. 5, 1968, 326-8.
PubMed
39) Prober, BR. et al. Complexities of intraventricular abnormalities. J Pediatr. 108, 1986, 545-51.
 
40) Halliday, J. et al. X-linked hydrocephalus : a survey of a 20 year period in Victoria, Australia. J Med Genet. 23, 1986, 23-31.
PubMed
41) Camera, G. et al. "Birth prevalence of skeletal dysplasias in the Italian multicentric monitoring for birth defects". Skeletal Dysplasias. New York, Alan R, Liss Publishers, 1982, 441-9.
 
42) Cartlidge, PHT. et al. Value and quality of perinatal and infant postmortem examination : Cohort analysis of 400 consecutive deaths. BMJ. 310, 1995, 155.
 
43) Copper, RL. et al. Risk factors for fetal death in white, black, and hispanic women. Obstet Gynecol. 84, 1994, 490.
PubMed
44) Fretts, RC. et al. Causes of fetal death in women of advanced maternal age. Obstet Gynecol. 89, 1997, 40-5.
PubMed
45) Lammer, EJ. et al. Classification and analysis of fetal deaths in Massachusetts. JAMA. 261, 1989, 1757.
PubMed
46) Pauli, RM. et al. Wisconsin Stillbirth Service Program : II. Analysis of diagnoses and diagnostic categories in the first 1000 referrals. Am J Med Genet. 50, 1994, 135.
 
47) Cooper, LZ. The history and medical consequences of rubella. Rev Infect Dis. 7 (1), 1985, S2.
PubMed
48) Peckharm, C. Congenital rubella in United Kingdom before 1970 : The prevaccine Era. Rev Infect Dis. 7 (1), 1985, S11.
 
49) Anderson, MJ. Human parvovirouses. J Infect Dis. 161, 1990, 603.
 
50) American College of Obstetrics and Gynecologist. "Perinatal viral and parasitic infections." ACOG Practice Bulletin. No.20. Washington DC, ACOG, September 2000.
 
51) Bates, HR. Coxsackie virus B3 calcific pancarditis and hydrops fetalis. Am J Obstet Gynecol. 106, 1970, 629-30.
PubMed
52) Dobson, PC. et al. Mortality and morbidity of fetal growth retardation. Aust NZ J Obstet Gynecol. 21, 1981, 69.
 
53) Starfield, B. et al. Mortality and morbidity in infants with intrauterine growth retardation. J Pediatr. 101, 1982, 978.
PubMed
54) Reisman, IE. Chromosomal abnormalities and intrauterine growth retardation. Pediatr Clin North Am. 17, 1970, 101.
 
55) Chen, ATL. et al. The effects of chromosomal abnormalities on birth weight in man. Hum Hered. 22, 1972, 209.
 
56) Hook, E. Chromosome abnormalities and spontaneous fetal death following amniocentesis : further data and associations with maternal age. Am J Hum Genet. 35, 1983, 110.
PubMed
57) Snijders, RJM. et al. Fetal growth retardation : Associated malformations and chromosomal abnormalities. Am J Obstet Gynecol. 168, 1993, 547.
 
58) Knab, DR. Abruptio placentae. Obstet Gynecol. 52, 1978, 625.
PubMed
59) Abdella, TN. et al. Relationship of hypertensive disease to abruptio placentae. Obstet Gynecol. 63, 1984, 365.
PubMed
60) Hibbard, BM. et al. Abruptio placenta. Obstet Gynecol. 27, 1966, 155-67.
PubMed
61) Laube, DW. et al. Fetomaternal bleeding as a cause for "unexplained" fetal death. Obstet Gynecol. 60, 1982, 649-51.
PubMed
62) Owen, J. et al. Comparison of predelivery versus postdelivery Kleihauer-Betke stains in cases of fetal death. Am J Obstet Gynecol. 161, 1989, 663-6.
PubMed
63) Samadi, R. et al. Massive fetomaternal hemorrhage and fetal death : Is it predictable? Am J Obstet Gynecol. 174, 1996, 391.
 
64) Dippel, AL. Death of foetus in utero. Johns Hopkins Medical Journal. 54, 1934, 24.
 
65) Bruce, S. et al. Umbilical cord complications as a cause of perinatal morbidity and mortality. J Perinat Med. 6, 1978, 89.
PubMed
66) Naeye, RL. Placenta previa. Obstet Gynecol. 52, 1978, 521.
PubMed
67) Nicolaides, KH. et al. The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. Am J Obstet Gynecol. 152, 1985, 341.
 
68) Nicolaides, KH. et al. Fetal haematology in rhesus isoimmunization. Br Med J. 290, 1985, 661.
 
69) Branch, DW. Immunologic disease and fetal death. Clin Obstet Gynecol. 30, 1987, 295-311.
PubMed
70) Christiaens, GC. et al. Spontaneous abortion in proven intact pregnancies. Lancet. 2, 1984, 571.
PubMed
71) Lind, T. et al. Human pregnancy failure. Lancet. 1, 1986, 91.
PubMed
72) Parke, AL. Systemic Lupus Erythematosus. Lahita, RG. ed. New York, Churchill Livingstone, 1992, 543.
 
73) Fausett, MB. et al. Autoimmunity and pregnancy loss. Semin in Preprod Med. 18, 2000, 379-92.
 
74) Slate, WG. et al. Scleroderma and pregnancy. Am J Obstet Gynecol. 101, 1968, 335.
PubMed
75) Johnson, TR. et al. Scleroderma and pregnancy. Obstet Gynecol. 23, 1964, 467.
PubMed
76) Ballou, SP. et al. Pregnancy and systemic sclerosis. Arthritis Rheum. 27, 1984, 295.
PubMed
77) Kaufman, RL. et al. Pregnancy in mixed connective tissue disease : comparison with systemic lupus erythematosus. J Rheumatol. 9, 1982, 549.
PubMed
78) Gutierrez, G. et al. Polymyositis/dermatomyositis and pregnancy. Arthritis Rheum. 27, 1984, 291.
PubMed
79) Bauer, KA. et al. Polymiositis complicating pregnancy. Arch Intern Med. 139, 1979, 449.
 
80) Robertson, H. et al. Thrombophilia in pregnancy : a systemic review. Br J Haematol. 132, 2005, 171.
 
81) Lockshin, MD. et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 313, 1985, 152-6.
PubMed
82) Lockwood, CJ. et al. Anti-phospholipid antibody and pregnancy wastage. Lancet. 2 (8509), 1986, 742-3.
PubMed
83) Oshiro, BT. et al. Antiphospholipid antibodies and fetal death. Obstet Gynecol. 87, 1996, 489-93.
PubMed
84) Aoki, K. et al. Clinical significance of beta 2-glycoprotein I-dependent cardiolipin antibodies in the reproductive autoimmune failure syndrome : correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol. 172, 1995, 926-31.
 
85) Branch, DW. et al. Outcome of treated pregnancies in women with antiphospholipid syndrome : An update of the experience. Obstet Gynecol. 80, 1992, 614-20.
PubMed
86) Backos, M. et al. Pregnancy complications in women with recurrent miscarriage associated with antiphospholopid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol. 106, 1999, 102-7.
 
87) Empson, et al. Prevention of recurrent misscarrege for woman with antiphospholipid antibody or lupus anticoagulant. The Cochrane Database of Systemic Reviews 2005, Issue 2.
PubMed
88) Edelberg, ST. et al. Decreased fetal movements with sustained maternal hyperglycemia using the glucose clamp technique. Am J Obstet Gynecol. 156, 1987, 1101.
 
89) Kariniemi, V. et al. Reduced short term variability of fetal heart rate in association with maternal hyperglycemia during pregnancy in insulin dependent diabetic woman. Am J Obstet Gynecol. 147, 1983, 793.
PubMed
90) Bracero, L. et al. Umbilical artery velocimetry in diabetes and pregnancy. Obstet Gynecol. 68, 1986, 654.
PubMed
91) Phillips, AF. et al. Consequences of perturbation of fetal fuels in ovine pregnancy. Diabetes. 34 (2), 1985, 32.
 
92) Lin, C. et al. Fetal outcome in hypertensive disorders of pregnacy. Am J Obstet Gynecol. 142, 1982, 255.
 
93) Sibai, BM. et al. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol. 61, 1983, 571.
PubMed
94) Sibai, BM. et al. Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol. 64, 1984, 319.
PubMed
95) Poulson, AM. et al. Fetal death secondary to nonpenetrating trauma to the gravid uterus. Am J Obstet Gynecol. 116, 1973, 580.
 
96) WHO : recommended definitions, terminology and format for statistical tables related to perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended, October 14, 1976. Acta Obstet Gynecol Scand. 56, 1977, 247-53.
PubMed
97) FIGO. Report of the FIGO subcommittee on perinatal epidemiology and health statistics following a workshop in Cairo Nov. 11-18 1984. FIGO, London, 1986, 54.
 
98) American College of Obstetricians and Gynecologists. Quality, Evaluation, and Improvement in Practice : Postterm pregnancy. Committee on Quality Assessment. Criteria Set No. 10. 1995. 8.
 
99) 日本産科婦人科学会編. 産科婦人科用語集・用語解説集. 改訂第2版. 東京, 金原出版, 2008, 143.
 
100) 厚生労働省雇用均等・児童家庭局母子保健課, 母子衛生研究会. 母子保健の主なる統計. 母子保健事業団, 2011, 49.
 
101) Unger, C. et al. Does labor start too late? J Perinat Med. 24, 1996, 661-7.
PubMed
102) Campbell, MK. et al. Post-term birth : Risk factors and outcomes in a 10-year cohort of norwegain birth. Obstet Gynecol. 89, 1997, 543-8.
 
103) Feldman, GB. Prospective risk of stillbirth. Obstet Gynecol. 79, 1992, 547-53.
PubMed
104) Allen, VM. et al. Managing prolonged pregnancy. Contemp Obstet Gynecol. 45, 2000, 106-10.
 
105) Freeman, RK. et al. Postdate pregnancy : utilization of contraction stress testing for primary fetal surveillance. Am J Obstet Gynecol. 140, 1981, 128.
PubMed
106) The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. A clinical trial of induction of labor versus expectant management in postterm pregnancy. Am J Obstet Gynecol. 170, 1994, 716-23.
PubMed
107) Goldstein, DP. et al. Circulatory fibrinolytic activity : a precursor of hypofibrinogemia following fetal death in utero. Obstet Gynecol. 22, 1963, 174-80.
 
108) Tricomi, V. et al. Fetal death in utero. Am J Obstet Gynecol. 74, 1957, 1092.
PubMed
109) Anderson, HM. "Maternal hematologic disorders". Maternal and Fetal Medicine : Princeple and practice. 3rd ed. Creasy, RK. et al. eds. Philadelphia, WB Saunders, 1993, 890.
 
110) Prichard, JA. Fetal death in utero. Obstet Gynecol. 14, 1959, 573.
 
111) Phillips, LL. et al. Hypofibrinogenemia and intrauterine death. Am J Obstet Gynecol. 89, 1964, 903.
PubMed
112) Prichard, JA. et al. Studies of fibrinogen and other hemostatic factors in women with intrauterine death and delayed delivery. Surg Gynecol Obstet. 101, 1955, 467.
 
113) Malone, FD., D'Alton, ME. Management of multiple gestations complicated by a single anomalous fetus. Curr Opin Obstet Gynecol. 9 (3), 1997, 213-6.
PubMed
114) Jimenez, JM. et al. Pathogenesis and treatment of coagulation defects resulting from fetal death. Obstet Gynecol. 32, 1968, 449.
PubMed
115) Lerner, R. et al. Heparine in the treatment of hypofibrinogenemia complicating fetal death in utero. Am J Obstet Gynecol. 97, 1967, 373.
PubMed
116) Chasen, ST., Luo, G., Perni, SC. et al. Are in vitro fertilization pregnancies with early spontaneous reduction high risk? Am J Obstet Gynecol. 195 (3), 2006, 814-7.
PubMed
117) ACOG Practice Bulletin. No.56. Multiple gestation : complicated twin, triplet, and high-order multifetal pregnancy. 2004.
PubMed
118) Ong, SS., Zamora, J., Khan, KS. et al. Prognosis for the cotwin following single-twin death : a systematic review. BJOG. 113 (9), 2006, 992-8.
 
119) Nicolinim, U., Poblete, A. Single intrauterine death in monochorionic twin pregnancies. Ultrasound Obstet Gynecol. 14(5), 1999, 297-301.
 
120) 日本産科婦人科学会周産期委員会報告 (委員長 : 神保利春). 日本産科婦人科学会雑誌. 48, 1996, 1032-3.
 
121) 泉章夫ほか. "子宮内胎児死亡". 異常妊娠. 武谷雄二編. 東京, 中山書店, 1998, 221-4 (新女性医学大系23).
 
122) 川口晴菜, 光田信明. 死亡時期の明確なMD双胎1児子宮内死亡の扱いについて. 産婦人科の実際. 59, 2010, 969-74.
 
123) Freeman, RK. et al. The significance of a previous stillbirth. Am J Obstet Gynecol. 151, 1985, 7-13.
PubMed
124) Samueloff, A. et al. Recurrent stillbirth : Significance and characteristics. J Reprod Med. 88, 1993, 883.
 
125) Weeks, JW. et al. Antepartum surveillance for a history of stillbirth : When to begin? Am J Obstet Gynecol. 172, 1995, 486.
 
126) Goldenberg, RL. et al. Pregnancy outcome following a second-trimester loss. Obstet Gynecol. 81, 1993, 444.
PubMed
127) American College of Obstetricians and Gynecologists. Antepartum fetal surveillance. Practice Bulletin. No.9. 1999. Oct.
 

第10章 妊娠第3三半期における性器出血

P.200 掲載の参考文献
1) 社団法人日本産科婦人科学会編. 産婦人科用語集・用語解説集. 金原出版, 2003.
 
2) Hurd, WW. et al. Selective management of abruptio placentae : A prospective study. Obstet Gynecol. 61, 1983, 467-73.
PubMed
3) Karegard, M., Gennser, G. Incidence and recurrence rate of abruptio placentae in Sweden. Obstet Gynecol. 67, 1986, 523.
PubMed
4) Ananth, CV. et al. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy : A meta-analysis of observational studies. Obstet Gynecol. 93(4), 1999, 622-8.
PubMed
5) Saftlas, A. et al. National trends in the incidence of abruptio placenta. Obstet Gynecol. 78, 1991, 1081-6.
PubMed
6) Broers, T. et al. The occurrence of abruptio placentae in Canada : 1990 to 1997. Chronic Dis Can. 25(2), 2004, 16-20.
PubMed
7) Knab, D. Abruptio placentae : An assessment of the time and method of delivery. Obstet Gynecol. 52, 1978, 625.
PubMed
8) Rusmussen, S. et al. The occurrence of placental abruption in Norway 1967-1991. Acta Obstet Gynecol Scand. 75, 1996, 222.
 
9) Hibbard, BM., Jeffcoate, TNA. Abruptio Placentae. Obstet Gynecol. 27, 1966, 155.
 
10) Katz, VL. et al. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv. 45, 1990, 719-26.
PubMed
11) Ananth, CV. et al. Placental abruption among singleton and twin births in the United States : risk factor profiles. Am J Epidemiol. 15(153), 2001, 771-8.
PubMed
12) Pritchard, J. et al. Genetics of severe placental abruption. Am J Obstet Gynecol. 108, 1970, 22.
 
13) Ananth, CV. et al. Placental abruption and its association with hypertension and prolonged rupture of membranes : A methodologic review and mete-analysis. Obstet Gynecol. 88, 1996, 309.
 
14) Nath, CA. et al. Histologic evidence of inflammation and risk of placental abruption. Am J Obstet Gynecol. 197, 2007, 319. e1-e6.
 
15) Gherman, RB., Goodwin, TM. Obstetric implications of activated protein C resistance and factor V Leiden mutation. Obstet Gynecol Surv. 55, 2000, 117.
PubMed
16) Towery, R. et al. Evaluation of pregnant woman after blunt injury. J Trauma. 35, 1993, 731.
PubMed
17) Pearlman, MD. et al. A prospective controlled study of outcome after trauma during pregnancy. Am J Obstet Gynecol. 162(6), 1990, 1502-7.
PubMed
18) Furunishi, M. et al. Pregnancy following placental abruption. Arch Gynecol Obstet. 267, 2002, 11-3.
 
19) Dombrowski, MP. et al. Cocain abuse is associated with abruptio placentae and decreased birth weight, but not shorter labor. Obstet Gynecol. 77, 1991, 139.
 
20) Rice, JP. et al. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol. 160, 1989, 1212-6.
PubMed
21) Coronado, GD. et al. Complications in pregnancy, labor, and delivery with uterine leiomyomas : a population-based study. Obstet Gynecol. 95, 2000, 764-9.
PubMed
22) Toohey, JS. et al. The "dangerous multipara" : Fact or fiction? Am J Obstet Gynecol. 172, 1985, 683.
PubMed
23) Rasmussen, S. et al. Occurrence of placental abruption in relatives. BJOG. 116(5), 2009, 693-9.
PubMed
24) Signore, C. et al. Circulating angiogenic factors and placental abruption. Obstet Gynecol. 108(2), 2006, 338-44.
PubMed
25) Nyberg, DA. et al. Sonographic spectrum of placental abruption. AJR. 148, 1987, 161-4.
PubMed
26) Bond, A. et al. Expectant management of abruptio placentae before 35 weeks gestation. Am J Perinatol. 6, 1989, 121.
PubMed
27) Towers, CV. et al. Is tocolysis safe in the management of third-trimester bleeding? Am J Obstet Gynecol. 180, 1999, 1572-8.
PubMed
28) Prichard, JA. et al. On reducing the frequency of severe abruptio placentae. Am J Obstet Gynecol. 165, 1991, 1345-51.
 
29) 雨宮章. 胎盤早期剥離の成因とその管理. 日本産科婦人科学会誌. 1998, N-147.
 
30) 小林隆夫. 常位胎盤早期剥離. 周産期医学. 31, 2001, 254-6.
 
31) Conningham, FG. et al. "Placental abruption". Williams Obstetrics. 23st ed. New York, McGraw-Hill, 2010, 761-69.
 
32) Quilligan, EJ., Zuspan, FP. "Third trimester bleeding". Current Therapy in Obstetrics and Gynecology. 5 th. W B Saunders, 2000, 360-4.
 
33) Iyasu, S. et al. The epidemiology of placenta previa in the United States, 1979 through 1987. Am J Obstet Gynecol. 168, 1993, 1424.
PubMed
34) Ananth, CV. et al. Effect of maternal age and parity on the risk of uteroplacental bleeding disorders in pregnancy. Obstet Gynecol. 88, 1996, 511.
PubMed
35) Babinszki, A. et al. Perinatal outcome in grand and greatgrand multiparity. Am J Obstet Gynecol. 181, 1999, 669.
PubMed
36) Miller, DA. et al. Incidence of placenta previa with previous cesarean. Am J Obstet Gynecol. 174, 1996, 345.
 
37) Frederiksen, MC. et al. Placenta previa : a 22-year analysis. Am J Obstet Gynecol. 180(6 Pt 1), 1999, 1432-7.
 
38) Williams, MA. et al. Cigarette smoking during pregnancy in relation to placenta previa. Am J Obstet Gynecol. 165, 1991, 28.
PubMed
39) Clark, SL. et al. Placenta previa/accreta and prior cesarean section. Obstet Gynecol. 66, 1985, 89.
PubMed
40) Cox, S. et al. Placental percreta : Ultrasound diagnosis and conservative surgical management. Obstet Gynecol. 71, 1988, 454.
PubMed
41) Hoffman-Tretin, JC. et al. Placenta accreta : Additional sonographic observations. J Ultrasound Med. 11(1), 1992, 29.
PubMed
42) 鮫島浩. 前置胎盤症例における癒着胎盤の画像診断. 産婦人科の実際. 57(6), 2008, 899-903.
 
43) Lerner, JP. et al. Characterization of placenta accreta using transvaginal sonography and color Doppler imaging. Ultrasound Obstet Gynecol. 5, 1995, 198.
PubMed
44) Taipale, P. et al. Perinatal diagnosis of placenta accreta and percreta with ultrasonography, color doppler, and magnetic resonance imaging. Obstet Gynecol. 104, 2004, 537-40.
 
45) Levine, D. et al. Placenta accreta : Evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology. 205(3), 1997, 773.
 
46) Chen, MM. et al. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 112(2 Pt 1), 2008, 333-40.
 
47) Ash, A. et al. Caesarean scar pregnancy. BJOG. 114(3), 2007, 253-63.
PubMed
48) Comstock, CH. et al. The early sonographic appearance of placenta accreta. J Ultrasound Med. 22(1), 2003, 19-23.
 
49) Hung, TH. et al. Risk factors for placenta accreta. Obstet Gynecol. 93(4), 1999, 545-50.
PubMed
50) Sekizawa, A. et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem. 48(2), 2002, 353-4.
PubMed
51) Miura, K. et al. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy. Prenat Diagn. 28(9), 2008, 805-9.
 
52) Bhide, A. et al. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. Br J Obstet Gynaecol. 110, 2003, 860-4.
 
53) Bronsteen, R. et al. Effect of a low-lying placenta on delivery outcome. Ultrasound Obstet Gynecol. 33(2), 2009, 204-8.
PubMed
54) Vergani, P. et al. Placenta previa : distance to internal os and mode of delivery. Am J Obstet Gynecol. 201(3), 2009, 266. e1-5.
 
55) Fung, TY., Lau, TK. Poor perinatal outcome associated with vasa previa : is it preventable? A report of three cases and review of the literature. Ultrasound Obstet Gynecol. 12, 1998, 430-3.
PubMed
56) Conningham, FG. et al. "Placenta Previa". Williams Obstetrics. 23st ed. New York, McGraw-Hill, 2010, 769-73.
 
57) Taipale, P. et al. Diagnosis of placenta previa by transvaginal sonographic screening at 12-16 weeks in a nonselected population. Obstet Gynecol. 89(3), 1997, 364.
 
58) Wing, DA. et al. Management of the symptomatic placental previa : A randomized, controlled trial of inpatient versus outpatient expectant management. Am J Obstet Gynecol. 175, 1996, 806.
PubMed
59) Cotton, DB. et al. The conservative aggressive management of placenta previa. Am J Obstet Gynecol. 137, 1980, 687.
PubMed
60) Silver, R. et al. Placenta previa : aggressive expectant management. Am J Obstet Gynecol. 150, 1984, 15.
PubMed
61) Besinger, RE. et al. The effect of tocolytic use in the management of symptomatic placenta previa. Am J Obstet Gynecol. 172, 1995, 1770-8.
PubMed
62) Sharma, A. et al. Tocolytic therapy in conservative management of symptomatic placental previa. Int J Gynaecol Obstet. 84(2), 2004, 109-13.
PubMed
63) Druzin, ML. Packing of lower uterine segment for control of postcesarean bleeding in instances of placenta previa. Surg Gynaecol Obstet. 169, 1989, 543.
 
64) Abenhaim, HA. et al. Incidence and risk factors of amniotic fluid embolisms : a population-based study on 3 million births in the United States. Am J Obstet Gynecol. 199(1), 2008, 49. e1-8.
 
65) Eller, AG. et al. Optimal management strategies for placenta accreta. BJOG. 116(5), 2009, 648-54.
PubMed
66) Rossi, AC. et al. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding : a systematic review. Obstet Gynecol. 115(3), 2010, 637-44.
PubMed
67) Allam, J. et al. Cell salvage in obstetrics. Int J Obstet Anesth. 17(1), 2008, 37-45.
PubMed
68) Mussali, GM. et al. Placenta accreta and methotrexate therapy : three case reports. J Perinatol. 20, 2004, 331-4.
 
69) Sentilhes, L. et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 115(3), 2010, 526-34.
PubMed
70) Sumigama, S. et al. Placenta previa increta/percreta in Japan : aretrospective study of ultrasound findings, management and clinical course. J Obstet Gynaecol Res. 33(5), 2007, 606-11.
 
71) Iwata, A. et al. Limitations of internal iliac artery ligation for the reduction of intraoperative hemorrhage during cesarean hysterectomy in cases of placenta previa accreta. J Obstet Gynaecol Res. 36(2), 2010, 254-9.
PubMed
72) Dubois, J. et al. Placenta percreta : balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses. Am J Obstet Gynecol. 176, 1997, 723.
PubMed
73) Alvarez, M. et al. Prophylactic and emergent arterial catheterization for selective embolization in obstetric hemorrhage. Am J Perinatol. 9, 1992, 441.
PubMed
74) Greenberg, JI. et al. Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation : a cautionary case. Am J Obstet Gynecol. 197(5), 2007, 470. e1-4.
 
75) Baulies, S. et al. Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors. Prenat Diagn. 27(7), 2007, 595-9.
PubMed
76) Carlan, SJ., Knuppel, RA. Vasa previa : Approaches to detection. Fem Patient. 15, 1990, 37.
 
77) Oylese, Y. et al. Vasa previa : the impact of prenatal diagnosis on outcomes. Obstet Gynecol. 103, 2004, 937-42.
 
78) Hata, K. et al. An accurate antenatal diagnosis of vasa previa with transvaginal color Doppler ultrasonography. Am J Obstet Gynecol. 171, 1994, 265.
PubMed
79) Lijoi, AF., Brady, J. Vasa previa. Diagnosis and management. J Am Board Fam Pract. 16, 2003, 543-8.
PubMed
80) Daly-Jones, E. et al. Vasa previa : Secondtrimester diagnosis using color flow imaging. Br J Obstet Gynaecol. 103, 1996, 284-6.
 
81) American Institute of Ultrasound in Medicine. Standards for performance of the antepartum abstetrical ultrasound examination, 1994.
 

第11章 過期妊娠

P.211 掲載の参考文献
1) Clifford, SH. Postmaturity with placental dysfunction : Clinical syndrome and pathologic findings. J Pediatr. 44, 1954, 1-13.
PubMed
2) Minakami, H. et al. Stillbirth risk in Japan. Lancet. 341, 1993, 1603-4.
PubMed
3) Unger, C. et al. Does labor start too late?. J Perinat Med. 24, 1996, 661-7.
PubMed
4) Osanai, K. Present status of obstetrics analgesia and anesthesia, and concomitant use of elective induction of labor. 北里医学. 8, 1978, 32-50.
 
5) Eden, RD. et al. Perinatal characteristics of uncomplicated postdate pregnancies. Obstet Gynecol. 69, 1987, 296-9.
PubMed
6) Cheng, YW. et al. Perinatal outcomes in low-risk term pregnancies : do they differ by week of gestation? Am J Obstet Gynecol. 199(4), 2008, 370, e1-7.
 
7) Bruckner TA, et al. Increased neonatal mortality among normal-weight births beyond 41 weeks of gestation in California. Am J Obstet Gynecol. 199(4), 2008, 421. e1-7. E-pub 2008 Jul 17.
 
8) Nakling, J., Backe, B. Pregnancy risk increases from 41 weeks of gestation. Acta Obstet Gynecol Scand. 85(6), 2006, 663-8.
PubMed
9) Kistka, ZA. et al. Risk for postterm delivery after previous postterm delivery. Am J Obstet Gynecol. 196(3), 2007, 241. e1-6.
 
10) 桑原慶紀. 過期産の本態とその取り扱い方. 産婦人科治療. 50, 1985, 1985.
 
11) 塚田一郎. 過期妊娠の管理をめぐる問題点. 日本産科婦人科学会雑誌. 38, 1986, 1257.
 
12) 平野和雄ほか. 過期妊娠. 周産期医学. 16, 1986, 155-6.
 
13) 佐藤郁夫. 過期妊娠のケアのポイント. ペリネイタルケア. 9, 1990, 765-70.
 
14) Trimmer, KJ. et al. Observations on the cause of oligohydramnios in prolonged pregnancy. Am J Obstet Gynecol. 163, 1990, 1900-3.
PubMed
15) Reynolds, JW. et al. Fetoplacental steroid metabolism in prolonged pregnancies. Am J Obstet Gynecol. 154, 1986, 74-9.
PubMed
16) Rutherford, SE. et al. The four-quadrant assessment of amniotic fluid volume : an adjunct to antepartum fetal heart rate testing. Obstet Gynecol. 70, 1987, 353-6.
PubMed
17) Ahn, MO. et al. Antepartum fetal surveillance in the patient with decreased fetal movement. Am J Obstet Gynecol. 157, 1987, 860-4.
PubMed
18) Beischer, NA. et al. Studies in prolonged pregnancy : 3. Amniocentesis in prolonged pregnancy. Am J Obstet Gynecol. 103, 1969, 496-503.
PubMed
19) Phelan, JP. et al. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation. J Reprod Med. 32, 1987, 540-2.
PubMed
20) Veille, JC. et al. Fetal renal pulsed Doppler waveform in prolonged pregnancies. Am J Obstet Gynecol. 169, 1993, 882-4.
PubMed
21) Gabbe, SG. et al. Umbilical cord compression associated with amniotomy : laboratory observations. Am J Obstet Gynecol. 126, 1976, 353-5.
PubMed
22) 塚田一郎. 過期妊娠の管理をめぐって. 産婦人科治療. 53, 1986, 465.
 
23) Zhang, X. et al. How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol. 198(5), 2008, 517. e1-6.
 
24) Usher, RH. et al. Assessment of fetal risk in postdate pregnancies. Am J Obstet Gynecol. 158, 1988, 259-64.
PubMed
25) Leveno, KJ. et al. Prolonged pregnancy : 1. Observations concerning the causes of fetal distress. Am J Obstet Gynecol. 150, 1984, 465-73.
PubMed
26) Bruckner, TA. et al. Increased neonatal mortality among normal-weight births beyond 41 weeks of gestation in California. Am J Obstet Gynecol. 199(4), 2008, 421, e1-7.
 
27) Boehm, FH. et al. Improved outcome of twice weekly nonstress testing. Obstet Gynecol. 67, 1986, 566-8.
PubMed
28) Clement, D. et al. Acute oligohydramnios in postdate pregnancy. Am J Obstet Gynecol. 157, 1987, 884-6.
PubMed
29) Freeman, RK. et al. A prospective multi-institutional study of antepartum fetal heart rate monitoring : 2. Contraction stress test versus nonstress test for primary surveillance. Am J Obstet Gynecol. 143, 1982, 778-81.
PubMed
30) Gagnon, R. et al. Stimulation of human fetuses with sound and viblation. Am J Obstet Gynecol. 155, 1986, 848-51.
PubMed
31) Murata, Y. et al. Fetal heart rate accelerations and late decelerations during the course of intrauterine death in chronically catheterized rhesus monkeys. Am J Obstet Gynecol. 144, 1982, 218-23.
PubMed
32) Vintzileos, AM. et al. The relationships among the fetal biophysical profile, umbilical cord pH, and Apgar scores. Am J Obstet Gynecol. 157, 1987, 627-31.
PubMed
33) Manning, FA. et al. Fetal biophysical profile scoring : a prospective study in 1,184 high-risk patients. Am J Obstet Gynecol. 140, 1981, 289-94.
PubMed
34) Johnson, JM. et al. Biophysical profile scoring in the management of the postterm pregnancy : an analysis of 307 patients. Am J Obstet Gynecol. 154, 1986, 269-73.
PubMed
35) Grubb, DK. et al. Post-term pregnancy : fetal death rate with antepartum surveillance. Obstet Gynecol. 79, 1992, 1024-6.
PubMed
36) Manning, FA. et al. Fetal assessment based on fetal biophysical profile scoring : experience in 12,620 referred high-risk pregnancies : 1. Perinatal mortality by frequency and etiology. Am J Obstet Gynecol. 151, 1985, 343-50.
PubMed
37) Nageotte, MP. et al. Perinatal outcome with the modified biophysical profile. Am J Obstet Gynecol. 170, 1994, 1672-6.
PubMed
38) Clark, SL. et al. Nonstress testing with acoustic stimulation and amniotic fluid volume assessment : 5,973 tests without unexpected fetal death. Am J Obstet Gynecol. 160, 1989, 694-7.
 
39) 染英治ほか. 過期妊娠の病態に関する臨床的検討. 日本産科婦人科学会雑誌. 44, 1992, 669-75.
 
40) Augensen, K. et al. Randomised comparison of early versus late induction of labour in post-term pregnancy. Br Med J. 294, 1987, 1192-5.
 
41) Hannah, ME. et al. Induction of labor as compared with serial antenatal monitoring in post-term pregnancy : A randomized controlled trial. N Engl J Med. 326, 1992, 1587-92.
PubMed
42) The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. A clinical trial of induction of labor versus expectant management in postterm pregnancy. Am J Obstet Gynecol. 170, 1994, 716-23.
PubMed
43) Luckas, M. et al. Comparison of outcomes in uncomplicated term and post-term pregnancy following spontaneous labor. J Perinat Med. 26, 1998, 475-9.
PubMed
44) Egarter, C. et al. Is induction of labor indicated in prolonged pregnancy? : Results of a prospective randomised trial. Gynecol Obstet Invest. 27, 1989, 6-9.
PubMed
45) Dyson, DC. et al. Management of prolonged pregnancy : induction of labor versus antepartum fetal testing. Am J Obstet Gynecol. 156, 1987, 928-34.
PubMed
46) 日本産科婦人科学会周産期委員会報告. 日本産科婦人科学会雑誌. 51, 1999, 243-5.
 
47) American College of Obstetricians and Gynecologists. Quality, evaluation, and improvement in practice : postterm pregnancy. Committee on quality assessment, criteria set No.10. August 1995. Int J Gynaecol Obstet. 53, 1996, 89-90.
 
48) Kazzi, GM. et al. Efficacy and safety of Laminaria digitata for preinduction ripening of the cervix. Obstet Gynecol. 60, 1982, 440-3.
PubMed
49) Magann, EF. et al. Management of pregnancies beyond fortyone weeks' gestation with an unfavorable cervix. Am J Obstet Gynecol. 178, 1998, 1279-87.
PubMed
50) Miyazaki, FS. et al. Saline amnioinfusion for relief of variable or prolonged decelerations : A preliminary report. Am J Obstet Gynecol. 15(146), 1983, 670-8.
 
51) Nageotte, MP. et al. Prophylactic amnioinfusion in pregnancies complicated by oligohydramnios : a prospective study. Obstet Gynecol. 77, 1991, 677-80.
PubMed
52) Macri, CJ. et al. Prophylactic amnioinfusion improves outcome of pregnancy complicated by thick meconium and oligohydramnios. Am J Obstet Gynecol. 167, 1992, 117-21.
PubMed
53) ACOG Committee Opinion Number 346. amnioinfusion does not prevent meconium aspiration syndrome. Obstet Gynecol. 108(4), 2006, 1053.
 
54) Biban, P. et al. International Liaison Committee on Resuscitation (ILCOR) ; European Resuscitation Council (ERC) ; American Heart Association (AHA) ; American Academy of Pediatrics (AAP). New cardiopulmonary resuscitation guidelines 2010 : managing the newly born in delivery room. Early Hum Dev. 87, 2011 Suppl 1 : S9-11. Epub 2011 Jan 19.
 
55) Benedetti, TJ. et al. Shoulder dystocia : A complication of fetal macrosomia and prolonged second stage of labor with midpelvic delivery. Obstet Gynecol. 52, 1978, 526-9.
PubMed
56) Naeye, RL. Causes of perinatal mortality excess in prolonged gestations. Am J Epidemiol. 108, 1978, 429-33.
PubMed
57) Sims, ME. et al. Neonatal morbidity and mortality and longterm outcome of postdate infants. Clin Obstet Gynecol. 32, 1989, 285-93.
PubMed
58) Bishop, EH. Pelvic scoring for elective induction. Obstet Gynecol. 24, 1964, 266.
PubMed

第12章 胎児well - beingの評価

P.219 掲載の参考文献
1) Vindla, S., James, D. Fetal behavior as a test of fetal wellbeing. Br J Obstet Gynaecol. 102, 1995, 597.
PubMed
2) Sorokin, Y., Bottoms, SF., Dierker, CJ. et al. The clustering of fetal heart rate changes and fetal movements in pregnancies between 20 and 30 weeks gestation. Am J Obstet Gynecol. 143, 1982, 952.
 
3) Rayburn, WF. Clinical significance of perceptible fetal motion. Am J Obstet Gynecol. 138, 1980, 210.
PubMed
4) Sadovsky, E., Yaffe, H. Daily fetal movement recording and fetal prognosis. Obstet Gynecol. 41, 1973, 845.
PubMed
5) Moore, TR., Piaquadio, K. A prospective evaluation of fetal movement screening to reduce the incidence of antepartum fetal death. Am J Obstet Gynecol. 160, 1989, 1075.
 
6) Grant, A. et al. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet. 2, 1989, 345.
PubMed
7) Ray, M., Freeman, R., Pine, S. et al. Clinical experience with the oxytocin challenge test. Am J Obstet Gynecol. 114, 1972, 1.
PubMed
8) Lee, CY., Diloreto, PC., O'Lane, JM. A study of fetal heart rate acceleration pattern. Obstet Gynecol. 45, 1975, 142.
 
9) National Institute of Child Health and Human Development Research Planning Workshop, Electronic fetal heart rate : Research guide lines for interpretation. Am J Obstet Gynecol. 177, 1997, 1385.
 
10) Pillai, M., James, D. Development of fetal heart rate patterns during normal pregnancy. Obstet Gynecol. 76, 1990, 812.
PubMed
11) Eller, DP., Scardo, JA., Dillon, AE. et al. Distance from an intrauterine hydrophone as a factor affecting intrauterine sound pressure levels produced by the vibroacoustic stimulation test. Am J Obstet Gynecol. 173, 1995, 523.
PubMed
12) Freeman, R. et al. A prospective multi-institutional study of antepartum fetal heart rate monitoring I : Risk of perinatal mortality and morbidity according to antepartum feta heart rate result. Am J Obstet Gynecol. 143, 1982, 771.
 
13) Freeman, RK., Anderson, G., Dorchester, W. A prospective multi-institutional study of antepartum fetal heart rate monitoring II : Contraction stress test versus nonstress test for primary surveillance. Am J Obstet Gynecol. 143, 1982, 778.
 
14) Manning, FA., Platt, LD., Sipos, L. Antepartum fetal evaluation : Development of a fetal biophysical profile. Am J Obstet Gynecol. 136, 1980, 787.
PubMed
15) Manning, FA., Snijders, R., Harman, CR., Nicolaides, K., Menticoglous, S., Morrison, I. Fetal biophysical profile score VI : Correlation with antepartum umbilical venous fetal pH. Am J Obstet Gynecol. 169, 1993, 755.
 
16) Manning, FA., Harman, CR., Morrison, I. et al. Fetal assessment based on fetal biophysical scoring IV : An analysis of perinatal morbidity and mortality. Am J Obstet Gynecol. 150, 1984, 245.
 
17) Clark, SL., Sabey, P., Jolly, K. Nonstress testing with acoustic stimulation and amnionic fluid volume assessment : 5973 tests without unexpected fetal death. Am J Obstet Gynecol. 160, 1989, 694.
 
18) Gardner, M., Rouse, D., Goldenberg, R. et al. Cost comparison of induction of labor at 41 weeks versus expectant management in the postterm pregnancy. Am J Obstet Gynecol. 174, 1996, 351.
 
19) Cunningham, FC., Gant, NF., Leveno, KJ. et al. eds. "Antepartum Assessment". Williams Obstetrics. 21st ed. McGraw-Hill, 2001, 1095-110.
 
20) Trudinger, B. Doppler : More or less?. Ultrasound Obstet Gynecol 29, 2007, 243-6.
 
21) Gonzalez, JM., Stramilio, DM., Ural, S. et al. Relationship between abnormal fetal testing and adverse perinatal outcomes in intrauterine growth restriction. Am J Obstet Gynecol. 196, 2007, e48.
 
22) Konje, JC., Bell, SC., Taylor, DT. Abnormal Doppler velocimetry and blood flow volume in the middle cerebral artery in sever intrauterine growth restriction : Is the occurrence of reversal of compensatory flow too late? Br J Obstet Gynaecol. 108, 2001, 973.
 
23) Moise, KJ Jr. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol. 198, 2008, 161.
 
24) 茨聡. IUGRの出生直後の状態と予後. 日本新生児学会雑誌. 26, 1994, 39-48.
 
25) 丸山有子, 茨聡ほか. 頭囲発育停止を指標にしたIUGR娩出のタイミング. 周産期学シンポジウム. 22, 2004, 121-8.
 
26) Platt, LD., Paul, RH., Phelan, J. et al. Fifteen years of experience, with antepartum fetal testing. Am J Obstet Gynecol. 156, 1987, 1509.
PubMed
27) Manning, FA., Bondaji, N., Harman, CR. et al. Fetal assessment based on fetal biophysical profile scoring VIII : The incidence of cerebral palsy in tested an untested perinates. Am J Obstet Gynecol. 178, 1998, 696.
PubMed

第13章 分娩時胎児評価

P.237 掲載の参考文献
1) National Institute of Child Health and Human Development Research Planning Workshop. Electronic fetal heart rate monitoring : Research guidelines for interpretation. Am J Obstet Gynecol. 177(6), 1997, 1385-90.
PubMed
2) 日本産科婦人科学会胎児心拍数図の用語および定義検討小委員会報告. 日本産科婦人科学会雑誌. 55, 2003, 1205-16.
 
3) Intrapartum Fetal Heart Rate Monitoring : Nomenclature, Interpretation, and General Management Principles. ACOG Practice Bulletin. Number 106. July 2009.
 
4) Macones, GA., Hankins, GD., Spong, CY., Hauth, J., Moore, T. The 2008 National Institute of Child Health and Human Development Workshop Report on Electric Fetal Monitoring : Update on Definitions, Interpretation, and Research Guidelines. J Obstet Gynecol Neonatal Nurs. 37, 2008, 510-5., Obstet Gynecol. 112(3), 2008, 661-6.
 
5) Okai, T., Ikeda, T., Kawarabayashi, T. et al. and The Perinatology Committee of Japan Society of Obstetrics and Gynecology. Intrapartum management guidelines based on fetal heart rate pattern classification. J Obstet Gynecol Res. 36(5), 2010, 925-8.
 
6) 日本産科婦人科学会, 日本産婦人科医会編集・監修. "CQ410分娩監視の方法は?" "CQ411分娩監視装置モニターの読み方・対応は?". 産婦人科診療ガイドライン : 産科編2011. 2011, 195-205.
 
7) Parer, JT. Handbook of fetal heart rate monitoring. 2nd ed. WB. Saunders company, 1997, 286p.
 
8) 日本産科婦人科学会周産期委員会 胎児機能不全診断基準の妥当性検討に関する小委員会「胎児心拍数図に関する用語・定義」の改訂に関する提案. 2012年6月.
 
9) Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit. The use of electronic fetal monitoring : evidence-based clinical guidelines. No.8. London, RCOG Press, 2001, 136p.
 
10) Liston, R., Sawchuck, D., Young, D., Society of Obstetrics and Gynaecologists of Canada : British Columbia Perinatal Health Program. Fetal health surveillance : antepartum and intrapartum consensus guideline. J Obstet Gynaecol Can. 29(9 Suppl 4), 2007, S3-56.
 
11) Parer, JT., Ikeda, T. A framework for standardized management of intrapartum fetal heart rate patterns. Am J Obstet Gynecol. 197(1), 2007, 26, e1-6.
 
12) Parer, JT., King, T., Flanders, S. et al. Fetal acidemia and electronic fetal hear rate patterns : Is there evidence of an association? J Matern Fetal Neonatal Med. 19, 2007, 289-94.
 
13) Murata, Y., Martin, CB., Ikenoue, T. et al. Fetal heart rate accelerations and late decelerations during the course of intrauterine death in chronically catheterized rhesus monkeys. Am J Obstet Gynecol. 144, 1982, 218.
PubMed
14) Kubli, FW., Hon, EH., Khazin, AF., Takemura, H.Observations of fetal heart rate and pH in the human fetus during labor. Am J Obstet Gynecol. 104, 1969, 1190-206.
PubMed
15) Murata, Y., Miyake, Y., Yamamoto, T. et al. Experimentally produced sinusoidal fetal heart rate patterns in chronically instrumented fetal lamb. Am J Obstet Gynecol. 153, 1985, 693.
 
16) Low, JA. The role of blood gas and acid-base assessment in the diagnosis of intrapartum fetal asphyxia. Am J Obstet Gynecol. 159(5), 1988, 1235-40.
PubMed
17) Low, JA. et al. Newborn complications after intrapartum asphyxia with metabolic acidosis in the term fetus. Am J Obstet Gynecol. 170, 1994, 1081.
PubMed
18) Westgren, M. et al. Lactate compared with pH analysis at fetal scalp blood sampling : a prospective randomized study. Br J Obstet Gynaecol. 105(1), 1998, 29-33.
 
19) Smith, CV. et al. Intrapartum assessment of fetal well-being : A comparison of fetal acoustic stimulation with acid-base determinations. Am J Obstet Gynecol. 155, 1986, 726-8.
PubMed
20) Irion, O. et al. Is intrapartum vibratory acoustic stimulation a valid alternative to fetal scalp pH determination? Br J Obstet Gynaecol. 103(7), 1996 Jul, 642-7.
PubMed
21) Chittacharoen, A. et al. Maternal perception of soundprovoked fetal movement in the early intrapartum period. Int J Gynecol Obstet. 56, 1997, 129-33.
 
22) Joseph, R. et al. Intrapartum fetal atrial bigeminy : Diagnostic and therapeutic role of the fetal scalp stimulation test. Am J Obstet Gynecol. 174, 1996, 1649-50.
 
23) Porter, TF. et al. Vibroacoustic and scalp stimulation. Obstetrics and Gynecology Clinics of North America. 26(4), 1999, 657-69.
PubMed
24) Chittacharoen, A. et al. Fetal acoustic stimulation for early intrapartum assessment of fetal well-being. Int J Gynecol Obstet. 69, 2000, 275-7.
 
25) Chester, B. et al. Electronic fetal monitoring : A brief summery of its development, problems and prospects. Eur J Obstet Gynecol Reprod Biol. 78, 1998, 133-40.
 
26) Katz, VL. et al. Meconium aspiration syndrome : Reflections on a murky subject. Am J Obstet Gynecol. 166, 1992, 171.
PubMed
27) Nathan, L. et al. Meconium : A 1990s prospective on an old obstetric hazard. Obstet Gynecol. 83, 1994, 328.
 
28) Walker, J. Foetal anoxia. I Obstet Gynaecol Br Commonw. 61, 1953, 162.
 
29) Mathews, TG. et al. Relevance of the gestational age distribution of meconium passage in utero. Pediatrics. 64, 1979, 30.
 
30) Ramin, KD. et al. Amniotic fluid meconium : A fetal environmental hazard. Obstet Gynecol. 87, 1996, 181.
PubMed
31) Pierce, J. et al. Intrapartum amnioinfusion for meconiumstained fluid : Meta-analysis of prospective clinical trials. Obstet Gynecol. 95, 2000, 1051.
PubMed
32) Strong, TH Jr. et al. Prophylactic intrapartum amnioinfusion : A randomized clinical trial. Am J Obstet Gynecol. 162(6), 1990, 1370-4.
PubMed
33) Schrimmer, DB. et al. Prophylactic amnioinfusion as a treatment for oligohydramnios in laboring patients : A prospective randomized trial. Am J Obstet Gynecol. 165, 1991, 972-5.
PubMed
34) Chauhan, SP. et al. Intrapartum amniotic fluid index is a poor diagnostic test for adverse perinatal outcome. J Repro Med. 41, 1996, 890-6.
 
35) Chauhan, SP. et al. Intrapartum oligohydramnios does not predict adverse peripartum outcome among high-risk parturients. Am J Obstet Gynecol. 176, 1997, 1130-8.
 
36) Owen, J. et al. A prospective randomized study of saline solution amnioinfusion. Am J Obstet Gynecol. 162, 1990, 1146.
 
37) Spong, CY. et al. Amniotic fluid index (AFI) predicts the relief of variable decelerations following amnioinfusion bolus. Am J Obstet Gynecol. 174, 1996, 480.
 
38) Chauhan, SP. et al. Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods : A metaanalysis. Am J Obstet Gynecol. 181(6), 1999, 1473-78.
PubMed
39) Pitt, C. et al. Prophylactic amnioinfusion for intapartum oligohydramnios : A meta-analysis of randomized controlled trials. Obstet Gynecol. 96(5p+2), 2000, 861-6.
 
40) Moses, J., Doherty, DA., Magann, EF., Chauhan, SP., Morrison, JC. A randomized clinical trial of the intrapartum assessment of amniotic fluid volume : Amniotic fluid index versu the single deepest pocket technique. Am J Obstet Gynecol. 190, 2004, 1564-70.
PubMed
41) Sarno, AP. et al. Intrapartum amniotic fluid volume assessed at term : Association of ruptured membranes, oligihydramnios, and increased fetal risk. J Repro Med. 35, 1990, 719-23.
 
42) Baron, C. et al. The impact of amniotic fluid volumes assessed intrapartum on perinatal outcome. Am J Obstet Gynecol. 173, 1995, 167-74.
PubMed
43) Chauhan, SP. et al. Intrapartum amniotic fluid volume index and adverse outcome : Experience at a community hospital. J Maternal Fetal Invest. 85, 1993, 9-13.
 
44) Feinkind, L. et al. Screening with Doppler velocimetry in labor. Am J Obstet Gynecol. 161, 1989, 765-70.
PubMed
45) Malcus, P. et al. Umbilical artery doppler velocimetry as a labor admission test. Obstet Gynecol. 77, 1991, 10-6.
PubMed
46) Farrel, T. et al. Intrapartum umbilical artery doppler velocimetry as a predictor of adverse perinatal outcome : A systematic review. Br J Obstet Gynaecol. 106, 1999, 783.
 
47) Dildy, GA. et al. Intrapartum fetal pulse oximetry : Fetal oxygen saturation trends during labor and relation to delivery outcome. Am J Obstet Gynecol. 171(3), 1994, 679-84.
PubMed
48) Chua, S. et al. Fetal oxygen saturation during labor. Br J Obstet Gynaecol. 104, 1997, 1080.
PubMed
49) Yam, J. et al. Intrapartum fetal pulse oximetry. Part I : Principles and technical issues. Obstet Gynecol Surv. 55, 2000, 163.
PubMed
50) Bloom, SL. et al. Fetal pulse oximetry : Duration of desaturation and integration outcome. Obstet Gynecol. 78, 1999, 15.
 
51) Seelbach-Gobel, B. et al. The prediction of fetal acidosis by means of intrapartum fetal pulse oximetry. Am J Obstet Gynecol. 180, 1999, 73-81.
PubMed
52) Garite, TJ. et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. Am J Obstet Gynecol. 183, 2000, 1049-58.
PubMed
53) ACOG Committee Opinion. Number 258, September 2001.
PubMed
54) Dildy, GA. et al. Intrapartum fetal pulse oximetry : Past, present, and future. Am J Obstet Gynecol. 175, 1996, 1-9.
PubMed
55) Schmidt, S. et al. Clinical usefulness of pulse oximetry in the fetus with non-reassuring heart rate pattern? J. Perinat. Med. 28, 2000, 298-305.
PubMed
56) Huddleston, JF. Intrapartum fetal assessment : A review clinics in perinatology. Clin Perinatol. 26(3), 1999, 549-68.
PubMed
57) Chura S. et al. Intrapartum fetal oxygen saturation monitoring in a busy labour ward. Eur J Obstet Gynecol Reprod Biol. 82, 1999, 185-9.
 
58) van den Berg, PP. et al. The efficacy of intrapartum fetal surveillance when fetal pulse oximetry is added to cardiotocography. Eur J Obstet Gynecol Reprod Biol. 72, 1997, 67-71.
 
59) Dildy, GA. et al. Current status of the multicenter randomized clinical trial on fetal oxygen sarturation monitoring in the United States. Eur J Obstet Gynecol Reprod Biol. 72, 1997, 43-50.
 
60) Langer, B. et al. Fetal pulse oximetry and fetal heart rate monitoring during stage II of labour. Eur J Obstet Gynecol Reprod Biol. 72, 1997, 57-61.
 
61) Carbonne, B. et al. Fetal oxygen saturation measured by pulse oximetry during labour with clear or meconium-stained amniotic fluid. Eur J Obstet Gynecol Reprod Biol. 72, 1997, 51-5.
PubMed
62) Faisst, K. et al. Intrapartum reflectance pulse oximetry : Effects of sensor location and fixation duration on oxygen saturation readings. Journal of Clinical Monitoring. 13, 1997, 299-302.
PubMed
63) Dildy, GA. et al. The relationship between oxygen saturation and pH in umbilical blood : Implications for intrapartum fetal oxygen saturation monitoring. Am J Obstet Gynecol. 175, 1996, 682-7.
PubMed
64) Alshimmiri, M. et al. Prediction of umbilical artery base excess by intrapartum fetal oxygen saturation monitoring. Am J Obstet Gynecol. 177, 1997, 775-9.
PubMed
65) East, CE. et al. Human fetal intrapartum oxygen saturation monitoring : Agreement between readings from two sensors on the same fetus. Am J Obstet Gynecol. 174, 1996, 1594-8.
PubMed
66) Luttkus, AK. et al. The safety of fetal pulse oximetry in partrrients requring fetal scalp blood sampling. Obstet Gynecol. 90, 1997, 533-7.
 
67) Gorenberg, DM., Garite, TJ. et al. Fetal pulse oximetry : Correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. Am J Obstet Gynecol. 189, 2003, 136-8.
PubMed
68) East, CE., Colditz, PB. Intrapartum Oximetry of the Fetus. Anesth Analg. 105(6), 2007, S59-65.
 
69) Strachan, BK. et al. For FECG Study Group Cardiotocography only versus cardiotocography plus PRinterval analysis in intrapartum surveillance : A randomized, multicentre trial. Lancet. 355(9202), 2000 Feb 5, 456-9.
 
70) Westgate, J. et al. Plymouth randomized trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases. Am J Obstet Gynecol. 169, 1993, 1151.
PubMed
71) Amer-Walin, I. et al. Cardiotocography only versus cardiotocography plus ST analysis of fetal Electrocardiogram for intrapartum fetal monitoring : A Swedish randomized Controlled trial. Lancet. 358(9281), 2001 Aug, 18534-8.
 
72) Luzietti, R. et al. European Community Multi-Center Trial "Fetal ECG Analysis During Labor" : ST plus CTG analysis. J Perinat Med. 27(6), 1999, 431-40.
PubMed
73) van Wijngaarden, WJ. et al. Improved intrapartum surveillance with PR interval analysis of the fetal electrocardiogram : A randomized trial showing a reduction in fetal blood sampling. Am J Obstet Gynecol. 174, 1996, 1295-9.
PubMed
74) van Wijngaarden, WJ. et al. Improving intrapartum surveillance : An individualized T/QRS ratio? Eur J Obstet Gynecol Reprod Biol. 88(1), 2000, 43-8.
PubMed
75) Dervaitis, KL. et al. ST segment analysis of the fetal electrocardiogram plus electronic fetal heart rate monitoring in labor and its relationship to umbilical cord arterial blood gases. Am J Obstet Gynecol. 191, 2004, 879-84.
PubMed
76) Richardson, BS. et al. Cerebral oxidative metabolism in lambs during perinatal period : Relationship to electrocorticalstate. Am J Physiol. 257, 1989, 1251-7.
 
77) Thaler, I. et al. Real-time spectral analysis of fetal EEG : A new approach to monitoring sleep states and fetal condition during labor. Pediatric Research. 48(3), 2000, 340-5.
 
78) 上山博史ほか. 2%セボフルラン-フェンタニル麻酔中の脳波の年齢による変化. 日本小児麻酔学会誌. 10, 2004, 138-42.
Medical*Online
79) Inder, TE. et al. Lowered Electroencephalographic Spectral Edge Frequency predicts the presence of cerebral white matter injury in premature infants. Pediatrics. 111(1), 2003, 27-33.
PubMed
80) Frasch, MG., Keen, AE., Gagnon, R., Ross, MG., Richardson, BS. Monitoring Fetal Electrocortical Activity during Labour foe Predicting Worsening Acidemia : A Prospective Study in the Ovine Fetus Near Term. PLoSone. 6(7), 2011, e22100.
 
81) 杉本健郎ほか. 分娩時仮死は脳性麻痺の主原因か? 産婦人科の実際. 46(8), 1997, 1133-8.
 
82) The American College of Obstetrics and Gynecology (ACOG). Inappropriate Use of the Terms Fetal Distress and Birth Asphyxia. ACOG Committee Opinion. 1998, Number 197.
 
83) A Consensus Statement from the Perinatal Society of Australia and New Zealand and International Contributing Experts : A template for defining a causal relationship between acute intrapartum events and cerebral palsy. 1998, 7th draft.
 
84) Volpe, JJ. Value of MR in Definition of the Neuropathology of Cerebral Palsy in Vivo. Am J Neuroradiol. 13, 1992, 79-83.
PubMed
85) Bedrick, AD. et al. Perinatal Asphyxia and Cerebral Palsy. Am J Dis Child. 143, 1989, 1139-40.
PubMed
86) Bax, M. et al. Birth Asphyxia : a statement ; A Task Force set up by the World Federation of Neurology Group for the prevention of cerebral palsy and related neurological disorders. Dev Med Child Neurol. 35, 1993, 1022-4.
 
87) Nelson, KB. et al. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med. 334 (10), 1996, 613-8.
PubMed
88) Perlman, JM. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy : medicolegal issues. Pediatrics. 99(6), 1997, 851-7.
PubMed
89) Badai, N. et al. What constitutes cerebral palsy? Dev Med Child Neurol. 40, 1998, 520-7.
 
90) ACOG committee opinion. Use and abuse of the Apgar score. Number 174. July 1996. Committee on Obstetric Practice and American Academy of Pediatrics : Committee on Fetus and Newborn. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 54(3), 1996, 303.
 
91) Low, JA. Intrapartum fetal asphyxia : Definition, diagnosis, and classification. Am J Obstet Gynecol. 176, 1997, 957-9.
PubMed
92) Low, JA. et al. Threshold of metabolic acidosis associated with newborn complications. Am J Obstet Gynecol. 177, 1997, 1391-4.
PubMed
93) Belai, YI. et al. Umbilical arteriovenous PO2 and PCO2 differences and neonatal morbidity in term infants with severe acidosis. Am J Obstet Gynecol. 178, 1998, 13-9.
 
94) Committee on Fetus and Newborn, American Academy of Pediatrics, and Committee on Obstetric Practice, American College of Obstetricians and Gynecologists. Use and Abuse of the Apgar Score. Pediatrics. 98, 1996, 141-2.
 
95) Spencer, JA. et al. The intrapartum CTG prior to neonatal encephalopathy at term : a case-control study. Br J Obstet Gynaecol. 104, 1997, 25-8.
PubMed
96) Low, JA. et al. The prediction and prevention of intrapartum fetal asphyxia in term pregnancies. Am J Obstet Gynecol. 184, 2001, 724-30.
PubMed
97) Berkus, MD. et al. Intrapartum fetal surveillance : A reappraisal. Pediatric Annals. 25(4), 1996, 200-5.
PubMed
98) Low, JA. Intrapartum fetal surveillance : Is it worthwhile? Obstet Gynecol Clin North Am. 26(4), 1999, 725-39.
PubMed
99) Low, JA. et al. Predictive value of electronic fetal monitoring for intrapartum fetal asphyxia with metabolic acidosis. Obstet Gynecol. 93, 1999, 285-91.
PubMed
100) Phelan, JP. et al. Fetal heart rate observations in the braindamaged infant. Seminars in Perinatology. 24(3), 2000, 221-9.
PubMed
101) Bergmans, MGM. How to diagnose intrapartum fetal distress? Eur J Obstet Gynecol Reprod Biol. 79, 1998, 119-21.
 
102) Boehm, FH. Intrapartum fetal heart rate monitoring. Obstet Gynecol Clin North Am. 26(4), 1999, 623-39, vi-vii.
 
103) Bernardes, J. et al. Further concerns about the National Institute of Child Health and Human Development guidelines for interpretation of electronic fetal heart rate monitoring. Am J Obstet Gynecol. 184(7), 2001, 1587-8.
PubMed
104) Beckley, S. et al. The development and evaluation of computer-assisted teaching programme for intrapartum fetal monitoring. N Engl J Med. 107, 2000, 1138-44.
 
105) Devoe, L. et al. A comparison of visual analyses of intrapartum fetal heart rate tracings according to the new National Institute of Child Health and Human Development guidelines with computer analyses by an automated fetal heart rate monitoring system. Am J Obstet Gynecol. 183, 2000, 361-6.
 
106) Chung, DY. et al. Spectral analysis of fetal heart rate variability as a predictor of intrapartum fetal distress. Int J Gynaecol Obstet. 73, 2001, 109-16.
PubMed
107) Strachan, BK. et al. Computerized analysis of the fetal heart rate and relation to acidemia at delivery. BJOG. 108, 2001, 848-52.
PubMed
108) Williams, KP. et al. Intrapartum fetal heart rate patterns in the prediction of neonatal acidemia. Am J Obstet Gynecol. 2003, 188, 820-3.
PubMed
109) Coletta, J., Murphy, E., Rubeo, Z., Gyamfi-Bannerman, C. The 5-tier system of assessing fetal heart rate tracings is superior to the 3-tier system in identifying fetal acidemia. Am J Obstet Gynecol. 206, 2012, 226, e1-5.
 
P.241 掲載の参考文献
1) Cunningham, FG. et al. "Intrapartum Assessment". Williams Obstetrics. 21st ed. McGraw-Hill companies, 2001, 331-60.
 
2) Parer, JT. "Fetal Heart Rate". Maternal-Fetal Medicine. 4th ed. Creasy, RK. et al. eds. WB Saunders company, 1999, 270-99.
 
P.245 掲載の参考文献
1) Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit. The use of electronic fetal monitoring : evidence-based clinical guidelines. No.8 London, RCOG Press, 2001, 136p.
 
2) Liston, R., Sawchuck, D., Young, D., Society of Obstetrics and Gynaecologists of Canada : British Columbia Perinatal Health Program. Fetal health surveillance : antepartum and intrapartum consensus guideline. J Obstet Gynaecol Can. 29(9 Suppl 4), 2007, S3-56.
 
3) Parer, JT., Ikeda, T. A framework for standardized management of intrapartum fetal heart rate patterns. Am J Obstet Gynecol. 197(1), 2007, 26, e1-6.
 
4) Bannerman, CG., Grobman, WA., Antoniewicz, L., Hutchinson, M., Blackwell, S. Assessment of the concordance among 2-tier, 3-tier, and 5-tier fetal heart rate classification systems. Am J Obstet Gynecol. 205(3), 2011, 288. e1-4. Epub 2011 Jun 24.
 
5) 日本産科婦人科学会周産期委員会 (委員長 : 岡井崇). 胎児機能不全の診断基準の作成と妥当性の検証に関する小委員会報告. 胎児心拍数波形の判読に基づく分娩時胎児管理の指針. 日本産科婦人科学会雑誌. 60(6), 2008, 1220-1.
 
6) 日本産科婦人科学会周産期委員会 (委員長 : 齋藤滋). 胎児機能不全診断基準とその妥当性の検討委員会報告 (委員長 : 池田智明). 胎児心拍数波形の分類に基づく分娩時胎児管理の指針 (案). 日本産科婦人科学会雑誌. 62(8), 2010, 1518-20.
 
7) Okai, T., Ikeda, T., Kawarabayashi, T., Kozuma, S., Sugawara, J., Chisaka, H., Yoneda, S., Matsuoka, R., Nakano, H., Okamura, K., Saito, S., Perinatology Committee of the Japan Society of Obstetrics and Gynecology. Intrapartum management guidelines based on fetal heart rate pattern classification. J Obstet Gynaecol Res. 36(5), 2010, 925-8.
PubMed
8) 日本産科婦人科学会・日本産婦人科医会 編集・監修. "CQ411 分娩監視装置モニターの読み方・対応は?". 産婦人科診療ガイドライン : 産科編2011. 2011, 199-205.
 

第14章 分娩進行異常

P.263 掲載の参考文献
1) 日本産科婦人科学会編. 産科婦人科用語集・用語解説集. 改訂新版. 東京, 金原出版, 2003, 603p.
 
2) Fraser, WD. et al. "Dysfunctional Labor". Current Therapy in Obstetrics and Gynecology. 5th ed. Quilligan, EJ. et al. eds. Philadelphia, W. B. Saunders, 2000, 271-3.
 
3) American College of Obstetricians and Gynecologists. Dystocia and the Augmentation of Labor. ACOG Technical Bulletin. No.218, Washington DC, ACOG, 1995.
 
4) Barau, G. et al. Linear association between maternal prepregnancy body mass index and risk of caesarean section in term deliveries. BJOG. 113(10), 2006, 1173-7.
PubMed
5) Gifford, DS. et al. Lack of progress in labor as a reason for cesarean. Obstet Gynecol. 95, 2000, 589.
PubMed
6) Notzon, FC. et al. Cesarean section delivery in the 1980s : International comparison by indication. Am J Obstet Gynecol. 170, 1994, 495.
PubMed
7) Menacker, F. et al. Recent trends in cesarean delivery in the United States. NCHS Data Brief. 35, 2010, 1-8.
PubMed
8) Gross, SJ. et al. Shoulder dystocia : Predictors and outcomes ; A five-year review. Am J Obstet Gynecol. 156, 1987, 334.
PubMed
9) Olah, KSL. et al. Failure to progress in the management of labour. Br J Obstet Gynecol. 101, 1994, 1.
 
10) Blair, E. et al. Intrapartum asphyxia : a rare cause of cerebral palsy. J Pediatr. 112, 1988, 515.
PubMed
11) American College of Obstetricians and Gynecologists. Fetal and neonatal Neurologic Injury. ACOG Technical Bulletin. No.163. Jun, 1992.
 
12) American College of Obstetricians and Gynecologists. Shoulder dystocia. ACOG Practice Patterns. No.7. Oct, 1997.
 
13) Jazayeri, A., Hefferon, JA, Phillips, R. et al. Macrosomia prediction using ultrasound fetal abdominal circumference of 35 centimeters or more. Obstet Gynecol. 93, 1999, 523-6.
PubMed
14) Cunningham, FG. et al. eds. Williams Obstetrics. 21st ed. McGraw-Hill, 2001, 437-42.
 
15) Yeast, JD., Jones, A., Poskin, M. Induction of labar and the relationship to cesarean delivery : A review of 7001 consecutive inductions. Am J Obstet Gynecol. 180, 1999, 628.
 
16) Hamer, B., Mann, S., Greenberg, P. et al. Low-risk inductions of labor and cesarean delivery for nulliparous and parous women at term. Am J Obstet Gynecol. 185, 2001, S215.
 
17) Caldeyro-Barcia, R. et al. A better understanding of contractivity through simultaneous recording with internal and a seven channel external method. Surg Obstet Gynecol. 91, 1950, 641.
 
18) Hauth, JC. et al. Uterine contraction pressures with oxytocin induction/augmentation. Obstet Gynecol. 68, 1986, 305.
PubMed
19) Friedman, EA. ed. Labor : clinical evaluation and management. 2nd ed. New York, Appleton-Century-Croft, 1978.
 
20) Friedman, EA. Primigravid labor : A graphicostatistical analysis. Obstet Gynecol. 6, 1955, 567.
PubMed
21) Friedman, EA. et al. Amniotomy and the course of labor. Obstet Gynecol. 22, 1963, 755.
PubMed
22) Sokol, RJ. et al. Normal abnormal labor progress, 1 : A quantitative assessment and survey of the literature. J Reprod Med. 18, 1977, 47.
PubMed
23) World Health Organization partograph in management of labour. World Health Organization Maternal Health and Safe Motherhood Programme. Lancet. 343(8910), 1994, 1399-404.
PubMed
24) Friedman, EA. An objective approach to the diagnosis and management of abnormal labor. Bull NY Acad Med. 48, 1972, 842.
 
25) Menticoglou, SM. et al. Perinatal outcomes in relation to second-stage duration. Am J Obstet Gynecol. 173, 1995, 906.
PubMed
26) Sharma, SK. et al. Update : Epidural analgesia during labor does not increase cesarean births. Curr Anesthe Reports. 2, 2000, 18.
 
27) Lieberman, E., O'donoghue, C. Unintended effects of epidural analgesia during labor : A systematic review. Am J Obstet Gynecol. 186(5 Suppl Nature), 2002, S31-68.
 
28) Bloom, SL. et al. Lack of effect of walking on labor and delivery. N Engl J Med. 339, 1998, 76.
PubMed
29) Parnell, C. et al. Pushing method in the expulsive phase of labor : A randomized trial. Acta Obstet Gynecol Scand. 72, 1993, 31.
PubMed
30) Bloom, SL. et al. A randomized trial of coached versus uncoached maternal pushing during the second stage of labor. Am J Obstet Gynecol. 194(1), 2006, 10-3.
PubMed
31) Moore, MM. et al. Fetal dose estimates for CT pelvimetry. Radiology. 171, 1989, 265.
PubMed
32) Cunningham, FG. et al. eds. Williams Obstetrics. 22nd ed. McGraw-Hill, 2005, 500.
 
33) 超音波胎児計測の標準化と日本人の基準値2003年. J Med Ultrasonics. 30, 2003, J415-40.
 
34) ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol. 104(3), 2004, 647-51.
PubMed
35) Royal College of Obstetricians and Gyneacologists. Pelvimetry-Clinical Indication. London, RCOG Press, 1998 Guideline. No.14.
 
36) Zaretsky, MV. et al. Magnetic resonance imaging pelvimetry and the prediction of labor dystocia. Obstet Gynecol. 106(5 Pt 1), 2005, 919-26.
 
37) Sporri, S. et al. Pelvimetry by magnetic resonance imaging as a diagnostic tool to evaluate dystocia. Obstet Gynecol. 89(6), 1997, 902-8.
PubMed
38) Cunningham, F. et al. eds. Williams Obstetrics. 23rd ed. McGraw-Hill, 2010.
 
39) Chen, HY. et al. Evaluation of midpelvis contraction. Int Surg. 67, 1982, 516.
PubMed
40) American College of Obstetricians and Gynecologists. Guidelines for Diagnostic Imaging During Pregnancy. ACOG Committee Opinion. No.158. Sept, 1995.
 
41) Spong, CY. et al. An objective definition of shoulder dystocia : prolonged head-to-body delivery intervals and/or the use of ancillary obstetric maneuvers. Obstet Gynecol. 86, 1995, 433.
PubMed
42) Garite, TJ. et al. The influence of elective amniotomy on fetal heart rate patterns and the course of labor in term patients : a randomized study. Am J Obstet Gynecol. 168, 1993, 1827.
PubMed
43) Fenwick, L. et al. Maternal positioning to prevent or alleviate dystocia in labor. Clin Obstet Gynecol. 30, 1987, 83.
PubMed
44) Gardosi, J. et al. A randomized controlled trial. Br J Obstet Gynecol. 96, 1989, 1290.
 
45) Rouse, DJ., McCullough, C., Wren, AL. et al. Active phase labor arrest : A randomized trial of chorioaminion management. Obstet Gynecol. 83, 1994, 937.
PubMed
46) Gardberg, M. et al. Intrapartum sonography and persistent occiput posterior position : A study of 408 deliveries. Obstet Gynecol. 91, 1998, 117.
 
47) 日本産婦人科医会編. 急速遂娩. 研修ノート. No.58. 1998.
 
48) American College of Obstetricians and Gynecologists. Operative Vaginal Delivery. (ACOG Practice Bulletin, 17). Washington DC, ACOG, 2000.
 
49) Vacca, A. Handbook of Vacuum Delivery in Obstetric Practice. Brisbane, Vacca Research, 2003.
 
50) Vacca, A. et al. Portmouth operative delivery trial : a comparison of vacuum extraction and forceps delivery. Br J Obstet Gynecol. 90, 1983, 1107.
 
51) Gherman, RB. et al. Analysis of McRoberts' maneuver by x-ray pelvimetry. Obstet Gynecol. 95, 2000, 43.
PubMed
52) Johanson, RB. et al. Vacuum extraction versus forceps for assisted vaginal delivery (Cochrane Review). (The Cochrane Library, Issue 4), 1999. Oxford : Update Software (Metaanalysis).
 
53) Tower, D. et al. Effect of mode of delivery in nulliparous women on neonatal intracranial injury. N Engl J Med. 341, 1990, 1709.
 
54) Bahl, R. et al. Neurodevelopmental outcome at 5 years after operative delivery in the second stage of labor : a cohort study. Am J Obstet Gynecol. 197(2), 2007, 147. e1-6.
 
55) Deneux-Tharaux, C. et al. Postpartum maternal mortality and cesarean delivery. Obstet Gynecol. 108(3 Pt 1), 2006, 541-8.
 
56) Govaert, P. et al. Cranial haemorrhage in the newborn infants. Clin Dev Med. 129, 1993, 1-223.
 
57) Vacca, A. The troubles with vacuum extraction. Curr Obstet Gynecol. 9, 1999, 41-5.
 
58) Iffy, L., Lancet, M. The vacuum extractor. Operative Perinatology. 1984, 582-3 (III).
 
59) Johanson, R., Menon, V. Soft versus rigid vacuum extractor cups for assisted vaginal delivery. Cochrane database syst rev. 2000, CD000446.
 
60) 日本産科婦人科学会/日本産婦人科医会編. 産婦人科診療ガイドライン : 産科編2011. CQ406 : 吸引・鉗子分娩の適応と要約, および, 施行時の注意事項は? 2011, 183.
 
61) Matsuo, K. et al. Use of uterine fundal pressure maneuver at vaginal delivery and risk of severe perineal laceration. Arch Gynecol Obstet. 280, 2009, 781-6. Epub 2009 Mar 5.
 
62) Cohen, W. Influence of the duration of second stage labor on perinatal outcome and puerperal morbidity. Obstet Gynecol. 49, 1977, 266.
PubMed
63) Rouse, DJ. et al. Active-phase labor arrest : Oxytocin augmentation for at least 4 hours. Obstet Gynecol. 93, 1999, 323.
PubMed
64) Vacca, A. Handbook of Vacuum Extraction in Obstetrics Practice. Australia, Vacca Research, 1992.
 
65) Smith, RB. et al. Shoulder dystocia : What happens at the next delivery? Br J Obstet Gynecol. 101, 1994, 713.
 
66) Baskett, TF. et al. Perinatal implications of shoulder dystocia. Obstet Gynecol. 86, 1995, 15.
 
P.272 掲載の参考文献
1) Hale, RW. ed. Dennen's Forceps Deliveries. 4th ed. Washington, DC, American College of Obstetricians and Gynecologists, 2001, 1-154.
 
2) Laufe, LE. et al. "Assisted Vaginal Delivery". Obstetric Forceps and Vacuum Extraction Techniques. New York, McGraw-Hill, 1992, 1-140.
 
3) Pritchard, JA. et al. Williams Obstetrics. 17th eds. Norwalk, Appleton-Century-Crofts, 1985. Chapter 41.
 
4) Burkman, RT. "Forceps and vacuum-assisted delivery". Intrapartum Obstetrics. Repke, JT. ed. New York, Churchill Livingstone, 1996, 165-83.
 
5) American College of Obstetricians and Gynecologists. Operative vaginal delivery. Practice Bulletin. No.17. June, 2000.
 
6) Cunningham, FG. et al. "Forceps delivery and vacuum extraction". Williams Obstetrics. 21st ed. New York, McGraw-Hill, 2001, 485-508.
 
7) 日本母性保護産婦人科医会編. "鉗子分娩". 急速遂娩術. 研修ノート. No.58, 1998, 25-49.
 
8) Hagadorn-Freathy, AS. et al. Validation of the 1988 ACOG forceps classification system. Obstet Gynecol. 77, 356-60.
PubMed
9) Pritchard, JA. et al. Williams Obstetrics. 17th eds. Norwalk, Appleton-Century-Crofts, 1985, Chapter 11.
 
10) Cunningham, FG. et al. "Anotomy of the reproductive trace". Williams Obstetrics. 21st ed. New York, McGraw-Hill, 2001, 51-61.
 
11) Shipp, TD. et al. "Normal labor and delivery". Intrapartum Obstetrics. Repke, JT. ed. New York, Churchill Livingstone, 1996, 67-79.
 
12) Norwitz, ER. et al. "Labor and delivery". Obstetrics : Normal and Problem Pregnancies. 4th ed. Gabbe, SG. et al. eds. New York, Churchill Livingstone, 2002, 358-63.
 
13) Weinstein, L. et al. Operative vaginal delivery : risk & benefits. ACOG Update. 27-5, 2001.
 
14) 神崎徹. "分娩時の処置と手術 : 鉗子分娩". 産科手術と処置. 千葉喜英編. 東京, 中山書店, 2001, 65-76 (新女性医学大系33).
 
15) 雨森良彦. 私の鉗子手術. 産婦人科の世界. 30, 1978, 357-63.
 
16) Cargill, YM. et al. Guidelines for operative vaginal birth. J Obstet Gynaecol Can. 26, 2004, 747-53.
 
17) Shaffer, BL. et al. Manual rotation of the fetal occiput : predictors of success and delivery. Am J Obstet Gynecol. 194, 2006, e7-9.
PubMed
18) Le Ray, C. et al. Manual rotation in occiput posterior or transverse positions: risk factors and consequences on the cesarean delivery rate. Obstet. Gynecol. 110, 2007, 873-9.
 
19) Reichman, O. et al. Digital rotation from occipito-posterior to occipito-anterior decreases the need for cesarean section. Eur J Obstet Gynecol Reprod Biol. 136, 2008, 25-8.
PubMed
20) Yeomans, ER. Operative vaginal delivery. Obstet Gynecol. 115, 2010, 645-53.
PubMed
21) Sultam, AH. et al. Anal sphincter trauma during instrumental delivery. Int J Gynecol Obstet. 43, 1993, 263-70.
 
22) Emerson, MV. et al. Incidence and rate of disappearance of retinal hemorrhage in newborns. Ophthalmology. 108, 2001, 36-9.
PubMed
23) Towner, D. et al. Effect of mode of delivery in nulliparous women on neonatal intracranial injury. N Engl J Med. 341, 1999, 1709-14.
PubMed
24) Menticoglou, SM. et al. High cervical spinal cord injury in neonates delivered with forceps : report of 15 cases. Obstet Gynecol. 86, 1995, 589-94.
PubMed
25) Sadan, O. et al. What to do after a failed attempt of vacuum delivery? Eur J Obstet Gynnecol Reprod Biol. 107, 2003, 151-5.
 
26) Johanson, RB. et al. Vacuum extraction versus forceps for assisted vaginal delivery. Cochrane Database Syst Rev. 2, 2000, CD000224.
PubMed
27) 日本産科婦人科学会・日本産婦人科医会編集・監修. "吸引・鉗子分娩の適応と要約, および, 施行時の注意事項は?". 産婦人科診療ガイドライン : 産科編2011. 2011, 181-5.
 
28) Hankins, GD. et al. Operative vaginal delivery-year 2000. Am J Obstet Gynecol. 175, 1996, 275-82.
PubMed
29) Dupuis, O. et al. Assessment of forceps blade orientations during their placement using an instrumented childbirth simulator. BJOG. 116, 2009, 327-33.
PubMed

第15章 胎児位置異常

P.289 掲載の参考文献
1) 日本産科婦人科学会編. 産科婦人科用語集・用語解説集. 改訂第2版. 東京, 金原出版, 2008, 231.
 
2) 鈴木雅洲ほか編. 分娩・産褥異常・胎児・胎児付属物異常. 東京, 中山書店. 1972, 64-85 (現代産婦人科学大系47).
 
3) Cunningham, FG. et al. eds. "Breech presentation and Delivery". Williams Obstetrics. 23rd ed. McGraw-Hill, 2010, 524-43.
 
4) Weisman, AI. An antepartum study of fetal polarity and rotation. Am J Obstet Gynecol. 48, 1944, 550.
 
5) Ventura, SJ., Martin, JA., Curtin, SC. et al. Births : final data for 1997. Natl Vital Rep. 47(18), 1999, 1-96.
PubMed
6) 三宅良明ほか. 産科の手術処置 : 胎児の外回転術. 臨床婦人科産科. 56(4), 2002, 445-7.
 
7) Phelan, JP. et al. The role of external version in the intrapartum management of the transverse lie presentation. Am J Obstet Gynecol. 151, 1985, 724-6.
PubMed
8) Quilligan, EJ., Zuspan, FP. "Breech, Transverse, and Compound Presentation". Douglas-Stromme : Operative Obstetrics. 4th ed. Appleton-Century-Crofts, 1982, 557-98.
 
9) Stevenson, CS. Principle cause of breech presentation in single term pregnancies. Am J Obstet Gynecol. 60, 1950, 641.
 
10) Morley, GW. Breech presentation : a 15 years review. Obstet Gynecol. 30, 1967, 745.
 
11) Pop, VT. et al. Low concentrations of maternal thyroxin during early gestation : a risk factor of breech presentation? BJOG. 111(9), 2004, 925-30.
 
12) Nordtveit, TI., Melve, KK., Albrechtsen, S. et al. Maternal and paternal contribution to intergenerational recurrence of breech delivery : population based cohort study. BJM. 336, 2008, 872-6.
 
13) Chasen, ST., D'Angelo, M. Effectiveness of clinical assessment of fetal presentation at term. (Abst.) Am J Obstet Gynecol. 1182, 2000, S146.
 
14) Wright, RC. Reduction of perinatal mortality and morbidity in breech delivery through routine use of cesarean section. Obstet Gynecol. 93, 1959, 237-42.
 
15) Hannah, ME. et al. For the Term Breech Trial collaborative group : Planned caesarean section versus planned vaginal birth for breech presentation at term ; a rondomised multicentre trial. Lancet. 356, 2000, 1375-83.
 
16) Albrechtsen, S. et al. Evaluation of a protocol for selecting fetuses in breech presentation for vaginal delivery or cesarean section. Am J Obstet Gynecol. 177, 1997, 586-92.
PubMed
17) Alarab, M., Regan, C. et al. Singleton vaginal breech delivery at term : Still a safe option. Obstet Gynecol. 103, 2004, 407-12.
 
18) Munstedt, K. et al. Term breech and long-term morbidity : cesarean section versus vaginal breech delivery. Eur J Obstet Gynecol Reprod Biol. 96, 2001, 163-7.
PubMed
19) Krebs, L., Langhoff-Roos, J. The relation of breech presentation at term to epilepsy in childhood. Eur J Obstet Gynecol Reprod Biol. 127, 2006, 26-8.
PubMed
20) Hannah, ME. et al. Maternal outcome at 2 years after planned cesarean section versus planned vaginal birth for breech presentation at term : The International Randomized Term Breech Trial. Am J Obstet Gynecol. 191, 2004, 917-27.
PubMed
21) Hall, MH., Bewley, S. Why mothers die : Maternal mortality and mode of delivery. Lancet. 354, 1999, 776.
 
22) Shennan, A., Bewley, S. How to manage term breech deliveries : Avoid vaginal breech deliveries but offer external cephalic version. BMJ. 323(4), 2001, 244-5.
 
23) Chinnock, M., Robson, S. Obaterric trainees' experience in vaginal delivery : implications for future practice. Obstet Gynecol. 110(4), 2007, 900-3.
PubMed
24) Zhang, J. et al. Efficacy of external cephalic version, including safety, cost-benefit analysis, and impact on the cesarean delvert rate. Obstet Gynecol. 82, 1993, 306.
 
25) Committee on Practice Guidelines : Gynecology, American College of Obstetrics and Gynecologists. External cephalic version. Int J Gynaecol Obstet. 72(2), 2001, 198-204.
PubMed
26) de Meeus, JB. et al. External cephalic version after previous cesarean section : a series of 38 cases. Eur J Obstet Gynecol Reprod Biol. 81, 1998, 65-8.
PubMed
27) Grootscholten, K., Koh, M., Guid Oei, S. et al. External Cephalic Version : Related Risks ; A Meta-analysis. Obstet Gynecol. 112, 2008, 1143-51.
 
28) Boucher, M., Marquette, GP., Varin, J. at al. Fetomaternal hemorrhage during external cephalic version. Obstet Gynecol. 112, 2008, 79-84.
 
29) Lau, TK. et al. Predictors of successful external cephalic version at term : a prospective study. Br J Obstet Gynaecol. 104, 1997, 798-802.
PubMed
30) Newman, RB. et al. Predictiong success of external cephalic version. Am J Obstet Gynecol. 169, 1993, 245-50.
 
31) Smith, C., Crowther, C., Wilkinson, C. et al. Knee-chest postural management for breech at term : A randomized control trial. BIRTH. 26(2), 1999, 71-5.
PubMed
32) ACOG Committee Opinion. No. 265. Mode of term singleton breech delivery. Obstet. Gynecol. 98(6), 2001, 1189-90.
PubMed
33) Kinugasa, M., Sato, T., Tamura, M. et al. Antepartum detection of cord presentation by transvaginal ultrasonography for term breech presentation : Potential prediction and prevention of cord prolapse. J Obstet Gynecol Res. 33, 2007, 612-8.
 
34) ACOG Committee Opinion. Number 340. July 2006. Mode of Term Singleton Breech Delivery. Obstet Gynecol. 108, 2006, 235-37.
 
35) Eide, MG., Oyen, N., Skjaerven, R. et al. Breech Delivery and Intelligence : A Population-Based Study of 8,738 Beech Infants. Obstet Gynecol. 105, 2005, 4-11.
 
36) Herbst, A., Kallen, K. Influence of mode of delivery on neonatal mortality and morbidity in spontaneous preterm breech delivery. Eur J Obstet Gynecol Reprod Biol. 133, 2007, 25-9.
PubMed
37) Cruikshank, DP., White, CA. Obstetric malpresentations : Twenty years experience. Am J Obstet Gynecol. 116, 1973, 1097.
PubMed
38) Smith, JF. et al. Fetal laceration injury at cesarean delivery. Obstet Gynecol. 90, 1997, 344-6.
PubMed
39) Johnson, CE. Transverse presentation of fetus. JAMA. 71, 1964, 237.
 
40) Flowers, CE. Shoulder presentation. Am J Obstet Gynecol. 96, 1966, 145.
 

第16章 分娩時における特殊手技

P.308 掲載の参考文献
1) Hannah, ME. Post term pregnancy : should all women have labour induced? Fetal and Med review. 5, 1993, 3-17.
 
2) Resnik, R. "Post-term pregnancy". Maternal-Fetal Medicine. 4th ed. W. B. Saunders, 1999, 532-9.
 
3) Gulmezoglu, AM., Crowther, CA., Middleton P. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database of Systematic Reviews Issue. 4, 2009.
 
4) 佐藤和雄監修. 分娩誘発法. 研修ノートNo.43, 1992, 日本産婦人科医会.
 
5) Dodd, JM. et al. Morning compared with evening induction of labor : a nested randomized controlled trial. Obstet Gynecol. 108(2), 2006, 350-60.
PubMed
6) 坂元正一ほか監修. "分娩誘発法". プリンシパル産科婦人科学. 第2版. 東京, メジカルビュー社. 1998, 669-82.
 
7) Thomas, J. et al. Oestrogens alone or with amniotomy for cervical ripening or induction of labour. Cochrane library review. 2002.
 
8) Magann, EF. et al. Cervical ripening before medical induction of labor : A comparison of prostaglandin E2, estradiol, and oxytocin. Am J Obstet Gynecol. 172(6), 1995, 1702-8.
PubMed
9) 合阪幸三ほか. 分娩誘発時におけるDHA-S投与の臨床効果に対する総合的解析. 日本産科婦人科学会雑誌. 38(9), 1986, 1605-12.
 
10) 矢内原巧. 本邦における胎盤性sulfatase欠損症. 日本産科婦人科学会雑誌. 39(5), 1987, 861-6.
 
11) Kavanagh, J. et al. Hyaluronidase for cervical priming and induction of labour. Cochrane library review. 2002
 
12) Scott-Barrileaux, P. et al. Cervical ripening and induction of labor with misoprostol, dinoprostone gel and a Foley catherter : A randomized trial of 3 techniques. Am J Obstet Gynecol. 186(6), 1124-9. 2002
 
13) Frohn, WE. et al. Prostaglandine E2 gel vs misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks. Obstet Gynecol. 99(2), 2002, 206-10.
PubMed
14) 日本産科婦人科学会編. 産科婦人科用語集・用語解説集. 改訂第2版, 金原出版, 2008.
 
15) Quilligan, EJ., Zuspan, FP. eds. "Induction of labor". Current Therapy in Obstetrics and Gynecology. 5th ed. W. B. Saunders, 2000, 334-7.
 
16) Challis, JRG. et al. Endocrinology of labour. Fetal-Medicine review. 1, 1991, 47-66.
 
17) Ramsey, PS. et al. Misoprostol, a Prostaglandin E1 analog, for prelabour ripening of the unfavourable uterine cervix. Fetal and Med review. 8, 1998, 217-27.
 
18) Hofmeyr, GJ. Amnioinfusion for umbilical cord compression in labour. Cochrane library review. 2002.
 
19) Hofmeyr, GJ. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane library review. 2002.
PubMed
20) Broekhuizen, FF. Misoprostol, its use in Obstetrics and Gynecology. Curr Probl Obstet Gynecol Fertile. November/December 2000, 198-217.
 
21) Alfirevic, Z. Oral misoprostol for induction of labour. Cochrane library review. 2002.
 
22) Fonseca, L. et al. Randomized trial of prediction cervical ripening : misoprostol vs oxytocin. Am J Obstet Gynecol. 199(3), 2008, 305 e1-5.
 
23) Wing, DA. et al. Misoprostol vaginal insert compared with dinoprostone vaginal insert : a randomized controlled trial. Obstet Gynecol. 112(4), 2008, 801-12.
PubMed
24) ACOG Practice Bulletin. No. 107. Clinical management guidelines for obstetrician -gynecologists. Induction of Labor. 2009 August.
 
25) Ellwood, DA. Estrogens, Prostaglandins, and Cervical Ripening. Lancet. 1979, 376-7.
PubMed
26) Maradny, EEL. et al. Interleukin-8 induced cervical ripening in rabbits. Am J Obstet Gynecol. 171(1), 1994, 77-83.
 
27) Kelly, AJ. et al. Relaxin for cervical ripening and induction of labour. Cochrane library review. 2002.
 
28) Hayes, EJ. et al. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin. Am J Obstet Gynecol. 198(6), 2008, 622 e1-7.
 
29) 日本産科婦人科学会・日本産婦人科医会. 子宮収縮薬による陣痛誘発・陣痛促進に際しての留意点. 改訂2011年版.
 
30) Simpson, KR. et al. Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rare patterns. Am J Obstet Gynecol. 199(1), 2008, 34 e1-5.
 
31) Kelly, AJ., Tan, B. Intravenous oxytocin alone cervical ripening and induction of labour. Cochrane library review. 2002.
 
32) Tan, BP., Hannah, ME. Prostaglandins versus oxytocin for prelabour rupture of membranes at or near term. Cochrane library review. 2002.
 
33) Luckas, M., Bricker, L. Intravenous prostaglandin for induction of labour. Cochrane library review. 2002.
 
34) French, L. Oral prostaglandin E2 for induction of labour. Cochrane library review. 2002.
 
35) Hannah, ME. et al. Prelabour rupture of membranes at term. Fetal and Med. review. 10, 1998, 61-8.
 
36) Mozurkewich, EL., Wolf, FM. Premature rupture of membranes at term : a meta-analysis of three management schemes. Obstet Gynecol. 89(6), 1997, 1035-43.
PubMed
37) Boulvian, M. et al. Mechanical methods for induction of labour. Cochrane library review. 2002.
 
38) Miyazaki, FS., Talor, NA. Saline amnioinfusion for relief of variable or prolonged decelerations. Am J Obstet Gynecol. 146(6), 1983, 670-8.
PubMed
39) Kazzi, GM. et al. Efficacy and safety of la minaria digitata for preinduction ripening of the cervix. Obstet Gynecol. 160(4), 1982, 440-3.
 
40) Krammer, J. et al. Mechanical methods of cervical ripening. Clin Obstet Gynecol. 38(2), 1995, 280-6.
PubMed
41) Obrien, WF. Cervical ripening and labor induction : Progres and challenges. Clin Obstet Gynecol. 38(2), 1995, 221-3.
 
42) Magann, EF. et al. Management of pregnancies beyond fortyone weeks gestation with unfavorable cervix. Am J Obstet Gynecol. 178(6), 1998, 1279-87.
PubMed
43) Manabe, Y. et al. F prostaglandin levels in amniotic fluid during balloon-induced cervical ripening and labor at term. Prostaglandins. 23(2), 1982, 247-56.
 
44) Busowski, JD. et al. Amniotomy to induced labor. Clin Obstet Gynecol. 38(2), 1995, 246-57.
PubMed
45) Boulvian, M. et al. Membrane sweeping for induction of labour. Cochrane library review. 2002.
 
46) Tan, PC. et al. Membrane sweeping at initiation of formal labor induction : a randomized controlled trial. Obstet Gynecol. 107(3), 2006, 569-77.
PubMed
47) Manabe, Y. et al. Condition of the cervix for the increase of plasma levels of 13,14-dehydro-15-keto-Prostaglandin F2α after amniotomy at term. Prostaglandins. 33(5), 1987, 757-66.
 
48) Boulvain, M., Stan, CM., Irion, O. Membrane sweeping for induction of labour. Cochrane Database of Systematic Reviews Issue. 4, 2009.
 
49) Manabe, Y. et al. Plasma levels of 13,14-dehydro-15-keto prostagrandine F2α, estrogens and progesterone during stretch-induced labor at term. Prostaglandins. 30(1), 1985, 141-52.
 
50) Manabe, Y. et al. Decidual morphology and F prostaglandin in amniotic fluid in stretch-induced abortion. Obstet Gynecol. 64(5), 1984, 661-5.
 
51) Sherman, DJ. et al. Balloon cervical ripening with extraamniotic infusion of saline or prostaglandine E2 : A doubleblind, randomized controlled study. Obstet Gynecol. 97(3), 2001, 375-80.
 
52) Sciscione, AC. et al. Transcervical Foley catheter for preinduction cervical ripening in an outpatient vs inpatient setting. Obstet Gynecol. 98(5), 2001, 751-6.
 
53) Levy, R. et al. A randomized comparison of early vs late amniotomy following cervical ripening with a Foley catheter. BJOG. 109, 2002, 168-72.
 
54) Cromi, A. et al. Cervical ripening with a Foley catheter : the role of pre- and postripening ultrasound examination of the cervix. Am J Obstet Gynecol. 196(1), 2007, 41, e1-7.
 
55) Mozurkewich, EL. et al. Methods of induction of labour : a systematic review. BMC Pregnancy Childbirth. 11, 2011, 84.
PubMed
56) Jozwiak, M. et al. Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial) : an open-label, randomised controlled trial. Lancet. Early Online Publication, 25 October 2011.
 
57) Fraser, WD. et al. A randomized controlled trial of early amniotomy. Br J Obstet Gynaecol. 98(1), 1991, 84-91.
PubMed
58) 佐藤和雄監修. 産婦人科臨床コンパス. 第1版. メディカルレビュー社, 1994, 418-30.
 
59) Bricker, L., Luckas, M. Amniotomy alone for induction of labour. Cochrane library review. 2002.
 
60) Kavanagh, J. et al. Breast stimulation for cervical ripening and induction of labor. Cochrane library review. 2001.
 
61) Kavanagh, J., Kelly, AJ., Thomas, J. Breast stimulation for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews Issue. 3, 2005.
PubMed
62) Smith, CA. et al. Acupuncture to induce labor : a randomized controlled trial. Obstet Gynecol. 112(5), 2008. 1067-74.
PubMed
63) Heinemann, J. et al. Do mechanical methods of cervical ripening increase infectious morbidity? A systematic review. Am J Obstet Gynecol. 199(2), 2008, 177-87.
PubMed
64) Fraser, WD. et al. Amniotomy for shortening spontaneous labour. Cochrane library review. 2002.
 
65) Manabe, Y. Nelaton catheter for gradual and safe cervical dilatation : An ideal substitute for laminaria. Am J Obstet Gynecol. 140(4), 1981, 465-6.
PubMed
66) Hofmeyr, GJ. Amnioinfusion for meconium-stained liquor in labour. Cochrane library review. 2002.
 
67) Rathore, AM. et al. Randomized trial of amnioinfusion during labour with meconium stained amniotic fluid. Br J Obstet Gynaecol. 109, 2002, 17-20.
 
68) Regi, A. et al. Amnioinfusion for relief of recurrent severe and moderate variable decelerations in labor. J Reprod Med. 54, 2009, 295-02.
PubMed
69) ACOG Committee Opinion. Amnioinfusion does not prevent meconium aspiration syndrome. Obstet Gynecol. 108, 2006, 1053-5.
 
70) Fraser, WD. et al. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med. 109, 2002, 17-20.
 
71) Hofmeyr, GJ. Amnioinfusion for preterm rupture of membranes. Cochrane library review. 2002.
 
72) Laine, K. et al. Decreasing the incidence of anal sphincter tears during delivery. Obstet Gynecol. 111(5), 2008, 1053-7.
PubMed
73) Prendiville, WJ. et al. Active versus expectant management in the third stage of labor. Cochrane library review. 2000.
 
74) McDonald, S. et al. Prophylatic syntometrine versus oxytocin for delivery of the placenta. Cochrane library review. 2000.
 
75) Gulmezoglu, AM. et al. Prostaglandins for prevention of postpartum hemorrhage. Cochrane library review. 2001.
 
76) Althabe, F. et al. A behavioral intervention to improve obstetrical care. New Engl J Med. 358 s(18), 2008, 1929-40.
 
77) American College of Obstetricians-Gynecologists. Episiotomy : clinical management guidelines for obstetriciangynecologists. ACOG Practice Bulletin. Number 71. Obstet Gynecol. 107, 2006, 957-62.
PubMed

第17章 帝王切開術

P.320 掲載の参考文献
1) Clark, SL., Belfort, MA. et al. Maternal death in the 21st century : causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 199(1), 2008, 36 e1.
 
2) Kalish, RB. et al. Intrapartum elective cesarean delivery : A previously unrecognized clinical entitya. Obstet Gynecol. 103, 2004, 1137-41.
 
3) NIH consensus state sci. Statement : Cesarean Delivery on maternal request. 23, 2006, 1-29.
PubMed
4) Nygaard, I. et al. Should all women be offered elective cesarean delivery? Obstet Gynecol. 102, 2003, 217-9.
PubMed
5) Smith, GC. et al. Cesarean section and risk of unexplained stillbirth in subsequent pregnancy. Lancet. 362, 2003, 1779-84.
PubMed
6) Matthews, TG., Crowley, P., Chong, A., McKenna, P., McGarvey, C., O'Regan, M. Rising caesarean section rates : a cause for concern? Br J Obstet Gynaecol. 2003, 110, 346-9.
 
7) Cunningham, FG., Leveno, KJ. et al. eds. "Cesarean delivery and postpartum hysterectomy". Williams Obstetrics. 22nd ed. New York, McGraw-Hill, 2005, 587-606.
 
8) 厚生労働省. 母子保健の主なる統計. 施設別, 分娩及び帝王切開術の件数. 2009.
 
9) ACOG Task Force on Cesarean Delivery rates. Evaluation of cesarean delivery. June 2000.
 
10) Cragin, E. Conservatism in obstetrics. N Y Med J. 104, 1916, 1.
 
11) Alison, G. et al. Racial disparity in the success and complications of vaginal birth after cesarean delivery. Obstet Gynecol. 111, 2008, 654-8.
 
12) Landon, MB. et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean section. N Engl J Med. 351, 2004, 2581-9.
PubMed
13) Mozurkewich, EL. et al. Elective repeat cesarean delivery versus trial of labor : A meta analysis of the literture from 1989 to 1999. Am J Obstet Gynecol. 183, 2000, 1187.
 
14) Rossi, AC. et al. Maternal morbidity following a trial of labor after cesarean section vs elective repeat cesarean delivery : systematic review with metaanalysis. Am J Obstet Gynecol. 199(3), 2008, 224.
PubMed
15) Gray, R. et al. Cesarean delivery and risk of stillbirth in subsequent pregnancy : a retrospective cohort study in an English population. BJOG. 114, 2007, 264-70.
 
16) Bowes, Jr WA. et al. "Clinical aspects of normal and abnormal labor". Maternal-fetal medicine. 5th ed. Creasy, RK., Resnik, R. eds. Philadelphia, W B Saunders, 2003, 671-705.
 
17) Macara, LM. et al. The contribution of dystocia to the cesarean section rate. Am J Obstet Gynecol. 171, 1994, 71-7.
 
18) ACOG Technical Bulletin. Dystocia and the augmentation of labor. Number 218. December 1995.
PubMed
19) Stephenson, J. Health agencies update : An unkind Cut? JAMA. 283, 2000, 2514.
PubMed
20) Rouse, DJ. et al. Active-phase labor arrest : oxytocin augmentation for at least 4 hours. Obstet Gynecol. 93, 1999, 323-8.
PubMed
21) ACOG Committee Opinion. Vaginal delivery after a previous cesarean birth. Number 143. October 1994.
PubMed
22) Chauhan, SP. et al. Cesarean section for suspected fetal distress : Does the decision-incision time make a difference? J Reprod Med. 42, 1997, 347-52.
PubMed
23) MacKenzie, IZ., Cooke, I. What is a reasonable time from decision-to-delivery by caesarean section? : Evidence from 415 deliveries. BJOG. 109, 2002, 498-504.
PubMed
24) Leung, AS. et al. Uterine rupture after previous cesarean delivery : maternal and fetal consequences. Am J Obstet Gynecol. 169, 1993, 945-50.
PubMed
25) Haverkamp, AD. et al. A controlled trial of the differential effects of intrapartum fetal monitoring. Am J Obstet Gynecol. 134, 1979, 399-412.
PubMed
26) Garite, TJ. et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. Am J Obstet Gynecol. 183, 2000, 1049-58.
PubMed
27) Hannah, ME. et al. Planned caesarean section versus planned vaginal birth for breech presentation at term : a randomised multicentre trial : Term Breech Trial Collaborative Group. Lancet. 356, 2000, 1375-83.
 
28) ACOG Committee Opinion. Mode of term singleton breech delivery. Number 265. December 2001.
 
29) Whyte, H. et al. Outcomes of children at 2 years after planned cesarean birth versus planned vaginal birth for breech presentation at term : the International Randomized Term Breech Trial. Am J Obstet Gynecol. 191, 2004, 864-71.
PubMed
30) Giuliani, A. et al. Mode of delivery and outcome of 699 term singleton breech deliveries at a single center. Am J Obstet Gynecol. 187(6), 2002, 1694-8.
 
31) ACOG Committee Opinion. Mode of term singleton breech delivery. Number 340, July 2006.
 
32) Conway, DL., Langer, O. Elective delivery of infants with macrosomia in diabetic women : reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol. 178, 1998, 922-5.
PubMed
33) Gonen, O. et al. Induction of labor versus expectant management in macrosomia : A randomized study. Obstet Gynecol. 89, 1997, 913.
PubMed
34) Sanchez-Ramos, L. et al. Expectant management versus labor induction for suspected fetal macrosomia : systemic review. Obstet Gynecol. 100, 2002, 997.
 
35) Zhang, X. et al. How big is too big? : The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol. 198, 2008, 517e1-6.
PubMed
36) ACOG Practice Bulletin. Fetal macrosomia. Number 22. November 2000a.
 
37) Ment, LR. et al. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol. 172, 1995, 795-800.
PubMed
38) Lee, HC., Gould, J. Survival advantage associated with cesarean delivery in very low birth weight vertex neonates. Obstet Gynecol. 107(1), 2006, 97-105.
PubMed
39) Bottoms, SF., Paul, RH. et al. Obstetric determinants of neonatal survival : antenatal predictors of neonatal survival and morbidity in extremely low birth weight infants. Am J Obstet Gynecol. 180(3 Pt 1), 1999, 665-9.
 
40) Malloy, MH. Impact of cesarean section on neonatal mortality rates among very preterm infants in the United States 2000-2003. Pediatrics. 122(2), 2008, 285-92.
PubMed
41) Batton, B., Burnett, C. et al. Extremely preterm infant mortality rates and cesarean diliveries in the United States. Obstet Gynecol. 118(1), 2011, 43-8.
PubMed
42) Hogle, KL. et al. Cesarean delivery for twins : a systematic review and meta-analysis. Am J Obstet Gynecol. 188(1), 2003, 220-7.
PubMed
43) Mauldin, JG. et al. Cost-effective delivery management of the vertex and nonvertex twin gestation. Am J Obstet Gynecol. 179, 1998, 864-9.
PubMed
44) Garite, TJ. et al. Twins and triplets : the effect of plurality and growth on neonatal outcome compared with singleton infants. Am J Obstet Gynecol. 191, 2004, 700-7.
PubMed
45) Nassar, AH. et al. Severe preeclampsia remote from term : labor induction or elective cesarean delivery? Am J Obstet Gynecol. 179, 1998, 1210-3.
PubMed
46) Alexander, JM. et al. Severe preeclampsia and the very low birth weight infant : is induction of labor harmful? Obstet Gynecol. 93, 1999, 485-8.
PubMed
47) Chervenak, FA., McCullough, LB. Ethical analysis of the intrapartum management of pregnancy complicated by fetal hydrocephalus with macrocephaly. Obstet Gynecol. 68, 1986, 720-5.
PubMed
48) Luthy, DA. et al. Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally. N Engl J Med. 324, 1991, 662-6.
PubMed
49) ACOG Practice Bulletin. Management of herpes in pregnancy. Number 8. October 1999.
PubMed
50) ACOG Committee Opinion. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234. May 2000.
PubMed
51) Hung, TH. et al. Risk factors for placenta accreta. Obstet Gynecol. 93, 1999, 545-50.
PubMed
52) Clark, SL. et al. Placenta previa/accreta and prior cesarean section. Obstet Gynecol. 66(1), 1985, 89-92.
PubMed
53) Ikeda, T., Sameshima, H., Kawaguchi, K., Yamauchi, N., Ikenoue, T. Tourniquet technique prevents profuse blood loss in placenta accreta cesarean section. J Obstet Gynaecol Res. 31, 2005, 27-31.
 
54) Liu, S. et al. Maternal mortality and severe morbidity associated with low risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ. 176(4), 2007, 455-60.
PubMed
55) Lilford, RJ. et al. The relative risks of caesarean section (intrapartum and elective) and vaginal delivery : a detailed analysis to exclude the effects of medical disorders and other acute pre-existing physiological disturbances. Br J Obstet Gynaecol. 97, 1990, 883-92.
PubMed
56) Vadnais, M. et al. Maternal mortality with cesarean delivery : Literature Review. Semiar Perinatol. 30, 2006, 242-6.
 
57) Deneux-Tharaux, C. et al. Postpartum maternal mortality and cesarean delivery. Obstet Gynecol. 108, 2006, 541-8.
PubMed
58) Rouse, MG. Consensus Task Force on Cesarean Childbirth. National Institutes of Health, NIH Publication, Number 82. 1981, 2067.
 
59) Briery, CM. et al. Planned vs emergent cesarean hysterectomy. Am J Obstet Gynecol. 197, 2007, 154e1-5.
 
60) Reisner, LS. Anesthesia for cesarean section. Clin Obstet Gynecol. 23, 1980, 517-23.
PubMed
61) Bowes, WA Jr. "Clinical aspects of normal and abnormal labor". Maternal-Fetal Medicine. 4th ed. Creasy, RK., Resnik, R. eds. Philadelphia, WB Saunders, 1999, 541-68.
 
62) Cohen, SE. The aspiration syndrome. Clin Obstet Gynaecol. 9, 1982, 235-54.
PubMed
63) 妊産婦死亡検討委員会. 日本の母体死亡 : 妊産婦死亡症例集. 東京, 三宝社, 1998.
 
64) 杉本充弘. 帝王切開術. 産科と婦人科増刊号 : 産婦人科手術マニュアル. 70, 2003, 5060-70.
 
65) Siddiqui, M. et al. Comolications of exteriorized comared with in situ uterine repair at cesarean delivery under spinal anesthesia. Obstet Gynecol. 110, 2007, 570-5.
 
66) Park, RC., Duff, WP. Role of cesarean hysterectomy in modern obstetric practice. Clin Obstet Gynecol. 23, 1980, 601-20.
PubMed
67) Hager, RM. et al. Complications of cesarean deliveries : rates and risk factors. Am J Obstet Gynecol. 190, 2004, 428-34.
PubMed
68) Ott, WJ. Primary cesarean section : factors related to postpartum infection. Obstet Gynecol. 57, 1981, 171-6.
PubMed
69) Tran, TS. et al. Risk factors for postcesarean surgical site infection. Obstet Gynecol. 95, 2000, 367-71.
PubMed
70) Smaill, F., Hofmeyr, GJ. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev. CD000933. 2002.
 
71) Sullivan, SA. et al. Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity : a randomized, control trial. Am J Obstet Gynecol. 196, 2007, 455 e1-e5.
 
72) ACOG Practice Bulletin. Prophylactic antibiotics in labor and delivery. Number 47. October 2003.
PubMed
73) Bates, SM., Ginsberg, JS. Thrombosis in pregnancy. Curr Opin Hematol. 4, 1997, 335-43.
PubMed
74) 小林隆夫. 深部静脈血栓症・肺塞栓症の予防と治療. 周産期医学. 33, 2003, 991-5.
 
75) Rodger, MA. et al. Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section. Am J Obstet Gynecol. 194, 2006, 436-7.
PubMed
76) 肺塞栓研究会編. 静脈血栓塞栓症の予防および妊娠中の抗血栓薬の使用. 第7回ACCPガイドライン. Medical Front International Limited, 2006.
 
77) Silver, RM. et al. Maternal Morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 207, 2007, 1226.
 
78) Nisenblat, V. et al. Maternal complications associated with multiple cesarean deliveries. Obstet Gynecol. 108, 2006, 21.
PubMed
79) Yang, Q. et al. Association of cesarean delivery for first birth with placenta previa and placental abruption in second pregnancy. BJOG. 114, 2007, 609-13.
PubMed
80) Schreiner, RL. et al. Respiratory distress following elective repeat cesarean section. Am J Obstet Gynecol. 143, 1982, 689-92.
PubMed
81) Heritage, CK., Cunningham, MD. Association of elective repeat cesarean delivery and persistent pulmonary hypertension of the newborn. Am J Obstet Gynecol. 152, 1985, 627-9.
PubMed
82) Makihara, K. et al. Echocardiographic assessment of systolic time intervals in vaginal and cesarean delivered neonates. Am J Perinatol. 10, 1993, 53-7.
PubMed
83) MacDorman, MF. et al. Infant and neonatal mortality for primary cesarean and vaginal births to women with "no indicated risk," United States, 1998-2001 birth cohorts. Birth. 33, 2006, 175-82.
PubMed
84) Tita, AT. et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med. 360, 2009, 111-20.
PubMed
85) Smith, JF. et al. Fetal laceration injury at cesarean delivery. Obstet Gynecol. 90, 1997, 344-6.
PubMed

第18章 分娩・産褥期出血

P.347 掲載の参考文献
1) 厚生労働省統計情報データベース検索結果一覧. 東京, 厚生労働省 [cite 2011年4月28日]. http://winet.nwec.jp/toukei/save/xls/L100220.xls
 
2) 鈴木芳子. 過去5年間における分娩時出血の実態調査. 印刷局医報. 35, 1989, 47-54.
 
3) 堀大蔵ほか. 弛緩出血. 産婦人科の実際. 39, 1990, 1203-7.
 
4) 沖 利貴, 永田行博. 分娩後出血の母体に与える影響. 周産期医学. 19, 1989, 69-72.
 
5) 有賀敏ほか. 当院における経腟分娩時異常出血の現状. 北海道産科婦人科学会誌. 36, 1991, 89-90.
 
6) Browning, DJ. Serious side effects of ergometrine and its use in routine obstetric practice. Med J Austral. 1, 1974, 957.
PubMed
7) Rogers, J. et al. Active versus expectant management of third stage of labour. The Hinchingbrooke randomised controlled trial. Lancet. 351(9104), 1998, 693.
PubMed
8) Sheehan, HL., Murdoch, R. Postpartum necrosis of the anterior pituitary : Pathological and clinical aspects. Br J Obstet Gynaecol. 45, 1938, 456-89.
 
9) CDC. Kaposi's sarcoma and pneumocystis pneumonia among homosexual men : New York City and California. MMWR. 30, 1981, 305-8.
PubMed
10) Mahony, R. et al. Internal anal sphincter defect influences continence outcome following obstetric anal sphincter injury. Am J Obstet Gynecol. 196, 2007, 217, e1-e5.
 
11) Fitzpatrick, M. et al. Randomised clinical trial to assess anal sphincter function following forceps or vacuum assisted vaginal delivery. BJOG. 110, 2003, 424-9.
PubMed
12) Grant, A. The choice of suture materials and techniques for repair of perineal trauma : An overview of the evidence from controlled trials. Br J Obstet Gynaecol. 96, 1989, 1281-9.
PubMed
13) Goldaber, KG. et al. Postpartum perineal morbidity after fourth-degree perineal repair. Am J Obstet Gynecol. 168, 1993, 489-93.
PubMed
14) Nordenstam, J. et al. Immediate or delayed repair of obstetric anal sphincter tears : a randomized controlled trial. BJOG. 115, 2008, 857-65.
 
15) Roberts, PL. et al. Manometric assessment of patients with obstetric injuries and fecal incontinence. Dis Colon Rectum. 33, 1990, 16-20.
PubMed
16) Eden, RD. et al. Rupture of the pregnant uterus : A 53-year review. Obstet Gynecol. 68, 1986, 671-4.
PubMed
17) Rachagan, SP. et al. Rupture of the pregnant uterus-A 21-year review. Aust NZJ Obstet Gynaecol. 31, 1991, 37-40.
 
18) Rodriguez, MH. et al. Uterine rupture : Are intrauterine pressure catheters useful in the diagnosis? Am J Obstet Gynecol. 161, 1989, 666-9.
PubMed
19) Fuchs, K. et al. The "grand multipara" : Is it a problem? A review of 5785 cases. Int J Gynaecol Obstet. 23, 1985, 321-6.
PubMed
20) Chauhan, SP. et al. Maternal and perinatal complications with uterine rupture in 142,075 patients who attempted vaginal birth after cesarean delivery : A review of the literature. Am J Obstet Gynecol. 189, 2003, 408-17.
PubMed
21) Mizunoya, F. et al. Management of vaginal birth after cesarean. J Obstet Gynaecol Res. 18, 2002, 240-4.
 
22) Obara, H. et al. Vaginal birth after cesarean delivery : results in 310 pregnancies. J Obstet Gynaecol Res. 24, 1998, 129-34.
PubMed
23) Shiono, PH. et al. Recent trends in cesarean birth and trial of labor rates in the United States. JAMA. 257, 1987, 494-7.
PubMed
24) Flamm, BL. et al. Vaginal birth after cesarean section : Results of a multicenter study. Am J Obstet Gynecol. 158, 1988, 1079-84.
PubMed
25) Farmer, RM. et al. Uterine rupture during trial of labor after previous cesarean section. Am J Obstet Gynecol. 165, 1991, 996-1001.
PubMed
26) Dhall, K. et al. Childbirth following primary cesarean section : evaluation of a scoring system. Int J Gynaecol Obstet. 25, 1987, 199-205.
PubMed
27) Fedorkow, DM. et al. Ruptured uterus in pregnancy : A Canadian hospital's experience. Can Med Assoc J. 137, 1987, 27-9.
 
28) Taylor, PJ., Cummings, DC. Spontaneous rupture of a primigravid uterus. J Reprod Med. 22, 1979, 169.
 
29) Orhue, AAE. A randomised trial of 45 minutes and 15 minutes incremental oxytocin infusion regimes for the induction of labour in women of high parity. Br J Obstet Gynaecol. 100, 1993, 126-9.
 
30) Cahill, DJ. et al. Does oxytocin augmentation increase perinatal risk in primigravid labor? Am J Obstet Gynecol. 166, 1992, 847-50.
PubMed
31) Mokgokong, ER., Marivate, M. Treatment of the ruptured uterus. Afr Med J. 50, 1976, 1621-4.
 
32) Sheth, SS. Results of treatment of rupture of the uterus by suturing. J Obstet Gynaecol Br Commonw. 75, 1968, 55-8.
PubMed
33) Burchell, RC. Internal iliac artery ligation : hemodynamics. Obstet Gynecol. 24, 1964, 737-9.
PubMed
34) Mengert, WJ. et al. Pregnancy after bilateral ligation of the internal iliac and ovarian arteries. Obstet Gynecol. 34, 1969, 664-6.
 
35) Zahn, CM., Yeomans, ER. Postpartum hemorrhage : Placental accreta, uterine inversion and puerperal hematomas. Clin Obstet Gynecol. 33, 1990, 422-31.
PubMed
36) Pritchard, JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology. 26, 1965, 393-9.
PubMed
37) Walker, JW., McDowell, JS. Pregnancy after uterine artery embolization for leiomyomata : A series of 56 completed pregnancies. Am J Obstet Gynecol. 195, 2006, 1266-71.
 
38) Gilstrap, LC. et al. Effect of type of anesthesia on blood loss at cesarean section. Obstet Gynecol. 69, 1987, 328-32.
PubMed
39) 富永好之ほか. 子宮弛緩症に対するProstaglandin F2αの子宮筋直接投与法の試み. 産婦人科の世界. 26, 1974, 95-8.
 
40) 森透ほか. Prostaglandin F2αの子宮筋直接注入法による弛緩性出血の予防について. 産婦人科治療. 34, 1977, 378-81.
 
41) B-Lynch, C. et al. The B-Lynch surgical technique for the control of massive postpartum haemorrhage : an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 104, 1997, 372-5.
 
42) Pelage, JP. et al. Selective arterial embolization of the uterine arteries in the management of intractable postpartum hemorrhage. Acta Obstet Gynecol Scand. 78, 1999, 698-703.
PubMed
43) Read, JA. et al. Placenta accreta : Changing clinical aspects and outcome. Obstet Gynecol. 56, 1980, 31-4.
PubMed
44) Breen, JL. et al. Placenta accreta, increta, and percreta : A survey of 40 cases. Obstet Gynecol. 49, 1977, 43-7.
PubMed
45) Usta, MI. et al. Placenta previa-accreta : Risk factors and complications. Am J Obstet Gynecol. 193, 2005, 1045-9.
 
46) Fox, H. Placenta accreta, 1945-1969. Obstet Gynecol Surv. 27, 1972, 475-90.
 
47) Armstrong, CA. et al. Is placenta accrete catching up with us? Aust NZJ Obstet Gynaecol. 44, 2004, 210-3.
 
48) Archer, GH., Furlong, LA. Acute abdomen caused by placenta percreta in the second trimester. Am J Obstet Gynecol. 157, 1987, 146-7.
 
49) Berchuck, A., Sokol, RJ. Previous cesarean section, placenta increta, and uterine rupture in second-trimester abortion. Am J Obstet Gynecol. 145, 1983, 766-7.
PubMed
50) Pasto, ME. et al. Ultrasonographic findings in placenta increta. J Ultrasound Med. 2, 1983, 155-9.
PubMed
51) Tabsh, KMA. et al. Ultrasound diagnosis of placenta increta. J Clin Ultrasound. 10, 1982, 288-90.
 
52) Greenberg, IJ. et al. Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation : cautionary case. Am J Obstet Gynecol. 197, 2007, 470, e1-e4.
 
53) Platt, LD., Druzin, ML. Acute puerperal inversion of the uterus. Am J Obstet Gynecol. 141, 1981, 187-90.
PubMed
54) Shah-Hosseini, R., Evrard, JR. Puerperal uterine inversion. Obstet Gynecol. 73, 1989, 567-70.
PubMed
55) Catanzarite, VA. et al. New approaches to the management of acute puerperal uterine invasion. Obstet Gynecol. 68, 1986, 7S-10S.
 
56) Kovacs, BW., DeVore, GR. Management of acute and subacute puerperal uterine inversion with terbutaline sulfate. Am J Obstet Gynecol. 150, 1984, 784-6.
PubMed
57) Thiery, M., Delbeke, L. Acute puerperal uterine inversion : Two-step management with a β-mimetic and a prostaglandin. Am J Obstet Gynecol. 153, 1985, 891-2.
 
58) Huntington, JL. Acute inversion of the uterus. Boston Med Surg J. 184, 1921, 376-80.
 
59) Van Vugt, PJH. et al. Inversio uteri puerperalis. Acta Obstet Gynecol Scand. 60, 1981, 353-62.
 
60) Lee, CY. et al. Ultrasonic evaluation of the postpartum uterus in the management of postpartum bleeding. Obstet Gynecol. 58, 1981, 227-32.
PubMed
61) Adrinopoulos, GC., Mendenhall, HW. Prostaglandin F2α in the management of delayed postpartum hemorrhage. Am J Obstet Gynecol. 146, 1983, 217-8.
 
62) Goldstein, AI. et al. Prostaglandin E2 vaginal suppositories in the treatment of intractable late-onset postpartum hemorrhage : A case report. J Reprod Med. 28, 1983, 425-6.
PubMed

第19章 産科麻酔

P.363 掲載の参考文献
1) Kitahara T, et al. The spread of drugs used for spinal anesthesia. Anesthesiology. 17, 1956, 205-8.
PubMed
2) 福光一夫. "産科麻酔 : 帝王切開術の麻酔". 周産期麻酔マニュアル. 木内恵子, 北村征治. 東京, 真興交易医書出版部, 2003, 277-82.
 
3) Samsoon, GL. et al. Difficult tracheal intubation : a retrospective study. Anaesthesia. 42, 1987, 487-90.
PubMed
4) Mallampati, SR. et al. A clinical sign to predict difficult tracheal intubation : a prospective study. Can Anaesth Soc J. 32(4), 1985, 429-34.
PubMed
5) Kodali, BS. et al. Airway changes during labor and delivery. Anesthesiology. 108(3), 2008, 357-62.
PubMed
6) Fulton, IC. et al. Is normal pregnancy cholestatic? Clin Chim Acta. 130(2), 1983, 171-6.
PubMed
7) Hould, FS. et al. Progesterone receptors regulate gallbladder motility. J Surg Res. 45(6), 1988, 505-12.
PubMed
8) Swisher, SG. et al. Biliary disease during pregnancy. Am J Surg. 168(6), 1994, 576-9.
PubMed
9) American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Practice guidelines for obstetric anesthesia : an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology. 106(4), 2007, 843-63.
PubMed
10) Murphy, DF. et al. Effect of metoclopramide on gastric emptying before elective and emergency caesarean section. Br J Anaesth. 56(10), 1984, 1113-6.
PubMed
11) Gintzler, AR. Endorphin-mediated increases in pain threshold during pregnancy. Science. 210, 1980, 193-5.
PubMed
12) Palatiniuk, RJ. et al. Pregnancy decreases the requirement for inhaled anesthetic agents. Anesthesiology. 41, 1974, 82-3.
 
13) Ueyama, H. et al. Pregnancy does not enhance volatile anesthetic sensitivity on the brain : an electroencephalographic analysis study. Anesthesiology. 113(3), 2010, 577-84.
 
14) Trudinger, BJ. et al. Uteroplacental blood flow velocity time wave forms in normal and complicated pregnancy. Br J Obstet Gynaecol. 92, 1985, 39-45.
 
15) Ralston, DH. Effects of equipotent ephedrine, metaraminol, mephentermine and methoxamine on uterine blood flow in the pregnant ewe. Anesthesiology. 40, 1974, 354-70.
PubMed
16) Lee, A. et al. A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal hypotension. Anesth Analg. 94, 2002, 920-6.
 
17) Vallejo, MC. et al. Should a-agonists be used as first line management of spinal hypotension? Int J Obstet Anesth. 12, 2003, 243-5.
PubMed
18) Clyburn, P. Spinal anaesthesia for caesarean section : Time for re-appraisal? Anaesthesia. 60, 2005, 633-5.
PubMed
19) Shnider, SM. et al. Uterine blood flow and plasma norepinephrine changes during maternal stress in the pregnant ewe. Anesthesiology. 50, 1979, 524-7.
PubMed
20) Shnider, SM. et al. Maternal catecholamines decrease during labar after lumber epideral anesthesia. Am J Obstet Gynecol. 147, 1983, 13-5.
 
21) Kennel, J. et al. Continuous emotional support during labor in a US hospital, a randomized controlled trial. JAMA. 265, 1991, 2197-201.
 
22) Melzack, R. et al. Seventy of labour pain : influence of physical as well as psychologic variables. Can Med Assoc J. 130, 1984, 579-84.
 
23) Leighton, BL. et al. The effects of epidural analgesia on labor, maternal, and neonatal outcomes : a systematic review. Am J Obstet Gynecol. 186, 2002, S69-77.
PubMed
24) Cunningham, FG. et al. eds. "Analgesia and Anesthesia". Williams Obstetrics. Chapter 16. Norwalk, Connecticut, Appleton and Lange, 1993.
 
25) Arzola, C. et al. Ultrasound using the transverse approach to the lumbar spine provides reliable landmarks for labor epidurals. Anesth Analg. 104, 2007, 1188-92.
 
26) Thompson, TT. et al. Does epidural analgesia cause dystocia? J Clin Anesth. 10(1), 1998, 58-65.
PubMed
27) Halpern, SH. et al. Effect of epidural vs parenteral opioid analgesia on the progress of labor : a meta-analysis. JAMA. 280(24), 1998, 2105-10.
PubMed
28) Cheek, TG. et al. Normal saline i.v. fluid load decreases uterine activity in active labour. Br J Anaesth. 77(5), 1996, 632-5.
 
29) Cheng, YW. et al. How long is too long : Does a prolonged second stage of labor in nulliparous women affect maternal and neonatal outcomes? Am J Obstet Gynecol. 191(3), 2004, 933-8.
 
30) Ramin, SM. et al. Randomized Trial of Epidural Versus Intravenous Analgesia During Labor. Obstetrics & Gynecology. 86(5), 1995, 783-9.
PubMed
31) Sharma, SK. et al. Cesarean delivery : a randomized trial of epidural versus patient-controlled meperidine analgesia during labor. Anesthesiology. 87(3), 1997, 487-94.
PubMed
32) Segal, S. et al. The effect of a rapid change in availability of epidural analgesia on the cesarean delivery rate : A metaanalysis. Am J Obstet Gynecol. 183, 2000, 974-8.
 
33) Thorp, JA. et al. The effect of intrapartum epidural analgesia on nulliparous labor : a randomized, controlled, prospective trial. Am J Obstet Gynecol. 169, 1993, 851-8.
PubMed
34) Nageotte, MP. et al. Epidural analgesia compared with combined spinal-epidural analgesia during labor in nulliparous women. N Engl J Med. 337, 1997, 1715-9.
PubMed
35) Goetzl, LM. ACOG Practice Bulletin no.36. Clinical management guidelines for obstetrician- gynecologists : obstetric analagesia and anesthesia. Obstet Gynecol. 100, 2002, 177-91.
 
36) Ohel, G. et al. Early versus late initiation of epidural analgesia in labor : Does it increase the risk of cesarean section? ; A randomized trial. Am J Obstet Gynecol. 194, 2006, 600-5.
PubMed
37) Vinson, DC. et al. Association between epidural analgesia during labor and fever. J Fam Pract. 36, 1993, 617-22.
PubMed
38) Goetzl, L. et al. Elevated maternal and fetal serum interleukin-6 levels are associated with epidural fever. Am J Obstet Gynecol. 187(4), 2002, 834-8.
PubMed
39) Lieberman, E. et al. Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics. 99(3), 1997, 415-9.
PubMed
40) Dashe, JS. et al. Epidural analgesia and intrapartum fever : Placental findings. Obstet Gynecol. 93, 1999, 341-4.
PubMed
41) Negishi, C. et al. Opioids inhibit febrile responses in humans, whereas epidural analgesia does not : An explanation for hyperthermia during epidural analgesia. Anesthesiology. 94, 2001, 218-222.
 
42) Pattee, C. et al. Epidural analgesia for labour and delivery : Informed consent issues. Can J Anaesth. 44, 1997, 918-3.
PubMed
43) Husaini, SW. et al. Volume preload : lack of effect in the prevention of spinal-induced hypotension at caesarean section. Int J Obstet Anesth. 7, 1998, 76-81.
PubMed
44) Mendiola, J. et al. Effects of intrapartum maternal glucose infusion on the normal fetus and newborn. Anesth Analg. 61, 1982, 32-5.
PubMed
45) Andrews, PJD. et al. Aortocaval compression in the sitting and lateral decubitus positions during extradural catheter placement in the parturient. Can J Anaesth. 40, 1993, 320-4.
 
46) Pan, PH. et al. Incidence and characteristics of failures in obstetric neuraxial analgesia and anesthesia : a retrospective analysis of 19,259 deliveries. Int J Obstet Anesth. 13(4), 2004, 227-33.
 
47) Albright, G. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology. 51, 1979, 285-7.
PubMed
48) Mhyre, JM. et al. A systematic review of randomized controlled trials that evaluate strategies to avoid epidural vein cannulation during obstetric epidural catheter placement. Anesth Analg. 108(4), 2009, 1232-42.
PubMed
49) Norris, MC. et al. Does epinephrine improve the diagnostic accuracy of aspiration during labor epidural analgesia? Anesth Analg. 88, 1999, 1073-6.
PubMed
50) Norris, MC. et al. Labor epidural analgesia without an intravascular "test dose". Anesthesiology. 88(6), 1998, 1495-501.
PubMed
51) Poppers, PJ. Evaluation of local anesthetic agents for regional anesthesia in obstetrics. Br J Anaesth. 47, 1975, 322-7.
PubMed
52) Aberg, G. Toxicological and local anaesthetic effects of optically active isomers of 2 local anaesthetic compounds. Acta Pharmacol Toxicol. 31, 1972, 273-86.
 
53) Rigler, ML. et al. Distribution of catheter-injected local anesthetic in a model of the subarachnoid space. Anesthesiology. 75, 1991, 684-92.
 
54) Arkoosh, VA. et al. A randomized, double-masked, multicenter comparison of the safety of continuous intrathecal labor analgesia using a 28-gauge catheter versus continuous epidural labor analgesia. Anesthesiology. 108, 2008, 286-98.
PubMed
55) Russell, I. In the event of accidental dural puncture by an epidural needle in labour, the catheter should be passed into the subarachnoid space. Int J Obstet Anesth. 11, 2002, 23-7.
 
56) Russell, I. A prospective controlled study of continuous spinal analgesia versus repeat epidural analgesia after accidental dural puncture in labour. Int J Obstet Anesth. 21, 2012, 7-16.
 
57) Tsen, L. et al. Is combined spinal-epidural analgesia associated with more rapid cervical dilation in nulliparous patients when compared with conventional epidural analgesia? Anesthesiology. 91, 1999, 920-5.
PubMed
58) Wong, CA. et al. The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. N Engl J Med. 352, 2005, 655-65.
PubMed
59) Abrao, KC. et al. Elevation of uterine basal tone and fetal heart rate abnormalities after labor analgesia : a randomized controlled trial. Obstet Gynecol. 113, 2009, 41-7.
PubMed
60) Hughes, D. et al. Intrathecal ropivacaine or bupivacaine with fentanyl for labour. Br J Anaesth. 87, 2001, 733-7.
PubMed
61) 中井祐一郎ほか. 緊急帝王切開術に要する時間の実態. 産婦人科治療. 94(2), 2007, 197-200.
Medical*Online
62) 川島康男. 日本の産科麻酔. 臨床麻酔. 26, 2002, 447-52.
 
63) Rout, CC. et al. Intravenous ranitidine reduces the risk of acid aspiration of gastric contents at emergency cesarean section. Anesth Analg. 76(1), 1993, 156-61.
PubMed
64) Norris, MC. Height, weight and the spread of subarachnoid hyperbaric bupivacaine in the term parturient. Anesth Analg. 67, 1988, 555-87.
PubMed
65) Dahlgren, G. et al. Intrathecal sufentanil, fentanyl or placebo added to bupivacaine for cesarean section. Anesth Analg. 85, 1997, 1288-93.
 
66) Fukumitsu, K. et al. Reduced-tip needle for spinal anesthesia. Anesth Analg. 79(11), 1994, 1207-8.
 
67) Husaini, SW. et al. Volume preload : lack of effect in the prevention of spinal-induced hypotension at caesarean section. Int J Obstet Anesth. 7, 1998, 76-81.
PubMed
68) Preston, PG. et al. Epidural anesthesia with fentanyl and lidocaine for cesarean section : Maternal effects and neonatal outcome. Anesthesiology. 68, 1988, 938-42.
PubMed
69) Hawkins, JL. et al. Anesthesia-related deaths during obstetric delivery in the United States, 1979-1990. Anesthesiology. 86(2), 1997, 277-84.
PubMed
70) de Veciana, M. et al. Pulmonary injury associated with appendicitis in pregnancy : who is at risk? Am J Obstet Gynecol. 171(4), 1994, 1008-13.
PubMed
71) Nezhat, FR. et al. Laparoscopy during pregnancy : A literature review. J Soc Laparoendosc Surg. 1, 1997, 17-27.
 

第20章 母体救急疾患と集中管理

P.392 掲載の参考文献
1) 平成20年厚生労働科学特別研究事業「救急部門と周産期部門の連携強化に資する具体的手法に関する研究」 (主任研究者 杉本壽).
 
2) 消防庁. 平成20年中の救急搬送における医療機関の受入状況等実態調査.
 
3) 日本産科婦人科学会・日本救急医学会. 「地域母体救命救急体制整備のための基本的枠組の構築に関する提言」平成20年.
 
4) 杉本壽. "全国救命救急センターにおける妊産婦入院例に関する研究". 平成20年度厚生労働科学研究費補助金厚生労働科学特別研究 救急部門と周産期部門との連携強化に資する具体的手法に関する研究 総括研究報告書. 2009, 1-13.
 
5) 平成22年度 厚生労働科学研究費補助金 (生育疾患克服等次世代育成基盤研究事業) 「妊産婦死亡及び乳幼児死亡の原因究明と予防策に関する研究」 (主任研究者 池田智明).
 
6) 厚生統計協会編. "人口動態". 国民衛生の動向. 2008, 43-67.
 
7) 厚生労働省大臣官房統計情報部. 平成19年人口動態調査. 人口動態統計年報. 2009.
 
8) 周産期医療と救急医療の確保と連携に関する懇談会. 周産期医療と救急医療の確保と連携に関する懇談会報告書 : 周産期救急医療における「安心」と「安全」の確保にむけて. 2009年3月4日.
 
9) Lewis, G. et al. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers' lives : reviewing maternal deaths to make motherhood safer-2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London, CEMACH, 2007.
 
10) Department of Health, Welsh Office, Scottish Office Department of Health, Department of Health and Social Services, Nothern Ireland. Why mothers die. Report on confidential enquiries into maternal deaths in the United Kingdom 2000-2002. London (UK), The Stationery Office, 2004.
 
11) Didy, GA. et al. Cardiac arrest during pregnancy. Obstet Gynecol Clin North Am. 22, 1995, 303-14.
 
12) Morris, S. et al. ABC of resuscitation. Resuscitation in pregnancy. BMJ. 327, 2005, 1277-9.
 
13) Katz, V. et al. Perimortem cesarean delivery : were our assumptions correct? Am J Obstet Gynecol. 192(6), 2005, 1916-20.
PubMed
14) Windle, WF. Brain damage at birth : Functional and structural modifications with time. JAMA. 206, 1968, 1967-72.
PubMed
15) Dijkman, A. et al. Cardiac arrest in pregnancy : increasing use of perimortem caesarean section due to emergency skills training? BJOG, 117, 2010, 282-7.
PubMed
16) Anthony, C. Acute pulmonary edema in pregnancy. Obstet Gynecol. 101, 2003, 511-5.
 
17) Lee, W. et al. Septic shock during pregnancy. Am J Obstet Gynecol. 159, 1988, 410-6.
PubMed
18) Mabie, WC. et al. Septic shock during pregnancy. Obstet Gynecol. 90, 1997, 553-61.
PubMed
19) Fisher, M. Treatment of acute anaphylaxis. Med Clin North Am. 76, 1992, 841.
 
20) Fisher, M. Treatment of acute anaphylaxis. BMJ. 311, 1995, 731.
PubMed
21) 板倉敦夫. 産科DICのための輸血法. 産科と婦人科. 6(81), 2010, 703-8.
 
22) Kobayashi, T. et al. Recombinant activated factor VII (rFVIIa/NovoSeven(R)) in the management of severe postpartum haemorrhage : initial report of a multicenter case series in Japan. Int J Hematol. 95, 2012, 57-63.
 
23) 寺尾俊彦, 真木正博, 池ノ上克. DICからみた常位胎盤早期剥離40症例の解析. 産婦人科治療. 55, 1987, 332-40.
 
24) Terao, T., Maki, M., Ikenoue, T. A prospective study in 38 patients with abrupt placentae of 70 cases complicated by DIC. Asia Oceania J Obstet Gynaecol. 13(1), 1987, 1-13.
 
25) Resnik, JL. et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 193, 2005, 450-4.
PubMed
26) Richard, C. et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome : a randomized trial. JAMA. 290, 2003, 2713-20.
PubMed
27) National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 354, 2006, 2213-24.
PubMed
28) Gattinoni, L. et al. Lung structure and function in different stages of severe adult respiratory distress syndrome. JAMA. 271(22), 1994, 1772-9.
PubMed
29) Ware, LB. et al. The acute respiratory distress syndrome. N Engl J Med. 342(18), 2000, 1334-49.
PubMed
30) Pittet, JF. et al. Biological markers of acute lung injury : prognostic and pathogenic significance. Am J Respir Crit Care Med. 155(4), 1997, 1187-205.
 
31) Sibai, BM. et al. Pulmonary edema in severe preeclampsiaeclampsia : analysis of thirty-seven consecutive cases. Am J Obstet Gynecol. 156(5), 1987, 1174-9.
PubMed
32) Wiedemann, HP. et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 354(24), 2006, 2564-75.
PubMed
33) Wheeler, AP. et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 354(21), 2006, 2213-24.
PubMed
P.395 掲載の参考文献
1) 小林隆夫. 血栓塞栓症と羊水塞栓症 (産科的塞栓). 産婦人科治療. 100, 2010, 716-23.
Medical*Online
2) Abenhaim, HA. et al. Incidence and risk factors of amniotic fluid embolisms : a population-based study on 3 million births in the United States. Am J Obstet Gynecol. 199(1), 2008, 49. e1-8.
 
3) Conde-Agudelo, A. et al. Amniotic fluid embolism : an evidence-based review. Am J Obstet Gynecol. 201(5), 2009, 445. e1-13.
 
4) Kanayama, N. et al. Maternal death analysis from the Japanese autopsy registry for recent 16 years : significance of amniotic fluid embolism. J Obstet Gynaecol Res. 37(1), 2011, 58-63.
PubMed
5) 竹内真. 羊水塞栓症. 産科と婦人科. 78(2), 2001, 171-5.
 
6) Fineschi, V. et al. The diagnosis of amniotic fluid embolism : an immunohistochemical study for the quantification of pulmonary mast cell tryptase. Int J Legal Med. 111(5), 1998, 238-43.
PubMed
7) Benson, MD. et al. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol. 97(4), 2001, 510-4.
PubMed
8) 中山雅弘ほか. 羊水塞栓症における肺・子宮での組織および免疫組織学的検討. 産科と婦人科. 78(2), 2011, 178-85.
Medical*Online
9) Benson, MD. Current concepts of immunology and diagnosis in amniotic fluid embolism. Clin Dev Immunol. 2012 : 946576, 2012, 1-7.
 
10) Stolte, L. et al. Failure to produce the syndrome of amniotic fluid embolism by infusion of amniotic fluid and meconium into monkeys. Am J Obstet Gynecol. 98(5), 1967, 694-7.
PubMed
11) 山出一郎ほか. 母体死亡に至った羊水塞栓症の2例. 産婦人科の進歩. 48(4), 1996. 411-8.
 
12) Kramer, MS. et al. Amniotic-fluid embolism and medical induction of labour : a retrospective, population-based cohort study. Lancet. 368(9545), 2006, 1444-8.
PubMed
13) Knight, M. et al. Amniotic fluid embolism incidence, risk factors and outcomes : a review and recommendations. BMC Pregnancy Childbirth. 12 : 7, 2012, 1-11.
PubMed
14) Kanayama, N. et al. Determining zinc coproporphyrin in maternal plasma : a new method for diagnosing amniotic fluid embolism. Clin Chem. 38(4), 1992, 526-9.
PubMed
15) Kobayashi, H. et al. A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc. Am J Obstet Gynecol. 168(3 Pt 1), 1993, 848-53.
 
16) 金山尚裕. 羊水塞栓症. 連載 : いますぐ知りたい最新情報はこれだ! 産科危機的出血への対応up-to-date. 最終回. ペリネイタルケア. 30, 2011, 819-24.
 
17) James, CF. et al. Massive amniotic fluid embolism : diagnosis aided by emergency transesophageal echocardiography. Int J Obstet Anesth. 13(4), 2004, 279-83.
PubMed
18) Stanten, RD. et al. Amniotic fluid embolism causing catastrophic pulmonary vasoconstriction : diagnosis by transesophageal echocardiogram and treatment by cardiopulmonary bypass. Obstet Gynecol. 102(3), 2003, 496-8.
PubMed
19) 小林隆夫. 血栓塞栓症・羊水塞栓症 (産科的塞栓). 日本産科婦人科学会雑誌. 61, 2009, N427-34.
 
20) 野田洋一. DICおよびDICの処置. 日本産科婦人科学会雑誌. 61, 2009, N6-10.
 
21) Leighton, BL. et al. Use of recombinant factor VIIa in patients with amniotic fluid embolism : a systematic review of case reports. Anesthesiology. 115(6), 2011, 1201-8.
PubMed
22) Roberts, CL. et al. Amniotic fluid embolism in an Australian population-based cohort. BJOG. 117(11), 2010, 1417-21.
 
23) Tuffnell, DJ. United kingdom amniotic fluid embolism register. BJOG. 112(12), 2005, 1625-9.
PubMed
24) Abecassis, P. et al. Is amniotic fluid embolism likely to recur in a subsequent pregnancy? Int J Obstet Anesth. 15(1), 2006, 90.
 
25) Stiller, RJ. et al. Successful pregnancy after suspected anaphylactoid syndrome of pregnancy (amniotic fluid embolus) : A case report. J Reprod Med. 45(12), 2000, 1007-9.
PubMed

第21章 出生前胎児診断法

P.440 掲載の参考文献
1) Malone, FD. et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 353(19), 2005, 2001-11.
 
2) Bevis, DC. Composition of liquor amnii in haemolytic disease of newborn. Lancet. 2(6631), 1950, 443.
PubMed
3) Walker, AH. Liquor amnii studies in the prediction of haemolytic disease of the newborn. Br Med J. 2(5041), 1957, 376-8.
PubMed
4) Fuchs, F., Riis, P. Antenatal sex determination. Nature. 177(4503), 1956, 330.
PubMed
5) Steele, MW., Breg, WR Jr. Chromosome analysis of human amniotic-fluid cells. Lancet. 1(7434), 1966, 383-5.
PubMed
6) Jacobson, CB., Barter, RH. Intrauterine diagnosis and management of genetic defects. Am J Obstet Gynecol. 99(6), 1967, 796-807.
PubMed
7) Valenti, C., Schutta, EJ., Kehaty, T. Prenatal diagnosis of Down's syndrome. Lancet. 2(7561), 1968, 220.
PubMed
8) Nadler, HL. Antenatal detection of hereditary disorders. Pediatrics. 42(6), 1968, 912-8.
PubMed
9) Hook, EB., Cross, PK., Schreinemachers, DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA. 249(15), 1983, 2034-8.
PubMed
10) Hook, EB. Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol. 58(3), 1981, 282-5.
PubMed
11) Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U. K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects. Lancet. 2(8144), 1979, 651-62.
 
12) Romero, R. et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol. 161(3), 1989, 817-24.
PubMed
13) Shim, SS., Romero, R. et al. Clinical significance of intraamniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 191(4), 2004, 1339-45.
PubMed
14) Gluck, L. et al. The interpretation and significance of the lecithin-sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol. 120(1), 1974, 142-55.
PubMed
15) Hallman, M. et al. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid : indices of lung maturity. Am J Obstet Gynecol. 125(5), 1976, 613-7.
PubMed
16) Liley, AW. Liquor amnil analysis in the management of the pregnancy complicated by resus sensitization. Am J Obstet Gynecol. 82, 1961, 1359-70.
PubMed
17) Mari, G. et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 342(1), 2000, 9-14.
 
18) Cosmi, E., Mari, G. et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol. 187(5), 2002, 1290-3.
PubMed
19) Elias, S. et al. Genetic amniocentesis in twin gestations. Am J Obstet Gynecol. 138(2), 1980, 169-74.
PubMed
20) Hsu, LY., Perlis, TE. United States survey on chromosome mosaicism and pseudomosaicism in prenatal diagnosis. Prenat Diagn. 4, 1984, 97-130.
PubMed
21) Gosden, C., Nicolaides, KH., Rodeck, CH. Fetal blood sampling in investigation of chromosome mosaicism in amniotic fluid cell culture. Lancet. 1(8586), 1988, 613-7.
PubMed
22) Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy. JAMA. 236(13), 1976, 1471-6.
PubMed
23) An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis. Br J Obstet Gynaecol. 85, Suppl 2, 1978, 1-41.
 
24) Golbus, MS. et al. Prenatal genetic diagnosis in 3000 amniocenteses. N Engl J Med. 300(4), 1979, 157-63.
PubMed
25) Hill, LM., Platt, LD., Kellogg, B. Rh sensitization after genetic amniocentesis. Obstet Gynecol. 56(4), 1980, 459-61.
PubMed
26) Johnson, JM. et al. Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial. Prenat Diagn. 19(8), 1999, 732-8.
 
27) Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Lancet. 351(9098), 1998, 242-7.
PubMed
28) Nicolaides, K. et al. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet. 344(8920), 1994, 435-9.
PubMed
29) Vandenbussche, FP., Kanhai, HH., Keirse, MJ. Safety of early amniocentesis. Lancet. 344(8928), 1994, 1032.
PubMed
30) Sundberg, K. et al. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet. 350(9079), 1997, 697-703.
PubMed
31) Philip, J. et al. Late first-trimester invasive prenatal diagnosis : results of an international randomized trial. Obstet Gynecol. 103(6), 2004, 1164-73.
PubMed
32) Hahnemann, N. Early prenatal diagnosis : a study of biopsy techniques and cell culturing from extraembryonic membranes. Clin Genet. 6(4), 1974, 294-306.
PubMed
33) Brambati, B., Terzian, E., Tognoni, G. Randomized clinical trial of transabdominal versus transcervical chorionic villus sampling methods. Prenat Diagn. 11(5), 1991, 285-93.
PubMed
34) Jackson, LG. et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U. S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med. 327(9), 1992, 594-8.
 
35) Bianchi, DW. et al. Origin of extraembryonic mesoderm in experimental animals : relevance to chorionic mosaicism in humans. Am J Med Genet. 46(5), 1993, 542-50.
PubMed
36) Poenaru, L. First trimester prenatal diagnosis of metabolic diseases : a survey in countries from the European community. Prenat Diagn. 7(5), 1987, 333-41.
PubMed
37) Chorionic villus sampling or amniocentesis. Lancet. 1(8633), 1989, 334-5.
 
38) Rhoads, GG. et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 320(10), 1989, 609-17.
PubMed
39) Evaluation of chorion villus sampling. Lancet. 338(8764), 1991, 449-50.
PubMed
40) Saura, R. et al. Operator experience and fetal loss rate in transabdominal CVS. Prenat Diagn. 14(1), 1994, 70-1.
PubMed
41) Brambati, B. et al. Chorionic villus sampling : an analysis of the obstetric experience of 1,000 cases. Prenat Diagn. 7(3), 1987, 157-69.
PubMed
42) Hogge, WA., Schonberg, SA., Golbus, MS. Chorionic villus sampling : experience of the first 1000 cases. Am J Obstet Gynecol. 154(6), 1986, 1249-52.
PubMed
43) Blakemore, KJ. et al. Rise in maternal serum alphafetoprotein concentration after chorionic villus sampling and the possibility of isoimmunization. Am J Obstet Gynecol. 155(5), 1986, 988-93.
PubMed
44) Brambati, B. et al. Feto-maternal transfusion after chorionic villus sampling : clinical implications. Hum Reprod. 1(1), 1986, 37-40.
PubMed
45) Moise, KJ Jr., Carpenter, RJ Jr. Increased severity of fetal hemolytic disease with known rhesus alloimmunization after first-trimester transcervical chorionic villus biopsy. Fetal Diagn Ther. 5(2), 1990, 76-8.
PubMed
46) Firth, HV. et al. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet. 337(8744), 1991, 762-3.
PubMed
47) Hoyme, HE. et al. Vascular pathogenesis of transverse limb reduction defects. J Pediatr. 101(5), 1982, 839-43.
PubMed
48) Burton, BK., Schulz, CJ., Burd, LI. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol. 79(5 : Pt 1), 71992, 26-30.
 
49) Limb-reduction defects and chorion villus sampling. Lancet. 337(8749), 1991, 1091-2.
PubMed
50) Jenkins, TM., Wapner, RJ. First trimester prenatal diagnosis : chorionic villus sampling. Semin Perinatol. 23(5), 1999, 403-13.
PubMed
51) Brambati, B. et al. First-trimester genetic diagnosis in multiple pregnancy : principles and potential pitfalls. Prenat Diagn. 11(10), 1991, 767-74.
PubMed
52) Pergament, E. et al. The risk and efficacy of chorionic villus sampling in multiple gestations. Prenat Diagn. 12(5), 1992, 377-84.
PubMed
53) Wapner, RJ. et al. Prenatal diagnosis in twin gestations : a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling. Obstet Gynecol. 82(1), 1993, 49-56.
PubMed
54) Appelman, Z., Furman, B. Invasive genetic diagnosis in multiple pregnancies. Obstet Gynecol Clin North Am. 32(1), 2005, 97-103, ix.
PubMed
55) De Catte, L., Liebaers, I., Foulon, W. Outcome of twin gestations after first trimester chorionic villus sampling. Obstet Gynecol. 96(5 Pt 1), 2000, 714-20.
 
56) Brambati, B. et al. Outcome of first-trimester chorionic villus sampling for genetic investigation in multiple pregnancy. Ultrasound Obstet Gynecol. 17(3), 2001, 209-16.
PubMed
57) Daffos, F., Capella-Pavlovsky, M., Forestier, F. Fetal blood sampling via the umbilical cord using a needle guided by ultrasound. Report of 66 cases. Prenat Diagn. 3(4), 1983, 271-7.
PubMed
58) Ledbetter, DH. et al. Cytogenetic results of chorionic villus sampling : high success rate and diagnostic accuracy in the United States collaborative study. Am J Obstet Gynecol. 162(2), 1990, 495-501.
PubMed
59) Daffos, F., Capella-Pavlovsky, M., Forestier, F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound : a study of 606 consecutive cases. Am J Obstet Gynecol. 153(6), 1985, 655-60.
PubMed
60) Shulman, LP., Elias, S. Percutaneous umbilical blood sampling, fetal skin sampling, and fetal liver biopsy. Semin Perinatol. 14(6), 1990, 456-64.
PubMed
61) Johnson, MP. et al. In utero surgical treatment of fetal obstructive uropathy : a new comprehensive approach to identify appropriate candidates for vesicoamniotic shunt therapy. Am J Obstet Gynecol. 170(6), 1994, 1770-6, discussion 76-9.
 
62) Sermon, K. et al. Preimplantation genetic diagnosis. Lancet. 363(9421), 2004, 1633-41.
PubMed
63) Harper, JC., Delhanty, JD. Preimplantation genetic diagnosis. Curr Opin Obstet Gynecol. 12(2), 2000, 67-72.
PubMed
64) Hardy, K. et al. Human preimplantation development in vitro is not adversely affected by biopsy at the 8-cell stage. Hum Reprod. 5(6), 1990, 708-14.
 
65) Thornhill, AR. et al. ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'. Hum Reprod. 20(1), 2005, 35-48.
PubMed
66) Van Voorhis, BJ. Clinical practice. In vitro fertilization. N Engl J Med. 356(4), 2007, 379-86.
PubMed
67) Munne, S. et al. Assessment of numeric abnormalities of X, Y, 18, and 16 chromosomes in preimplantation human embryos before transfer. Am J Obstet Gynecol. 172(4 Pt 1), 1995, 1191-9, discussion 99-201.
 
68) Laverge, H. et al. Fluorescent in-situ hybridization on human embryos showing cleavage arrest after freezing and thawing. Hum Reprod. 13(2), 1998, 425-9.
PubMed
69) Traeger-Synodinos, J. Real-time PCR for prenatal and preimplantation genetic diagnosis of monogenic diseases. Mol Aspects Med. 27(2-3), 2006, 176-91.
 
70) Jackson, L. Fetal cells and DNA in maternal blood. Prenat Diagn. 23(10), 2003, 837-46.
PubMed
71) Bianchi, DW. et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood : analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn. 22(7), 2002, 609-15.
PubMed
72) Lo, YM. et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 350(9076), 1997, 485-7.
PubMed
73) Lo, YM. et al. Quantitative analysis of fetal DNA in maternal plasma and serum : implications for noninvasive prenatal diagnosis. Am J Hum Genet. 62(4), 1998, 768-75.
PubMed
74) Maron, JL. et al. Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest. 117(10), 2007, 3007-19.
 
75) Wataganara, T. et al. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum Genet. 112(2), 2003, 204-8.
 
76) Lo, YM., Chiu, RW. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis. Clin Chem. 54(3), 2008, 461-6.
PubMed
77) Lejeune, J., Gauthier, M., Turpin, R. [Human chromosomes in tissue cultures]. [Article in French] C R Hebd Seances Acad Sci. 248(4), 1959, 602-3.
 
78) Morris, JK., Wald, NJ., Watt, HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn. 19(2), 1999, 142-5.
 
79) Abuhamad, A. Technical aspects of nuchal translucency measurement. Semin Perinatol. 29(6), 2005, 376-9.
PubMed
80) Malone, FD. et al. First-trimester screening for aneuploidy : research or standard of care? Am J Obstet Gynecol. 182(3), 2000, 490-6.
 
81) Nicolaides, KH., Heath, V., Cicero, S. Increased fetal nuchal translucency at 11-14 weeks. Prenat Diagn. 22(4), 2002, 308-15.
PubMed
82) Wald, NJ. et al. First and second trimester antenatal screening for Down's syndrome : the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess. 7(11), 2003, 1-77.
PubMed
83) Moscoso, G. Fetal nuchal translucency : a need to understand the physiological basis. Ultrasound Obstet Gynecol. 5(1), 1995, 6-8.
PubMed
84) Snijders, RJ. et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 352(9125), 1998, 343-6.
PubMed
85) Canick, JA., Kellner, LH. First trimester screening for aneuploidy : serum biochemical markers. Semin Perinatol. 23(5), 1999, 359-68.
PubMed
86) Malone, FD. et al. First-trimester septated cystic hygroma : prevalence, natural history, and pediatric outcome. Obstet Gynecol. 106(2), 2005, 288-94.
PubMed
87) Molina, FS. et al. Cystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation. Obstet Gynecol. 107(3), 2006, 678-83.
PubMed
88) Comstock, CH. et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol. 195(3), 2006, 843-7.
 
89) Cicero, S. et al. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Ultrasound Obstet Gynecol. 2003, 22(1), 31-5.
PubMed
90) Malone, FD., D'Alton, ME. First-trimester sonographic screening for Down syndrome. Obstet Gynecol. 102(5 Pt 1), 2003, 1066-79.
 
91) Nicolaides, KH. et al. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies : results and estimation of the potential impact of individual riskorientated two-stage first-trimester screening. Ultrasound Obstet Gynecol. 25(3), 2005, 221-6.
PubMed
92) Falcon, O. et al. Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6 -week scan : association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol. 27(6), 2006, 609-12.
 
93) Sebire, NJ. et al. Early prediction of severe twin-to-twin transfusion syndrome. Hum Reprod. 15(9), 2000, 2008-10.
PubMed
94) Spencer, K., Nicolaides, KH. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic : a review of three years experience. BJOG. 110(3), 2003, 276-80.
 
95) Wald, NJ., Rish, S., Hackshaw, AK. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. Prenat Diagn. 23(7), 2003, 588-92.
PubMed
96) Wald, NJ., Watt, HC. Choice of serum markers in antenatal screening for Down's syndrome. J Med Screen. 1(2), 1994, 117-20.
PubMed
97) Crandall, BF., Robinson, L., Grau, P. Risks associated with an elevated maternal serum alpha-fetoprotein level. Am J Obstet Gynecol. 165(3), 1991, 581-6.
PubMed
98) Yaron, Y. et al. Second-trimester maternal serum marker screening : maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol. 181(4), 1999, 968-74.
PubMed
99) Kuller, JA. et al. Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin. Am J Perinatol. 12(2), 1995, 93-7.
PubMed
100) Morssink, LP. et al. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester : relation to fetal weight and preterm delivery. Prenat Diagn. 15(11), 1995, 1041-6.
PubMed
101) Benn, P. Trisomy 16 and trisomy 16 Mosaicism : a review. Am J Med Genet. 79(2), 1998, 121-33.
PubMed
102) Santolaya-Forgas, J. et al. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol. J Reprod Med. 41(2), 1996, 87-90.
PubMed
103) Kowalczyk, TD., Cabaniss, ML., Cusmano, L. Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome. Obstet Gynecol. 91(3), 1998, 396-400.
PubMed
104) Nyberg, DA. et al. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester : description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol. 12(1), 1998, 8-14.
PubMed
105) Nyberg, DA. et al. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med. 20(10), 2001, 1053-63.
PubMed
106) Benacerraf, BR., Frigoletto, FD Jr. Soft tissue nuchal fold in the second-trimester fetus : standards for normal measurements compared with those in Down syndrome. Am J Obstet Gynecol. 157(5), 1987, 1146-9.
PubMed
107) Nyberg, DA. et al. Prenatal sonographic findings of Down syndrome : review of 94 cases. Obstet Gynecol. 76(3 Pt 1), 1990, 370-7.
 
108) Nyberg, DA. et al. Femur length shortening in the detection of Down syndrome : is prenatal screening feasible? Am J Obstet Gynecol. 162(5), 1990, 1247-52.
PubMed
109) Nyberg, DA. et al. Humerus and femur length shortening in the detection of Down's syndrome. Am J Obstet Gynecol. 168(2), 1993, 534-8.
PubMed
110) Shipp, TD. et al. Variation in fetal femur length with respect to maternal race. J Ultrasound Med. 20(2), 2001, 141-4.
 
111) Brown, DL., Roberts, DJ., Miller, WA. Left ventricular echogenic focus in the fetal heart : pathologic correlation. J Ultrasound Med. 13(8), 1994, 613-6.
PubMed
112) Shipp, TD. et al. The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race. Ultrasound Obstet Gynecol. 15(6), 2000, 460-2.
PubMed
113) Benacerraf, BR. et al. Fetal pyelectasis : a possible association with Down syndrome. Obstet Gynecol. 76(1), 1990, 58-60.
PubMed
114) Bromley, B. et al. Fetal nose bone length : a marker for Down syndrome in the second trimester. J Ultrasound Med. 21(12), 2002, 1387-94.
PubMed
115) Vintzileos, A., Walters, C., Yeo, L. Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk population. Obstet Gynecol. 101(5 Pt 1), 2003, 905-8.
 
116) Wapner, R. et al. First-trimester screening for trisomies 21 and 18. N Engl J Med. 349(15), 2003, 1405-13.
PubMed
117) Platt, LD. et al. Sequential pathways of testing after firsttrimester screening for trisomy 21. Obstet Gynecol. 104(4), 2004, 661-6.
PubMed
118) Cuckle, HS. et al. Contingent screening for Down syndromeresults from the FaSTER trial. Prenat Diagn. 28(2), 2008, 89-94.
PubMed
119) Cuckle, H. Down's syndrome screening in twins. J Med Screen. 5(1), 1998, 3-4.
PubMed
120) Spencer, K., Salonen, R., Muller, F. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG. Prenat Diagn. 14(7), 1994, 537-42.
PubMed
121) O'Brien, JE. et al. Race-ethnicity-specific variation in multiple-marker biochemical screening : alpha-fetoprotein, hCG, and estriol. Obstet Gynecol. 89(3), 1997, 355-8.
PubMed
122) Wald, NJ. et al. Maternal serum alpha-fetoprotein and diabetes mellitus. Br J Obstet Gynaecol. 86(2), 1979, 101-5.
PubMed
123) Crossley, JA. et al. Insulin-dependent diabetes mellitus and prenatal screening results : current experience from a regional screening programme. Prenat Diagn. 16(11), 1996, 1039-42.
PubMed
124) Crandall, BF., Matsumoto, M. Routine amniotic fluid alphafetoprotein assay : experience with 40,000 pregnancies. Am J Med Genet. 24(1), 1986, 143-9.
PubMed
125) Lennon, CA., Gray, DL. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Obstet Gynecol. 94(4), 1999, 562-6.
 
126) Boyd, PA. et al. Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe. J Med Screen. 7(4), 2000, 169-74.
 
127) Nicolaides, KH. et al. Ultrasound screening for spina bifida : cranial and cerebellar signs. Lancet. 2(8498), 1986, 72-4.
PubMed
128) Crandall, BF., Chua, C. Risks for fetal abnormalities after very and moderately elevated AF-AFPs. Prenat Diagn. 17(9), 1997, 837-41.
PubMed
129) Seppala, M., Ruoslahti, E. Alpha fetoprotein in amniotic fluid : an index of gestational age. Am J Obstet Gynecol. 114(5), 1972, 595-8.
PubMed
130) Seppala, M. et al. Congenital nephrotic syndrome : prenatal diagnosis and genetic counselling by estimation of aminoticfluid and maternal serum alpha-fetoprotein. Lancet. 2(7977), 1976, 123-5.
PubMed
131) Kjessler, B. et al. Alpha-fetoprotein in antenatal diagnosis of congenital nephrosis. Lancet. 1(7904), 1975, 432-3.
PubMed
132) Kestila, M. et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell. 1(4), 1998, 575-82.
PubMed
133) Lenkkeri, U. et al. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet. 64(1), 1999, 51-61.
PubMed
134) Hallman, N., Hjelt, L. Congenital nephrotic syndrome. J Pediatr. 55(2), 1959, 152-62.
PubMed
135) Holmberg, C. et al. Renal transplantation in small children with congenital nephrotic syndrome of the Finnish type. Transplant Proc. 23(1 Pt 2), 1991, 1378-9.
 
136) Heinonen, S. et al. Prenatal screening for congenital nephrosis in east Finland : results and impact on the birth prevalence of the disease. Prenat Diagn. 16(3), 1996, 207-13.
PubMed
137) Suren, A. et al. Prenatal diagnosis of congenital nephrosis of the Finnish type (CNF) in the second trimester. Int J Gynaecol Obstet. 41(2), 1993, 165-70.
PubMed
138) Wapner, RJ. et al. Prenatal diagnosis of congenital nephrosis by in utero kidney biopsy. Prenat Diagn. 21(4), 2001, 256-61.
PubMed
139) Bianchi, DW. et al. Fetology. McGraw-Hill, 2000, 3-10, 11-33, 1007-16.
 
140) Epstein, CJ. "Down syndrome (trisomy 21)". The Metaboloc and Molecular Bases of Inherited Disease. Scriver, CR. et al. eds. New York, McGraw-Hill, 1995, 749-94.
 
P.445 掲載の参考文献
・ Creasy, RK. et al. Creasy & Resnik's Maternal-Fetal Medicine : Principles and Practice. Philadelphia, Saunders, 2009, 221-74.
 
・ Bianchi, DW. et al. Fetology. New York, McGraw-Hill, 2010, 1-68, 901-68.
 
・ Milunsky, A. et al. Genetic Disorders and the fetus : Diagnosis, Prevention and Treatment. 6th ed. U. K., Wiley-Blackwell, 2010.
 
・ Benacerraf, B. Ultrasound of Fetal Syndromes. New York, Churchill Livingstone, 2008.
 
・ Jones, KL. Smith's Recognizable Patterns of Human Malformation. 6th ed. Philadelphia, Elsevier Saunders, 2006.
 
・ Firth, HV. et al. eds. Oxford Desk Reference Clinical Genetics. New York, Oxford Univercity Press, 2009.
 
・ Cunningham, FG. et al. eds. Williams Obstetrics. 23rd ed. New York, McGraw-Hill, 2009.
 
・ Nussbaum, RL. et al. Thompson & Thompson Genetics in Medicine. 7th ed. Philadelphia, Saunders, 2007.
 
・ Haper, PS. Practical Genetic Counselling. 6th ed. London, Hodder Arnold Publishers, 2004.
 
・ McKinlay Gardner, RJ., Sutherland, GR. Chromosome Abnormalities and Genetic Counselling. 3rd ed. New York, Oxford University Press, 2003.
 
・ 新川詔夫監修, 福嶋義光編. 遺伝カウンセリングマニュアル. 東京, 南江堂, 2003, 360p.
 
・ 川滝元良著, 宝田正志監修. 胎児心エコー診断へのアプローチ. 東京, メジカルビュー社, 2004, 1-23.
 

第22章 胎児発育異常

P.457 掲載の参考文献
1) 平成23年度厚生労働科学研究費補助金 (成育疾患克服等次世代育成基盤研究事業) 「地域における周産期医療システムの充実と医療資源の適正配置に関する研究」. 研究代表者 : 海野信也. 「胎児推定体重と胎児発育曲線」 保健指導マニュアル. 平成24年3月.
 
2) Lin, CC., Evans, MI. Intrauterine growth retardation. New York, McGraw-Hill, 1984, 10.
 
3) 茨聡, 池ノ上克ほか. 当院出生IUGRの周産期異常と予後. 日本周産期学会シンポジウム論文集. 7, 1989, 120-35.
 
4) Manning, FA. "Intrauterine growth retardation. " Fetal medicine : Principle and practice. Manning, FA. ed. Norwalk, Connecticut, Appleton & Lange, 1995, 307-93.
 
5) Pollack, RN., Divon, MY. Intrauterine growth retardation : definition, classification, and etiology. Clin Obstet Gynecol. 35, 1993, 99.
 
6) Zhang, X., Cnattingius, S. et al. Are babies born to short, primiparous, or thin mothers "normally" or "abnormally" small? J Pediatr. 150, 2007, 603-7.
 
7) Boggess, KA., Beck, JD. et al. Maternal periodontal disease in early pregnancy and risk for a small-for-gestational-age infant. Am J Obstet Gynecol. 194, 2006, 1316-22.
PubMed
8) Haeri, S., Khoury, J. et al. The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. Am J Obstet Gynecol. 199, 2008, 278.
 
9) van Eijsden, M., Hornstra, G. et al. Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight : a prospective cohort study. Am J Clin Nutr. 87, 2008, 887-95.
 
10) 茨聡, 池ノ上克ほか. IUGRの出生直後の状態と予後. 日本新生児学会雑誌. 26, 1990, 39-48.
 
11) Crispi, F., Hernandez-Andrade, E. et al. Cardiac dysfunction and cell damage across clinical stages of severity in growthrestricted fetuses. Am J Obstet Gynecol. 199, 2008, 254.
 
12) Ibara, S., Tokunaga, M., Ikenoue, T., Murata, Y., Hirano, T., Asano, H., Uemura Y. Histologic observation of the ductus arteriosus in premature infants with intrauterine growth retardation. Journal of Perinatology. 14, 1994, 411-6.
PubMed
13) Yang, SL. Intrauterine growth retardation. New York, McGraw-Hill, 1984, 157.
 
14) 浅野仁, 茨聡ほか. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) の新生児顆粒球減少および敗血症に対する効果の検討. 日本産婦人科新生児血液学会雑誌. 6, 1996, 9-10.
 
15) Robinson, HP., Fleming, JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol. 82(9), 1975, 702-10.
PubMed
16) Larciprete, G., Valensise, H. et al. Ultrasound-determined fetal subcutaneous tissue thickness for a birthweight prediction model. J Obstet Gynaecol Res. 33, 2007, 635-40.
 
17) 丸山有子, 茨聡, 加藤博美ほか. 頭囲発育停止を指標にしたIUGR娩出のタイミング. 周産期学シンポジウム. 22, 2004, 121-8.
 
18) Itabashi, K., Mishina, J., Tada, H. et al. Longitudinal followup of height up to five years of age in infants born preterm small for gestational age : comparison to full-term small for gestational age infants. Early Hum Dev. 83(5), 2007, 327-33. Epub 2006 Aug 22.
 
19) Hales, CN., Barker, DJ. Type 2 (non-insulin-dependent) diabetes mellitus : the thrifty phenotype hypothesis. Diabetologia. 35(7), 1992, 595-601.
PubMed
20) Barker, DJ. Fetal origins of coronary heart disease. BMJ. 311(6998), 1995, 171-4.
PubMed
21) Sherman, DJ., Arieli, S., Tovbin, J. et al. A comparison of clinical and ultrasonic estimation of fetal weight. Obstet Gynecol. 91, 1998, 212-7.
PubMed
22) Bunchanan, TA., Kjos, SL., Montoro, MN. et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. 17, 1994, 275-83.
 
23) Genen, O., Rosen, DJ., Dolfin, Z.et al. Induction of labor versus expectant management in macrosomia : a randomized study. Obstet Gynecol. 89, 1997, 913-7.
 
24) Zhang, X., Decker, A., Platt, RW. et al. How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol. 198, 2008, 517.
 
25) ACOG Practice Bulletin clinical management guidelines for obstetrician-gynecologistd : Shoulder dystocia. Number 40. November 2002. Obstet Gynecol. 100, 2002, 1045-50.
PubMed
26) Benedetti, TJ., Gabbe, SG. Shoulder dystocia. A complication of fetal macrosomia and prolonged second stage of labor with midpelvic delivery. Obstet Gynecol. 52, 1978, 526-9.
PubMed

第23章 胎児形態異常

P.462 掲載の参考文献
Souka, AP., Krampl, E, Bakalis, S. et al. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol. 18(1), 2001, 9-17.
PubMed
P.500 掲載の参考文献
1) Malone, FD. "First trimester screening for aneuploidy". Ultrasonography in Obstetrics and Gynecology. 5th ed. Callen, P. ed. Philadelphia, Saunders, 2007, 60-9.
 
2) Malone, FD. et al. First-trimester sonographic screening for Down syndrome. Obstet Gynecol. 102(5 Pt 1), 2003, 1066-79.
 
3) Snijders, RJ. et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 352(9125), 1998, 343-6.
PubMed
4) Malone, FD. et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 353(19), 2005, 2001-11.
 
5) Nicolaides, K. "The 11-13+6 weeks scan". Fetal Medicine Foundation. Nicolaides, K. ed. London, 2004.
 
6) Cuckle, H. et al. Calculating correct Down's syndrome risks. Br J Obstet Gynaecol. 106(4), 1999, 371-2.
PubMed
7) Comstock, CH. et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol. 195(3), 2006, 843-7.
 
8) Ghi, T. et al. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol. 18(6), 2001, 610-4.
PubMed
9) Souka, AP. et al. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol. 18(1), 2001, 9-17.
PubMed
10) Souka, AP. et al. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol. 192(4), 2005, 1005-21.
PubMed
11) Snijders, RJ. et al. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol. 7(3), 1996, 216-26.
PubMed
12) Frey Tirri, B. et al. Quality management of nuchal translucency measurement in residents. Ultraschall Med. 28(5), 2007, 484-8.
PubMed
13) 日本産科婦人科学会/日本産婦人科医会編集・監修. "NT (nuchal translucency) 肥厚が認められた時の対応は". 産婦人科診療ガイドライン : 産科編2008. 東京, 社団法人日本産科婦人科学会事務局, 2008, 37-41.
 
14) Cicero, S. et al. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation : an observational study. Lancet. 358(9294), 2001, 1665-7.
PubMed
15) Cicero, S. et al. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Ultrasound Obstet Gynecol. 22(1), 2003, 31-5.
PubMed
16) Malone, FD. et al. First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol. 104(6), 2004, 1222-8.
PubMed
17) Nicolaides, KH. et al. Multicenter study of first-trimester screening for trisomy 21 in 75, 821 pregnancies : results and estimation of the potential impact of individual risk orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol. 25(3), 2005, 221-6.
PubMed
18) Huggon, IC. et al. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart. 89(9), 2003, 1071-3.
PubMed
19) Borrell, A. et al. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy. Prenat Diagn. 23(11), 2003, 921-6.
PubMed
20) Borenstein, M. et al. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol. 32(1), 2008, 5-11.
 
21) Eik-Nes, SH. et al. Routine ultrasound fetal examination in pregnancy : the 'Alesund' randomized controlled trial. Ultrasound Obstet Gynecol. 15(6), 2000, 473-8.
PubMed
22) ACOG Practice Bulletin No.101 : Ultrasonography in pregnancy. Obstet Gynecol. 113(2 Pt 1), 2009, 451-61.
 
23) AIUM practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med. 29(1), 2010, 157-66.
PubMed
24) Sonographic examination of the fetal central nervous system : guidelines for performing the 'basic examination' and the 'fetal neurosonogram'. Ultrasound Obstet Gynecol. 29(1), 2007, 109-16.
PubMed
25) Malinger, G. et al. Differential diagnosis in fetuses with absent septum pellucidum. Ultrasound Obstet Gynecol. 25(1), 2005, 42-9.
PubMed
26) Gray, DL. et al. Optimal nuchal skin-fold thresholds based on gestational age for prenatal detection of Down syndrome. Am J Obstet Gynecol. 171(5), 1994, 1282-6.
PubMed
27) Van den Hof, MC. et al. Fetal soft markers in obstetric ultrasound. J Obstet Gynaecol Can. 27(6), 2005, 592-636.
 
28) Vintzileos, AM. "The second trimester genetic sonogram". Ultrasonography in Obstetrics and Gynecology. 5th ed. Callen, PW. ed. Philadelphia, Saunders, 2007, 547-602.
 
29) Nyberg, D. et al. "Chromosome abnormality". Diagnostic Imaging of Fetal anomalies. Nyberg, D. et al. eds. Philadelphia, Lippincott Williams & Wilkins, 2003, 86-96.
 
30) Yeo, L. et al. Prenatal detection of fetal trisomy 18 through abnormal sonographic features. J Ultrasound Med. 22(6), 2003, 581-90, quiz 91-2.
 
31) Lehman, CD. et al. Trisomy 13 syndrome : prenatal US findings in a review of 33 cases. Radiology. 194(1), 1995, 217-22.
 
32) Vintzileos, AM. et al. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol. 172(3), 1995, 837-44.
PubMed
33) Nicolaides, KH. et al. Rapid karyotyping in non-lethal fetal malformations. Lancet. 1(8476), 1986, 283-7.
PubMed
34) Achiron, R. et al. Fetal lateral ventricle choroid plexus cysts : the dilemma of amniocentesis. Obstet Gynecol. 78(5 Pt 1), 1991, 815-8.
 
35) Fitzsimmons, J. et al. Choroid plexus cysts in fetuses with trisomy 18. Obstet Gynecol. 73(2), 1989, 257-60.
PubMed
36) Nadel, AS. et al. Isolated choroid plexus cysts in the secondtrimester fetus : is amniocentesis really indicated? Radiology. 185(2), 1992, 545-8.
PubMed
37) Perpignano, MC. et al. Fetal choroid plexus cysts : beware the smaller cyst. Radiology. 182(3), 1992, 715-7.
PubMed
38) Benacerraf, BR. et al. Sonographic identification of secondtrimester fetuses with Down's syndrome. N Engl J Med. 317(22), 1987, 1371-6.
PubMed
39) Baumann, C. et al. Pregnancy outcome and infant follow-up after diagnosis of nuchal anomalies at the 1st or 2nd trimester ultrasound examination. J Gynecol Obstet Biol Reprod (Paris). 30(1 Suppl), 2001, 68-74.
PubMed
40) Tran, SH. et al. Ethnic variation in the prevalence of echogenic intracardiac foci and the association with Down syndrome. Ultrasound Obstet Gynecol. 26(2), 2005, 158-61.
PubMed
41) Ouzounian, JG. et al. Isolated choroid plexus cyst or echogenic cardiac focus on prenatal ultrasound : is genetic amniocentesis indicated? Am J Obstet Gynecol. 196(6), 2007, 595, e1-3, discussion e3.
PubMed
42) Bromley, B. et al. Significance of an echogenic intracardiac focus in fetuses at high and low risk for aneuploidy. J Ultrasound Med. 17(2), 1998, 127-31.
PubMed
43) Nyberg, D. et al. "Abdomen and Gastrointestinal Tract". Diagnostic Imaging of Fetal Anomalies. Nyberg, D. et al. eds. Philadelphia, Lippincott Williams & Wilkins, 2003, 547-602.
 
44) Lockwood, C. et al. A sonographic screening method for Down syndrome. Am J Obstet Gynecol. 157(4 Pt 1), 1987, 803-8.
 
45) Nyberg, DA. et al. Humerus and femur length shortening in the detection of Down's syndrome. Am J Obstet Gynecol. 168(2), 1993, 534-8.
PubMed
46) Corteville, JE. et al. Fetal pyelectasis and Down syndrome : is genetic amniocentesis warranted? Obstet Gynecol. 79(5 Pt 1), 1992, 770-2.
 
47) Benacerraf, BR. et al. Fetal pyelectasis : a possible association with Down syndrome. Obstet Gynecol. 76(1), 1990, 58-60.
PubMed
48) Bromley, B. et al. The genetic sonogram : a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med. 21(10), 2002, 1087-96, quiz 97-8.
 
49) Levi, S. Ultrasound in prenatal diagnosis : polemics around routine ultrasound screening for second trimester fetal malformations. Prenat Diagn. 22(4), 2002, 285-95.
PubMed
50) Grandjean, H. et al. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol. 181(2), 1999, 446-54.
PubMed
51) Driscoll, DA. et al. Screening for fetal aneuploidy and neural tube defects. Genet Med. 11(11), 2009, 818-21.
PubMed
52) Chatzipapas, IK. et al. The 'Mickey Mouse' sign and the diagnosis of anencephaly in early pregnancy. Ultrasound Obstet Gynecol. 13(3), 1999, 196-9.
PubMed
53) Cunningham, FG. et al. "Fetal Imaging". Williams Obstetrics. 23rd ed. Cunningham, FG. et al. eds. New York, McGraw-Hill, 2009, 349-71.
 
54) Nicolaides, KH. et al. Ultrasound screening for spina bifida : cranial and cerebellar signs. Lancet. 2(8498), 1986, 72-4.
PubMed
55) Shaer, CM. et al. Myelomeningocele : a review of the epidemiology, genetics, risk factors for conception, prenatal diagnosis, and prognosis for affected individuals. Obstet Gynecol Surv. 62(7), 2007, 471-9.
PubMed
56) Babcook, CJ. et al. Prenatally detected fetal myelomeningocele : is karyotype analysis warranted? Radiology. 194(2), 1995, 491-4.
PubMed
57) Luthy, DA. et al. Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally. N Engl J Med. 324(10), 1991, 662-6.
PubMed
58) Lewis, D. et al. Elective cesarean delivery and long-term motor function or ambulation status in infants with meningomyelocele. Obstet Gynecol. 103(3), 2004, 469-73.
PubMed
59) Merrill, DC. et al. The optimal route of delivery for fetal meningomyelocele. Am J Obstet Gynecol. 179(1), 1998, 235-40.
PubMed
60) Bowman, RM. et al. Spina bifida outcome : a 25-year prospective. Pediatr Neurosurg. 34(3), 2001, 114-20.
PubMed
61) Rauzzino, M. et al. Chiari II malformation and syringomyelia. Neurosurg Clin N Am. 6(2), 1995, 293-309.
PubMed
62) Budorick, NE. et al. Sonography of the fetal spine : technique, imaging findings, and clinical implications. AJR Am J Roentgenol. 164(2), 1995, 421-8.
PubMed
63) Main, DM. et al. Neural tube defects : issues in prenatal diagnosis and counselling. Obstet Gynecol. 67(1), 1986, 1-16.
PubMed
64) Rieder, MJ. Prevention of neural tube defects with periconceptional folic acid. Clin Perinatol. 21(3), 1994, 483-503.
PubMed
65) Erickson, JD. Folic acid and prevention of spina bifida and anencephaly. 10 years after the U.S. Public Health Service recommendation. MMWR Recomm Rep. 51(RR-13), 2002, 1-3.
 
66) 厚生省児童家庭局母子保健課長ほか. 神経管閉鎖障害の発症リスク低減のための妊娠可能な年齢の女性等に対する葉酸の摂取に係る適切な情報提供の推進について. 2000 [cited 2009 10. 1. 2009] ; Available from : http://www1.mhlw.go.jp/houdou/1212/h1228-1_18.html
 
67) Achiron, R. et al. Fetal mild idiopathic lateral ventriculomegaly : is there a correlation with fetal trisomy? Ultrasound Obstet Gynecol. 3(2), 1993, 89-92.
 
68) Salomon, LJ. et al. Reference ranges for fetal ventricular width : a non-normal approach. Ultrasound Obstet Gynecol. 30(1), 2007, 61-6.
PubMed
69) McGaham, JP. "Cerebral Malformation". Diagnostic Imaging of Fetal Anomalies. Nyberg, D. et al. eds. Philadelphia, Lippincott Williams & Wilkins, 2003, 225-31.
 
70) Jeanty, P. "Fetal biometry". The Practice of Ultrasonography in Obstetrics and Gynecology. 4 ed. Fleischer, AC., Manning, FA., Jeanty, PJ., James, AE. eds. Appleton & Lange, 1991, 93.
 
71) Cardoza, JD. et al. Exclusion of fetal ventriculomegaly with a single measurement : the width of the lateral ventricular atrium. Radiology. 169(3), 1988, 711-4.
PubMed
72) Chervenak, FA. et al. The diagnosis of fetal hydrocephalus. Am J Obstet Gynecol. 147(6), 1983, 703-16.
PubMed
73) Ouahba, J. et al. Prenatal isolated mild ventriculomegaly : outcome in 167 cases. BJOG. 113(9), 2006, 1072-9.
PubMed
74) Melchiorre, K. et al. Counseling in isolated mild fetal ventriculomegaly. Ultrasound Obstet Gynecol. 34(2), 2009, 212-24.
PubMed
75) Chervenak, FA. et al. Ethical challenges in perinatal medicine : the intrapartum management of pregnancy complicated by fetal hydrocephalus with macrocephaly. Semin Perinatol. 11(3), 1987, 232-9.
PubMed
76) Anteby, EY. et al. Route of delivery of fetuses with structural anomalies. Eur J Obstet Gynecol Reprod Biol. 106(1), 2003, 5-9.
PubMed
77) Varadi, V. et al. Heterogeneity and recurrence risk for congenital hydrocephalus (ventriculomegaly) : a prospective study. Am J Med Genet. 29(2), 1988, 305-10.
PubMed
78) Lynch, HT. et al. Genetic counseling in cleft lip and cleft palate. Plast Reconstr Surg. 68(5), 1981, 800-15.
PubMed
79) Turner, GM. et al. The facial profile in the diagnosis of fetal abnormalities. Clin Radiol. 47(6), 1993, 389-95.
PubMed
80) Benacerraf, BR. et al. Fetal cleft lip and palate : sonographic diagnosis and postnatal outcome. Plast Reconstr Surg. 92(6), 1993, 1045-51.
PubMed
81) Davalbhakta, A. et al. The impact of antenatal diagnosis on the effectiveness and timing of counselling for cleft lip and palate. Br J Plast Surg. 53(4), 2000, 298-301.
PubMed
82) Loffredo, LC. et al. Oral clefts and vitamin supplementation. Cleft Palate Craniofac J. 38(1), 2001, 76-83.
PubMed
83) Wilcox, AJ. et al. Folic acid supplements and risk of facial clefts : national population based case-control study. BMJ. 334(7591), 2007, 464.
 
84) Malone, FD. et al. First-trimester septated cystic hygroma : prevalence, natural history, and pediatric outcome. Obstet Gynecol. 106(2), 2005, 288-94.
PubMed
85) Fisher, R. et al. Cystic hygroma : comparison between prenatal and postnatal diagnosis. J Pediatr Surg. 31(4), 1996, 473-6.
PubMed
86) Bronshtein, M. et al. A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy. Am J Obstet Gynecol. 188(4), 2003, 1016-20.
PubMed
87) Malone, FD. et al. "Cystic hygroma in early pregnancy". Fetology : Diagnosis and Management of the Fetal Patient. 2nd ed. D'Alton, ME. et al. eds. New York, McGraw Hill, 2010, 237-41.
 
88) Malone, FD. et al. "Cystic hygroma in late pregnancy". Fetology : Diagnosis and Management of the Fetal Patient. 2nd ed. D'Alton, ME. et al. eds. New York, McGraw Hill, 2010, 241-8.
 
89) Pascoli, I. et al. EXIT (Ex Utero Intrapartum Treatment) technique - management of a giant fetal lymphangioma. J Matern Fetal Neonatal Med. 23(2), 190-2.
PubMed
90) Hancock, BJ. et al. Complications of lymphangiomas in children. J Pediatr Surg. 27(2), 1992, 220-4, discussion 4-6.
 
91) Tricoire, J. et al. Familial cystic hygroma. Report of 8 cases in 3 families. Genet Couns. 4(4), 1993, 265-9.
PubMed
92) Longaker, MT. et al. Primary fetal hydrothorax : natural history and management. J Pediatr Surg. 24(6), 1989, 573-6.
PubMed
93) Brodman, RF. Congenital chylothorax. Recommendations for treatment. N Y State J Med. 75(4), 1975, 553-7.
PubMed
94) Klam, S. et al. Predicting outcome in primary fetal hydrothorax. Fetal Diagn Ther. 20(5), 2005, 366-70.
PubMed
95) Adams, H. et al. The sonographic features and implications of fetal pleural effusions. Clin Radiol. 39(4), 1988, 398-401.
PubMed
96) Hagay, Z. et al. Isolated fetal pleural effusion : a prenatal management dilemma. Obstet Gynecol. 81(1), 1993, 147-52.
PubMed
97) Waller, K. et al. Chromosomal abnormalities among 246 fetuses with pleural effusions detected on prenatal ultrasound examination : factors associated with an increased risk of aneuploidy. Genet Med. 7(6), 2005, 417-21.
PubMed
98) Aubard, Y. et al. Primary fetal hydrothorax : A literature review and proposed antenatal clinical strategy. Fetal Diagn Ther. 13(6), 1998, 325-33.
PubMed
99) Weber, AM. et al. Fetal pleural effusion : a review and metaanalysis for prognostic indicators. Obstet Gynecol. 79(2), 1992, 281-6.
PubMed
100) Deurloo, KL. et al. Isolated fetal hydrothorax with hydrops : a systematic review of prenatal treatment options. Prenat Diagn. 27(10), 2007, 893-9.
PubMed
101) Yinon, Y. et al. Fetal pleural effusions. Best Pract Res Clin Obstet Gynaecol. 22(1), 2008, 77-96.
PubMed
102) Seeds, JW. et al. Results of treatment of severe fetal hydrothorax with bilateral pleuroamniotic catheters. Obstet Gynecol. 68(4), 1986, 577-80.
PubMed
103) Petres, RE. et al. Congenital bilateral chylothorax. Antepartum diagnosis and successful intrauterine surgical management. JAMA. 248(11), 1982, 1360-1.
PubMed
104) Crombleholme, TM. et al. "Hydrothrax". Fetology : Diagnosis and Management of the Fetal Patient. D'Alton, ME. et al. eds. New York, McGraw-Hill, 2010, 292-300.
 
105) Harrison, MR. et al. Congenital diaphragmatic hernia : the hidden mortality. J Pediatr Surg. 13(3), 1978, 227-30.
PubMed
106) Hasegawa, T. et al. Use of lung-thorax transverse area ratio in the antenatal evaluation of lung hypoplasia in congenital diaphragmatic hernia. J Clin Ultrasound. 18(9), 1990, 705-9.
PubMed
107) Metkus, AP. et al. Sonographic predictors of survival in fetal diaphragmatic hernia. J Pediatr Surg. 31(1), 1996, 148-51 ; discussion 51-2.
 
108) Jani, J. et al. Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia. Ultrasound Obstet Gynecol. 30(1), 2007, 67-71.
PubMed
109) Fuke, S. et al. Antenatal prediction of pulmonary hypoplasia by acceleration time/ejection time ratio of fetal pulmonary arteries by Doppler blood flow velocimetry. Am J Obstet Gynecol. 188(1), 2003, 228-33.
PubMed
110) Pober, BR. Congenital Diaphragmatic Hernia Overview. GeneReviews at GeneTests : Medical Genetics Information Resource (database online) 2009 [cited 2009 March 1, 2009] ; Available from : http://www.genetests.org
 
111) Sharland, GK. et al. Prognosis in fetal diaphragmatic hernia. Am J Obstet Gynecol. 166(1 Pt 1), 1992, 9-13.
 
112) Adzick, NS. et al. Diaphragmatic hernia in the fetus : prenatal diagnosis and outcome in 94 cases. J Pediatr Surg. 20(4), 1985, 357-61.
 
113) Conforti, AF. et al. Perinatal management of congenital diaphragmatic hernia. Early Hum Dev. 82(5), 2006, 283-7.
PubMed
114) Downard, CD. et al. Analysis of an improved survival rate for congenital diaphragmatic hernia. J Pediatr Surg. 38(5), 2003, 729-32.
PubMed
115) Wolff, G. Familial congenital diaphragmatic defect : review and conclusions. Hum Genet. 54(1), 1980, 1-5.
PubMed
116) Pober, BR. et al. Infants with Bochdalek diaphragmatic hernia : sibling precurrence and monozygotic twin discordance in a hospital-based malformation surveillance program. Am J Med Genet A. 138A(2), 2005, 81-8.
 
117) Stocker, JT. et al. Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum. Hum Pathol. 8(2), 1977, 155-71.
PubMed
118) Leininger, BJ. et al. Congenital cystic adenomatoid malformation of the left lower lobe with compression of the remaining lung tissue in a newborn. Clin Pediatr (Phila). 12(3), 1973, 182-6.
 
119) Adzick, NS. et al. Fetal lung lesions : management and outcome. Am J Obstet Gynecol. 179(4), 1998, 884-9.
PubMed
120) Cass, DL. et al. Cystic lung lesions with systemic arterial blood supply : a hybrid of congenital cystic adenomatoid malformation and bronchopulmonary sequestration. J Pediatr Surg. 32(7), 1997, 986-90.
PubMed
121) Adzick, NS. Management of fetal lung lesions. Clin Perinatol. 30(3), 2003, 481-92.
PubMed
122) Crombleholme, TM. et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J Pediatr Surg. 37(3), 2002, 331-8.
 
123) MacGillivray, TE. et al. Disappearing fetal lung lesions. J Pediatr Surg. 28(10), 1993, 1321-4, discussion 4-5.
 
124) Mann, S. et al. Antenatal diagnosis and management of congenital cystic adenomatoid malformation. Semin Fetal Neonatal Med. 12(6), 2007, 477-81.
PubMed
125) Azizkhan, RG. et al. Congenital cystic lung disease : contemporary antenatal and postnatal management. Pediatr Surg Int. 24(6), 2008, 643-57.
PubMed
126) Wilson, RD. et al. Cystic adenomatoid malformation of the lung : review of genetics, prenatal diagnosis, and in utero treatment. Am J Med Genet A. 140(2), 2006, 151-5.
PubMed
127) Miller, JA. et al. Congenital cystic adenomatoid malformation in the fetus : natural history and predictors of outcome. J Pediatr Surg. 31(6), 1996, 805-8.
PubMed
128) Peranteau, WH. et al. Effect of maternal betamethasone administration on prenatal congenital cystic adenomatoid malformation growth and fetal survival. Fetal Diagn Ther. 22(5), 2007, 365-71.
PubMed
129) Tsao, K. et al. Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy. J Pediatr Surg. 38(3), 2003, 508-10.
PubMed
130) Adzick, NS. et al. Fetal cystic adenomatoid malformation : prenatal diagnosis and natural history. J Pediatr Surg. 20(5), 1985, 483-8.
PubMed
131) Hoffman, JI. Congenital heart disease : incidence and inheritance. Pediatr Clin North Am. 37(1), 1990, 25-43.
PubMed
132) 安藤正彦. "心臓の形成と発達". 臨床発達心臓病学. 改訂3版. 高尾篤良ほか編. 中外医学社, 1997, 21-42.
 
133) Cardiac screening examination of the fetus : guidelines for performing the 'basic' and 'extended basic' cardiac scan. Ultrasound Obstet Gynecol. 27(1), 2006, 107-13.
PubMed
134) 里見元義ほか. 胎児新エコー検査ガイドライン. 日本小児循環器学会. 22(5), 2006, 591-613.
 
135) Kirk, JS. et al. Sonographic screening to detect fetal cardiac anomalies : a 5-year experience with 111 abnormal cases. Obstet Gynecol. 89(2), 1997, 227-32.
PubMed
136) Comstock, CH. Normal fetal heart axis and position. Obstet Gynecol. 70(2), 1987, 255-9.
PubMed
137) Smith, RS. et al. Ultrasonographic left cardiac axis deviation : a marker for fetal anomalies. Obstet Gynecol. 85(2), 1995, 187-91.
PubMed
138) Chiba, Y. et al. Quantitative analysis of cardiac function in non-immunological hydrops fetalis. Fetal Diagn Ther. 5(3-4), 1990, 175-88.
PubMed
139) Akita, A. Fetal screening of congenital heart disease. Nihon Sanka Fujinka Gakkai Zasshi. 41, 1989, 1394-400.
PubMed
140) Satomi, G. Prenatal diagnosis of Ebstein's anomaly and tricuspid valve dysplasia in relation to lung hypoplasia. Echocardiography. 11(3), 1994, 215-20.
 
141) Kirk, JS. et al. Prenatal screening for cardiac anomalies : the value of routine addition of the aortic root to the fourchamber view. Obstet Gynecol. 84(3), 1994, 427-31.
 
142) DeVore, GR. Color Doppler examination of the outflow tracts of the fetal heart : a technique for identification of cardiovascular malformations. Ultrasound Obstet Gynecol. 4(6), 1994, 463-71.
PubMed
143) Yoo, SJ. et al. Three-vessel view of the fetal upper mediastinum : an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol. 9(3), 1997, 173-82.
PubMed
144) Abuhamad, AZ. et al. "Genetic aspect of congenital disease". A Practical Guide to Fetal Echocardiography : Normal and Abnormal Hearts. 2nd ed. Abuhamad, AZ. et al. eds. Philadelphia, Lippincott Williams & Wilkins, 2009, 11-21.
 
145) Nora, JJ. et al. Update on counseling the family with a firstdegree relative with a congenital heart defect. Am J Med Genet. 29(1), 1988, 137-42.
PubMed
146) Burn, J. et al. Recurrence risks in offspring of adults with major heart defects : results from first cohort of British collaborative study. Lancet. 351(9099), 1998, 311-6.
PubMed
147) Holder, TM. et al. Esophageal Atresia and Tracheoesophageal Fistula. A Survey of Its Members by the Surgical Section of the American Academy of Pediatrics. Pediatrics. 34, 1964, 542-9.
 
148) Gross, RE. ed. The Surgery of Infancy and Childhood : Its Principles and Techniques. Philadelphia, WB Saunders, 1953.
 
149) Louhimo, I. et al. Esophageal atresia : primary results of 500 consecutively treated patients. J Pediatr Surg. 18(3), 1983, 217-29.
PubMed
150) Sparey, C. et al. Esophageal atresia in the Northern Region Congenital Anomaly Survey, 1985-1997 : prenatal diagnosis and outcome. Am J Obstet Gynecol. 182(2), 2000, 427-31.
PubMed
151) Pretorius, DH. et al. Tracheoesophageal fistula in utero. Twenty-two cases. J Ultrasound Med. 6(9), 1987, 509-13.
 
152) Pletcher, BA. et al. Familial occurrence of esophageal atresia with and without tracheoesophagel fistula : report of two unusual kindreds. Am J Med Genet. 39(4), 1991, 380-4.
PubMed
153) Felix, JF. et al. Genetic and environmental factors in the etiology of esophageal atresia and/or tracheoesophageal fistula : an overview of the current concepts. Birth Defects Res A Clin Mol Teratol. 85(9), 2009, 747-54.
 
154) Balcar, I. et al. Antenatal detection of Down syndrome by sonography. AJR Am J Roentgenol. 143(1), 1984, 29-30.
PubMed
155) Fonkalsrud, EW. et al. Congenital atresia and stenosis of the duodenum : A review compiled from the members of the Surgical Section of the American Academy of Pediatrics. Pediatrics. 43(1), 1969, 79-83.
 
156) Farrant, P. et al. Antenatal diagnosis of duodenal atresia. Br J Radiol. 54(643), 1981, 633-5.
PubMed
157) Davey, RB. Congenital intrinsic duodenal obstruction : a comparative review of associated anomalies. Aust Paediatr J. 16(4), 1980, 274-8.
PubMed
158) Grosfeld, JL. et al. Duodenal atresia and stenosis : reassessment of treatment and outcome based on antenatal diagnosis, pathologic variance, and long-term follow-up. World J Surg. 17(3), 1993, 301-9.
PubMed
159) Shimizu, S. et al. Fetal hemorrhage associated with congenital intestinal atresia. J Obstet Gynaecol Res. 29(5), 2003, 312-6.
PubMed
160) Bendon, RW. et al. Umbilical cord ulceration and intestinal atresia : a new association? Am J Obstet Gynecol. 164(2), 1991, 582-6.
PubMed
161) Miyachi, K. et al. Sudden fetal hemorrhage from umbilical cord ulcer associated with congenital intestinal atresia. J Obstet Gynaecol Res. 33(5), 2007, 726-30.
PubMed
162) Nijagal, A. et al. Intrauterine umbilical cord hemorrhage with associated jejunal atresia captured by real-time ultrasound. Am J Obstet Gynecol. 200(3), 2009, e5-6.
PubMed
163) Nicolaides, KH. et al. Fetal gastro-intestinal and abdominal wall defects : associated malformations and chromosomal abnormalities. Fetal Diagn Ther. 7(2), 1992, 102-15.
PubMed
164) Escobar, MA. et al. Duodenal atresia and stenosis : long-term follow-up over 30 years. J Pediatr Surg. 39(6), 2004, 867-71, discussion -71.
 
165) Touloukian, RJ. Diagnosis and treatment of jejunoileal atresia. World J Surg. 17(3), 1993, 310-7.
PubMed
166) Louw, JH. et al. Congenital intestinal atresia : observations on its origin. Lancet. 269(6899), 1955, 1065-7.
PubMed
167) Grosfeld, JL. et al. Operative management of intestinal atresia and stenosis based on pathologic findings. J Pediatr Surg. 14(3), 1979, 368-75.
 
168) Langer, JC. et al. Prenatal diagnosis of gastroschisis : development of objective sonographic criteria for predicting outcome. Obstet Gynecol. 81(1), 1993, 53-6.
PubMed
169) Nixon, HH. et al. Etiology and treatment of small intestinal atresia : analysis of a series of 127 jejunoileal atresias and comparison with 62 duodenal atresias. Surgery. 69(1), 1971, 41-51.
PubMed
170) Rescorla, FJ. et al. Intestinal atresia and stenosis : analysis of survival in 120 cases. Surgery. 98(4), 1985, 668-76.
PubMed
171) Surana, R. et al. Small intestinal atresia : effect on fetal nutrition. J Pediatr Surg. 29(9), 1994, 1250-2.
PubMed
172) Arnal-Monreal, F. et al. Multiple hereditary gastrointestinal atresias : study of a family. Acta Paediatr Scand. 72(5), 1983, 773-7.
PubMed
173) Guttman, FM. et al. Multiple atresias and a new syndrome of hereditary multiple atresias involving the gastrointestinal tract from stomach to rectum. J Pediatr Surg. 8(5), 1973, 633-40.
 
174) Shorter, NA. et al. A proposed classification system for familial intestinal atresia and its relevance to the understanding of the etiology of jejunoileal atresia. J Pediatr Surg. 41(11), 2006, 1822-5.
 
175) Evers-Kiebooms, G. et al. A child with cystic fibrosis : II. Subsequent family planning decisions, reproduction and use of prenatal diagnosis. Clin Genet. 37(3), 1990, 207-15.
PubMed
176) Baird, PA. et al. An epidemiologic study of congenital malformations of the anterior abdominal wall in more than half a million consecutive live births. Am J Hum Genet. 33(3), 1981, 470-8.
PubMed
177) Redford, DH. et al. Gastroschisis and exomphalos : precise diagnosis by midpregnancy ultrasound. Br J Obstet Gynaecol. 92(1), 1985, 54-9.
PubMed
178) Palomaki, GE. et al. Second-trimester maternal serum alphafetoprotein levels in pregnancies associated with gastroschisis and omphalocele. Obstet Gynecol. 71(6 Pt 1), 1988, 906-9.
 
179) Nyberg, DA. et al. Chromosomal abnormalities in fetuses with omphalocele. Significance of omphalocele contents. J Ultrasound Med. 8(6), 1989, 299-308.
PubMed
180) Getachew, MM. et al. Correlation between omphalocele contents and karyotypic abnormalities : sonographic study in 37 cases. AJR Am J Roentgenol. 158(1), 1992, 133-6.
PubMed
181) How, HY. et al. Is vaginal delivery preferable to elective cesarean delivery in fetuses with a known ventral wall defect? Am J Obstet Gynecol. 182(6), 2000, 1527-34.
PubMed
182) Segel, SY. et al. Fetal abdominal wall defects and mode of delivery : a systematic review. Obstet Gynecol. 98(5 Pt 1), 2001, 867-73.
 
183) Lurie, S. et al. Omphalocele delivery enigma : the best mode of delivery still remains dubious. Eur J Obstet Gynecol Reprod Biol. 82(1), 1999, 19-22.
 
184) Forrester, MB. et al. Epidemiology of abdominal wall defects, Hawaii, 1986-1997. Teratology. 60(3), 1999, 117-23.
PubMed
185) Hughes, MD. et al. Fetal omphalocele : prenatal US detection of concurrent anomalies and other predictors of outcome. Radiology. 173(2), 1989, 371-6.
PubMed
186) Osuna, A. et al. Four cases of omphalocele in two generations of the same family. Clin Genet. 9(3), 1976, 354-6.
PubMed
187) Goldbaum, G. et al. Risk factors for gastroschisis. Teratology. 42(4), 1990, 397-403.
PubMed
188) Santiago-Munoz, PC. et al. Outcomes of pregnancies with fetal gastroschisis. Obstet Gynecol. 110(3), 2007, 663-8.
PubMed
189) Werler, MM. et al. Demographic, reproductive, medical, and environmental factors in relation to gastroschisis. Teratology. 45(4), 1992, 353-60.
PubMed
190) Torfs, CP. et al. A population-based study of gastroschisis : demographic, pregnancy, and lifestyle risk factors. Teratology. 50(1), 1994, 44-53.
PubMed
191) deVries, PA. The pathogenesis of gastroschisis and omphalocele. J Pediatr Surg. 15(3), 1980, 245-51.
PubMed
192) Hoyme, HE. et al. The vascular pathogenesis of gastroschisis : intrauterine interruption of the omphalomesenteric artery. J Pediatr. 98(2), 1981, 228-31.
PubMed
193) Romeo, R. "The abdominal wall". Prenatal diagnosis of congenital anomalies. Romeo, R. et al. eds. Norwalk, Appleton & Lange, 1988, 414-26.
 
194) Drewett, M. et al. The perinatal management of gastroschisis. Early Hum Dev. 82(5), 2006, 305-12.
PubMed
195) Oh, KS. et al. Abnormal intestinal motility in gastroschisis. Radiology. 127(2), 1978, 457.
PubMed
196) Carroll, SG. et al. Fetal protein loss in gastroschisis as an explanation of associated morbidity. Am J Obstet Gynecol. 184(6), 2001, 1297-301.
PubMed
197) Crawford, RA. et al. The importance of serial biophysical assessment of fetal wellbeing in gastroschisis. Br J Obstet Gynaecol. 99(11), 1992, 899-902.
PubMed
198) Puligandla, PS. et al. The significance of intrauterine growth restriction is different from prematurity for the outcome of infants with gastroschisis. J Pediatr Surg. 39(8), 2004, 1200-4.
PubMed
199) Lewis, DF. et al. Fetal gastroschisis and omphalocele : is cesarean section the best mode of delivery? Am J Obstet Gynecol. 163(3), 1990, 773-5.
PubMed
200) Strauss, RA. et al. Gastroschisis : the effect of labor and ruptured membranes on neonatal outcome. Am J Obstet Gynecol. 189(6), 2003, 1672-8.
PubMed
201) Puligandla, PS. et al. Routine cesarean delivery does not improve the outcome of infants with gastroschisis. J Pediatr Surg. 39(5), 2004, 742-5.
PubMed
202) Snyder, CL. Outcome analysis for gastroschisis. J Pediatr Surg. 34(8), 1999, 1253-6.
PubMed
203) Torfs, CP. et al. Familial cases of gastroschisis in a population-based registry. Am J Med Genet. 45(4), 1993, 465-7.
 
204) van Eerde, AM. et al. Vesico-ureteral reflux in children with prenatally detected hydronephrosis : a systematic review. Ultrasound Obstet Gynecol. 29(4), 2007, 463-9.
PubMed
205) Ismaili, K. et al. Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population. Am J Obstet Gynecol. 188(1), 2003, 242-6.
 
206) Woodward, M. et al. Postnatal management of antenatal hydronephrosis. BJU Int. 89(2), 2002, 149-56.
PubMed
207) Lee, RS. et al. Antenatal hydronephrosis as a predictor of postnatal outcome : a meta-analysis. Pediatrics. 118(2), 2006, 586-93.
PubMed
208) Sidhu, G. et al. Outcome of isolated antenatal hydronephrosis : a systematic review and meta-analysis. Pediatr Nephrol. 21(2), 2006, 218-24.
PubMed
209) Pates, JA. et al. Prenatal diagnosis and management of hydronephrosis. Early Hum Dev. 82(1), 2006, 3-8.
PubMed
210) Ghidini, A. et al. Ureteropelvic junction obstruction in utero and ex utero. Obstet Gynecol. 75(5), 1990, 805-8.
PubMed
211) Zerres, K. et al. Autosomal recessive polycystic kidney disease. Problems of prenatal diagnosis. Prenat Diagn. 8(3), 1988, 215-29.
PubMed
212) Osathanondh, V. et al. Pathogenesis of Polycystic Kidneys. Type 1 Due to Hyperplasia of Interstitial Portions of Collecting Tubules. Arch Pathol. 77, 1964, 466-73.
PubMed
213) Bronshtein, M. et al. First and early second-trimester diagnosis of fetal urinary tract anomalies using transvaginal sonography. Prenat Diagn. 10(10), 1990, 653-66.
PubMed
214) Romero, R. et al. The diagnosis of congenital renal anomalies with ultrasound. II : Infantile polycystic kidney disease. Am J Obstet Gynecol. 150(3), 1984, 259-62.
PubMed
215) Nasu, K. et al. Magnetic resonance imaging of fetal autosomal recessive polycystic kidney disease. J Obstet Gynaecol Res. 24(1), 1998, 33-6.
PubMed
216) Liu, YP. et al. Autosomal recessive polycystic kidney disease : appearance on fetal MRI. Pediatr Radiol. 36(2), 2006, 169.
PubMed
217) Kaplan, BS. et al. Autosomal recessive polycystic kidney disease. Pediatr Nephrol. 3(1), 1989, 43-9.
PubMed
218) Bergmann, C. et al. Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int. 67(3), 2005, 829-48.
PubMed
219) Gough, DC. et al. Multicystic renal dysplasia diagnosed in the antenatal period : a note of caution. Br J Urol. 76(2), 1995, 244-8.
PubMed
220) Resnick, J. et al. Cystic disease of the kidney in the newborn infant. Clin Perinatol. 8(2), 1981, 375-90.
PubMed
221) Atiyeh, B. et al. Contralateral renal abnormalities in patients with renal agenesis and noncystic renal dysplasia. Pediatrics. 91(4), 1993, 812-5.
PubMed
222) Weinstein, A. et al. Simple multicystic dysplastic kidney disease : end points for subspecialty follow-up. Pediatr Nephrol. 23(1), 2008, 111-6.
PubMed
223) Reffensperger, J., Abousleiman, A. Abdominal masses in children under on year of age. Surgery. 63(3), 1968, 514-21.
 
224) Oddone, M. et al. Wilms' tumor arising in a multicystic kidney. Pediatr Radiol. 24(4), 1994, 236-8.
 
225) Bianchi, DW. et al. "Multicystic dysplastic kidney". Fetology : Diagnosis and Management of the Fetal Patient. 2nd ed. D'Alton, ME. et al. eds. New York, McGraw Hill, 2010, 530-4.
 
226) Droste, S. et al. Size of the fetal adrenal in bilateral renal agenesis. Obstet Gynecol. 76(2), 1990, 206-9.
PubMed
227) Bronshtein, M. et al. The significance of early secondtrimester sonographic detection of minor fetal renal anomalies. Prenat Diagn. 15(7), 1995, 627-32.
PubMed
228) Potter, EL. Facial characteristics of infants with bilateral renal agenesis. Am J Obstet Gynecol. 51, 1946, 885-8.
PubMed
229) Bronshtein, M. et al. The early prenatal sonographic diagnosis of renal agenesis : techniques and possible pitfalls. Prenat Diagn. 14(4), 1994, 291-7.
PubMed
230) Gembruch, U. et al. Artificial instillation of amniotic fluid as a new technique for the diagnostic evaluation of cases of oligohydramnios. Prenat Diagn. 8(1), 1988, 33-45.
PubMed
231) Hoffman, CK. et al. The "lying down" adrenal sign : a sonographic indicator of renal agenesis or ectopia in fetuses and neonates. J Ultrasound Med. 11(10), 1992, 533-6.
PubMed
232) DeVore, GR. The value of color Doppler sonography in the diagnosis of renal agenesis. J Ultrasound Med. 14(6), 1995, 443-9.
PubMed
233) Roodhooft, AM. et al. Familial nature of congenital absence and severe dysgenesis of both kidneys. N Engl J Med. 310(21), 1984, 1341-5.
PubMed
234) Song, JT. et al. Incidence of vesicoureteral reflux in children with unilateral renal agenesis. J Urol. 153(4), 1995, 1249-51.
PubMed
235) Heaney, JA. et al. Giant cyst of the seminal vesicle with renal agenesis. AJR Am J Roentgenol. 149(1), 1987, 139-40.
PubMed

第24章 胎児水腫

P.524 掲載の参考文献
1) Potter, EL. Universal edema of the fetus unassociated with erythroblastosis. Am J Obstet Gynecol. 46, 1943, 130-4.
 
2) Holzgreve, W. "The fetus with nonimmune hydrops". The Unborn Patient. 2nd ed. Harrison, MR. et al. eds. WA Saunders, 1990, 228-48.
 
3) Cunningham, FG. et al. eds. "Disease and injuries of the fetus and newborn". Williams Obstetrics. 23rd ed. New York, McGraw-Hill, 2010, 620-25.
 
4) 日本産科婦人科学会編. 産科婦人科用語集・用語解説集. 改訂第2版. 東京, 金原出版, 2008, 235.
 
5) Bianchi, DW., Crombleholme, TM., D'Alton, ME. eds. "Nonimmune hydrops fetalis". Fetology : Diagnosis and management of the fetal patient. New York, McGraw-Hill, 2000, 959-65.
 
6) Santolaya, J. et al. Antenatal classification of hydrops fetalis. Obstet Gynecol. 78, 1992, 256-9.
 
7) Heinonen, S. et al. Etiology and outcome of second trimester non-immunologic fetal hydrops. Act Obstet Gynecol Scand. 79, 2000, 15-8.
 
8) Midgley, DY. et al. The Mirror syndrome. Eur J Obstet Gynecol Reprod Biol. 88, 2000, 201-2.
PubMed
9) Tannirandorn, Y. et al. New approaches in the treatment of haemolytic disease of the fetus. Baillieres Clin Haematol. 2, 1990, 289-320.
PubMed
10) ACOG. Prevention of Rh D alloimmunization. Practice Bulletin. No 4. 1999.
PubMed
11) ACOG. Management of isoimmunization in pregnancy. Educational Bulletin. No 227. 1998.
 
12) Bowman, JM. Controversies in Rh prophylaxis : Who needs Rh immune globulin and when should it be given? Am J Obstet Gynecol. 151, 1985, 289-94.
 
13) 日本産科婦人科学会・日本産婦人科医会編集・監修. 産婦人科診療ガイドライン : 産科編2011. 2011, 91-5.
 
14) Freda, VJ. et al. Prevention of Rh hemolytic disease : ten years' clinical experience with Rh immune globulin. N Eng J Med. 292, 1975, 1014-6.
 
15) Mari, G. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med. 342, 2000, 9-14.
PubMed
16) Bullock, R. et al. Prediction of fetal anemia in pregnancies with red-cell alloimmunization : comparison of middle cerebral artery peak systolic velocity and amniotic fluid OD450. Ultrasound Obstet Gynecol. 25, 2005, 331-4.
PubMed
17) Kumar, S., Regan, F. Management of pregnancies with RhD alloimmunization. BMJ. 330, 2005, 1255-8.
PubMed
18) Liley, AW. Liquor amnii analysis in the management of pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol. 82, 1961, 1359-70.
 
19) Queenan, JT. et al. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation : a proposal for clinical management. Am J Obstet Gynecol. 168, 1993, 1370-6.
 
20) Nicolaides, KH. et al. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet. 1(8594), 1988, 1073-5.
PubMed
21) Ghidini, A. et al. Complications of fetal blood sampling. Am J Obstet Gynecol. 168, 1993, 1339-44.
PubMed
22) Harman, CR. et al. Intrauterine transfusion : Intraperitoneal versus intravascular approach ; A case-control comparison. Am J Obstet Gynecol. 162, 1990, 1053-9.
PubMed
23) Howe, DT. et al. Intraperitoneal transfusion in severe earlyonset Rh isoimmunizaion. Obstet Gynecol. 110, 2007, 880-4.
PubMed
24) Nicolini, U. et al. When to perform the next intra-uterine transfusion in patients with Rh allo-immunization : combined intravascular and intraperitoneal transfusion allows longer intervals. Fetal Ther. 4, 1989, 14-20.
PubMed
25) Nicolini, U. et al. Pathophysiology of pressure changes during intrauterine transfusion. Am J Obstet Gynecol. 160, 1989, 1139-45.
PubMed
26) Gibson, BES. "Transfusion in the fetus and newborn". Fetal and neonatal haematology. Hann, IM. et al. eds. Bailliere Tindall, 1991.
 
27) 鮫島浩ほか. "胎児輸血". 周産期医療と出血 母体編. 中村幸夫編. ペリネイタルケア. 15 (新春増刊), 1996, 129-36.
 
28) Nicolaides, KH. et al. Rh disease : intravascular fetal blood transfusion by cordocentesis. Fetal Ther. 1, 1986, 185-92.
PubMed
29) Rodeck, CH. et al. "The fetus with immune hydrops". The unborn patient. 2nd ed. Harrison, MR. et al. eds. WA Saunders, 1990, 215-27.
 
30) Nicolaides, KH. et al. Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol. 155, 1987, 50-3.
 
31) 永田秀昭ほか. 非免疫性胎児水腫の診断と胎児治療 : 適応と限界. 周産期シンポジウム. 12, 1994, 59-69.
 
32) Ayida, GA. et al. Survival in non-immune hydrops fetalis without malformation or chromosomal abnormalities after invasive treatment. Fetal Diagn Ther. 10, 1995, 101-5.
PubMed
33) Copel, JA. et al. The clinical significance of the irregular fetal heart rhythm. Am J Obstet Gynecol. 182(4), 2000, 813-7.
PubMed
34) Clark, JM. et al. "Fetal arrhythmias". Clinical Pediatric Arrhythmias. 2nd ed. Gillette, PC. et al. eds. WB Saunders, 1999, 293-302.
 
35) Friedman, AH. et al. Fetal echocardiography and fetal cardiology : Indications, diagnosis, and management. Sem Perinatol. 17, 1993, 76-88.
 
36) Younis, JS. et al. Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol. 157, 1987, 1268-9.
PubMed
37) Allan, LD. et al. Flecainide in the treatment of fetal tachycardias. Br Heart J. 65, 1991, 46-8.
PubMed
38) Buyon, JP. et al. In utero identification and therapy of congenital heart block. Lupus. 116, 1995, 116-21.
PubMed
39) Schmidt, KG. et al. Perinatal outcome of fetal complete atrioventricular block : A multicenter experience. J Am Coll Cardiol. 91, 1991, 1360-6.
 
40) Harris, JP. et al. Medical therapy for the hydropic fetus with congenital complete atrioventricular block. Am J Perinatol. 10, 1993, 217-9.
PubMed
41) Watson, WJ. et al. Steroid therapy for hydrops associated with antibody-mediated congenital heart block. Am J Obstet Gynecol. 165, 1991, 553-4.
PubMed
42) Wladimiroff, JW. et al. M-mode ultrasonic assessment of fetal cardiovascular dynamics. Br J Obstet Gynaecol. 88, 1981, 1241-5.
PubMed
43) Kanzaki, T. et al. Evaluation of the preload condition of the fetus by inferior vena caval blood flow pattern. Fetal Diagn Ther. 5(3-4), 1990, 168-74.
PubMed
44) Buttiker, V. et al. Chylothorax in children : guidelines for diagnosis and management. Chest. 116, 1999, 682-7.
PubMed
45) Eddleman, KA. et al. Reliability of pleural fluid lymphocyte counts in the antenatal diagnosis of congenital chylothorax. Obstet Gynecol. 78, 1991, 530-2.
PubMed
46) Mussat, P. et al. Congenital chylothorax with hydrops : postnatal care and outcome following antenatal diagnosis. Acta Paediatr. 84, 1995, 749-55.
PubMed
47) Booth, P. et al. Pleuro-amniotic shunting for fetal chylothrax. Early Hum Dev. 15, 1987, 365-7.
 
48) Choavaratana, R. et al. Feto-maternal transfusion in normal pregnancy and during delivery. J Med Assoc Thai. 80(2), 1997, 96-100.
PubMed
49) de Almeida, V. et al. Massive fetomaternal hemorrhage : Manitoba experience. Obstet Gynecol. 83(3), 1994, 323-8.
PubMed
50) Zelop, C. et al. The causes and natural history of fetal ascites. Prenat Diagn. 14, 1994, 941-6.
PubMed
51) Dirkes, K. et al. The natural history of meconium peritonitis diagnosed in utero. J Pediatr Surg. 30(7). 1995, 979-82.
PubMed
52) Chalubinski, K. et al. Meconium peritonitis : extrusion of meconium and different sonographical appearances in relation to the stage of the disease. Prenat Diagn. 12(8), 1992, 631-6.
 
53) Ohmichi, M. et al. Meconium peritonitis : Changes in fetal C-reactive protein and CA 125 levels in relation to stage of disease. J Ultrasound Med. 16, 1997, 289-92.
 
54) Dommergues, M. et al. Congenital cystic adenomatoid malformation of the lung : when is active fetal therapy indicated? Am J Obstet Gynecol. 177, 1997, 953-8.
PubMed
55) Adsick, NS. et al. Fetal lung lesions : management and outcome. Am J Obstet Gynecol. 179, 1998, 884-9.
 
56) Rodis, JF. et al. Management of parvovirus infection in pregnancy and outcomes of hydrops : a survey of members of the society of perinatal obstetricians. Am J Obstet Gynecol. 179, 1998, 985-8.
 
57) Mazeron, MC. et al. Transient hydrops fetalis associated with intrauterine cytomegalovirus infection : perinatal diagnosis. Obstet Gynecol. 84, 1994, 692-4.
 
58) 金子政時ほか. サイトメガロウイルス胎内感染の3症例 : 周産期の臨床経過と神経学的予後. 日本新生児学会雑誌. 34, 1998, 659-65.
 
59) Negishi, H. et al. Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus. J Perinatol. 18, 1998, 466-9.
 
60) Revello, MG. et al. Prenatal treatment of congenital human cytomegalovirus infection by fetal intravascular administration of ganciclovir. Clin Diagn Virol. 1, 1993, 61-7.
 
61) Liechty, KW. et al. Intrapartum airway management for giant fetal neck masses : the EXIT (ex utero intrapartum treatment) procedure. Am J Obstet Gynecol. 177(4), 1997, 870-4.
PubMed
62) Ulreich, S. et al. "Fetal hydrops and ascites". Diagnostic Imaging of Fetal Anomalies. Nyberg, DA., McGahan, JP., Pretorius, DH., Pilu, G. eds. Philadelphia, Lippincott Williams & Wilkins, 2003, 726-34.
 
63) Jauniaux, E. Diagnosis and management of early non-immune hydrops fetalis. Prenat Diagn. 17(13), 1997, 1261-8.
PubMed
64) McCoy, MC. et al. Non-immune hydrops after 20 weeks' gestation : review of 10 years' experience with suggestions for management. Obstet Gynecol. 85(4), 1995, 578-82.
PubMed
65) Anandakumar, C. et al. Management of non-immune hydrops : 8 years' experience. Ultrasound Obstet Gynecol. 8(3), 1996, 196-200.
PubMed
66) Wy, CA. Outcome of infants with a diagnosis of hydrops fetalis in the 1990s. Am J Perinatol. 16(10), 1999, 561-7.
PubMed
67) Romeo, R. et al. "Nonimmune hydrops fetalis". Prenatal diagnosis of congenital anomalies. Romeo, R., Pilu, G., Jeanty, P., Ghidini, A., Hobbins, JC. eds. Norwalk, Appleton & Lange, 1988, 414-26.
 
68) Wilkins, I. "Nonimmune hydrops fetalis". Maternal-Fetal Medicine. 4th ed. Creasy, RK. Resnik, R. eds. Philadelphia, Saunders, 1999, 769-82.
 
69) Radunovic, N. et al. The severely anemic and hydropic isoimmune fetus : changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol. 79(3), 1992, 390-3.
PubMed
70) Weber, AM. et al. Fetal pleural effusion : a review and metaanalysis for prognostic indicators. Obstet Gynecol. 79(2), 1992, 281-6.
PubMed
71) Norton, ME. Nonimmune hydrops fetalis. Semin Perinatol. 18, 1994, 321-32.
PubMed

第25章 胎内治療

P.549 掲載の参考文献
1) Barker, DJP. The Developmental Origins of Adult Disease. J Am Coll Nutr. 23(6), 2004, 588S-595S.
 
2) Vidaeff, AC. et al. Mirror syndrome : a case report. J Reprod Med. 47, 2002, 770-4.
PubMed
3) Carbillon, L. et al. Clinical biological features of Ballantyne syndrome and the role of placental hydrops. Obstet Gynecol Survey. 52, 1997, 310-4.
 
4) Harrison, MR. "Professional considerations in fetal treatment". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 3-9.
 
5) Harrison, MR. "Historical perspective". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 11-8.
 
6) Flake, AW. "Fetal therapy : medical and surgical approaches". Maternal-Fetal Medicine. Creasy, RK. et al. eds. Philadelphia, Saunders, 2004, 483-94.
 
7) Bianchi, DW. et al. eds. "Invasive fetal therapy and fetal surgery". Fetology. New York, McGraw-Hill. 2000, 35-54.
 
8) Sinhue Hahn. Wolfgang Holzgreve. Prenatal diagnosis using fetal cells from maternal blood. Prenatal Diagnosis. Mark I. Evans, et al. McGraw-Hill companies. 2004. ISBN. 505-12
 
9) Benn, P., Cuckle, H., Pergament, E. Non-invasive prenatal diagnosis for Down syndrome : the paradigm will shift, but slowly. Ultrasound Obset Gynecol. 39, 2012, 127-130
 
10) Nicolaidas, KH., Syngelaki, A., Ashoor, G. et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol. 207(5) 2012. 374. e1-e6
 
11) 千葉敏雄ほか. 周産期薬理学と胎児の管理・治療. 産科と婦人科. 71, 2004, 645-52.
Medical*Online
12) Burger, GA. "Principles of perinatal pharmacology". Ostheimer's Manual of Obstetric Anesthesia. Birnbach, DJ. ed. New York, Churchill Livingstone, 2000, 44-63.
 
13) Evans, MI. et al. "Pharmacologic fetal therapy". Fetal therapy. Evans, MI. et al. eds. New York, Parthenon Publishing, 2001, 67-76.
 
14) Rayburn, W. "Transplacental drug therapy". Fetal therapy. Fisk, NM. et al. eds. Cambridge University Press, 1997, 3-8.
 
15) Kleinman, CS. et al. "Fetal cardiac arrhythmias". Maternal and Fetal Medicine. Creasy, RK. et al. eds. Philadelphia, Saunders, 2004, 465-82.
 
16) Simpson, J. "Fetal arrhythmias". Textbook of fetal cardiology. Allan, L. et al. eds. London, Greenwich Medical Media, 2000, 423-37.
 
17) Gembruch, U. "Fetal tachyarrhythmia". Fetal cardiology. Yagel, S. et al. eds. London, Martin Dunitz, 2003, 355-71.
 
18) Vidaeff, AC., Mastrobattista, JM. Controversies in the use of antenatal steroids for fetal maturation. Semin Perinatol. 25, 2001, 385-96.
PubMed
19) ACOG Committee on Obstetric Practice. Committee opinion : Antenatal corticosteroid therapy for fetal maturation. 1998 compendium of selected publications, 7-8. The American College of Obstetricians and Gynecologists.
 
20) National Institutes of Health Consensus Development Panel. Antenatal Corticosteroids revisited : repeat courses. National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol. 98, 2001, 144-50.
PubMed
21) Jobe, AH., Soll, RF. Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol. 190, 2004, 878-81.
PubMed
22) Flake, AW. "In utero hematopoietic stem cell transplantation". Fetal therapy. Evans, MI. et al. eds. New York, Parthenon Publishing, 2001, 103-10.
 
23) Adzick, NS. Harrison, MR. "The fetus as patient". Surgery of Infants and Children. Oldham, KT. et al. eds. Philadelphia, Lippincott-Raven, 1997, 48-64.
 
24) 千葉敏雄ほか. Fetal Surgery : Past, Present, and Future. 日本新生児学会雑誌. 36, 2000, 524-39.
 
25) 千葉敏雄. 胎児外科治療 : その最近の変貌と将来の方向. 日本新生児学会雑誌. 39, 2003, 573-83.
 
26) Cauldwell, CB. et al. "Anesthesia and monitoring for fetal intervention". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 149-69.
 
27) Rychik, J. et al. Acute cardiovascular effects of fetal surgery in the human. Circulation. 110, 2004, 1549-56.
PubMed
28) Harrison, MR., Adzick, NS. Fetal surgical techniques. Semin Pediatr Surg. 2, 1993, 136-42.
PubMed
29) 千葉敏雄ほか. 胎児治療に用いる機器の安全性. 周産期医学. 34, 2004, 517-22.
 
30) Quintero, RA. et al. In utero fetal oximetry via visible light spectroscopy in twin-twin transfusion syndrome. Am J Obstet Gynecol. 199, 2008, 639.
 
31) Luks, FI. et al. Predictive value of monitoring parameters in fetal surgery. J Pediatr Surg. 33, 1998, 1297-31.
PubMed
32) Hess, P. "Preterm labor after fetal surgery". Anesthesia for Fetal Intervention and Surgery. Myers, LB. eds. Hamilton, BC Decker, 2005, 43-53.
 
33) Rossi, AC. et al. General vs local anesthesia for the percutaneous laser treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol. 199, 2008, 137.
 
34) Hache, JJ. et al. Bilateral fetal hydrothorax requiring intrauterine fetal thoracoamniotic shunts : anesthetic considerations and management. Scientific World Journal. 9, 2009, 435-40.
PubMed
35) Guinn, DA., Wheeler, M. "Maintenance therapy following successful arrest of preterm labor". Contemporary therapy in obstetrics and gynecology. Ransom, SB. et al. eds. Philadelphia, Saunders, 2002, 123-7.
 
36) Locksmith, G., Duff, P. Infection, antibiotics, and preterm delivery. Semin Perinatol. 25, 2001, 295-309.
PubMed
37) Papanna, R. et al. Chorioamnion separation as a risk for preterm premature rupture of membranes after laser therapy for twin-twin transfusion syndrome. Obstet Gynecol. 115, 2010, 771-6.
PubMed
38) Merz, W. et al. Maternal complications of fetoscopic laser photocoagulation (FLP) for treatment of twin-twin transfusion syndrome (TTTS). J Perinat Med. 2010 Feb 25. [Epub ahead of print].
 
39) Quintero, RA. et al. Treatment of iatrogenic previable premature rupture of membranes with intra-amniotic injection of platelets and cryoprecipitate (amniopatch) : Preliminary experience. Am J Obstet Gynecol. 181, 1999, 744-9.
PubMed
40) Robyr, R. et al. Cervical length as a prognostic factor for preterm delivery in twin-to-twin transfusion syndrome treated by fetoscopic laser coagulation of chorionic plate anastomoses. Ultrasound Obstet Gynecol. 25, 2005, 37-41.
PubMed
41) Peiro, JL. et al. Therapeutic indications of fetoscopy : a 5-year institutional experience. J Laparoendosc Adv Surg Tech A. 19, 2009, 229-36.
 
42) Harrison, MR., Chiba, T. Minimally invasive fetal procedures. J Jpn Soc Pediatr Surg. 36, 1999, 3-22.
 
43) Terada, S. et al. Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy. Cell Transplantation. 9, 2000, 701-4.
PubMed
44) Lewi, L. et al. Successful patching of iatrogenic rupture of the fetal membranes. Placenta. 25, 2004, 352-6.
PubMed
45) Pathak, B. et al. Amniopatch as a treatment for rupture of membranes following laser surgery for twin-twin transfusion syndrome. Fetal Diagn Ther. 27, 2010, 134-7.
PubMed
46) Papanna, R. et al. Chorioamnion plugging and the risk of preterm premature rupture of membranes after laser surgery in twin-twin transfusion syndrome. Ultrasound Obstet Gynecol. 35, 2010, 337-43.
PubMed
47) 千葉敏雄. 胎児水腎症の診断と治療 : 胎児閉塞性尿路疾患とその周産期管理. 小児外科. 35, 2003, 1110-6.
 
48) Cendron, M. et al. Prenatal diagnosis and management of the fetus with hydronephrosis. Semin Perinatol. 18, 1994, 163-81.
PubMed
49) Kleiner, B. et al. Sonographic analysis of the fetus with ureteropelvic junction obstruction. Am J Roentgenol. 148, 1987, 359-63.
 
50) Glick, PL. et al. Management of the fetus with congenital hydronephrosis : II. Prognostic criteria and selection for treatment. J Pediatr Surg. 20, 1985, 376-87.
PubMed
51) Mandelbrot, L. et al. Prenatal prediction of renal function in fetal obstructive uropathies. J Perinat Med. 19, 1991, 283-7.
 
52) Mahony, BS. et al. Fetal renal dysplasia : sonographic evaluation. Radiology. 152, 1984, 143-6.
PubMed
53) Callen, PW. et al. Ultrasonographic evaluation of fetal paranephric pseudocysts. J Ultrasound Med. 2, 1983, 309-12.
PubMed
54) Agarwal, SK., Fisk, NM. In utero therapy for lower urinary tract obstruction. Prenat Diagn. 21, 2001, 970-6.
PubMed
55) Quintero, RA. et al. Percutaneous fetal cystoscopy and endoscopic fulguration of posterior urethral valves. Am J Obstet Gynecol. 172, 1995, 206-9.
PubMed
56) Quintero, RA. et al. In-utero percutaneous cystoscopy in the management of fetal lower obstructive uropathy. Lancet. 346, 1995, 537-40.
PubMed
57) Holmes, N. et al. Fetal surgery for posterior urethral valves : long-term postnatal outcomes. Pediatrics. 108, 2001, E47.
 
58) Welsh, A. et al. Fetal cystoscopy in the management of fetal obstructive uropathy : experience in a single European centre. Prenat Diagn. 23, 2003, 1033-41.
 
59) Rychik, J. et al. Fetal cardiovascular effects of lower urinary tract obstruction with giant bladder. Ultrasound Obstet Gynecol. 2010 Apr 20. [Epub ahead of print].
 
60) Quintero, RA. et al. In utero management of fetal lower urinary tract obstruction with a novel shunt : A landmark development in fetal therapy. J Matern Fetal Neonatal Med. 2009 Dec 8. [Epub ahead of print].
 
61) Pluto Collaborative Study Group. et al. PLUTO trial protocol : percutaneous shunting for lower urinary tract obstruction randomised controlled trial. BJOG. 114, 2007, 904-5, e1-4.
 
62) Araujo Junior, E. et al. Percutaneous fetal surgery using epidural catheter : preliminary experience acquired from 24 cases. Arch Gynecol Obstet. 276, 2007, 29-33.
PubMed
63) Sago, H, et al. Endoscopic fetal urethrotomy for anterior urethral valves : a preliminary report. Fetal Diagn Ther. 24, 2008, 92-5.
 
64) 千葉敏雄, 師田信人. 胎児脳神経外科手術. 脳神経外科 速報. 14, 2004, 1198-204.
 
65) 千葉敏雄, 師田信人. 胎児脳神経外科 (2). 産科と婦人科. 71, 2004, 1219-25.
 
66) Tulipan, N., Bruner, JP. "Intrauterine myelomenin-gocele repair". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 453-66.
 
67) Fichter, MA. et al. Fetal spina bifida repair : current trends and prospects of intrauterine neurosurgery. Fetal Diagn Ther. 23, 2008, 271-86.
PubMed
68) Kohl, T., Gembruch, U. Current status and prospects of fetoscopic surgery for spina bifida in human fetuses. Response to Fichter et al : Fetal spina bifida repair ; current trends and prospects of intrauterine neurosurgery. Fetal Diagn Ther. 24, 2008, 318-20.
PubMed
69) Adzick, NS. Fetal myelomeningocele : natural history, pathophysiology, and in-utero intervention. Semin Fetal Neonatal Med. 15, 2010, 9-14.
PubMed
70) Danzer, E. et al. Structural and functional characterization of bladder smooth muscle in fetal rats with retinoic acidinduced myelomeningocele. Am J Physiol Renal Physiol. 262, 2007, F197-206.
 
71) Danzer, E. et al. Morphologic analysis of the neuromuscular development of the anorectal unit in fetal rats with retinoic acid induced myelomeningocele. Neurosci Lett. 430, 2008, 157-62.
PubMed
72) Walsh, DS. et al. The rationale for in utero repair of myelomeningocele. Fetal Diagn Ther. 16, 2001, 312-22.
PubMed
73) Adzick, NS., Walsh, DS. Myelomeningocele : prenatal diagnosis, pathophysiology, and management. Semin Pediatr Surg. 12, 2003, 168-74.
PubMed
74) Walsh, DS., Adzick, NS. Fetal surgery for spina bifida. Semin Neonatol. 8, 2003, 197-205.
PubMed
75) Hutchins, GM. et al. Acquired spinal cord injury in human fetuses with myelomeningocele. Pediatr Pathol Lab Med. 16, 1996, 701-12.
PubMed
76) Stiefel, D., Meuli, M. Scanning electron microscopy of fetal murine myelomeningocele reveals growth and development of the spinal cord in early gestation and neural tissue destruction around birth. J Pediatr Surg. 42, 2007, 1561-5.
 
77) Stiefel, D. et al. Fetal spina bifida in a mouse model : loss of neural function in utero. J Neurosurg. 106, 2007, 213-21.
 
78) Hirose, S., Farmer, DL. Fetal surgery for myelomeningocele. Clin Perinatol. 36, 2009, 431-8.
PubMed
79) Danzer, E. et al. Preschool neurodevelopmental outcome of children following fetal myelomeningocele closure. Am J Obstet Gynecol. 202, 2010, 450.
 
80) Koszutski, T. et al. Babies with myelomeningocele in Poland : parents' attitudes on fetal surgery versus termination of pregnancy. Childs Nerv Syst. 25, 2009, 207-10.
PubMed
81) Carr, MC. Fetal myelomeningocele repair : urologic aspects. Curr Opin Urol. 17, 2007, 257-62.
PubMed
82) Wilson, RD. et al. Does a myelomeningocele sac compared to no sac result in decreased postnatal leg function following maternal fetal surgery for spina bifida aperta? Fetal Diagn Ther. 22, 2007, 345-51.
 
83) Zambelli, H. et al. Assessment of neurosurgical outcome in children prenatally diagnosed with myelomeningocele and development of a protocol for fetal surgery to prevent hydrocephalus. Childs Nerv Syst. 23, 2007, 421-5.
PubMed
84) Barini, R. et al. Abruptio placentae during fetal myelomeningocele repair. Fetal Diagn Ther. 21, 2006, 115-7.
PubMed
85) Fontecha, CG. et al. Inert patch with bioadhesive for gentle fetal surgery of myelomeningocele in a sheep model. Eur J Obstet Gynecol Reprod Biol. 146, 2009, 174-9.
 
86) Kohl, T. et al. Percutaneous fetoscopic patch closure of human spina bifida aperta : advances in fetal surgical techniques may obviate the need for early postnatal neurosurgical intervention. Surg Endosc. 23, 2009, 890-5.
PubMed
87) Johnson, MP. et al. Fetal myelomeningocele repair : shortterm clinical outcomes. Am J Obstet Gynecol. 189, 2003, 482-7.
PubMed
88) Tulipan, N. Intrauterine myelomeningocele repair. Clin Perinatol. 30, 2003, 521-30.
PubMed
89) Tulipan, N. et al. The effect of intrauterine myelomeningocele repair on the incidence of shunt-dependent hydrocephalus. Pediatr Neurosurg. 38, 2003, 27-33.
PubMed
90) Tulipan, N. Intrauterine closure of myelomeningocele : an update. Neurosurg Focus. 16, 2004, E2.
PubMed
91) Bruner, JP. Intrauterine repair of spina bifida : preoperative predictors of shunt-dependant hydrocephalus. Am J Obstet Gynecol. 190, 2004, 1305-12.
PubMed
92) Tubbs, RS. et al. Late gestational intrauterine myelomeningocele repair does not improve lower extremity function. Pediatr Neurosurg. 38, 2003, 128-32.
 
93) Sbragia, L. et al. Fetal myelomeningocele and the potential in-utero repair : follow up of 58 fetuses. Arq Neuropsiquiatr. 62, 2004, 487-91.
PubMed
94) Holzbeierlein, J. et al. The urodynamic profile of myelodysplasia in childhood with spinal closure during gestation. J Urol. 164, 2000, 1336-9.
PubMed
95) Holmes, NM. et al. Fetal intervention for myelomeningocele : effect on postnatal bladder function. J Urol. 166, 2001, 2383-6.
PubMed
96) ACOG Committee on Obstetric Practice. Committee opinion : Fetal surgery for open neural tube defects. 2002 compendium of selected publications. 21-22. The American College of Obstetricians and Gynecologists.
 
97) Lyerly, AD., Mahowald, MB. Maternal-fetal surgery for treatment of meningomyelocele. Clin Perinatol. 30, 2003, 155-65.
PubMed
98) Kohl, T. Minimally invasive fetoscopic interventions : an overview in 2010. Surg Endosc. 24, 2010, 2056-67.
PubMed
99) Danzer, E. et al. Reversal of hindbrain herniation after maternal-fetal surgery for myelomeningocele subsequently impacts on brain stem function. Neuropediatrics. 39, 2008, 359-62.
PubMed
100) Danzer, E. et al. Fetal head biometry assessed by fetal magnetic resonance imaging following in utero myelomeningocele repair. Fetal Diagn Ther. 22, 2007, 1-6.
PubMed
101) Adzick, NS., Thom, EA., Spong, CY. et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 364, 2011, 993.
PubMed
102) Fauza, DO. et al. Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida. Surgery. 144, 2008, 367-73.
 
103) Farmer, DL., Albanese, CT. "Fetal hydrothorax". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 373-8.
 
104) Weber, A., Philipson, EH. Fetal pleural effusion : A review and meta-analysis for prognostic indicators. Obstet Gynecol. 79, 1992, 281.
PubMed
105) Aubard, Y. et al. Primary fetal hydrothorax : A literature review and proposed antenatal clinical strategy. Fetal Diagn Ther. 13, 1998, 325-33.
PubMed
106) Yinon, Y. et al. Perinatal outcome following fetal chest shunt insertion for pleural effusion. Ultrasound Obstet Gynecol. 36, 2010, 58-64.
PubMed
107) Deurloo, KL. et al. Isolated fetal hydrothorax with hydrops : a systematic review of prenatal treatment options. Prenat Diagn. 27, 2007, 893-9.
PubMed
108) Slodki, M. et al. Hydrothorax treated in utero and monitored by fetal echocardiography. Ginekol Pol. 80, 2009, 386-9.
PubMed
109) Okawa, T. et al. A new fetal therapy for chylothorax : pleurodesis with OK-432. Ultrasound Obstet Gynecol. 18, 2001, 376-7.
PubMed
110) Tanemura, M. et al. A case of successful therapy for congenital chylothorax by intrapleural injection of OK-432. Ultrasound Obstet Gynecol. 18, 2001, 371-5.
PubMed
111) Adzick, NS. "The fetus with a lung mass". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 287-96.
 
112) Goldstein, RB. "Ultrasound evaluation of the fetal thorax". Ultrasonography in Obstetrics and Gynecology. 4th ed. Callen, PW. ed. Philadelphia, Saunders, 2000, 426-55.
 
113) Crombleholme, TM. et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J Pediatr Surg. 37, 2002, 331-8.
 
114) Rice, HE. et al. Congenital cystic adenomatoid malformation : A sheep model of fetal hydrops. J Pediatr Surg. 29, 1994, 692-6.
PubMed
115) Higby, K. et al. Spontaneous resolution of nonimmune hydrops in a fetus with a cystic adenomatoid malformation. J Perinatol. 18, 1998, 308-10.
 
116) Tsao, K. et al. Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy. J Pediatr Surg. 38, 2003, 508-10.
PubMed
117) Adzick, NS. et al. Fetal surgery for cystic adenomatoid malformation of the lung. J Pediatr Surg. 28, 1993, 806-12.
 
118) Adzick, NS. et al. Fetal lung lesions : Management and outcome. Am J Obstet Gynecol. 179, 1998, 884-9.
PubMed
119) Dommergues, M. et al. Congenital adenomatoid malformation of the lung : when is active fetal therapy indicated? Am J Obstet Gynecol. 177, 1997, 953-8.
PubMed
120) Clements, BS., Warner, JO. Pulmonary sequestration and related congenital broncho-pulmonary vascular malformations : nomenclature and classification based on anatomical and embryological considerations. Thorax. 42, 1987, 401-8.
 
121) Clements, BS. et al. Congenital bronchopulmonary vascular malformations : clinical application of a simple anatomical approach in 25 cases. Thorax. 42, 1987, 409-16.
PubMed
122) Achiron, R. et al. Fetal lung dysplasia : clinical outcome based on a new classification system. Ultrasound Obstet Gynecol. 24, 2004, 127-33.
PubMed
123) Achiron, R. Fetal lung lesions : a spectrum of disease. New classification based on pathogenesis, two-dimensional and color Doppler ultrasound. Ultrasound Obstet Gynecol. 24, 2004, 107-14.
PubMed
124) Flake, AW. "The fetus with sac4ococcygeal teratoma". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 315-23.
 
125) Chiba, T. et al. In utero repair of rectal atresia after complete resection of a sacrococcygeal teratoma. Fetal Diagn Ther. 15, 2000, 187-90.
PubMed
126) Kitano, Y. et al. Aberrant venous flow measurement may predict the clinical behavior of a fetal extralobar pulmonary sequestration. Fetal Diagn Ther. 23, 2008, 299-302.
PubMed
127) Kitano, Y. et al. Venous arterialization in extralobar pulmonary sequestration associated with fetal hydrops. J Pediatr Surg. 41, 2006, 490-4.
PubMed
128) Kunisaki, SM. et al. Large fetal congenital cystic adenomatoid malformations : growth trends and patient survival. J Pediatr Surg. 42, 2007, 404-10.
PubMed
129) Xie, HN. et al. Prenatal surveillance of bronchopulmonary sequestration using 3-dimensional ultrasonography. J Ultrasound Med. 28, 2009, 989-94.
PubMed
130) Peranteau, WH. et al. Effect of maternal betamethasone administration on prenatal congenital cystic adenomatoid malformation growth and fetal survival. Fetal Diagn Ther. 22, 2007, 365-71.
PubMed
131) Oepkes, D. et al. Successful ultrasound-guided laser treatment of fetal hydrops caused by pulmonary sequestration. Ultrasound Obstet Gynecol. 29, 2007, 457-9.
PubMed
132) Witlox, RS. et al. Single-needle laser treatment with drainage of hydrothorax in fetal bronchopulmonary sequestration with hydrops. Ultrasound Obstet Gynecol. 34, 2009, 355-7.
PubMed
133) Makin, EC. et al. Outcome of antenatally diagnosed sacrococcygeal teratomas : single-center experience (1993-2004). J Pediatr Surg. 41, 2006, 388-93.
PubMed
134) Sy, ED. et al. Prognostic role of tumor-head volume ratio in fetal sacrococcygeal teratoma. Fetal Diagn Ther. 26, 2009, 75-80.
PubMed
135) 千葉敏雄ほか. 先天性横隔膜ヘルニアと胎児外科治療 (1). 産科と婦人科. 72, 2005, 375-81.
Medical*Online
136) 千葉敏雄ほか. 先天性横隔膜ヘルニアと胎児外科治療 (2). 産科と婦人科. 72, 2005, 486-91.
Medical*Online
137) Skari, H. et al. Congenital diaphragmatic hernia : a metaanalysis of mortality factors. J Pediatr Surg. 35, 2000, 187-97.
 
138) Dillon, E. et al. Congenital diaphragmatic herniation : antenatal detection and outcome. Br J Radiol. 73, 2000, 360-5.
PubMed
139) Beresford, MW., Shaw, NJ. Outcome of congenital diaphragmatic hernia. Pediatr Pulmonol. 30, 2000, 249-56.
PubMed
140) Reickert, CA. et al. Congenital diaphragmatic hernia survival and use of extracorporeal life support at selected level III nurseries with multimodality support. Surgery. 123, 1998, 305-10.
PubMed
141) Kim, ES., Stolar, CJ. ECMO in the newborn. Am J Perinatol. 17, 2000, 345-56.
PubMed
142) Wilson, JM. et al. Congenital diaphragmatic hernia : a tale of two cities ; the Boston experience. J Pediatr Surg. 32, 1997, 401-5.
PubMed
143) Kays, DW. et al. Detrimental effects of standard medical therapy in congenital diaphragmatic hernia. Ann Surg. 230, 1999, 340-51.
PubMed
144) Boloker, J. et al. Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnia/spontaneous respiration/elective repair. J Pediatr Surg. 37, 2002, 357-66.
PubMed
145) Stege, G. et al. Nihilism in the 1990s : The true mortality of congenital diaphragmatic hernia. Pediatrics. 112, 2003, 532-5.
PubMed
146) The congenital diaphragmatic hernia study group. Prenatal detection of lethal pulmonary hypoplasia : the hyperoxygenation test for pulmonary artery reactivity. J Pediatr Surg. 36, 2001, 141-5.
 
147) Broth, RE. et al. Prenatal detection of lethal pulmonary hypoplasia : the hyperoxygenation test for pulmonary artery reactivity. Am J Obstet Gynecol. 187, 2002, 940-5.
 
148) Albanese, CT. et al. Fetal liver position and perinatal outcome for congenital diaphragmatic hernia. Prenat Diagn. 18, 1998, 1138-42.
PubMed
149) Lipshutz, GS. et al. Prospective analysis of lung-to-head ratio predicts survival for patients with prenatally diagnosed congenital diaphragmatic hernia. J Pediatr Surg. 32, 1997, 1634-6.
PubMed
150) Laudy, JA. et al. Congenital diaphragmatic hernia : an evaluation of the prognostic value of the lung-to-head ratio and other prenatal parameters. Prenat Diagn. 23, 2003, 634-9.
PubMed
151) Keller, RL. et al. The lung-to-head ratio and fetoscopic temporary tracheal occlusion : prediction of survival in severe left congenital diaphragmatic hernia. Ultrasound Obstet Gynecol. 21, 2003, 244-9.
PubMed
152) Sydorak, RM. et al. Congenital diaphragmatic hernia and hydrops : a lethal association? J Pediatr Surg. 37, 2002, 1678-80.
PubMed
153) DiFiore, JW. et al. Experimental fetal tracheal ligation reverses the structural and physiologic effects of pulmonary hypoplasia in congenital diaphragmatic hernia. J Pediatr Surg. 29, 1994, 248-57.
PubMed
154) Sylvester, KG. et al. Tracheal occlusion reverses the high impedance to flow in the fetal pulmonary circulation and normalizes its physiological response to oxygen at full term. J Pediatr Surg. 33, 1998, 1071-5.
PubMed
155) Flageole, H. et al. The plug-unplug sequence : an important step to achieve type II pneumocyte maturation in the fetal lamb model. J Pediatr Surg. 33, 1998, 299-303.
 
156) Luks, FI. et al. Short-term tracheal occlusion corrects pulmonary vascular anomalies in the fetal lamb with diaphragmatic hernia. Surgery. 128, 2000, 266-72.
PubMed
157) Wild, YK. et al. Short-term tracheal occusion in fetal lamb with diaphragmatic hernia improves lung function, even in the absence of lung growth. J Pediatr Surg. 35, 2000, 775-9.
 
158) Papadakis, K. et al. Temporary tracheal occusion causes catch-up lung maturation in a fetal model of diaphragmatic hernia. J Pediatr Surg. 33, 1998, 1030-7.
 
159) Davey, MG. et al. Temporary tracheal occusion in fetal sheep with lung hypoplasia does not improve postnatal lung function. J Appl Physiol. 94, 2003, 1054-62.
 
160) Walters, DV., Olver, RE. The role of catecholamines in lung liquid absorption at birth. Pediatr Res. 12, 1978, 239-42.
PubMed
161) Lawson, EE. et al. The effect of epinephrine on tracheal fluid flow and surfactant efflux in fetal sheep. Am Rev Respir Dis. 118, 1978, 1023-6.
PubMed
162) Mychalishka, GB. et al. Operating on placental support : the ex utero intrapartum treatment procedure. J Pediatr Surg. 32, 1997, 227-30.
 
163) Harrison, MR. et al. Correction of congenital diaphragmatic hernia in utero IX : fetuses with poor prognosis (liver herniation and low lung-to-head ratio) can be solved by fetoscopic temporary tracheal occlusion. J Pediatr Surg. 33, 1998, 1017-22.
 
164) Chiba, T. et al. Balloon tracheal occlusion for congenital diaphragmatic hernia : experimental studies. J Pediatr Surg. 35, 2000, 1566-70.
PubMed
165) Harrison, MR. et al. Fetoscopic temporary tracheal occlusion by means of detachable balloon for congenital diaphragmatic hernia. Am J Obstet Gynecol. 185, 2001, 730-3.
PubMed
166) Papadakis, K. et al. Single-port tracheoscopic surgery in the fetal lamb. J Pediatr Surg. 33, 1998, 918-20.
 
167) Deprest, JA. et al. Tracheoscopic endoluminal plugging using an inflatable device in the fetal lamb model. Eur J Obstet Gynecol Reprod Biol. 81, 1998, 165-9.
PubMed
168) Deprest, JA. et al. Tracheal side effects of endoscopic balloon tracheal occlusion in the fetal lamb model. Eur J Obstet Gynecol Reprod Biol. 92, 2000, 119-26.
PubMed
169) Keller, RL. et al. Infant pulmonary function in a randomized trial of fetal tracheal occlusion for severe congenital diaphragmatic hernia. Pediatr Res. 56, 2004, 818-25.
 
170) Jani, J. et al. Observed to expected lung area to head circumference ratio in the prediction of survival in fetus with isolated diaphragmatic hernia. Ultrasound Obstet Gynecol. 30, 2007, 67-71.
PubMed
171) Jani, JC. et al. Prenatal prediction of neonatal morbidity in survivors with congenital diaphragmatic hernia : a multicenter study. Am Ultrasound Obstet Gynecol. 33, 2009, 64-9.
 
172) Jani, JC. et al. Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 34, 2009, 304-10.
PubMed
173) 千葉敏雄ほか. 先天性横隔膜ヘルニアと胎児外科治療 (3). 産科と婦人科. 72, 2005, 626-31.
Medical*Online
174) Grethel, EJ., Nobuhara, KK. Fetal surgery for congenital diaphragmatic hernia. J Paediatr Child Health. 42, 2006, 79-85.
PubMed
175) de Buys Roessingh, AS. et al. Role of ATP-dependent potassium channels in pulmonary vascular tone of fetal lambs with congenital diaphragmatic hernia. Pediatr Res. 60, 2006, 537-42.
PubMed
176) 千葉敏雄. 胎児外科. 東京, 日本評論社. 2007.
 
177) Grushka, JR. et al. The effect of in vitro tracheal occlusion on branching morphogenesis in fetal lung explants from the rat nitrofen model of congenital diaphragmatic hernia. J Pediatr Surg. 45, 2010, 943-7.
PubMed
178) Van Mieghem, T. et al. Fetal cerebral blood flow velocities in congenital diaphragmatic hernia. Ultrasound Obstet Gynecol. 36(4), 2010, 452-7.
PubMed
179) Ruano, R. et al. Comparison between fetal endoscopic tracheal occlusion using a 1.0-mm fetoscope and prenatal expectant management in severe congenital diaphragmatic hernia. Fetal Diagn Ther. 29(1), 2010, 64-70.
 
180) Cruz-Martinez, R. et al. Changes in lung tissue perfusion in the prediction of survival in fetuses with congenital diaphragmatic hernia treated with fetal endoscopic tracheal occlusion. Fetal Diagn Ther. 29(1), 2011, 101-7. Epub. 2010 Mar 9.
 
181) Cruz-Martinez, R. et al. Contribution of intrapulmonary artery Doppler to improve prediction of survival in fetuses with congenital diaphragmatic hernia treated with fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 35, 2010, 572-7.
PubMed
182) Sinha, CK. et al. Congenital diaphragmatic hernia : prognostic indices in the fetal endoluminal tracheal occlusion era. J Pediatr Surg. 44, 2009, 312-6.
PubMed
183) Danzer, E. et al. Fetal tracheal occlusion for severe congenital diaphragmatic hernia in humans : a morphometric study of lung parenchyma and muscularization of pulmonary arterioles. J Pediatr Surg. 43, 2008, 1767-75.
PubMed
184) Laberge, JM. Fetal tracheal occlusion for the treatment of congenital diaphragmatic hernia. World J Surg. 32, 2008, 2329.
PubMed
185) Biard, JM. et al. Main bronchus occlusion for treatment of congenital diaphragmatic hernia in fetal lambs. J Pediatr Surg. 43, 2008, 620-6.
PubMed
186) Saura, L. et al. Impact of fetal intervention on postnatal management of congenital diaphragmatic hernia. Eur J Pediatr Surg. 17, 2007, 404-7.
PubMed
187) Laberge, JM., Flageole, H. Fetal tracheal occlusion for the treatment of congenital diaphragmatic hernia. World J Surg. 31, 2007, 1577-86.
PubMed
188) Jani, JC. et al. Fetal lung-to-head ratio in the prediction of survival in severe left-sided diaphragmatic hernia treated by fetal endoscopic tracheal occlusion (FETO). Am J Obstet Gynecol. 195, 2006, 1646-50.
PubMed
189) Quintero, RA. et al. Minimally invasive intraluminal tracheal occlusion in a human fetus with left congenital diaphragmatic hernia at 27 weeks' gestation via direct fetal laryngoscopy. Prenat Neonat Med. 5, 2000, 134-40.
 
190) Flake, AW. et al. Treatment of severe congenital diaphragmatic hernia by fetal tracheal occlusion : Clinical experience with fifteen cases. Am J Obstet Gynecol. 183, 2000, 1059-66.
PubMed
191) Harrison, MR. et al. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med. 349, 2003, 1916-24.
PubMed
192) Ruano, R., Yoshisaki, CT., Da Silva, MM. et al. A randomized controlled trial of fetal endoscopic tracheal occlusion versus postnatal management of severe isolated congenital diaphragmatic hernia. Ultrasound Obstet Gynecol. 39, 2012, 20
 
193) Yamamoto, M., Ville Y. Fetal lung assessment in congenital diaphragmatic hernia : evidence for growth. Ultrasound Obstet Gynecol. 35, 2010, 522-4.
PubMed
194) Ruano, R. et al. Three-dimensional ultrasonographic measurements of the fetal lungs for prediction of perinatal outcome in isolated congenital diaphragmatic hernia. J Obstet Gynaecol Res. 35, 2009, 1031-41.
PubMed
195) Balassy, C. et al. Assessment of lung development in isolated congenital diaphragmatic hernia using signal intensity ratios on fetal MR imaging. Eur Radiol. 20, 2010, 829-37.
PubMed
196) Kilian, AK. et al. Congenital diaphragmatic hernia : predictive value of MRI relative lung-to-head ratio compared with MRI fetal lung volume and sonographic lung-to-head ratio. AJR Am J Roentgenol. 192, 2009, 153-8.
PubMed
197) Deprest, JA. et al. Antenatal prediction of lung volume and in-utero treatment by fetal endoscopic tracheal occlusion in severe isolated congenital diaphragmatic hernia. Semin Fetal Neonatal Med. 14, 2009, 8-13.
PubMed
198) Cannie, M. et al. Prenatal prediction of survival in isolated diaphragmatic hernia using observed to expected total fetal lung volume determined by magnetic resonance imaging based on either gestational age or fetal body volume. Ultrasound Obstet Gynecol. 32, 2008, 633-9.
 
199) Busing, KA. et al. MR relative fetal lung volume in congenital diaphragmatic hernia : survival and need for extracorporeal membrane oxygenation. Radiology. 248, 2008, 240-6.
PubMed
200) Busing, KA. et al. MR lung volume in fetal congenital diaphragmatic hernia : logistic regression analysis ; mortality and extracorporeal membrane oxygenation. Radiology. 248, 2008, 233-9.
PubMed
201) Ruano, R. et al. Predicting neonatal deaths and pulmonary hypoplasia in isolated congenital diaphragmatic hernia using the sonographic fetal lung volume-body weight ratio. AJR Am J Roentgenol. 190, 2008, 1216-9.
PubMed
202) Katayama, S. et al. Evaluation of normal fetal branch pulmonary artery diameters measured by ultrasonography : a comparison with congenital diaphragmatic hernia. Fetal Diagn Ther. 23, 2008, 303-7.
PubMed
203) Ruano, R. et al. Predicting perinatal outcome in isolated congenital diaphragmatic hernia using fetal pulmonary artery diameters. J Pediatr Surg. 43, 2008, 606-11.
PubMed
204) Neff, KW. et al. Prediction of mortality and need for neonatal extracorporeal membrane oxygenation in fetuses with congenital diaphragmatic hernia : logistic regression analysis based on MRI fetal lung volume measurements. AJR Am J Roentgenol. 189, 2007, 1307-11.
PubMed
205) Jani, JC. et al. Comparison of fetal lung area to head circumference ratio with lung volume in the prediction of postnatal outcome in diaphragmatic hernia. Ultrasound Obstet Gynecol. 30, 2007, 850-4.
PubMed
206) Hayakawa, M. et al. The MRI findings of the right-sided fetal lung can be used to predict postnatal mortality and the requirement for extracorporeal membrane oxygenation in isolated left-sided congenital diaphragmatic hernia. Pediatr Res. 62, 2007, 93-7.
PubMed
207) Kalache, KD. et al. Isolated left-sided congenital diaphragmatic hernia : cardiac axis and displacement before fetal viability has no role in predicting postnatal outcome. Prenat Diagn. 27, 2007, 322-6.
PubMed
208) Barnewolt, CE. et al. Percent predicted lung volumes as measured on fetal magnetic resonance imaging : a useful biometric parameter for risk stratification in congenital diaphragmatic hernia. J Pediatr Surg. 42, 2007, 193-7.
PubMed
209) Breysem, L. et al. T2 quantifications of lungs in the fetal lamb with experimentally-induced congenital diaphragmatic hernia. Fetal Diagn Ther. 22, 2007, 143-8.
PubMed
210) Sokol, J. et al. Fetal pulmonary artery diameter measurements as a predictor of morbidity in antenatally diagnosed congenital diaphragmatic hernia : a prospective study. Am J Obstet Gynecol. 195, 2006, 470-7.
PubMed
211) Ruano, R. et al. Quantitative analysis of fetal pulmonary vasculature by 3-dimensional power Doppler ultrasonography in isolated congenital diaphragmatic hernia. Am J Obstet Gynecol. 195, 2006, 1720-8.
PubMed
212) Bonfils, M. et al. Fetal lung volume in congenital diaphragmatic hernia. Arch Dis Child Fetal Neonatal Ed. 91, 2006, F363-4.
PubMed
213) Bargy, F. et al. Fetal lung growth in congenital diaphragmatic hernia. Fetal Diagn Ther. 21, 2006, 39-44.
PubMed
214) Mullassery, D. et al. Value of liver herniation in prediction of outcome in fetal congenital diaphragmatic hernia : a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 35, 2010, 609-14.
PubMed
215) Chen, G. et al. The impact of iatrogenic gastroschisis on pulmonary maturation in the fetal rabbit models of congenital diaphragmatic hernia. Pediatr Surg Int. 25, 2009, 635-40.
PubMed
216) Worley, KC. et al. Fetal magnetic resonance imaging in isolated diaphragmatic hernia : volume of herniated liver and neonatal outcome. Am J Obstet Gynecol. 200, 2009, 318.
 
217) Gucciardo, L. et al. Prediction of outcome in isolated congenital diaphragmatic hernia and its consequences for fetal therapy. Best Pract Res Clin Obstet Gynaecol. 22, 2008, 123-38.
PubMed
218) Wegrzyn, P. et al. Premature labor after fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia : postprocedure management problems. Ultrasound Obstet Gynecol. 36, 2010, 124-5.
PubMed
219) Deprest, J. et al. Tracheal side effects following fetal endoscopic tracheal occlusion for severe congenital diaphragmatic hernia. Pediatr Radiol. 40, 2010, 670-3.
PubMed
220) McHugh, K. et al. Tracheomegaly : a complication of fetal endoscopic tracheal occlusion in the treatment of congenital diaphragmatic hernia. Pediatr Radiol. 40, 2010, 674-80.
PubMed
221) Kilian, AK. et al. Fetal MR lung volumetry in congenital diaphragmatic hernia (CDH) : prediction of clinical outcome and the need for extracorporeal membrane oxygenation (ECMO). Klin Padiatr. 221, 2009, 295-301.
PubMed
222) Jelin, E., Lee, H. Tracheal occlusion for fetal congenital diaphragmatic hernia : the US experience. Clin Perinatol. 36, 2009, 349-61.
PubMed
223) Deprest, JA. et al. Current controversies in prenatal diagnosis 4 : Should fetal surgery be done in all cases of severe diaphragmatic hernia? Prenat Diagn. 29, 2009, 15-9.
PubMed
224) Arkovitz, MS. et al. Fetal lung-head ratio is not related to outcome for antenatal diagnosed congenital diaphragmatic hernia. J Pediatr Surg. 42, 2007, 107-10.
 
225) Ruano, R. et al. Four-dimensional ultrasonographic guidance of fetal tracheal occlusion in a congenital diaphragmatic hernia. J Ultrasound Med. 26, 2007, 105-9.
 
226) Saada, J. et al. Combining keratinocyte growth factor transfection into the airways and tracheal occlusion in a fetal sheep model of congenital diaphragmatic hernia. J Gene Med. 12, 2010, 413-22.
 
227) Goumy, C. et al. Fetal skin fibroblasts : a cell model for studying the retinoid pathway in congenital diaphragmatic hernia. Birth Defects Res A Clin Mol Teratol. 88, 2010, 195-200.
PubMed
228) Klaritsch, P. et al. Albumin as an adjunct to tracheal occlusion in fetal rats with congenital diaphragmatic hernia : a placebo-controlled study. Am J Obstet Gynecol. 202, 2010, 198.
 
229) Roubliova, XI. et al. The effect of maternal betamethasone and fetal tracheal occlusion on pulmonary vascular morphometry in fetal rabbits with surgically induced diaphragmatic hernia : a placebo controlled morphologic study. Prenat Diagn. 29, 2009, 674-81.
PubMed
230) Mayer, S. et al. Maternal administration of betamethasone inhibits proliferation induced by fetal tracheal occlusion in the nitrofen rat model for congenital diaphragmatic hernia : a placebo-controlled study. Pediatr Surg Int. 24, 2008, 1287-95.
PubMed
231) de Buys Roessingh, AS. et al. Neuronal nitric oxide synthase does not contribute to the modulation of pulmonary vascular tone in fetal lambs with congenital diaphragmatic hernia (nNOS in CDH lambs). Pediatr Pulmonol. 43, 2008, 313-21.
PubMed
232) Davey, MG. et al. Prenatal glucocorticoids improve lung morphology and partially restores surfactant mRNA expression in lambs with diaphragmatic hernia undergoing fetal tracheal occlusion. Pediatr Pulmonol. 41, 2006, 1188-96.
PubMed
233) Davey, MG. et al. Prenatal glucocorticoids and exogenous surfactant therapy improve respiratory function in lambs with severe diaphragmatic hernia following fetal tracheal occlusion. Pediatr Res. 60, 2006, 131-5.
PubMed
234) Santos, M. et al. Ghrelin expression in human and rat fetal lungs and the effect of ghrelin administration in nitrofeninduced congenital diaphragmatic hernia. Pediatr Res. 59, 2006, 531-7.
PubMed
235) 千葉敏雄ほか. 一絨毛膜性双胎と胎児外科治療 (1). 産科と婦人科. 71, 2004, 1359-66.
Medical*Online
236) 千葉敏雄ほか. 一絨毛膜性双胎と胎児外科治療 (2). 産科と婦人科. 71, 2004, 1766-71.
Medical*Online
237) 千葉敏雄ほか. 一絨毛膜性双胎と胎児外科治療 (3). 産科と婦人科. 71, 2004, 1886-93.
Medical*Online
238) Van Gemert, MJC. et al. Twin-twin transfusion syndrome : etiology, severity and rational management. Curr Opin Obstet Gynecol. 13, 2001, 193-206.
 
239) Wee, LY., Fisk, NM. The twin-twin transfusion syndrome. Semin Neonatol. 7, 2002, 187-202.
PubMed
240) Lewi, L. et al. Monochorionic diamniotic twins : complications and management options. Curr Opin Obstet Gynecol. 15, 2003, 177-94.
PubMed
241) Quintero, RA. et al. Staging of twin-twin transfusion syndrome. J Perinatol. 19, 1999, 550-5.
 
242) Taylor, MJ. et al. Validation of the Quintero staging for twintwin transfusion syndrome. Obstet Gynecol. 100, 2002, 1257-65.
PubMed
243) Luks, FI. et al. Limited prognostic value of a staging system for twin-to-twin transfusion syndrome. Fetal Diagn Ther. 19, 2004, 301-4.
 
244) Gratacos, E. et al. Incidence and characteristics of umbilical artery intermittent absent and/or reversed end-diastolic flow in complicated and uncomplicated monochorionic twin pregnancies. Ultrasound Obstet Gynecol. 23, 2004, 456-60.
PubMed
245) Mari, G. et al. Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome : results of the international amnioreduction registry. Am J Obstet Gynecol. 185, 2001, 708-15.
PubMed
246) Deprest, J., Ville, Y. "Obstetric endoscopy". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 213-31.
 
247) De Lia, JE. et al. Fetoscopic laser ablation of placental vessels in severe previable twin-twin transfusion syndrome. Am J Obstet Gynecol. 172, 1995, 1202-11.
PubMed
248) Ville, Y. et al. Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome. N Engl J Med. 332, 1995, 224-7.
PubMed
249) Gratacos, E. et al. Transient hydropic signs in the donor fetus after fetoscopic laser coagulation in severe twin-twin transfusion syndrome : incidence and clinical relevance. Ultrasound Obstet Gynecol. 19, 2002, 449-53.
 
250) Morine, M. et al. Transient hydrops fetalis of the donor fetus in twin-twin transfusion syndrome after therapeutic amnioreduction. Ultrasound Obstet Gynecol. 22, 2003, 182-5.
PubMed
251) Wee, LY. et al. Reversal of twin-twin transfusion syndrome : frequency, vascular anatomy, associated anomalies and outcome. Prenat Diagn. 24, 2004, 104-10.
PubMed
252) 千葉敏雄ほか. 心疾患の胎児治療. Annual Review循環器 2005. 矢崎義雄ほか編. 東京, 中外医学社. 2005, 279-88.
 
253) Hecher, K. et al. Endoscopic laser surgery versus serial amniocenteses in the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol. 180, 1999, 717-24.
PubMed
254) Lopriore, E. et al. Long-term neurodevelopmental outcome in twin-to-twin transfusion syndrome. Am J Obstet Gynecol. 189, 2003, 1314-9.
PubMed
255) Banek, CS. et al. Long-term neurodevelopmental outcome after intrauterine laser treatment for severe twin-twin transfusion syndrome. Am J Obstet Gynecol. 188, 2003, 876-80.
PubMed
256) 千葉敏雄ほか. 一絨毛膜性双胎と胎児外科治療 (4). 産科と婦人科. 72, 2004, 84-92.
 
257) Rodeck, C. et al. Thermocoagulation for the early treatment of pregnancy with an acardiac twin. N Engl J Med. 339, 1998, 1293-5.
PubMed
258) Tsao, K. et al. Selective reduction of acardiac twin by radiofrequency ablation. Am J Obstet Gynecol. 187, 2002, 635-40.
PubMed
259) Herberg, U. et al. Long term cardiac follow up of severe twin to twin transfusion syndrome after intrauterine laser coagulation. Heart. 92, 2006, 95-100.
PubMed
260) Guilherme, R. et al. Very early twin-to-twin transfusion syndrome and discordant activation of the renin-angiotensin system. Placenta. 30, 2009, 731-4.
PubMed
261) Fisk, NM. et al. The basic and clinical science of twin-twin transfusion syndrome. Placenta. 30, 2009, 379-90.
PubMed
262) Galea, P. et al. The placenta contributes to activation of the renin angiotensin system in twin-twin transfusion syndrome. Placenta. 29, 2008, 734-42.
PubMed
263) Halvorsen, CP. et al. Childhood cardiac function after twinto-twin transfusion syndrome : a 10-year follow up. Acta Paediatr. 98, 2009, 1468-74.
 
264) Bassil Eter, R. et al. Pulmonary diffuse arterial calcifications : a very rare complication in the recipient of a twin-to-twin transfusion syndrome. Cardiol Young. 19, 2009, 1-3.
 
265) Morine, M. et al. Vascular endothelial growth factor in monochorionic twins with twin-twin transfusion syndrome. J Endocrinol Invest. 31, 2008, 966-70.
PubMed
266) Habli, M. et al. Twin-to-twin transfusion syndrome : a comprehensive update. Clin Perinatol. 36, 2009, 391-416.
PubMed
267) Stirnemann, JJ. et al. Evaluation of the CHOP cardiovascular score as a prognostic predictor of outcome in twin-twin transfusion syndrome after laser coagulation of placental vessels in a prospective cohort. Ultrasound Obstet Gynecol. 36, 2010, 52-7.
 
268) Wagner, MM. et al. Short- and long-term outcome in stage 1 twin-to-twin transfusion syndrome treated with laser surgery compared with conservative management. Am J Obstet Gynecol. 201, 2009, 286.
 
269) Stamilio, DM. et al. Twin-twin transfusion syndrome : an ethics-based and evidence-based argument for clinical research. Am J Obstet Gynecol. 203, 2010, 3-16. 2010 Feb 18. [Epub ahead of print].
 
270) Bebbington, MW. et al. Outcomes in a cohort of patients with Stage I twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol. 36, 2010, 48-51.
 
271) Molina, S. et al. Management of Stage I twin-to-twin transfusion syndrome : an international survey. Ultrasound Obstet Gynecol. 36, 2010, 42-7.
 
272) Matias, A. et al. Screening for twin-twin transfusion syndrome at 11-14 weeks of pregnancy : the key role of ductus venosus blood flow assessment. Ultrasound Obstet Gynecol. 35, 2010, 142-8.
PubMed
273) Fichera, A. et al. Twin-to-twin transfusion syndrome presenting at early stages : is there still a possible role for amnioreduction? Prenat Diagn. 30, 2010, 144-8.
 
274) Stirnemann, JJ. et al. Profiling fetal cardiac function in twintwin transfusion syndrome. Ultrasound Obstet Gynecol. 35, 2010, 19-27.
 
275) Linskens, IH. et al. Discordance in nuchal translucency measurements in monochorionic diamniotic twins as predictor of twin-to-twin transfusion syndrome. Twin Res Hum Genet. 12, 2009, 605-10.
PubMed
276) Van Mieghem, T. et al. Amniotic fluid markers of fetal cardiac dysfunction in twin-to-twin transfusion syndrome. Am J Obstet Gynecol. 202, 2010, 48.
PubMed
277) Fox, CE. et al. Maternal serum markers of placental damage in uncomplicated dichorionic and monochorionic pregnancies in comparison with monochorionic pregnancies complicated by severe twin-to-twin transfusion syndrome and the response to fetoscopic laser ablation. Eur J Obstet Gynecol Reprod Biol. 144, 2009, 124-9.
PubMed
278) Rossi, AC., D'Addario, V. The efficacy of Quintero staging system to assess severity of twin-twin transfusion syndrome treated with laser therapy : a systematic review with metaanalysis. Am J Perinatol. 26, 2009, 537-44.
PubMed
279) Kontopoulos, EV., Quintero, RA. Assessment of the peak systolic velocity of the middle cerebral artery in twin-twin transfusion syndrome. Part I : preoperative assessment. Am J Obstet Gynecol. 200, 2009, 61.
 
280) Russell, Z. et al. What is the definition of pulsatile umbilical venous flow in twin-twin transfusion syndrome? Am J Obstet Gynecol. 199, 2008, 634.
 
281) Shah, AD. et al. Initial fetal cardiovascular profile score predicts recipient twin outcome in twin-twin transfusion syndrome. J Am Soc Echocardiogr. 21, 2008, 1105-8.
PubMed
282) Michelfelder, E. et al. Early manifestations and spectrum of recipient twin cardiomyopathy in twin-twin transfusion syndrome : relation to Quintero stage. Ultrasound Obstet Gynecol. 30, 2007, 965-71.
PubMed
283) Habli, M. et al. The outcome of twin-twin transfusion syndrome complicated with placental insufficiency. Am J Obstet Gynecol. 199, 2008, 424.
 
284) Senat, MV. et al. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. New Engl J M. 351, 2004, 136-44.
 
285) Meriki, N. et al. Immediate outcome of twin-twin transfusion syndrome following selective laser photocoagulation of communicating vessels at the NSW Fetal Therapy Centre. Aust N Z J Obstet Gynaecol. 50, 2010, 112-9.
PubMed
286) Curran, S. et al. Reflectance spectrometry for real-time hemoglobin determination of placental vessels during endoscopic laser surgery for twin-to-twin transfusion syndrome. J Pediatr Surg. 45, 2010, 59-64.
PubMed
287) Quintero, RA. et al. Trocar-assisted selective laser photocoagulation of communicating vessels : a technique for the laser treatment of patients with twin-twin transfusion syndrome with inaccessible anterior placentas. J Matern Fetal Neonatal Med. 23, 2010, 330-4.
PubMed
288) Assaf, SA. et al. Fetal heart rate changes associated with sequential selective laser surgery for twin-twin transfusion syndrome. J Perinatol. 30, 2010, 188-91.
PubMed
289) Nakata, M. et al. Modified sequential laser photocoagulation of placental communicating vessels for twin-twin transfusion syndrome to prevent fetal demise of the donor twin. J Obstet Gynaecol Res. 35, 2009, 640-7.
 
290) Luks, FI. et al. The pediatric surgeons' contribution to in utero treatment of twin-to-twin transfusion syndrome. Ann Surg. 250, 2009, 456-62.
PubMed
291) Lenclen, R. et al. Neurodevelopmental outcome at 2 years in children born preterm treated by amnioreduction or fetoscopic laser surgery for twin-to-twin transfusion syndrome : comparison with dichorionic twins. Am J Obstet Gynecol. 201, 2009, e1-5.
PubMed
292) Cincotta, RB. et al. Selective fetoscopic laser ablation in 100 consecutive pregnancies with severe twin-twin transfusion syndrome. Aust N Z J Obstet Gynaecol. 49, 2009, 22-7.
PubMed
293) Rossi, AC. D'Addario V. Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome : a metaanalysis and review of literature. Am J Obstet Gynecol. 198, 2008, 147-52.
PubMed
294) Huber, A. et al. Stage-related outcome in twin-twin transfusion syndrome treated by fetoscopic laser coagulation. Obstet Gynecol. 108, 2006, 333-7.
PubMed
295) Tan, TY., Sepulveda, W. Acardiac twin : a systematic review of minimally invasive treatment modalities. Ultrasound Obstet Gynecol. 22, 2003, 409-19.
PubMed
296) Lopriore, E. et al. Risk factors for neurodevelopment impairment in twin-twin transfusion syndrome treated with fetoscopic laser surgery. Obstet Gynecol. 113, 2009, 361-6.
PubMed
297) Gray, PH. et al. Cardiac outcomes of hydrops as a result of twin-twin transfusion syndrome treated with laser surgery. J Paediatr Child Health. 45, 2009, 45-52.
PubMed
298) Lopriore, E. et al. Long-term neurodevelopmental outcome in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery. Am J Obstet Gynecol. 196, 2007, 231.
 
299) Chmait, RH. et al. Residual vascular communications in twintwin transfusion syndrome treated with sequential laser surgery : Frequency and clinical implications. Placenta. 2010 May 5. [Epub ahead of print].
 
300) Lopriore, E. et al. Residual anastomoses after fetoscopic laser surgery in twin-to-twin transfusion syndrome : frequency, associated risks and outcome. Placenta. 28, 2007, 204-8.
PubMed
301) Slaghekke, F. et al. Twin Anemia-Polycythemia Sequence : Diagnostic Criteria, Classification, Perinatal Management and Outcome. Fetal Diagn Ther. 27. 2010. 181-90.
PubMed
302) Slaghekke, F. et al. Fetoscopic laser coagulation of the vascular equator for the treatment of twin-to-twin transfusion syndrome : the "Solomon Study" PROTOCOL- Version 1b. 2010.1-17
 
303) Obladen, M. Unequal but monozygous : a history of twin-twin transfusion syndrome. J Perinat Med. 38, 2010, 121-8.
PubMed
304) Quintero, R. et al. Twin-twin transfusion syndrome in a dichorionic-monozygotic twin pregnancy : The end of a paradigm? Fetal Pediatr Pathol. 29, 2010, 81-8.
 
305) van den Boom, J. et al. Twin-twin transfusion syndrome, coarctation of the aorta and hypoplastic aortic arch : a case series report. J Paediatr Child Health. 46, 2010, 76-9.
PubMed
306) De Paepe, ME. et al. Placental markers of twin-to-twin transfusion syndrome in diamniotic-monochorionic twins : A morphometric analysis of deep artery-to-vein anastomoses. Placenta. 31, 2010, 269-76.
PubMed
307) Tsukimori, K. et al. Ischemic ileal perforation in the donor of monochorionic twins complicated by twin-twin transfusion syndrome. Fetal Diagn Ther. 26, 2009, 173-6.
PubMed
308) Bebbington, M. Twin-to-twin transfusion syndrome : current understanding of pathophysiology, in-utero therapy and impact for future development. Semin Fetal Neonatal Med. 15, 2010, 15-20.
PubMed
309) Fichera, A. et al. Severe brain damage from twin-twin transfusion syndrome treated with serial amnioreductions after 26 weeks : a case to reconsider the gestational age limits of laser therapy. Fetal Diagn Ther. 25, 2009, 203-5.
 
310) Benirschke, K. The monozygotic twinning process, the twintwin transfusion syndrome and acardiac twins. Placenta. 30, 2009, 923-8.
PubMed
311) Nikkels, PG. et al. Pathology of twin placentas with special attention to monochorionic twin placentas. J Clin Pathol. 61, 2008, 1247-53.
PubMed
312) Lewi, L. et al. The outcome of twin reversed arterial perfusion sequence diagnosed in the first trimester. Am J Obstet Gynecol. 2010 Jun 2. [Epub ahead of print].
 
313) He, ZM. et al. Fetal reduction by bipolar cord coagulation in managing complicated monochorionic multiple pregnancies : preliminary experience in China. Chin Med J (Engl). 123, 2010, 549-54.
PubMed
314) 千葉敏雄ほか. 胎児心臓外科. 産科と婦人科. 71, 2004, 781-7.
Medical*Online
315) Parry, AJ., Hanley, FL. Prospects for fetal cardiac surgery. Fetal cardiology. Yagel, S. et al. eds. London, Saunders, 2003, 485-95.
 
316) Reich, O. et al. Long term results of percutaneous balloon valvoplasty of congenital aortic stenosis : independent predictors of outcome. Heart. 90, 2004, 70-6.
PubMed
317) Marshall, AU. et al. Result of in-utero atrial septoplasty in fetuses with hypoplastic left heart syndrome. Pranat Diag. 28, 2008, 1023-8.
 
318) Selamet Tierney, ES. et al. Changes in left heart hemodynamics after technically successful in-utero aortic valvoplasty. Ultrasound Obstet Gynecol. 30, 2007, 715-20.
 
319) Pavlovic, M. et al. Controversies of fetal cardiac intervention. Early Hum Dev. 84, 2008, 149-53.
PubMed
320) McElhinney, DB. et al. Current status of fetal cardiac intervention. Circulation. 121, 2010, 1256-63.
PubMed
321) Viesca, R., Huhta, JC. Update in fetal cardiac intervention. Curr Treat Options Cardiovasc Med. 8, 2006, 379-86.
PubMed
322) Gutgesell, HP. et al. Management of hypoplastic left heart syndrome in the 1990s. Am J Cardiol. 89, 2002, 842-6.
PubMed
323) Hoffman, GM. et al. Venous saturation and the anaerobic threshold in neonates after the Norwood procedure for hypoplastic left heart syndrome. Ann Thorac Surg. 70, 2000, 1515-21.
PubMed
324) 佐野俊二. "左心低形成症候群の手術成績". Annual Review循環器2003. 杉下靖郎ほか編. 東京, 中外医学社, 2003, 231-7.
 
325) Allan, LD. et al. Outcome after prenatal diagnosis of the hypoplastic left heart syndrome. Heart. 7, 1998, 371-4.
 
326) Kohl, T. et al. World experience of percutaneous ultrasoundguided balloon valvuloplasty in human fetuses with severe aortic valve obstruction. Am J Cardiol. 85, 2000, 1230-3.
PubMed
327) Hutha, J. et al. Advances in fetal cardiac intervention. Curr Opin Pediatr. 16, 2004, 487-93.
 
328) Tworetzky, W., Marshall, AC. Fetal interventions for cardiac defects. Pediatr Clin North Am. 51, 2004, 1503-13.
PubMed
329) Tulzer, G. et al. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet. 360, 2002, 1567-8.
 
330) Arzt, W. et al. Invasive intrauterine treatment of pulmonary atresia/intact ventricular septum with heart failure. Ultrasound Obstet Gynecol. 21, 2003, 186-8.
PubMed
331) Tworetzky, W. et al. Balloon dilation of severe aortic stenosis in the fetus : potential for prevention of hypoplastic left heart syndrome : candidate selection, technique, and results of successful intervention. Circulation. 110, 2004, 2125-31.
PubMed
332) Chervenak, FA., McCullough, LB. "Ethical considerations". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 19-25.
 
333) Edwards, DM. et al. Parenting stress and psychosocial health in mothers with twin-twin transfusion syndrome managed with laser surgery : a preliminary study. Twin Res Hum Genet. 10, 2007, 416-21.
PubMed
334) Skupski, D. et al. An ethically justified decision-making pathway for the management of pregnancies complicated by twin-to-twin transfusion syndrome. Fetal Diagn Ther. 22, 2007, 339-42.
PubMed
335) Goldsmith, MF. 2020 Vision : NIH heads forsee the future. JAMA. 282, 1999, 2287-91.
 
336) Bholat, OS., Krummel, TM. "Advanced technologies for future fetal treatment : surgical robotics". The Unborn Patient. 3rd ed. Harrison, MR. et al. eds. Philadelphia, Saunders, 2001, 681-92.
 
337) Aaronson, OS. et al. Robot-assisted endoscopic intrauterine myelomeningocele repair : a feasibility study. Pediatr Neurosurg. 36, 2002, 85-9.
PubMed
338) Knight, CG. et al. Robot-enhanced fetoscopic surgery. J Pediatr Surg. 39, 2004, 1463-5.
PubMed

第26章 感染症

P.636 掲載の参考文献
1) Wang, W., Dow, KE., Flavin, MP. Hyperthermia amplifies brain cytokine and reactive oxygen species response in a model of perinatal inflammation. Neurosci Lett. 445(3), 2008, 233-5.
 
2) Yoon, BH. et al. Interleukin-6 concentrations in mubilical and plasma are elevated in neonates with shite matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 174, 1996, 1433-40.
 
3) Yamashita, Y., Fujimoto, C., Nakajima, E. et al. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord. 33(4), 455-9, 2003.
PubMed
4) Brown, AS. Perinatal infection as a risk factor for schizophrenia. Schizophr Bull. 32,2006, 200-2.
 
5) 小島俊行, 野田俊一, 佐藤俊則ほか. トキソプラズマの母子感染の診断・予防に関する研究. 周産期シンポジウム. 18, 1999, 9-19.
 
6) Daffos, F., Capella-Pavlovsky, M., Forestier, F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound : Report of 66 cases. Prenat Diagn. 3, 1983, 271.
 
7) Enders, M., Weidner, A., Zoellner, I. et al. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy : prospective evaluation of 1018 cases. Prenat Diagn. 24, 2004, 513-8.
PubMed
8) Matsuda, H., Sakaguchi, K., Shibasaki, T. et al. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer bammaglobulin. J Perinat Med. 33, 2005, 561-3.
PubMed
9) 北中孝司, 竹林忠洋, 中村哲生ほか. サイトメガロウイルス (CMV) 胎内感染症 発症の予知と予防. 周産期学シンポジウム. No.18. 胎児・新生児の予後に影響を及ぼすウイルス感染. 2000, 39-43.
 
10) 日本産科婦人科学会・日本産婦人科医会 編集・監修. 産婦人科診療ガイドライン : 産科編2011. 2011, 41-3.
 
11) Zaman, K., Roy, E., Arifeen, SE. et al. Effectiveness of Maternal Influenza Immunization in Mothers and Infants. N Eng J Med. 359, 2008, 1555-64.
 
12) Nicolle, LE. et al. Infectious Diseases Society of America ; American Society of Nephrology ; American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 40(5), 2005. 643-54. Epub 2005 Feb 4. Erratum in : Clin Infect Dis. 40(10), 2005, 1556.
 
13) Duff, A., Sweet, RL., Edwards, RK. "Maternal and Fetal Infections". Maternal-Fetal Medicine. 6th ed. Cresy, RK., Resnick, R. eds. Philadelphia, Saunders Elsevier, 2009, 750-6.
 
14) Romero, R., Oyarzun, E., Mazor, M. et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol. 73, 1989, 576-82.
PubMed
15) Meis, PJ. et al. Factors associated with preterm birth in Cardiff, Wales. II. Indicated and spontaneous preterm birth. Am J Obstet Gynecol. 173, 1995, 597.
PubMed
16) Smaill, F., Vazquez, JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 18(2), 2007, CD000490.
 
17) Rouse, DJ., Andrews, WW., Goldenberg, RL., Owen, J. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis : a cost-effectiveness and cost-benefit analysis. Obstet Gynecol. 86(1), 1995, 119-23.
PubMed
18) Sheffield, JS., Cunningham, FG. Urinary tract infection in women. Obstet Gynecol. 106(5 Pt 1), 2005, 1085-92.
 
19) Hill, JB., Sheffield, JS., McIntire, DD., Wendel, GD Jr. Acute pyelonephritis in pregnancy. Obstet Gynecol. 105(1), 2005, 18.
PubMed
20) Towers, CV., Kaminskas, CM., Garite, TJ. et al. Pulmonary injury associated with antepartum pyelonephritis : can patients at risk be identified? Am J Obstet Gynecol. 164, 1991, 974-8.
PubMed
21) Sandberg, T., Brorson, JE. Efficacy of long-term antimicrobial prophylaxis after acute pyelonephritis in pregnancy. Scand J Infect Dis. 23(2), 1991, 221.
PubMed
22) Dammann, O., Leviton, A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 42, 1997, 1.
PubMed
23) Yoon, BH., Romero, R., Yang, SH., Jun, JK., Kim, IO., Choi, JH., Syn, HC. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 174(5), 1996, 1433-40.
PubMed
24) Wu, YW., Escobar, GJ., Grether, JK., Croen, LA., Greene, JD., Newman, TB. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 290(20), 2003, 2677.
PubMed
25) Gomez, R. et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 179, 1998, 194-202.
PubMed
26) Yoon, BH., Romero, R., Kim, KS., Park, JS., Ki, SH., Kim, BI., Jun, JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 181(4), 1999, 773-9.
PubMed
27) Choi, CW., Kim, BI., Park, JD., Koh, YY., Choi, JH., Choi, JY. Risk factors for the different types of chronic lung diseases of prematurity according to the preceding respiratory distress syndrome. Pediatr Int. 47(4), 2005, 417-23.
 
28) Romero, R., Espinoza, J., Goncalves, LF. et al. Fetal cardiac dysfunction in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 16, 2004, 146.
PubMed
29) Di Naro, E., Cromi, A., Ghezzi, F., Giocolano, A., Caringella, A., Loverro, G. Myocardial dysfunction in fetuses exposed to intraamniotic infection : new insights from tissue Doppler and strain imaging. Am J Obstet Gynecol. 203(5), 2010, 459. e1.
 
30) Gotsch, F., Romero, R., Kusanovic, JP., Mazaki-Tovi, S., Pineles, BL., Erez, O., Espinoza, J., Hassan, SS. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 50(3), 2007, 652-83.
PubMed
31) Lencki, SG., Maciulla, MB., Eglinton, GS. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. Am J Obstet Gynecol. 170(5 Pt 1), 1994, 1345-51.
 
32) Romero, R., Yoon, BH., Mazor, M. et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 169(4), 1993, 839-51.
PubMed
33) 中山雅弘. 目で見る胎盤病理. 東京, 医学書院, 2002, 19-25.
 
34) Gibbs, RS., Dinsmoor, MJ., Newton, ER., Ramamurthy, RS. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol. 72, 1988, 823.
PubMed
35) Grether, JK., Nelson, KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA. 278(3), 1997, 207-11.
PubMed
36) Usui, R., Ohkuchi, A., Matsubara, S. et al.Vaginal lactobacilli and preterm birth. J Perinat Med. 30, 2002, 458-66.
PubMed
37) Yamada, H., Cho, K., Yamada, T. et al. Early onset group B streptococcal neonatal infection in the Hokkaido University Hospital during the era of intrapartum antibiotic prophylaxis. 北海道産科婦人科学会誌. 48, 2005, 20-2.
 
38) ACOG Committee Opinion (No.279). Prevention of earlyonset group B Streptococcal disease in newborns. Obstet Gynecol. 100, 2002, 1405-12.
 
39) Alvarez, JR., Williams, SF., Ganesh, VL. et al. Duration of antimicrobial prophylaxis for group B streptococcus in patients with preterm premature rupture of membranes who are not in labor. Am J Obstet Gynecol. 197, 2007, 390. e1-4.
 
40) 保科清, 鈴木葉子, 仁志田博司ほか. 最近6年間のB群レンサ球菌についてのアンケート調査結果. 日本周産期・新生児医学会雑誌. 42, 2006, 7-11.
 
41) Rocout, F. et al. Quantitative risk assessment of Listeria monocytogenes in ready-to eat foods : the FAO/WHO approach. FEMS Immunol Med Microbiol. 35(3), 2003, 263-7.
 
42) Cherubin, CE. et al. Epidemiologic sectrum and current treatment of listeriosis. Rev Infect Dis. 13, 1991, 1180.
 
43) MacDonald, PDM. et al. Outbreak of listeriosis among Mexican immigrants as a result of consumption of illicitly produced Mexican-style cheese. Clin Infect Dis. 40, 2005, 677.
PubMed
44) Southwick, FS. et al. Intracellular pathogenesis of listeriosis. N Eng J Med. 334(12), 1996, 770-6.
 
45) Kalstone, C. Successful antepartum treatment of listeriosis. Am J Ob Gyn. 164, 1991, 571.
 
46) Rouse, D. et al. "Puerperal Infection". Williams Obstetrics. 22nd ed. Cunningham, FG. et al. eds. New York, McGraw-Hill, 2005, 711-24.
 
47) DiZerega, G. et al. A comparison of clindamycin/gentamicin and penicillin/gentamicin in the treatment of post-cesarean section endomyometritis. Am J Obstet Gynecol. 134, 1979, 238.
PubMed
48) Cotch, MF. et al. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy : Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 178, 1998, 374-80.
 
49) Caramalac, DA., da Silva Ruiz, L., de Batista, GC., Birman, EG., Duarte, M., Hahn, R., Paula, CR. Candida isolated from vaginal mucosa of mothers and oral mucosa of neonates : occurrence and biotypes concordance. Pediatr Infect Dis J. 26(7), 2007, 553-7.
PubMed
50) Cotch, MF., Pastorek, JG 2nd., Nugent, RP., Hillier, SL., Gibbs, RS., Martin, DH., Eschenbach, DA., Edelman, R., Carey, JC., Regan, JA., Krohn, MA., Klebanoff, MA., Rao, AV., Rhoads, GG. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 24(6), 1997, 353.
 
51) Klebanoff, MA., Carey, JC., Hauth, JC., Hillier, SL., Nugent, RP., Thom, EA., Ernest, JM., Heine, RP., Wapner, RJ., Trout, W., Moawad, A., Leveno, KJ., Miodovnik, M., Sibai, BM., Van Dorsten, JP., Dombrowski, MP., O'Sullivan, MJ., Varner, M., Langer, O., McNellis, D., Roberts, JM. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med. 345(7), 2001, 487.
PubMed
52) Carter, JE., Whithaus, KC. Neonatal respiratory tract involvement by Trichomonas vaginalis : a case report and review of the literature. Am J Trop Med Hyg. 78(1), 2008, 17.
PubMed
53) Caro-Paton, T. et al. Is metronidazole teratogenic? : A metaanalysis. Br J Clin Pharmacol. 44, 1997, 179-82.
PubMed
54) Burtin, P. et al. Safety of metronidazole in pregnancy : A meta-analysis. Am J Obstet Gynecol. 172, 1995, 525-9.
PubMed
55) Amsel, R. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 74, 1983, 14-22.
PubMed
56) Nugent, RP. et al. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 29, 1991, 297-301.
PubMed
57) Klebanoff, MA., Schwebke, JR., Zhang, J., Nansel, TR., Yu, KF., Andrews, WW. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol. 104(2), 2004, 267-72.
PubMed
58) Leitich, H., Bodner-Adler, B., Brunbauer, M., Kaider, A., Egarter, C., Husslein, P. Bacterial vaginosis as a risk factor for preterm delivery : a meta-analysis. Am J Obstet Gynecol. 189(1), 2003, 139-47.
PubMed
59) McDonald, HM., Brocklehurst, P., Gordon, A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 24(1), 2007, CD000262.
 
60) Nygren, P. et al. U. S. Preventive Services Task Force. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis : an update review for the U.S. Preventive Services Task Force. Ann Intern Med. 148(3), 2008, 220-33. Review.
 
61) 厚生労働省/国立感染症研究所. 感染症発生動向調査. 感染症週報 (IDWR). 10(12), 2008, 32.
 
62) Mascola, L. Inadequate treatment of syphilis in pregnancy. AJOG. 150, 1984, 945-7.
 
63) Alexander, JM., Sheffield, JS. et al. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol. 93, 1999, 5-8.
PubMed
64) Centers for Diseases Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep. 51(RR-6), 2002.
 
65) Burkman, RT. Tonascia, JA., Atienza, MF. et al. Untreated endocervical gonorrhea and endometritis following elective abortion. AJOG. 126, 1976, 648.
 
66) Alger, LS., Lovchik, JC., Hebel, JR. et al. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. AJOG. 159, 1988, 397.
 
67) 大石正夫. 妊娠中の感染症の取り扱い : 淋菌感染症. 産婦人科の実際. 50 (9), 2001, 1155-8.
 
68) Blas, MM., Canchihuaman, FA., Alva, IE., Hawes, SE. Pregnancy outcomes in women infected with Chlamydia trachomatis : a population-based cohort study in Washington State. Sex Transm Infect. 83(4), 2007, 314-8. Epub 2007 Mar 7.
 
69) Alary, M., Joly, JR., Moutquin, JM. et al. Randmised comparison of amoxycillin and erythromycin in treatment of genital chlamydial infection in pregnancy. Lancet. 344, 1994, 1461.
PubMed
70) Hammerschlag, MR., Cummings, C., Roblin, PM., Williams, TH., Delke, I. Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. N Engl J Med. 320(12), 1989, 769-72.
PubMed
71) CDC. Sexually transmitted diseases treatment guidelines, 2006. MMWR. 55, 2006, RR-11.
 
72) CDC. Contraceptive practices before and after an intervention promoting condom use to prevent HIV infection and other sexually transmitted diseases among woman : selected. U. S. Sites, 1993-1995. MMWR. 46, 1997, 373.
PubMed
73) Rando, RF., Lindheim, S., Hasty, L. et al. Increased frequency of detection of human papilloma virus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol. 161, 1989, 50.
PubMed
74) Shah, K., Kashima, H., Polk, BF. et al. Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol. 68, 1986, 795.
PubMed
75) エイズ動向委員会. 平成23年エイズ発生動向年報. http://api-net.jfap.or.jp/status/2012/12nenpo/
 
76) Dictor, M. et al. HIV-1 : the role of HIV-1-infected women in relation to viral transmission, infectious HIV-1 and RNA load in plasma. Scand J Infect Dis. 33, 2001 , 27-32.
 
77) The European Collaborative Study. Vertical transmission of HIV-1. Maternal immune status and obstetric factors. AIDS. 10, 1996. 1975-81.
 
78) Warszawski, J. et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 22(2), 2008, 289-99.
PubMed
79) Shah, I. Is elective caesarian section really essential for prevention of mother to child transmission of HIV in the era of antiretroviral therapy and abstinence of breast feeding? J Trop Pediatr. 52(3), 2006, 163-5.
PubMed
80) 厚生労働科学特別研究事業「HTLV-1の母子感染予防に関する研究班」平成21年度総括・分担研究報告書. 2010.
 
81) Ando, Y. et al. Long-term serological outcome of infants wo received frozen-thawed milk from human T-lymphotropic virus type-1 positive mothers. J Obstet Gynecol Res. 30, 2004, 436-8.
 
82) Takezaki, T. et al. Short-term breast feading may reduce the risk of vertical transmission of HTLV-1. The Tsushima ATL Study Group. Leukemia. 11, 1997, 60-2.
 
83) 野田俊一, 野田 彬, 柚木康彰ほか. 南九州における妊婦のトキソプラズマスクリーニング. 感染症学雑誌. 74, 2000, 192-3.
 
84) Villena, I., Ancelle, T., Delmas, C. et al., Toxosurv network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007 : first results from a national surveillance system. Euro Surveill. 15(25), 2010, pii : 19600.
 
85) 小島俊行, 安田孝, 中田真木ほか. トキソプラズマ. 産婦の実際. 55, 2006, 519-30.
 
86) Hohlfeld, P., Daffos, F., Costa, JM. et al. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 331(11), 1994, 695-9.
PubMed
87) Remington, JS., McLeod, R., Thulliez, P. et al. "Toxoplasmosis". Infectious Diseases of the Fetus and Newborn Infant, 6th ed. Remington, JS., Klein, JO. ed. Philadelphia, Elsevier Sounders, 2006, 947-1092.
 
88) Wallon, M., Franck, J., Thulliez, P. et al. Accuracy of realtime polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet Gynecol. 115(4), 2010, 727-33.
PubMed
89) Foulon, W., Villena, I., Stray-Pedersen, B. et al. Treatment of toxoplasmosis during pregnancy : A multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol. 180, 1999, 410-5.
 
90) 矢野明彦. 先天性トキソプラズマ症. 小児科診療. 67(3), 2004, 461-8.
Medical*Online
91) Miller, E., Cradock-Watson, JE., Pollock, TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 2(8302), 1982, 781-4.
PubMed
92) Bullens, D., Smets, K., Vanhaesebrouck, P. Congenital rubella syndrome after maternal reinfection. Clin Pediatr (Phila). 39(2), 2000, 113-6.
PubMed
93) Shaver, KA., Boughman, JA., Nance, WE. Congenital rubella syndrome and diabetes: a review of epidemiologic, genetic, and immunologic factors. Am Ann Deaf. 130(6), 1985, 526-32.
PubMed
94) 干場勉. 風疹. 産科と婦人科. 67, 2000, 1578-83.
Medical*Online
95) Okuda, M., Yamanaka, M., Takahashi, T. et al. Positive rates for rubella antibody in pregnant women and benefit of postpartum vaccination in a Japanese perinatal center. J Obstet Gynaecol Res. 34(2), 2008, 168-73.
 
96) Hedman, K., Seppala, I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol. 8(3), 1988, 214-21.
PubMed
97) 風疹流行および先天性風疹症候群の発生抑制に関する緊急提言. 厚生労働省ホームページ. http://www.mhlw.go.jp/topics/2004/04/dl/tp0428-1c.pdf
 
98) Tanemura, M., Suzumori, K., Yagami, Y., Katow, S. Diagnosis of fetal rubella infection with reverse transcription and nested polymerase chain reaction: a study of 34 cases diagnosed in fetuses. Am J Obstet Gynecol. 174(2), 1996, 578-82.
PubMed
99) http://www.cdc.gov/cmv/trends-stats.html
 
100) Cannon, MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol. 46 [Suppl 4], 2009, S6-10.
 
101) 東寛, 高梨美乃子, 神前昌敏ほか. 1996年から2009年の間における妊婦のサイトメガロウイルス抗体保有率の推移について. 日本周産期新生児医学会雑誌. 46(4), 2010, 1273-9.
 
102) Hamprecht, K., Maschmann, J., Jahn, G. et al. Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol. 41(3), 2008, 198-205.
PubMed
103) Koyano, S., Inoue, N., Oka, A. et al. Japanese Congenital Cytomegalovirus Study Group. Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper : feasibility and outcomes from a multicentre study. BMJ Open. 1(1), 2011, e000118. doi : 10.1136/bmjopen-2011-000118.
 
104) Ross, SA., Fowler, KB., Ashrith, G. et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr. 148(3), 2006, 332-6.
PubMed
105) Ahlfors, K., Ivarsson, SA., Harris, S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis. 31(5), 1999, 443-57. Review.
PubMed
106) 森田 誠, 森島恒雄, 山崎俊夫ほか. サイトメガロウイルス母子感染全国調査. 日本小児科学会雑誌. 101, 1997, 769-75.
 
107) Pass, RF., Fowler, KB., Boppana, S. Progress in cytomegalovirus research. Proceedings of the Third International Cytomegalovirus Workshop. Bologna, Italy, 1991. Landini, MP. ed. London, Excerpta Medica, 1991, 3-10.
 
108) Lazzarotto, T, Guerra, B., Lanari, M. et al. New advances in the diagnosis of congenital cytomegalovirus infection. Clin Virol. 41(3), 2008, 192-7.
PubMed
109) 井上直樹. サイトメガロウイルスの新生児マススクリーニング・レトロスペイティブ診断・遺伝子型解析. 日本周産期新生児医学会雑誌. 44(4), 2008, 898-901.
 
110) Koyano, S., Inoue, N., Nagamori, T. et al. Dried umbilical cords in the retrospective diagnosis of congenital cytomegalovirus infection as a cause of developmental delays. Clin Infect Dis. 48(10), 2009, e93-5.
PubMed
111) 丸山有子, 茨 聡, 栄鶴義人ほか. サイトメガロウイルス母子感染の実際から見た管理方法の実際. 産婦人科の実際. 50(9), 2001, 1207-15.
 
112) Nigro, G., Adler, SP., La Torre, R. et al. Passive Immunization during pregnancy for congenital cytomegalovirus Infection. N Engl J Med. 353, 2005, 1350-62.
PubMed
113) 山田秀人, 松田秀雄, 上塘正人, 丸山有子ほか. 免疫グロブリンを用いた先天性ウイルス感染症に対する胎児治療 : 多施設研究の提案. 産婦人科の実際. 55(2), 2006, 257-65.
 
114) Maruyama, Y., Sameshima, H., Kamitomo, M. et al. Fetal manifestations and poor outcomes of congenital cytomegalovirus infections : Possible candidates for intrauterine antiviral treatments. J Obstet Gynecol Res. 33(5), 2007, 619-23.
 
115) Guerra, B. et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol. 183, 200, 476-82.
 
116) Tanaka-Kitajima, N. et al. Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pedeatr Infect Dis J. 24, 2005, 782-5.
 
117) Kimberlin, DW., Acosta, EP., Sanchez, PJ. et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 197, 2008, 836-45.
PubMed
118) Kimberlin, DW., Lin, CY., Sanchez, PJ. et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Pediatr. 143(1), 2003, 16-25.
 
119) 丸山有子, 茨聡, 金子政時ほか. CMV胎内感染治療の展望 : 予後から見た今後の治療のありかた. 日本周産期新生児医学会雑誌. 45(1), 2009, 5-9.
 
120) Revello, MG.,Percivall, E., Baldanti, F. et al. Prenatal treatment of congenital human cytomegalovirus infection by intravasucular administration of ganciclovir. Clin Diag. 1, 1993, 61-7.
 
121) Japanese Congenital Cytomegalovirus Infection Immunoglobulin Fetal Therapy Study Group. A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection. J Reprod Immunol. 95(1-2), 2012, 73-9.
 
122) Coors, LE., Spencer, R. Delayed presentation of cytomegalovirus retinitis in an infant with severe congenital cytomegalovirus infection. Retina. 30(4 Suppl), 2010, S59-62.
 
123) Yamashita, Y., Fujimoto, C., Nakajima, E. et al. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord. 33(4), 2003, 455-9.
PubMed
124) Cahill, AG., Odibo, AO., Stamilio, DM. et al. Screening and treating for primary cytomegalovirus infection in pregnancy : where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol. 201(5), 2009, 466. e1-7.
 
125) Ogawa, H., Suzutani, T., Baba, Y., Koyano, S., Nozawa, N., Ishibashi, K., Fujieda, K., Inoue, N., Omori, K. Etiology of severe sensorineural hearing loss in children : independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis. 195(6), 2007, 782-8.
PubMed
126) Grosse, SD., Ross, DS., Dollard, SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss : a quantitative assessment. J Clin Virol. 41(2), 2008, 57-62.
PubMed
127) Fowler, KB., Dahle, AJ., Boppana, SB. et al. Newborn hearing screening : will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 135(1), 1999, 60-4.
PubMed
128) Lackner, A., Acham, A., Alborno, T., Moser, M., Engele, H., Raggam, RB., Halwachs-Baumann, G., Kapitan, M., Walch, C. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection : four to 10 year follow up. J Laryngol Otol. 123(4), 2009, 391-6.
PubMed
129) Arvin, AM. et al. Vaccine development to prevent cytomegalovirus disease : report from the National Vaccine Advisory Committee.Clin Infect Dis. 39, 2004, 233-9.
PubMed
130) 東出誠司, 保坂憲光, 太田嘉則ほか. 新しい核酸抽出法を用いたLAMP法による単純ヘルペスウイルスの検出. 日本性感染症学会誌. 21(1), 2010, 120-7.
 
131) Baldwin, S., Whitley, RJ. Intrauterine herpes simplex virus infection. Teratology. 39(1), 1989, 1-10.
PubMed
132) ACOG . Management of Herpes in pregnancy: ACOG Practice Bulletin, Clinical Management Guidolines for Obstetrician-Gynecologists. 82, 2007, 1489-98.
PubMed
133) Brown, ZA., Gardella, C., Wald, A., Morrow, RA., Corey, L. Genital herpes complicating pregnancy. Obstet Gynecol. 106(4), 2005, 845-56.
PubMed
134) 木村宏, 葛島清隆, 森島恒雄ほか. 新生児ヘルペス全身型に伴う肝機能異常の早期診断における重要性について. 日本小児科学会雑誌. 95(4), 1991, 955-9.
 
135) Kimberlin, DW., Lin, CY., Jacobs, RF. et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 108(2), 2001, 230-8.
 
136) Stone, KM., Reiff-Eldridge, R., White, AD. et al. Pregnancy outcomes following systemic prenatal acyclovir exposure : Conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol. 70(4), 2004, 201-7.
PubMed
137) Randolph, AG., Hartshorn, RM., Washington, AE. Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes : a cost-effectiveness analysis. Obstet Gynecol. 88(4 Pt 1), 1996, 603-10.
 
138) Haake, DA, Zakowski, PC., Haake ,DL., Bryson, YJ. Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults : retrospective controlled study and review. Rev Infect Dis. 12(5), 1990, 788-98.
PubMed
139) Harger, JH., Ernest, JM., Thurnau, GR.et al. National Institute of Child Health and Human Development, Network of Maternal-Fetal Medicine Units. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 185(4), 2002, 422-7.
PubMed
140) 中野貴司. 水痘の母子感染と対策. 女性診療のための感染症のすべて. 産婦人科治療 増刊. 90, 2005, 600-4.
 
141) Higa, K., Dan, K., Manabe, H. Varicella-zoster virus infections during pregnancy : hypothesis concerning the mechanisms of congenital malformations. Obstet Gynecol. 69(2), 1987, 214-22.
PubMed
142) Schulze, A., Dietzsch, HJ. The natural history of varicella embryopathy : a 25-year follow-up. J Pediatr. 137(6), 2000, 871-4.
PubMed
143) Mouly, F., Mirlesse, V., Meritet, JF., Rozenberg, F., Poissonier, MH., Lebon, P., Daffos, F. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol. 177(4), 1997, 894-8.
PubMed
144) Pretorius, DH., Hayward, I., Jones, KL., Stamm, E. Sonographic evaluation of pregnancies with maternal varicella infection. J Ultrasound Med. 11(9), 1992, 459-63.
PubMed
145) Gershon, AA. Chickenpox, measles, and mumps. Infectious Diseases of the Fetus and Newborn infant. 7th ed. Jack, S. et al eds. Elsevier Saunders, 2011, 661-705.
 
146) Tan, MP., Koren, G. Chickenpox in pregnancy : revisited. Reprod Toxicol. 21(4), 2006, 410-20. Epub 2005 Jun 23.
 
147) Huang, YC., Lin, TY., Lin, YJ., Lien, RI., Chou, YH. Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. Eur J Pediatr. 160(2), 2001, 91-4.
PubMed
148) Eberhart-Phillips, JE., Frederick, PD., Baron, RC., Mascola, L. Measles in pregnancy : a descriptive study of 58 cases. Obstet Gynecol. 82(5), 1993, 797-801.
PubMed
149) 笠井正志ほか. 麻疹 : 妊娠中の麻疹罹患への対応と新生児期の麻疹感染. 周産期医学. 32, 2002, 853-6.
 
150) Ohyama, M., Fukui, T., Tanaka, Y., Kato, K., Hoshino, R., Sugawara, T., Yamanaka, M., Ijiri, R., Sata, T., Itani, Y. Measles virus infection in the placenta of monozygotic twins. Mod Pathol. 14(12), 2001, 1300-3.
PubMed
151) 八重樫伸生. パルボウイルスB19の母子感染 : 胎児水腫の発生機転を中心に. 日本産科婦人科学会雑誌. 50, 1998, 569-80.
 
152) Yaegashi, N., Okamura, K., Yajima, A., Murai, C., Sugamura, K. The frequency of humanparvovirus B19 infection in nonimmune hydrops fetalis. J Perinat. 22(2), 1994, 159-63.
PubMed
153) Enders, M., Weidner, A., Zoellner, I., Searle, K., Enders, G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy : prospective evaluation of 1018 cases. Prenat Diagn. 24(7), 2004, 513-8.
PubMed
154) Morey, AL., Keeling, JW., Porter, HJ., Fleming, KA. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol. 99(7), 1992, 566-74.
PubMed
155) Nagel, HT., de Haan, TR., Vandenbussche, FP., Oepkes, D., Walther, FJ. Long-termoutcome after fetal transfusion for hydrops associated with parvovirus B19infection. Obstet Gynecol. 109(1), 2007, 42-7.
 
156) Cosmi, E., Mari, G., Delle Chiaie, L. et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol. 187(5), 2002, 1290-3.
PubMed
157) Rodis, JF., Borgida, AF., Wilson, M. et al. Management of parvovirus infection in pregnancy and outcomes of hydrops : a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol. 179(4), 1998, 985-8.
 
158) Matsuda, H., Sakaguchi, K., Shibasaki, T., Takahashi, H., Kawakami, Y., Furuya, K. Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin. J Perinat Med. 33(6), 2005, 561-3.
PubMed
159) Neuzil, KM., Reed, GW., Mitchel, EF., Simonsen, L., Griffin, MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 148(11), 1998, 1094-102.
PubMed
160) ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women : population based cohort study. BMJ. 18, 2010, 340, c1279.
PubMed
161) Lapinsky, SE. Critical illness as a result of influenza A/H1N1 infection in pregnancy. BMJ. 340, 2010, 721-2.
 
162) Yamada, T., Yamada, T., Morikawa, M., Cho, K., Endo, T., Sato, SS., Saito, T., Sengoku, K.,Minakami, H. Pandemic (H1N1) 2009 in pregnant Japanese women in Hokkaido. J Obstet Gynaecol Res. 38(1), 2012, 130-6.
PubMed
163) Englund, JA. Maternal immunization with inactivated influenza vaccine : rationale and experience. Vaccine. 21(24), 2003, 3460-4.
PubMed
164) Limosin, F., Rouillon, F., Payan, C., Cohen, JM., Strub, N. Prenatal exposure to influenza as a risk factor for adult schizophrenia. Acta Psychiatr Scand. 107(5), 2003, 331-5.
PubMed
165) Wilkinson, DJ., Buttery, JP., Andersen, CC. Influenza in the neonatal intensive care unit. J Perinatol. 26, 2006, 772-6.
PubMed
166) 日本小児科学会新生児委員会. パンデミックインフルエンザA (H1N1) 2009の新生児症例についての2009年度全国調査. 日本小児科学会雑誌. 114, 2010, 1625-8.
 
167) 日本小児科学会新型インフルエンザ対策室. オセルタミビル治療を受けた生後3か月未満の乳児・新生児のパンデミックインフルエンザA (H1N1) 2009症例の調査解析 : 臨床像とオセルタミビルの臨床効果・副作用. 日本小児科学会雑誌. 114, 2010, 1294-7.
 
168) Zaman, K., Roy, E., Arifeen, SE., Rahman, M., Raqib, R., Wilson, E., Omer, SB., Shahid, NS., Breiman, RF., Steinhoff, MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 359(15), 2008, 1555-64.
PubMed
169) Greer, LG., Sheffield, JS., Rogers, VL., Roberts, SW., McIntire, DD., Wendel, GD Jr. Maternal and neonatal outcomes after antepartum treatment of influenza withmedications. Obstet Gynecol. 115(4), 2010, 711-6.
PubMed

第27章 妊産婦の栄養

P.653 掲載の参考文献
1) 日本肥満学会肥満症のてびき編集委員会編. 肥満・肥満症の指導マニュアル. 医歯薬出版, 1997, 1-26.
 
2) 厚生労働省. 日本人の食事摂取基準 (2010年版). 東京, 第一出版, 2010.
 
3) FAO. Human energy requirements. Report of a Joint FAO/WHO/UNU Expert Consultation. FAO Food and Nutrition Technical Report Series. No. 1. FAO, Rome, 2004.
 
4) Butte, NF., King, JC. Energy requirements during pregnancy and lactation. Public Health Nutr. 8, 2005, 1010-27.
PubMed
5) Goldberg, GR. et al. Longitudinal assessment of the components of energy balance in well-nourished lactating women. Am J Clin Nutr. 54, 1991, 788-98.
PubMed
6) Forsum, E., Kabir, N., Sadurskis, A. et al. Total energy expenditure of healthy Swedish women during pregnancy and lactation. Am J Clin Nutr. 56, 1992, 334-42.
PubMed
7) Goldberg, GR. et al. Longitudinal assessment of energy expenditure in pregnancy by the doubly labeled water method. Am J Clin Nutr. 57, 1993, 494-505.
 
8) Kopp-Hoolihan, LE., van Loan, MD., Wong, WW. et al. Longitudinal assessment of energy balance in well-nourished, pregnant women. Am J Clin Nutr. 69, 1999, 697-704.
PubMed
9) Butte, NF. et al. Energy requirements during pregnancy based on total energy expenditure and energy deposition. Am J Clin Nutr. 79, 2004, 1078-87.
PubMed
10) Takimoto, H., Sugiyama, T., Fukuoka, H. et al. Maternal weight gain ranges for optimal fetal growth in Japanese women. Int J Gynecol Obstet. 92, 2006, 272-8.
 
11) Hytten, FE., Leitch, I. The physiology of human pregnancy. 2nd ed. Oxford, Blackwell Scientific Publications, 1971.
 
12) Butte, NF., Wong, WW., Hopkinson, JM. Energy requirements of lactating women derived from doubly labeled water and milk energy output. J Nutr. 131, 2001, 53-8.
PubMed
13) 鈴木久美子, 佐々木晶子, 新澤佳代ほか. 離乳前乳児の哺乳量に関する研究. 栄養学雑誌. 62, 2004, 369-72.
Medical*Online
14) 廣瀬潤子, 遠藤美佳, 柴田克己ほか. 日本人母乳栄養児 (0～5カ月) の哺乳量. 日本母乳哺育学会雑誌. 2, 2008, 23-8.
 
15) Yamawaki, N., Yamada, M., Kan-no, T. et al. Macronutrient, mineral and trance element composition of breast milk from Japanese women. J Trace Elements Med Biol. 19, 2005, 171-81.
 
16) King, JC., Calloway, DH., Margen, S. Nitrogen retention, total body 40K and weight gain in teenage pregnant girls. J Nutr. 103, 1973, 772-85.
 
17) Butte, NE. et al. Composition of gestational weight gain impacts maternal fat retention and infant birth weight. Am J Obstet Gynecol. 189, 2003, 1423-32.
 
18) Livingstone, MB., Coward, WA., Prentice, AM. et al. Daily energy expenditure in free-living children : comparison of heart-rate monitoring with the doubly labeled water (2H2(18)O) method. Am J Clin Nutr. 56, 1992, 343-52.
 
19) Luke, A., Roizen, NJ., Sutton, M. et al. Energy expenditure in children with Down syndrome : correcting metabolic rate for movement. J Pediatr. 125, 1994, 829-38.
PubMed
20) 山本良郎ほか. 日本人の母乳組成に関する研究 (第1報). 小児保健研究. 40, 1981, 468-75.
 
21) 井戸田正ほか. 最近の日本人人乳組成に関する全国調査研究 (第1報) : 一般成分およびミネラルについて. 日本小児栄養消化器病学会誌. 5, 1991, 145-58.
 
22) 米山京子ほか. 母乳の栄養成分の授乳月数に伴う変動. 日本公衆衛生雑誌. 42, 1995, 472-81.
 
23) 磯村晴彦. 母乳成分の分析 : 最近の日本人の母乳分析に関して. 産婦人科の実際. 56, 2007, 305-13.
 
24) Dewy, KG., Lonnerdal, B. Milk and nutrient intake of breastfed infants from 1 to 6 months : Relation to growth and fatness. J Pediatr Gastroenterol Nutr. 2, 1983, 497-506.
 
25) Butte, NF. et al. Human milk intake and growth in exclusively breast-fed infants. J Pediatr. 104, 1984, 187-95.
PubMed
26) 中埜拓, 加藤 健, 小林直道ほか. 乳幼児の食生活に関する全国調査 : 離乳食および乳汁からの栄養素等の摂取状況について. 小児保健研究. 62, 2003, 630-9.
 
27) FAO/WHO/UNU. Energy and protein requirements : report of a Joint FAO/WHO/UNU Expert Consultation (Technical report series. No. 724). WHO, Geneva, 1985.
 
28) Innis, SM. Essential fatty acids in growth and development. Prog Lipid Res. 30, 1991, 39-103.
PubMed
29) Olsen, SF., Secher, NJ. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery : prospective cohort study. BMJ. 324, 2002, 447.
PubMed
30) 厚生労働省. 平成18年国民健康・栄養調査報告. 東京, 2009.
 
31) Bothwell, TH., Charton, RW. Iron deficiency in women. Washington D.C., The nutrition Foundation, 1981, 7-9.
 
32) Chanarin, I., Rothman, D., Ward, A. et al. Folate status and requirement in pregnancy. Br Med J. 2, 1968, 390-4.
PubMed
33) Daly, S., Mills, JL., Molloy, AM. et al. Minimum effective dose of folic acid for food fortifi cation to prevent neural-tube defects. Lancet. 350, 1997, 1666-9.
 
34) 福渡努, 柴田克己. パンを主食とした食事中に含まれる水溶性ビタミンの遊離型ビタミンに対する相対利用率. 日本家政学会誌. 60, 2009, 57-63.
 
35) Sauberlich, HE., Kretsch, MJ., Skala, JH. et al. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr. 46, 1987, 1016-28.
PubMed
36) 日本産科婦人科学会栄養問題委員会報告 (一條元彦). 婦人 (非妊婦・妊婦) および胎児・新生児の体格現状調査 (正常群). 日本産科婦人科学会雑誌. 40, 1988, 1487.
 
37) 厚生労働省. 妊産婦のための食生活指針 : 「健やか親子21」推進検討会報告書. 2006.
 
38) 妊娠中毒症. 研修ノートNo.64. 日本母性保護産婦人科医会. 2001.
 
39) Institute of Medicine : Weight gain during pregnancy. Washington DC, National Academic Press, 2009.
 
40) American College of Obstetricians and Gynecologists. Nutrition during Pregnancy. Technical Bulletin. No.179, April 1993.
 
41) Wall, PD., Deucy, EE., Glantz, JC., Pressman, EK. Vertical skin incisions and wound complications in the obese parturient. Obstet Gynecol. 102, 2003, 952-6.
PubMed
42) O'Brien, TE., Ray, JG., Chan, WS. Maternal body mass index and the risk of preeclampsia : a systemic overview. Epidemiology. 14, 2003, 368-74.
 
43) Cedergren, MI. Maternal morbid obesity and risk of adverse pregnancy outcome. Obstet Gynecol. 103, 2004, 219-24.
PubMed
44) Khashan, AS., Kenny, LC. The effects of maternal body mass index on pregnancy outcome. Eur J Epidemiol. 24(11), 2009, 697-705.
PubMed
45) Garn, SM., Clark, DC. Trends in fatness and the origins of obesity. Pediatrics. 57, 1976, 443-56.
PubMed
46) Curhan, GC. et al. Birth weight and adult hypertension and obesity in women. Circulation. 94, 1996, 1310-15.
PubMed
47) Erez-Weiss, I. et al. The association between maternal obesity, glucose intolerance and hypertensive disorders of pregnancy in nondiabetic pregnant women. Hypertens Pregnancy. 24(2), 2005, 125-36.
PubMed
48) Knight, M., Kurinczuk, JJ., Spark, P., Brocklehurst, P. Extreme obesity in pregnancy in the United Kingdom. Obstet Gynecol. 115(5), 2010, 989-97.
PubMed
49) Hauger, MS., Gibbons, L., Vik, T., Beliza-n, JM. Prepregnancy weight status and the risk of adverse pregnancy outcome. Acta Obstet Gynecol Scand. 87(9), 2008, 953-9.
 
50) Driul, L. et al. Prepregnancy body mass index and adverse pregnancy outcomes. Arch Gynecol Obstet. 278(1), 2008, 23-6.
PubMed
51) Graatsma, EM. et al. Maternal body mass index does not affect performance of fetal electrocardiography. Am J Perinatol. 27(7), 2010, 573-7.
 
52) Locatelli, A. et al. Antepartum and intrapartum risk factors for neonatal encephalopathy at term. Am J Perinatol. 27(8), 2010, 649-54.
PubMed
53) Buhimschi, CS., Buhimschi, IA., Malinow, AM., Weiner, CP. Intrauterine pressure during the second stage of labor in obese women. Obstet Gynecol. 103(2), 2004, 225-30.
PubMed
54) Rizzo, T. et al. Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med. 325, 1991, 911-6.
PubMed
55) Villamor, E., Cnattingius, S. Interpregnancy weight change and risk of adverse pregnancy outcomes : a population-based study. Lancet. 368(9542), 2006, 1164-70.
PubMed
56) Crane, JM. et al. The effect of gestational weight gain by body mass index on maternal and neonatal outcomes. J Obstet Gynaecol Can. 31(1), 2009, 28-35.
PubMed
57) Takimoto, H., Sugiyama, T., Fukuoka, H., Kato, N., Yoshiike, N. Maternal weight gain, prior obstetric history, pregnancy complications and fetal growth in term Japanese infants. Int J Gynecol Obstet. 92, 2006, 272-8.
 
58) Ricci, E. et al. Pre-pregnancy body mass index, maternal weight gain during pregnancy and risk of small-forgestational age birth : Results from a case-control study in Italy. J Matern Fetal Neonatal Med. 23(6), 2010, 501-5.
 
59) Salihu, HM. et al. Low pre-pregnancy body mass index and risk of medically indicated versus spontaneous preterm singleton birth. Eur J Obstet Gynecol Reprod Biol. 144(2), 2009, 119-23.
PubMed
60) Deutsch, AB. et al. Increased risk of placental abruption in underweight women. Am J Perinatol. 27(3), 2010, 235-40.
PubMed
61) Frederick, IO. et al. Pre-pregnancy body mass index, gestational weight gain, and other maternal characteristics in relation to infant birth weight. Matern Child Health J. 12(5), 2008, 557-67.
PubMed
62) 日本産科婦人科学会, 日本産婦人科医会 編集・監修. "CQ010 妊娠前の体格や妊娠中の体重増加については?". 産婦人科診療ガイドライン : 産科編2011. 2011, 34-38.
 

第28章 母乳育児

P.681 掲載の参考文献
1. Hale, TW. Medication and mothers'milk. 15th ed. Amarillo, Hale Publishing, 2012.
 
2. Hale, TW. 水野克己, 瀬川雅史監訳. 薬剤と母乳. 第13版. Amarillo, Hale Publishers, 2009
 
P.684 掲載の参考文献
1) アメリカ小児科学会母乳育児部会. 張尚美ほか訳. 母乳と母乳育児に関する方針宣言 : 2005年改訂版. 日本ラクテーション・コンサルタント協会. http://www.jalc-net.jp/dl/AAP2009-1.pdf
 
2) Amning orh foraldrars rokvanor barn fodda 2008-Breastfeeding and smoking habits among parents of infants born in 2008 : The National Board of Health and Welfare, Centre for Epidemiology, Sweden, 2010.
 
3) NHS. The Health and Social Care Information Centre. Infant Feeding Survey 2010 : Early Results. June 2011. http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestylesrelated-surveys/infant-feeding-survey/infant-feeding-survey-2010-early-results [2012年9月16日アクセス]
 
4) CDC. Breastfeeding among U.S. children born 2000-2009, CDC National Immunization Survey. http://www.cdc.gov/breastfeeding/data/NIS_data/index.htm [2012年9月16日アクセス]
 
5) 厚生労働省. 平成22年乳幼児身体発育調査の概況について. http://www.mhlw.go.jp/stf/houdou/2r9852000001t3so.html [2012年9月16日アクセス]
 
6) 厚生労働省. 授乳と離乳の支援ガイド. 2007. http://www.mhlw.go.jp/shingi/2007/03/s0314-17.html
 
7) A Joint WHO/UNICEF Statement. Protecting, Promoting and Supporting Breastfeeding : The Special Role of Maternity Services. Geneva, WHO, 1989. 〔邦訳〕日本母乳の会運営委員会. WHO/UNICEF共同声明. 母乳育児成功のために : だれでも知っておきたい母乳育児の保護・推進・支援 ; 産科医療施設の特別な役割, 1999.
 
8) WHO/UNICEF. Global strategy for infant and young child feeding. Geneva, WHO, 2003. 〔邦訳〕多田香苗, 瀬尾智子訳. 乳幼児の栄養に関する世界的な運動戦略. 札幌, 日本ラクテーション・コンサルタント協会, 2004.
 
9) WHO/UNICEF. Baby-friendly hospital initiative, Revised, updated and expanded for integrated care. Geneva. WHO, 2009. 〔邦訳〕BFHI2009翻訳編集委員会. UNICEF/WHO赤ちゃんとお母さんにやさしい母乳育児支援ガイド ベーシック・コース. 東京, 医学書院, 2009, 464p.
 
10) 大山牧子. NICUスタッフのための母乳育児支援ハンドブック. 第2版. 大阪, メディカ出版, 2010, 4.
 
11) Lawrence, RA., Lawrence, RM. "Anatomy of human breast". Breastfeeding : a guide for the medical profession. 7th ed. Philadelphia, Elsevier Mosby, 2011, 40-61.
 
12) Ramsay, DT. et al. Anatomy of the human breast redefined with ultrasound imaging. J Anat. 206, 2005, 525-34.
PubMed
13) Fuches, AR. "Physiology and endocrinology of lactation". Obstetrics. 3rd ed. Gabbe, SG. et al. eds. Churchill Livingstone, 1996, 138.
 
14) Riordan, J. wambach, K. "Anatomy and physiology of lactation". Breastfeeding and human lactation. 4th ed. Boston, Jones and Bartlett Publishers, 2010, 79-93.
 
15) Lawrence, RA., Lawrence, RM. "Physiology of lactation". Breastfeeding : a guide for the medical profession. 7th ed. Philadelphia, Elsevier Mosby, 2011, 62-97.
 
16) Walker, M. "Influence of the maternal and anatomy and physiology on lactation". Breastfeeding management for the clinician. 2nd ed. Jones and Bartlett Publishers, 2011, 116-8.
 
17) De Carvalho, M. et al. Effect of frequent breast-feeding on early milk production and infant weight gain. Pediatrics. 72, 1983, 307-11.
PubMed
18) シャスティン・ウヴネース・モベリ. 瀬尾智子・谷垣暁美訳. オキシトシン : 私たちのからだがつくる安らぎの物質. 東京, 晶文社, 2008, 238p.
 
19) Cregan, MD. et al. Milk prolactine, feed volume and duration between feeds in women breastfeeding their full-term infants over a 24h period. Exp Physiol. 87(2), 2002, 207-14.
 
20) Riordan, J. wambach, K. "Glossary". Breastfeeding and human lactation. 4th ed. Boston, Jones and Bartlett Publishers, 2010, 867.
 
21) Riordan, J. wambach, K. "Breastfeeding the preterm infant". Breastfeeding and human lactation. 4th ed. Boston, Jones and Bartlett Publishers, 2010, 441-2.
 
22) Walker, M. "First 24-48 hours : common challenges". Breastfeeding management for the clinician. 2nd ed. Jones and Bartlett Publishers, 2011, 274-6.
 
23) Woolridge, MW. The anatomy of infant sucking. Midwifery. 2(4), 1986, 168.
 
24) Riordan, J. wambach, K. "Anatomy and physiology of lactation". Breastfeeding and human lactation. 4th ed. Boston, Jones and Bartlett Publishers, 2010, 98-104, 847.
 
25) 水野克己, 水野紀子, 瀬尾智子. "新生児・乳児の哺乳行動". よくわかる母乳育児. 東京, へるす出版, 2007, 80-1.
 
26) 清水宏. "皮膚の構造と機能". 新しい皮膚科学. 東京, 中山書店, 2008, 23-5.
 
27) Royal College of Midwives. "Notes on less common problem". Successful breastfeeding. 3rd ed. Edinburgh, Churchill Livingstone, 2002, 120.
 
28) 柳澤美香. "陥没・扁平乳頭". すぐ使える70の事例から学ぶ母乳育児支援ブック. 涌谷桐子編. ペリネイタルケア夏季増刊. 大阪, メディカ出版, 2009, 188.
 
29) マレー・エンキンほか. 北井啓勝監訳. "分娩後のケア". 妊娠・出産ケアガイド : 安全で有効な産科管理. 東京, 医学書院, 1997, 368.
 
30) Fletcher, D. The imprementation of the HOT program at the Royal Women's Hospital. Breastfeeding Review. 8(1), 2000, 19-23.
 
31) Sullivan, RM., Toubas, P. Clinical usefulness of maternal odor in newborns : soothing and feeding preparatory responses. Biol Neonate. 74, 1998, 402-8.
PubMed
32) 田村正徳監修. 日本版救急蘇生ガイドラインに基づく新生児蘇生法テキスト. 東京, メジカルビュー社, 2008, 36-7.
 
33) Widstrom, AM. et al. Gastric suction in healthy newborn infants. Effects on circulation and developing feeding behaviour. Acta Paediatr Scand. 76(4), 1987, 566-72.
PubMed
34) Ransjo-Arvidson, AB. et al. Maternal analgesia during labor disturbs newborn behavior : effects on breastfeeding, temperature, and crying. Birth. 28(1), 2001, 5-12.
PubMed
35) Matthiesen, AS. et al. Postpartum maternal oxytocin release by newborns : Effects of infant hand massage and sucking. Birth. 28(1), 2001, 13-9.
PubMed
36) WHO/UNICEF. Baby-friendly hospital initiative, Revised, updated and expanded for integrated care. Geneva. WHO, 2009. 〔邦訳〕BFHI2009翻訳編集委員会. UNICEF/WHO赤ちゃんとお母さんにやさしい母乳育児支援ガイド ベーシック・コース. 東京, 医学書院, 2009, p.121-2.
 
37) 粟野雅代. "出生直後の授乳時間, 授乳間隔, 夜間授乳, 母子同室". 母乳育児支援スタンダード. 日本ラクテーション・コンサルタント協会編. 東京, 医学書院, 2008, 170-1.
 
38) 英国UNICEF. 井村真澄・瀬尾智子訳. あなたの赤ちゃんとベッドで一緒に寝ること : 母乳育児をしているお母さんたちへのガイド. http://www.jalc-net.jp/dl/UKUnicefbedsharing(mother).pdf [2012年4月20日アクセス]
 
39) 英国UNICEF. 井村真澄・瀬尾智子訳. 赤ちゃんが入院中に母親とベッドを共有する場合の方針のサンプル. http://www.jalc-net.jp/dl/UKUnicef-bedsharing(hospital). pdf [2012年4月20日アクセス]
 
40) ILCA. Clinical Guidelines for the Establishment of Exclusive Breastfeeding, 2005, 28p. http://www.ilca.org/pubs/ClinicalGuidelines2005.pdf [2010年8月31日アクセス] 〔邦訳〕ILCA. 日本ラクテーション・コンサルタント協会訳. 母乳だけで育てるための臨床ガイドライン. 札幌, 日本ラクテーション・コンサルタント協会, 2008, 10-1.
 
41) Smillie, C. "How to learn to feed : a neurobehavior model". Supporting sucking skills. Genna, CW. ed. Sudbury, Jones and Bartlett Publishers, 2008, 79-96.
 
42) Colson, SD. et al. Optimal position for the release of primitive neonatal reflexes stimulation breastfeeding. Early Human Development. 84, 2008, 441-9.
PubMed
43) 井村真澄. "褥婦の看護にかかわる技術 : 授乳姿勢". 母性看護学 : 母性看護技術. 横尾京子・中込さと子編. 大阪, メディカ出版, 2010, 105-9, (ナーシング・グラフィカ 31).
 
44) ILCA. Clinical Guidelines for the Establishment of Exclusive Breastfeeding, 2005, 28p. http://www.ilca.org/pubs/ClinicalGuidelines2005.pdf [2010年8月31日アクセス] 〔邦訳〕ILCA. 日本ラクテーション・コンサルタント協会訳. 母乳だけで育てるための臨床ガイドライン. 札幌, 日本ラクテーション・コンサルタント協会, 2008, 10-1. "Management strategy 2 : Assist the mother and infant in achieving a comfortable position and effective latch (attachment)". 8.
 
45) Hoover, K., Marasco, L. "Insufficent milk supply". Core curriculum for lactation consultant practice. 2nd ed. Mannel, R., Marten, PJ., Walker, M. eds. Boston, Jones and Bartlett, 2008, 701.
 
46) Walker, M. "Influence of the maternal and anatomy and physiology on lactation". Breastfeeding management for the clinician. 2nd ed. Jones and Bartlett Publishers, 2011, 587.
 
47) 橋本武夫. 母乳育児の推進. 小児科臨床. 53 (6), 2003, 38-44.
 
48) 大山牧子. "母乳が足りないお母さんへの支援". 母乳分泌不全に対するアプローチとリラクテーション (母乳復帰) 理論編. 札幌, 日本ラクテーション・コンサルタント協会, 2009, 39-40 (第26回母乳育児 学習会 in 名古屋).
 
49) 瀬尾智子. "母乳不足". すぐ使える70の事例から学ぶ母乳育児支援ブック. 涌谷桐子編. ペリネイタルケア夏季増刊. 大阪, メディカ出版, 2009, 175.
 
50) Walker, M. "Influence of the maternal and anatomy and physiology on lactation". Breastfeeding management for the clinician. 2nd ed. Jones and Bartlett Publishers, 2011, 586-8.
 
51) ILCA. Clinical Guidelines for the Establishment of Exclusive Breastfeeding, 2005, 28p. http://www.ilca.org/pubs/ClinicalGuidelines2005.pdf [2010年8月31日アクセス] 〔邦訳〕ILCA. 日本ラクテーション・コンサルタント協会訳. 母乳だけで育てるための臨床ガイドライン. 札幌, 日本ラクテーション・コンサルタント協会, 2008, p.13.
 
52) American Academy of Pediatrics, Committee on Nutrition : The use and misuse of fruit juice in pediatrics. Pediatrics. 107(5), 2001, 1210-3. 〔邦訳〕アメリカ小児科学会栄養に関する専門委員会. 子どもに果汁を与えるリスクと適切な摂取方法についての勧告. http://www.jalc-net.jp/PEDIATRICS.pdf. [2010年8月17日アクセス]
 
53) 厚生労働省. 授乳と離乳の支援ガイド. 離乳編3. 離乳の支援のポイント. 2007, 41. http://www.mhlw.go.jp/shingi/2007/03/dl/s0314-17c.pdf. [2010年8月17日アクセス]
 
54) Walker, M. "Influence of the maternal and anatomy and physiology on lactation". Breastfeeding management for the clinician. 2nd ed. Jones and Bartlett Publishers, 2011, 589-93.
 
55) Academy of Breastfeeding Medicine. ABM Clinical Protocol #3. Hospital guidlines for the use of supplementary feedings in the healthy term breastfed neonate, revised. 2009. Breastfeeding Medicine. 4, 2009. http://www.jalc-net.jp/dl/ABM_3_2010.pdf. [2010年8月17日アクセス].〔邦訳〕母乳育児医学アカデミー (ABM) の臨床指針. 第3号. 母乳で育てられている健康な正期産児の補足のための病院内での診療指針. 2009年改訂版. http://www.jalc-net.jp/3_Japanese.pdf. [2010年8月17日アクセス]
 
56) WHO/UNICEF. Baby-friendly hospital initiative, Revised, updated and expanded for integrated care. Geneva. WHO, 2009. Section 3. Breastfeeding promotion and support in a baby-friendly hospital, session 9 : Milk supply, A 20-hour course for maternity staff. 2009, 141. http://www.who.int/nutrition/publications/infantfeeding/9789241594981_s3.1and2.pdf. [2009年7月12日アクセス] 〔邦訳〕BFHI2009翻訳編集委員会. UNICEF/WHO赤ちゃんとお母さんにやさしい母乳育児支援ガイド ベーシック・コース. 東京, 医学書院, 2009, p.200.
 
57) ILCA. Clinical Guidelines for the Establishment of Exclusive Breastfeeding, 2005, 28p. http://www.ilca.org/pubs/ClinicalGuidelines2005.pdf [2010年8月31日アクセス] 〔邦訳〕ILCA. 日本ラクテーション・コンサルタント協会訳. 母乳だけで育てるための臨床ガイドライン. 札幌, 日本ラクテーション・コンサルタント協会, 2008, p.13, 21.
 
58) Mohrbacher, N., Stock, J. "Weight gain". The breastfeeding Answer Book. Schaumburg, La Leache League International, 2003, 148.
 
59) Powers, NG. Slusser, W. Breastfeeding update. 2 : Clinical lactation management. Pediatr Rev. 18, 1997, 147-61.
PubMed
60) 大山牧子. "母乳が足りないお母さんへの支援". 母乳分泌不全に対するアプローチとリラクテーション (母乳復帰) 理論編. 札幌, 日本ラクテーション・コンサルタント協会, 2009, 44. (第26回母乳育児 学習会 in 名古屋).
 
61) Powers, NG. Slusser, W. Breastfeeding update. 2 : Clinical lactation management. Pediatr Rev. 18, 1997, 46-7.
 
62) Hale, TW., Hartmann, PE. "Medications that alter milk production". Hale & Hartmann's Textbook of Human Lactation. Amarillo, Hale Publishing, 2007, 486.
 
63) 水野克己, 水野紀子, 瀬尾智子. "新生児・乳児の哺乳行動". よくわかる母乳育児. 東京, へるす出版, 2007, 98.
 
64) 河井昌彦. "糖代謝 : 新生児の低血糖". 新生児内分泌ハンドブック. 新生児内分泌研究会編. 大阪, メディカ出版, 2008, 76.
 
65) Academy of Breastfeeding Medicine. ABM Clinical Protocol #3. Hospital guidlines for the use of supplementary feedings in the healthy term breastfed neonate, revised. 2009. Breastfeeding Medicine. 4, 2009. http://www.jalc-net.jp/dl/ABM_3_2010.pdf. [2010年8月17日アクセス].〔邦訳〕母乳育児医学アカデミー (ABM) の臨床指針. 第3号. 母乳で育てられている健康な正期産児の補足のための病院内での診療指針. 2009年改訂版. http://www.jalc-net.jp/3_Japanese.pdf. [2010年8月17日アクセス] p.3.
 
66) Academy of Breastfeeding Medicine. ABM Clinical Protocol #3. Hospital guidlines for the use of supplementary feedings in the healthy term breastfed neonate, revised. 2009. Breastfeeding Medicine. 4, 2009. http://www.jalc-net.jp/dl/ABM_3_2010.pdf. [2010年8月17日アクセス].
 
67) 水野克己, 水野紀子, 瀬尾智子. "生後早期に注意するポイント : 黄疸". よくわかる母乳育児. 東京, へるす出版, 2007, . 92-3.
 
68) American Academy of Pediatrics. Clinical practice guideline. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 114(1), 2004, 297-316. http://pediatrics.aappublications.org/cgi/reprint/114/1/297 [2010年8月27日アクセス]
 
69) Academy of Breastfeeding Medicine. ABM Clinical Protocol #22. Guidelines for management of jaundice in the breastfeeding, infant equal to or grater tha 35 week's gestation. Breastfeeding Medicine. 5, 2010, 87. http://www.bfmed.org/Resources/Protocols.aspx [2010年8月27日アクセス]
 
70) 水野克己, 水野紀子, 瀬尾智子. "新生児・乳児の哺乳行動". よくわかる母乳育児. 東京, へるす出版, 2007, 93-7.
 
71) ABM. Academy of Breastfeeding Medicine. ABM Clinical Protocol #22. Guidelines for management of jaundice in the breastfeeding, infant equal to or grater tha 35 week's gestation. Breastfeeding Medicine. 5, 2010, 89. http://www.bfmed.org/Resources/Protocols.aspx [2010年8月27日アクセス].
 
72) AAP. American Academy of Pediatrics. Clinical practice guideline. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 114(1), 2004, 301. http://pediatrics.aappublications.org/cgi/reprint/114/1/297 [2010年8月27日アクセス]
 
73) AAP. American Academy of Pediatrics. Clinical practice guideline. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 114(1), 2004, 298. http://pediatrics.aappublications.org/cgi/reprint/114/1/297 [2010年8月27日アクセス]
 
74) 日本薬学会. 医学用語解説. http://www.pharm.or.jp/dictionary/. http://www.pharm.or.jp/dictionary/wiki.cgi?%e3%82%a2%e3%83%89%e3%83%92%e3%82%a2%e3%83%a9%e3%83%b3%e3%82%b9 [2010年9月26日アクセス]
 
75) 米国小児科学会. 平林円, 笠松堅實監訳. 医師のための母乳育児ハンドブック. 大阪, メディカ出版, 2007, 195.
 
76) American Academy of Pediatrics. Committee on Drugs. The transfer of the drugs and other chemicals into human milk. Pediatrics. 108, 2001, 776-98, 777. http://pediatrics.aappublications.org/cgi/reprint/108/3/776 [2010年8月19日アクセス]
 
77) 瀬尾智子. 母乳と薬剤. 札幌, 日本ラクテーション・コンサルタント協会, 2008, 14-22, 20 (第4回医師のための母乳育児支援セミナー in 埼玉).
 
78) WHO/UNICEF. Baby-friendly hospital initiative, Revised, updated and expanded for integrated care. Geneva. WHO, 2009. 〔邦訳〕BFHI2009翻訳編集委員会. UNICEF/WHO赤ちゃんとお母さんにやさしい母乳育児支援ガイド ベーシック・コース. 東京, 医学書院, 2009, p.294.
 
79) 田辺佳代子. "産後うつ病". 母乳育児支援ブック. 涌谷桐子編. ペリネイタルケア夏季増刊. 大阪, メディカ出版, 2009, 276.
 
80) Hale, TW. Medication and mothers' milk. 15th ed. Amarillo, Hale Publishing, 2012. 832-5.
 
81) Hale, TW. Medication and mothers' milk. 15th ed. Amarillo, Hale Publishing, 2012. 417-9.
 
82) Hale, TW. Medication and mothers' milk. 15th ed. Amarillo, Hale Publishing, 2012. 172-3.
 
83) 米国小児科学会. 平林円, 笠松堅實監訳. 医師のための母乳育児ハンドブック. 大阪, メディカ出版, 2007, 136-8.
 
84) 水野克己. 母乳 育児 感染. 東京, 南山堂, 2008, 36-7.
 
85) アメリカ小児科学会母乳育児部会. 張尚美ほか訳. 母乳と母乳育児に関する方針宣言 : 2005年改訂版. 3. 日本ラクテーション・コンサルタント協会.
 
86) 水野克己. 母乳 育児 感染. 東京, 南山堂, 2008, 89.
 
87) 水野克己. 母乳 育児 感染. 東京, 南山堂, 2008, 92.
 
88) 水野克己. 母乳 育児 感染. 東京, 南山堂, 2008, 82-3.
 
89) 水野克己. 母乳 育児 感染. 東京, 南山堂, 2008, 86-7.
 
90) 水野克己. 母乳 育児 感染. 東京, 南山堂, 2008, "母乳育児と感染症". 55-119.
 
91) 水野克己. 母乳 育児 感染. 東京, 南山堂, 2008, 130p.
 
92)Lawrence, RA., Lawrence, RM. Chapter 17. "Transmission of infectious diseases through breast milk and breastfeeding." : a guide for the medical profession. 7th ed. Philadelphia, Elsevier Mosby, 2011, 406-73.
 
93) Academy of Breastfeeding Medicine. ABM Clinical Protocol #4. Mastitis. Brestfeeding Medicine. 3, 2008, 177-80. http://www.bfmed.org/Resources/Protocols.aspx [2010年8月17日アクセス]
 
94) Walker, M. Mastitis in Lactating Woman. Lactation Consultant Series 2. Schaumburg, La Leche League International, 1999, 1-16.
 
95) 井村真澄. "40. 乳腺炎の予防と治療". 母乳育児支援スタンダード. NPO法人日本ラクテーション・コンサルタント協会編. 東京, 医学書院, 2007, 312.
 
96) WHO. Department of Child and Adolescent Health and Development. Mastitis : cause and management. Publication Number WHO/FCH/CAH/00.13. Geneva, WHO, 2000, 1-5. http://whqlibdoc.who.int/hq/2000/WHO_FCH_CAH_00.13.pdf [2010年8月17日アクセス]
 
97) Thomsen, AC., Espersen, T., Maiggard, S. Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol. 149(5), 1984, 492-5.
 
98) Fetherston, C., Lee, CS., Hartmann, P. Mammary grand defense. Ad Nutr Res. 10, 2001, 171-3.
 
99) 河田みどり, 杉下知子, 奥住捷子, 米山彰子, 木村哲. 健常な授乳女性における母乳中細菌の測定. 母性衛生. 43(4), 2002, 479-87.
Medical*Online
100) 黒島淳子, 村岡光恵. 産後の乳腺トラブルの対策. 産婦人科治療. 73(4), 1996, 402-5.
Medical*Online
101) 涌谷桐子.「おっぱいが痛い!」乳管閉塞と乳腺炎. NPO法人日本ラクテーション・コンサルタント協会. 第28回母乳育児学習会in富山 資料. 2010, 札幌, NPO法人日本ラクテーション・コンサルタント協会, 117-33.
 
102) American Academy of Pediatrics. RED BOOK : 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Glove Villege, American Academy of Pediatrics, 2009, 119-20.
 
・ American Academy of Pediatrics. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 115(2), 2005, 496-506.
 
・ American Academy of Pediatrics. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 129(3), 2012, e827-41. Epub 2012 Feb 27.
 
・ The Baby-Friendly Hospital Initiative in Norway : Country report to the WHO/UNICEF Seminar, 2001.
 
・ 涌谷桐子訳. ABM臨床指針第4号乳腺炎. NPO法人日本ラクテーション・コンサルタント協会, 2010. http://www.jalc-net.jp/dl/ABM_4_2010.pdf [2010年8月17日アクセス]
 

第29章 加齢と妊娠

P.691 掲載の参考文献
1) 母子保健の主なる統計 (平成22年刊行). 東京, 母子保健事業団, 2011.
 
2) Jacobsson, B., Ladfors, L., Milsom, I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol. 104(4), 2004, 727-33.
PubMed
3) Simchen, MJ., Yinon, Y., Moran, O., Schiff, E., Sivan, E. Pregnancy outcome after age 50. Obstet Gynecol, 108, 2006, 1084-8.
PubMed
4) Hook, EB., Cross, PK., Schreinemachers, DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA. 249, 1983, 2034-8.
PubMed
5) The American Congress of Obstetricians and Gynecologists. http://www.acog.org/publications/patient_education/bp094.cfm
 
6) Kajii, T. Predicted Prevalence of Down Syndrome Live Births in Japan, 1970-2006. Am J Med Genet A. 146A, 2008, 1387-8.
PubMed
7) 夫律子. NT (Nuchal Translucency) の評価法と問題点. 周産期医学. 41(4), 2011, 451-7.
Medical*Online
8) Delbaere, I., Verstraelen, H., Goetgeluk, S., Martens, G., De Backer, G., Temmerman, M. Pregnancy outcome in primiparae of advanced maternal age. Eur J Obstet Gynecol Reprod Biol. 135(1), 2007, 41-6.
PubMed
9) Lisonkova, S., Janssen, PA., Sheps, SB., Lee, SK., Dahlgren, L. The effect of maternal age on adverse birth outcomes : does parity matter' J Obstet Gynaecol Can. 32(6), 2010, 541-8.
 
10) Fretts, RC., Schmittdiel, J., McLean, FH., Usher, RH., Goldman, MB. Increased maternal age and the risk of fetal death. N Engl J Med. 333, 1995, 953-7.
PubMed
11) Nybo Andersen, AM., Wohlfahrt, J., Christens, P., Olsen, J., Melbye, M. Maternal age and fetal loss : population based register linkage study. BMJ. 320(7251), 2000, 1708-12.
PubMed
12) Hsieh, TT., Liou, JD., Hsu, JJ., Lo, LM., Chen, SF., Hung, TH. Advanced maternal age and adverse perinatal outcomes in an Asian population. Eur J Obstet Gynecol Reprod Biol. 248(1), 2010, 21-6.
 
13) Treacy, A., Robson, M., O'Herlihy, C. Dystocia increases with advancing maternal age. Am J Obstet Gynecol. 195(3), 2006, 760-3.
PubMed
14) 椋棒正昌, 市村隆也, 柴田和男. 高年妊娠の管理. 産科と婦人科. 51, 1997, 945-54.
 
15) Bayrampour, H., Heaman, M. Advanced maternal age and the risk of cesarean birth : A systematic review. 37(3), 2010, 219-26.
PubMed
16) Wang, Y., Tanbo, T., Abyholm, T., Henriksen, T. The impact of advanced maternal age and parity on obstetric and perinatal outcomes in singleton gestations. Arch Gynecol Obstet. 284(1), 2011, 31-37.
PubMed

書評

最近チェックした商品履歴

Loading...